data_1q48_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q48 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.313 0.578 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -82.21 -12.94 57.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.347 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -92.88 10.77 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.387 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 t -136.55 117.58 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.84 130.34 10.24 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 m -110.44 147.73 33.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.453 -1.028 . . . . 0.0 109.322 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.79 117.6 0.82 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.15 108.41 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.279 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.27 -172.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.33 -171.52 38.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -131.84 74.88 76.76 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.16 . . . . 0.0 109.653 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.27 -2.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.786 2.324 . . . . 0.0 112.148 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.543 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -79.48 -7.89 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 3.2 m -149.93 -56.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.927 . . . . 0.0 109.477 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.472 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . 144.03 54.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -124.9 136.64 53.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -1.186 . . . . 0.0 109.347 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.78 135.97 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.9 ttt -133.68 136.96 45.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.504 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -129.63 126.97 39.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 tt -132.47 132.82 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -131.08 133.5 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.153 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -116.16 149.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 14.5 tttm -111.59 136.3 50.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.714 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 t -129.28 116.57 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.168 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.661 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.8 m-20 -159.96 -34.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 109.893 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 51.8 t0 -62.29 50.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.305 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.661 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.9 m-20 81.61 54.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.505 -0.747 . . . . 0.0 109.266 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.64 0.98 9.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 53' ' ' ILE . 3.8 mm -93.01 164.25 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.292 -1.122 . . . . 0.0 109.468 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.453 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 3.3 mt -97.32 114.38 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -97.38 -38.86 9.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -124.39 151.33 44.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 109.783 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.61 99.56 3.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -94.4 175.21 6.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.641 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -165.02 176.91 8.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.474 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -166.31 110.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.7 p -129.13 96.65 4.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.954 . . . . 0.0 109.487 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -115.14 104.21 11.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.48 -41.3 0.28 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.76 ' HG ' ' H ' ' A' ' 66' ' ' ALA . 1.4 t -106.76 105.62 15.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -1.086 . . . . 0.0 109.219 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -67.0 74.44 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 67' ' ' ILE . 1.2 p 162.74 -42.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -1.172 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.76 ' H ' ' HG ' ' A' ' 63' ' ' CYS . . . -56.45 1.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.624 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.5 mp -73.32 -54.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.52 -71.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 t -45.78 -43.03 12.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 109.613 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.551 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.9 OUTLIER -51.0 -36.33 38.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.644 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -31.25 57.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -54.98 7.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 74' ' ' THR . 10.9 tt -58.18 -47.91 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.551 ' OG1' ' O ' ' A' ' 70' ' ' SER . 11.9 p -61.19 -34.19 74.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.08 -7.82 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.13 -0.981 . . . . 0.0 109.623 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -87.13 -36.82 17.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.419 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' GLY . 35.5 m -88.31 -28.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' N ' HG21 ' A' ' 77' ' ' VAL . 6.8 tttp -47.98 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.503 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 77' ' ' VAL . . . 120.38 -26.97 6.81 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.639 ' NZ ' ' OE1' ' A' ' 84' ' ' GLU . 7.1 mtpt -74.13 -165.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.92 163.5 24.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.97 . . . . 0.0 109.596 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.6 mt -55.81 -37.58 68.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.34 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -56.12 -32.56 64.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.3 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE1' ' NZ ' ' A' ' 80' ' ' LYS . 38.7 mt-10 -84.2 -42.96 15.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.83 69.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.15 43.86 3.07 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.04 -35.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.129 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.4 pt -52.52 157.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.455 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -129.23 164.99 22.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -30.08 69.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -60.65 -29.09 69.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -58.99 -56.22 25.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 mp -70.41 -38.97 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.96 55.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.623 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.42 -43.03 15.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.591 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' O ' ' CD ' ' A' ' 96' ' ' GLU . 12.6 tm-20 -63.93 -23.18 67.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.67 -37.9 9.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 67.57 73.44 0.32 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.51 149.17 60.9 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 102' ' ' VAL . 19.7 Cg_endo -61.86 157.71 41.84 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.759 2.306 . . . . 0.0 112.069 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.56 15.01 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.818 2.345 . . . . 0.0 112.315 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 100' ' ' PRO . 4.0 m -104.87 16.75 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -151.73 18.24 0.7 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 t -57.69 -14.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -51.19 -27.13 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 2.1 m -77.63 -75.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.524 ' C ' ' O ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -36.28 -33.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 106' ' ' CYS . 8.5 mt -68.26 -54.97 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.77 -19.64 51.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.46 -64.88 0.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.36 -45.74 86.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -54.64 -35.87 63.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.214 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.22 -57.83 9.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -50.01 -36.29 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.413 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.446 ' N ' HG23 ' A' ' 114' ' ' ILE . 2.8 tttt -63.24 -37.86 88.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.02 76.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.54 93.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.93 . . . . 0.0 109.501 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.61 -40.86 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.66 88.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.483 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.31 -16.38 60.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.413 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' A' ' 25' ' ' SER . 93.1 t80 -79.39 -31.61 42.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -94.27 -22.63 18.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.53 -18.48 58.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.468 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.505 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.67 6.14 36.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -120.21 -15.94 8.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.697 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -103.12 128.95 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.353 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -127.05 149.75 17.8 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 120' ' ' ASP . 52.2 m -127.71 149.16 50.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -1.081 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.87 125.37 2.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 ttt -119.74 92.9 3.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -1.205 . . . . 0.0 109.367 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 m -103.56 163.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 109.286 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.27 -176.08 29.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.26 96.07 10.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.337 -1.096 . . . . 0.0 109.386 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.501 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.9 Cg_exo -56.66 -26.37 64.76 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.652 2.235 . . . . 0.0 112.28 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.93 -59.99 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.34 -48.31 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.62 52.78 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -116.34 117.22 29.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.151 . . . . 0.0 109.416 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 m -105.92 141.47 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.9 128.82 31.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.28 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.78 HE21 ' NE2' ' A' ' 44' ' ' GLN . 25.4 tt0 -112.68 125.0 53.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.616 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tp -124.01 136.4 54.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.78 ' NE2' HE21 ' A' ' 42' ' ' GLN . 12.8 mt-30 -118.85 145.78 45.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 109.654 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pp -126.31 126.09 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -103.21 109.33 20.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' C ' ' A' ' 48' ' ' ASP . 24.5 t -94.57 110.83 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 47' ' ' VAL . 1.1 t70 -40.16 -77.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.437 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 7.2 t0 -179.71 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 0.0 108.862 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -84.06 -17.09 41.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.458 -0.776 . . . . 0.0 109.352 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.2 12.01 5.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.408 HG23 HD13 ' A' ' 52' ' ' ILE . 17.4 mm -104.87 134.39 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.413 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.452 HD13 HG23 ' A' ' 53' ' ' ILE . 93.2 mt -63.4 88.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.408 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.51 -52.38 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.261 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -143.24 -179.16 6.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 109.141 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.79 144.48 7.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.957 . . . . 0.0 109.743 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -135.32 162.59 32.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.342 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -145.81 167.92 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.368 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -165.83 114.29 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 80.7 p -108.95 141.93 40.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.43 99.65 2.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.9 -54.14 0.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 49.4 t -124.98 173.52 8.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -1.21 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.475 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -121.53 19.06 8.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.7 p -113.83 -8.63 13.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -1.127 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.42 -2.81 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.506 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 68' ' ' ALA . 8.5 mm -61.65 -53.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.402 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -41.4 -53.51 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.457 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 70' ' ' SER . 25.1 p -58.09 -54.26 48.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.531 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.8 OUTLIER -43.94 -38.01 3.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.7 m -71.02 -44.96 64.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.24 -55.62 26.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.61 ' CG2' ' H ' ' A' ' 74' ' ' THR . 2.2 tt -62.33 -61.75 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.61 ' H ' ' CG2' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -35.31 -32.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.78 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -85.57 -30.87 22.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 0.0 109.825 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.606 ' N ' ' O ' ' A' ' 73' ' ' ILE . 10.7 m0 -82.69 0.82 41.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.719 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -123.51 65.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.51 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -148.3 94.35 2.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.31 61.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 76' ' ' TRP . 7.5 mttp -72.17 -168.2 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.421 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -115.69 141.1 48.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mt -48.77 -11.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' SER . 35.1 tt0 -71.08 -55.59 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.235 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -66.36 -30.67 71.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.256 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -24.09 52.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 109.22 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.77 50.24 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.78 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -1.123 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.51 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -36.46 -23.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.744 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 87' ' ' ALA . 10.0 mttm 61.32 173.85 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.304 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.465 HD21 HG12 ' A' ' 108' ' ' ILE . 8.0 p-10 -95.73 -42.55 8.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.439 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 88.9 p -52.76 -50.02 64.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' SER . 4.5 tt0 -44.06 -65.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.194 -0.942 . . . . 0.0 109.779 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.5 mt -59.65 -32.01 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.713 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.58 -32.61 69.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.876 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.84 -33.92 24.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.689 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -55.94 -42.84 76.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.3 mt -83.0 -28.39 29.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 65.64 74.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 148.83 59.88 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.158 -0.963 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.61 148.64 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.58 2.187 . . . . 0.0 112.125 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.54 6.09 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.738 2.292 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.68 -35.88 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -135.52 42.43 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.436 ' CG2' ' HG ' ' A' ' 107' ' ' SER . 9.8 p -58.4 -18.79 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.432 ' CD2' ' C ' ' A' ' 105' ' ' HIS . 8.1 p-80 -45.32 -24.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.338 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -64.87 -47.35 78.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.167 -0.958 . . . . 0.0 109.2 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.436 ' HG ' ' CG2' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -65.28 -50.1 67.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.465 HG12 HD21 ' A' ' 90' ' ' ASN . 4.4 mm -56.0 -33.45 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.883 . . . . 0.0 109.369 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 110' ' ' ALA . 1.4 mp -63.92 -61.65 2.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -40.36 -53.68 2.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -61.15 -58.25 9.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.3 -34.07 2.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -64.92 -69.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.658 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.1 tp -37.78 -35.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -65.53 -68.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -43.33 -46.22 6.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.307 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.43 -40.72 71.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.456 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.22 -46.89 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.417 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.49 -58.11 7.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.53 ' CG ' ' O ' ' A' ' 29' ' ' THR . 5.2 m-20 -49.0 -59.6 3.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.715 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -51.08 -21.59 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.685 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -96.93 -8.6 30.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.18 -8.4 17.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.42 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.44 1.68 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.566 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -117.04 5.59 12.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.5 98.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.59 124.62 8.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -102.7 131.91 49.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -1.155 . . . . 0.0 109.329 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.93 96.44 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.0 ttt -99.52 133.44 43.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.144 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.23 156.11 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.035 -1.041 . . . . 0.0 109.808 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.06 121.61 2.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.13 87.09 28.0 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.263 -1.139 . . . . 0.0 109.428 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.99 36.25 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.893 2.395 . . . . 0.0 112.303 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.67 -39.64 1.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.8 t -177.02 -29.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.394 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.73 71.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.498 ' OD2' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER 62.7 -174.21 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -1.154 . . . . 0.0 109.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 m -95.46 149.45 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.384 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 8.5 ttt -142.34 133.29 25.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.46 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.451 ' HG2' HE21 ' A' ' 44' ' ' GLN . 7.4 tt0 -107.33 127.83 53.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.45 135.56 44.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.557 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.451 HE21 ' HG2' ' A' ' 42' ' ' GLN . 6.5 mp0 -138.19 137.54 37.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.419 ' H ' HG13 ' A' ' 45' ' ' ILE . 1.5 pp -120.64 143.36 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 109.427 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -102.31 152.14 21.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.96 116.72 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 48' ' ' ASP . 33.5 t0 -57.7 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.56 19.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -148.76 24.84 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.502 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.81 30.28 56.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 52' ' ' ILE . 31.5 mm -109.41 134.63 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -1.21 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.6 mt -80.56 81.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.22 -40.49 74.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -137.64 163.51 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.77 102.59 4.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.53 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -97.81 155.49 17.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -166.46 171.29 12.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -163.96 126.04 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.81 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.15 121.8 45.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.028 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 101.53 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.6 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 156.74 -57.25 0.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.8 148.6 26.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -1.117 . . . . 0.0 109.598 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.94 16.97 30.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -125.38 -35.49 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 0.0 109.459 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.11 -3.09 3.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.405 ' H ' ' C ' ' A' ' 65' ' ' SER . 16.9 mm -58.95 -35.32 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.339 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.12 -62.54 1.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' LEU . 3.9 m -58.38 -54.59 45.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.467 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.508 ' C ' ' O ' ' A' ' 69' ' ' SER . 50.6 m -36.98 -66.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.447 ' HG ' ' N ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -51.62 -30.52 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' SER . 12.2 tp -68.93 -73.89 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.578 ' O ' ' N ' ' A' ' 76' ' ' TRP . 0.9 OUTLIER -39.7 -59.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.473 ' H ' HG23 ' A' ' 73' ' ' ILE . 42.4 p -44.21 -44.95 8.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.317 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -73.46 -14.98 61.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.307 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.578 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.07 -11.71 35.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.91 61.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.4 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.09 103.1 7.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.481 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 4.01 89.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -78.55 -161.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -1.155 . . . . 0.0 109.39 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 83' ' ' GLU . 3.7 t -126.69 144.51 50.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -47.78 -15.07 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 0.0 109.24 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -80.71 -23.83 39.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.412 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -95.29 -18.78 20.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.0 -29.95 11.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.96 42.97 2.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -152.14 -37.0 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -1.137 . . . . 0.0 108.602 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -47.22 -175.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -141.38 -177.88 5.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 109.399 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.57 ' CG ' ' N ' ' A' ' 91' ' ' SER . 1.1 p-10 -87.69 -50.93 6.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -54.53 -22.31 12.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.25 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -68.0 -59.18 3.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 109.206 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.69 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 109.272 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.13 -36.49 73.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.245 -0.909 . . . . 0.0 109.196 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.19 -41.97 99.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.271 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.87 -32.9 73.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 0.0 109.047 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.5 mt -93.39 -28.36 16.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.301 -0.875 . . . . 0.0 109.112 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.4 tm-20 51.93 67.09 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.714 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.579 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.4 pt? -117.81 148.46 43.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.272 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -40.51 155.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.792 2.328 . . . . 0.0 112.268 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.08 -0.15 8.12 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.834 2.356 . . . . 0.0 112.177 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.32 -5.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.404 ' C ' ' N ' ' A' ' 105' ' ' HIS . 0.6 OUTLIER -125.72 -9.42 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 107' ' ' SER . 8.0 p -45.78 -24.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.489 ' C ' ' O ' ' A' ' 104' ' ' VAL . 15.2 m80 -38.9 -50.0 1.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.63 -36.47 64.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.114 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.628 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.1 p -66.31 -67.23 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.096 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.628 ' N ' ' OG ' ' A' ' 107' ' ' SER . 42.8 mt -45.91 -25.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.088 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 mp -75.98 -44.88 37.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.428 -0.795 . . . . 0.0 109.385 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.36 83.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.723 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.485 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 5.1 tp10 -65.93 -68.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -22.95 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.93 . . . . 0.0 109.641 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.19 -52.87 9.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -55.95 -40.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.59 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.495 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 5.7 tptt -66.14 -51.52 57.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.74 -41.99 64.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.415 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.34 -45.16 95.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 121' ' ' TYR . 61.7 mt -64.49 -61.12 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -40.69 -37.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.185 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -37.71 80.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.052 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 118' ' ' ILE . 7.5 t80 -72.35 -16.99 61.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -88.49 -44.94 10.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.209 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.1 95.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.317 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 179.899 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.2 m -85.71 -4.3 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -0.87 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.88 129.69 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.8 147.48 18.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.1 m -130.28 130.32 44.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -1.093 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.45 137.8 10.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.03 120.46 17.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -1.112 . . . . 0.0 109.351 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.75 146.6 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.89 -166.35 10.66 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.628 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -122.12 80.92 43.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.262 -1.14 . . . . 0.0 109.512 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.88 2.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.707 2.271 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.628 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -91.53 -3.73 56.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.41 -58.48 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.38 46.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.01 126.77 54.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 109.507 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 p -107.86 113.45 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -119.47 119.08 32.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 43' ' ' LEU . 7.1 tt0 -103.23 154.93 18.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.198 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.44 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -155.87 119.47 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.487 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -122.23 151.24 41.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.296 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.79 138.01 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 109.565 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -107.57 127.95 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.04 150.66 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.7 t0 -94.21 -103.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -139.45 4.25 2.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.43 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -128.97 17.28 6.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.21 10.2 85.73 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 mm -93.08 132.71 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -1.105 . . . . 0.0 109.529 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 53' ' ' ILE . 17.6 mt -81.54 93.38 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.413 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -53.54 56.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' HA ' ' HZ2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -132.04 139.35 48.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.72 133.31 55.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.67 161.38 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.406 ' CD1' HG22 ' A' ' 74' ' ' THR . 10.7 p90 -169.05 174.32 6.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 109.821 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -165.07 121.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.476 -0.765 . . . . 0.0 109.105 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.661 ' CG2' ' HG ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -124.3 142.57 51.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -158.55 -177.55 6.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.47 -56.82 2.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 66.4 m -120.94 158.64 27.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -1.141 . . . . 0.0 109.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.27 11.49 58.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.98 -39.84 4.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.14 -22.13 66.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.73 -44.96 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -46.73 -62.56 1.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -43.22 -48.05 6.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 109.717 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.661 ' HG ' ' CG2' ' A' ' 60' ' ' THR . 0.6 OUTLIER -49.55 -68.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 109.397 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -37.27 -39.22 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.617 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 73' ' ' ILE . 11.3 tp -66.89 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.536 ' C ' ' O ' ' A' ' 72' ' ' LEU . 4.4 tt -33.74 -48.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 110.054 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.406 HG22 ' CD1' ' A' ' 58' ' ' PHE . 3.2 p -49.8 -46.81 51.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.3 tp10 -86.15 -11.96 51.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.902 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -2.57 57.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.368 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.48 -27.11 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 0.0 109.61 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HZ2' ' HA ' ' A' ' 55' ' ' ASP . 9.8 ttmm -62.1 113.14 2.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.05 58.18 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.44 -164.88 1.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 m -121.02 175.0 6.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.861 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.55 -17.98 64.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.778 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -77.46 -40.6 42.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.73 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -69.16 -44.65 71.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 109.839 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.77 -33.84 52.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.54 52.27 4.68 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -171.9 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.4 pt -36.47 132.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' SER . 50.2 mttt -117.97 142.78 46.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -41.35 -25.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -66.44 -39.41 88.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.568 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -67.73 -55.88 11.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.466 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.74 -30.08 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.09 -60.29 2.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.742 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -55.27 -20.52 11.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -64.53 1.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.12 -14.46 63.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.651 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 52.81 43.62 31.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.894 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.613 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.5 pt? -85.8 151.21 54.84 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -41.52 105.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.559 2.173 . . . . 0.0 111.913 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.87 20.36 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.343 2.028 . . . . 0.0 112.338 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.416 ' H ' HG21 ' A' ' 102' ' ' VAL . 17.6 m -70.47 -40.63 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 104' ' ' VAL . 21.2 mttt -109.94 -23.44 11.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 103' ' ' LYS . 2.5 t 41.43 30.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.421 ' NE2' ' HB1' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -81.16 -35.64 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 60.7 m -59.73 -64.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.563 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 108' ' ' ILE . 2.6 m -51.45 -58.27 6.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.0 mt -42.12 -41.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -63.8 -46.42 85.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.63 -66.7 0.36 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.78 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.2 tm-20 -46.06 -69.64 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.536 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -38.75 -26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -73.87 -63.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.69 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 2.3 tp -46.13 -37.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.579 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 58.6 tttt -66.53 -43.49 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.59 77.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.493 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.25 -54.67 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mt -49.95 -34.85 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 109.256 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -56.86 10.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -11.52 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.415 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -85.0 -43.7 13.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -94.73 3.71 54.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.8 -33.06 10.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.329 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 tttt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 25' ' ' SER . 6.8 t0 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 14.5 m -101.55 5.36 41.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -117.59 37.39 3.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.476 ' CG1' ' NE2' ' A' ' 44' ' ' GLN . 2.7 t -143.41 98.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.359 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.08 132.55 11.29 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 m -108.85 134.11 51.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -1.111 . . . . 0.0 109.362 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.3 90.77 0.23 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ttm -108.94 128.8 55.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -1.164 . . . . 0.0 109.686 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 m -130.51 165.1 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.392 -0.818 . . . . 0.0 109.173 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.86 121.81 2.1 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.45 93.33 22.48 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.339 -1.095 . . . . 0.0 109.364 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.39 40.7 0.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.665 2.243 . . . . 0.0 112.271 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.543 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -144.55 -40.1 0.27 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.7 m -168.11 -32.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.29 -19.01 68.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.44 ' OD2' ' C ' ' A' ' 62' ' ' GLY . 1.6 m-20 61.06 -168.93 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 109.456 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -86.84 140.77 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -142.5 125.77 16.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.318 -0.864 . . . . 0.0 109.599 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.94 113.5 20.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.04 107.17 11.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 109.894 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.476 ' NE2' ' CG1' ' A' ' 27' ' ' VAL . 7.7 tt0 -109.67 129.18 55.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.07 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.56 144.81 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 109.699 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -108.96 138.94 44.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.99 151.5 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 23.5 t0 -81.93 -48.84 11.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.634 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 162.15 -22.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 9.5 p-10 -102.47 25.52 8.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.466 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.37 -4.7 58.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 52' ' ' ILE . 40.8 mm -81.16 146.46 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.348 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.24 108.61 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -44.03 32.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.78 164.41 28.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.273 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.09 118.83 16.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -96.05 133.83 39.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.476 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 10.3 p90 -136.08 168.88 18.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -171.89 104.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.803 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 p -96.42 147.95 23.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.085 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -162.0 111.58 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.701 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.44 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 130.58 -41.11 1.57 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.9 t -103.7 121.26 42.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.636 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 46.72 1.98 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -158.32 -12.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.157 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.88 37.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 67' ' ' ILE . 1.4 mp -48.29 -33.1 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.88 -41.73 74.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 71' ' ' SER . 17.9 p -67.11 -64.15 0.91 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.565 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.8 OUTLIER -38.76 -26.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.33 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 69' ' ' SER . 7.5 t -78.4 -44.7 24.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 69' ' ' SER . 21.4 tp -60.97 -52.14 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.948 . . . . 0.0 109.471 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 74' ' ' THR . 2.3 tt -58.9 -41.46 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.565 ' OG1' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -66.79 -19.35 65.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -92.02 -16.35 26.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.49 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.04 -17.0 18.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -109.07 40.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.661 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -118.8 96.44 5.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.97 -27.05 17.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -59.69 -160.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -1.124 . . . . 0.0 109.498 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.09 165.85 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.89 -41.27 82.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -24.72 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.593 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -90.7 -48.48 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.536 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.88 -17.36 56.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.84 11.65 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -148.47 -35.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -41.74 172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.538 -0.726 . . . . 0.0 109.654 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.33 168.44 19.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.55 -32.81 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.749 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.543 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -50.89 -33.22 23.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -73.83 -59.97 2.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.557 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.6 mt -46.02 -42.46 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 -46.71 74.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.355 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.4 -37.92 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -67.58 -45.01 76.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.5 -15.08 61.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.152 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.94 33.87 7.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.16 135.94 72.95 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.532 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -42.22 155.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.512 2.141 . . . . 0.0 112.245 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.24 -11.16 28.41 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.729 2.286 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.8 39.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -176.83 32.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.87 . . . . 0.0 109.189 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 t -74.68 -9.21 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.671 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.33 67.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 18.6 m -73.4 -59.26 2.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.651 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.54 ' HG ' ' H ' ' A' ' 108' ' ' ILE . 1.1 p -48.57 -56.17 9.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 108.974 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.54 ' H ' ' HG ' ' A' ' 107' ' ' SER . 82.3 mt -52.32 -35.58 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.17 -29.3 69.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -51.36 60.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.201 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.402 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 9.6 tp10 -71.73 -32.55 67.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.18 -33.98 75.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.223 -0.923 . . . . 0.0 109.314 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -72.09 -61.55 1.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -46.29 -35.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.129 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 114' ' ' ILE . 11.4 tttt -74.86 -31.38 61.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.853 . . . . 0.0 109.141 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.93 -43.43 83.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.188 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.31 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.2 mt -45.53 -50.76 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.69 -51.68 66.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.88 -21.54 64.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -71.69 -54.88 8.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.364 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -65.55 -34.67 78.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.91 55.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.4 tttt . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.425 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.29 8.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.398 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.566 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -115.17 3.26 14.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -122.1 92.45 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.84 155.0 47.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.4 m -131.41 118.56 20.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -1.224 . . . . 0.0 109.817 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.61 93.3 0.56 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -92.5 131.85 37.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.973 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.574 ' O ' ' O ' ' A' ' 41' ' ' MET . 18.5 m -144.53 177.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 108.997 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.62 178.97 41.12 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -118.69 82.31 19.98 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.336 -1.096 . . . . 0.0 109.352 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 37' ' ' CYS . 72.8 Cg_exo -43.97 -10.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.593 2.195 . . . . 0.0 111.99 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.623 ' O ' ' CB ' ' A' ' 37' ' ' CYS . . . -76.07 20.34 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 1.6 t 85.64 -18.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -43.3 -50.3 6.58 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.643 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 153.89 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -1.074 . . . . 0.0 109.424 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 46.9 t -113.56 150.56 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.574 ' O ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -145.73 140.88 27.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.106 -0.996 . . . . 0.0 109.78 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' N ' ' HG2' ' A' ' 41' ' ' MET . 6.0 tt0 -129.49 145.14 51.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.85 138.74 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.591 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -130.84 136.28 48.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.7 132.34 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -115.72 120.01 37.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.276 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.545 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 54.3 t -97.72 126.88 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -56.67 -60.02 4.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.3 OUTLIER 163.85 -22.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 0.0 109.197 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.45 -7.52 47.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.451 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.14 17.59 7.18 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 52' ' ' ILE . 46.5 mm -113.36 150.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -1.144 . . . . 0.0 109.504 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.532 ' O ' ' C ' ' A' ' 54' ' ' GLU . 36.1 mt -85.67 77.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 53' ' ' ILE . 2.5 tt0 -34.63 -48.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -153.04 167.68 28.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.94 122.97 13.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -103.99 142.08 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.328 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.468 ' CD1' ' CG2' ' A' ' 74' ' ' THR . 21.8 p90 -137.3 176.06 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.59 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -165.58 132.94 2.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.1 143.66 33.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -159.99 121.16 3.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.77 -61.02 0.29 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.5 t -121.39 140.74 51.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.124 . . . . 0.0 109.677 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.65 -6.98 87.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.6 p -95.13 0.43 54.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -1.15 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.46 2.76 45.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -83.16 -13.86 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.32 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.31 -64.41 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.435 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.465 ' H ' ' HG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -62.97 -30.21 71.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.93 . . . . 0.0 109.453 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.3 t -61.74 -46.14 90.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -64.68 -36.36 84.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.512 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -71.96 -74.54 0.16 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.524 ' C ' ' O ' ' A' ' 72' ' ' LEU . 2.7 tt -34.36 -46.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.873 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' CD1' ' A' ' 58' ' ' PHE . 34.0 p -60.16 -47.24 86.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.0 mt-10 -72.64 -5.92 40.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 109.652 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.63 58.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.477 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -138.1 105.22 5.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.431 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.4 87.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -83.77 -168.5 2.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -1.124 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 t -107.12 146.21 31.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.26 -27.68 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.319 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -61.03 -38.18 85.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.364 -0.835 . . . . 0.0 109.587 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -79.77 -28.91 40.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.648 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.31 -32.7 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.972 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.53 30.2 5.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.89 19.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.351 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.2 pt -91.7 -24.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 88' ' ' ILE . 11.3 mttp 56.72 152.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.581 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -79.55 -22.15 44.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.4 m -60.56 -39.99 89.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.52 -47.65 83.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.08 -36.42 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.19 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.25 -44.15 80.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.266 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.41 -31.83 72.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.79 -41.52 83.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -96.79 -35.36 10.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.646 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 94' ' ' ALA . 9.1 tt0 78.1 32.69 0.36 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.464 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 pp -48.1 147.13 3.84 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 102' ' ' VAL . 30.2 Cg_endo -67.56 147.17 76.09 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.61 2.207 . . . . 0.0 112.066 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.9 15.6 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.679 2.252 . . . . 0.0 112.323 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 100' ' ' PRO . 4.3 m -98.43 6.71 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.295 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -160.03 24.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.346 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' LYS . 26.9 t -38.4 -26.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.854 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.556 ' N ' ' O ' ' A' ' 103' ' ' LYS . 1.8 m-70 -42.95 -28.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 1.9 m -66.36 -37.17 84.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.779 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -68.26 -61.48 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.3 mt -52.29 -33.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.539 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.7 -42.99 94.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.63 -55.31 36.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.499 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -61.52 -56.58 18.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -48.87 -31.13 6.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.26 -65.03 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -49.86 -30.26 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.309 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.407 ' HG3' ' HZ3' ' A' ' 115' ' ' LYS . 63.3 tttp -72.54 -43.3 63.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.439 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.25 69.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.426 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.0 -58.62 3.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.94 . . . . 0.0 109.302 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.2 mt -48.8 -43.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.1 4.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.89 -35.54 15.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.69 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -69.63 -65.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.652 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -24.71 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.652 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.22 -4.74 3.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.5 mttm . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.636 -179.875 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.437 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 9.4 t -94.8 -0.62 54.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.55 12.04 22.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.01 107.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.24 150.29 18.64 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -135.75 148.88 48.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.23 103.22 0.29 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 ttp -92.93 129.27 38.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 0.0 109.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' MET . 2.9 m -150.63 -171.75 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.63 -174.52 32.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.94 93.74 26.21 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -1.136 . . . . 0.0 109.485 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.525 ' O ' ' C ' ' A' ' 36' ' ' ALA . 50.6 Cg_exo -50.43 -46.07 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.684 2.256 . . . . 0.0 112.254 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.65 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -37.36 -42.86 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.2 m 159.25 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -35.11 -57.3 0.84 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 153.09 169.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.393 -1.063 . . . . 0.0 109.523 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.563 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 7.6 p -96.12 146.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 108.909 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' VAL . 9.8 ttt -142.3 126.34 17.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 110.002 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -115.6 140.69 48.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.835 . . . . 0.0 108.922 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.24 121.33 13.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.805 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.438 ' HG2' ' N ' ' A' ' 45' ' ' ILE . 47.4 tt0 -122.57 152.88 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.21 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.438 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 0.9 OUTLIER -123.17 152.9 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.524 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -124.84 131.03 53.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.7 137.53 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.645 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -175.31 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.8 m-20 -63.2 51.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 0.0 109.108 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.645 ' N ' ' O ' ' A' ' 48' ' ' ASP . 6.3 m-80 72.17 55.15 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.634 -0.666 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.53 77.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 mm -97.61 157.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 109.524 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.442 HG21 HD12 ' A' ' 53' ' ' ILE . 54.0 mt -74.97 99.26 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -59.81 -51.51 69.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -148.98 -174.75 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.797 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.72 122.74 4.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.127 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -95.25 146.92 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 109.9 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.663 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -134.61 165.28 25.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.064 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -162.9 114.18 1.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.049 -1.032 . . . . 0.0 109.999 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 129.0 27.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.197 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.583 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -151.51 118.58 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -0.971 . . . . 0.0 109.759 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.89 -53.37 0.46 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.624 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -107.39 137.23 45.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -1.151 . . . . 0.0 109.392 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.53 26.26 4.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -121.73 -42.42 2.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -1.186 . . . . 0.0 109.493 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.61 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -65.29 -29.01 69.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.1 mm -50.87 -4.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.441 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.61 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -97.67 -56.26 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.547 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.0 -20.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 71' ' ' SER . 8.7 p -70.6 -63.09 1.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.546 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -51.33 -35.23 37.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.802 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 73' ' ' ILE . 6.7 tp -68.74 -79.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.949 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.486 HG21 ' H ' ' A' ' 74' ' ' THR . 3.3 tt -42.33 -48.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 109.915 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.486 ' H ' HG21 ' A' ' 73' ' ' ILE . 56.7 p -54.06 -36.81 63.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.685 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 72' ' ' LEU . 9.1 tt0 -79.38 -12.91 59.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.624 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -100.41 -4.22 29.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.7 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.27 32.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 105.94 14.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.043 -1.035 . . . . 0.0 109.105 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.59 10.62 61.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -90.63 -170.81 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -1.14 . . . . 0.0 109.451 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.37 148.46 35.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.1 -21.97 2.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -83.79 -15.35 48.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.907 . . . . 0.0 109.284 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.46 -28.13 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 0.0 109.253 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.58 -22.38 16.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.63 53.73 4.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.95 -34.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -1.131 . . . . 0.0 109.001 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 2.8 pt -45.45 162.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.42 -0.8 . . . . 0.0 109.364 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.37 -167.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.422 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.84 -24.39 13.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.345 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.8 t -68.98 -36.2 77.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' GLU . 9.1 mt-30 -62.02 -73.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLN . 2.2 mt -43.86 -41.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.68 -37.17 62.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.429 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' GLN . 31.9 tt0 -76.35 -38.34 56.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.401 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -39.42 76.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.81 -22.59 24.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 50.0 70.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.479 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.562 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.3 pt? -117.85 147.67 41.66 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.43 103.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.006 2.47 . . . . 0.0 112.354 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.0 Cg_exo -49.62 -14.86 0.78 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.818 2.345 . . . . 0.0 112.387 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.9 m -62.73 11.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 109.312 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.658 ' H ' ' C ' ' A' ' 101' ' ' PRO . 14.7 ttpp -165.89 64.05 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.055 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 57.6 t -86.54 39.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.808 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -84.68 -24.32 29.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.164 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 m -71.85 -52.83 15.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.96 -52.24 66.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.37 -36.68 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 mp -65.03 -39.49 93.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.913 . . . . 0.0 109.393 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.02 -43.88 94.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 88' ' ' ILE . 15.7 tp10 -66.98 -61.41 1.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -49.27 -22.3 1.03 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.11 -50.66 18.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.75 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.9 tp -56.54 -41.82 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 109.57 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.1 mtpp -62.81 -50.35 71.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 0.0 109.361 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -35.92 32.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.39 -62.06 2.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.379 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.0 mt -52.36 -38.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.404 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.78 -67.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.64 -48.4 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.281 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.563 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 2.9 t80 -49.54 -45.19 47.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -54.97 19.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.596 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.05 -46.41 22.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.693 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.1 mttt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 109.737 -179.74 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' A' ' 124' ' ' LYS . 3.0 t -101.75 5.57 41.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.369 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.26 -4.18 15.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.5 t -116.41 117.58 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.21 136.72 13.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -115.72 111.88 21.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -1.161 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.86 91.21 0.73 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.37 119.41 27.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.65 171.23 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.43 162.73 36.36 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -123.93 75.99 57.83 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.32 -8.54 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.69 2.26 . . . . 0.0 112.019 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -83.99 -30.22 26.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.88 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 9.9 p -112.66 -17.7 12.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.16 -0.963 . . . . 0.0 109.678 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.53 42.14 6.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.434 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 7.0 t70 -122.38 125.12 45.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.33 146.8 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -148.07 141.99 25.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.687 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -132.87 111.32 10.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.07 145.91 26.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -142.4 114.53 8.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.7 134.83 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HZ1' ' CG ' ' A' ' 57' ' ' LYS . 23.3 mttp -108.16 146.74 32.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.732 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.68 146.32 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.281 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.655 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -179.41 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.893 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.2 m-20 -62.77 44.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.321 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.655 ' N ' ' O ' ' A' ' 48' ' ' ASP . 3.2 m-80 76.98 51.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.13 -0.88 86.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.447 HD11 HG21 ' A' ' 52' ' ' ILE . 34.3 mm -95.12 146.83 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -1.174 . . . . 0.0 109.368 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.445 ' N ' HG22 ' A' ' 52' ' ' ILE . 34.4 mt -75.06 84.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.867 . . . . 0.0 109.259 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -46.85 66.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -142.75 177.59 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.07 123.54 4.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.468 ' CG ' ' HZ1' ' A' ' 46' ' ' LYS . 9.4 mmtt -103.47 154.16 19.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -142.12 175.81 9.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.505 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.37 99.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.253 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.96 130.34 55.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.408 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -144.45 129.33 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 109.581 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.24 -57.65 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.73 150.85 40.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.231 . . . . 0.0 109.543 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.88 56.57 0.51 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -144.06 -11.81 0.65 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.493 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.42 -12.02 17.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.557 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.6 mp -40.87 -54.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.404 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -49.9 -65.95 0.48 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 68' ' ' ALA . 10.9 m -38.94 -54.94 1.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.927 . . . . 0.0 109.533 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 19.4 p -50.57 -46.23 57.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.01 71.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' GLU . 58.8 tp -68.29 -76.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.477 ' C ' ' O ' ' A' ' 72' ' ' LEU . 1.4 tt -40.63 -45.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 70' ' ' SER . 6.8 p -55.81 -35.25 66.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.288 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 72' ' ' LEU . 7.4 mt-10 -93.78 4.16 54.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -106.27 -34.59 7.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.0 109.619 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.88 35.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -111.62 119.28 38.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.382 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.94 -2.92 85.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -85.53 -167.9 2.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.38 149.61 37.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.417 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.32 -20.79 46.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.98 -26.97 67.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -91.78 -38.06 12.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.79 -26.26 65.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.535 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.44 38.73 3.18 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -153.86 -34.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -1.104 . . . . 0.0 109.398 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.579 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.6 pt -40.52 169.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -140.92 161.6 37.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.369 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.617 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 14.7 p-10 -80.97 -28.79 35.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.59 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -57.5 7.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -55.65 -54.92 38.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.424 HD13 HG23 ' A' ' 93' ' ' ILE . 15.0 mt -55.64 -32.57 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.622 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.94 88.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 109.713 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -69.87 -22.69 63.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -74.7 -38.04 62.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -98.27 -15.31 19.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 109.599 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 47.76 68.81 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.334 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.451 ' H ' HD22 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -97.28 149.35 35.62 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.703 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 102' ' ' VAL . 71.6 Cg_exo -41.32 101.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.989 2.459 . . . . 0.0 112.352 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.23 -8.63 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.618 2.212 . . . . 0.0 111.937 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' A' ' 100' ' ' PRO . 18.3 m -77.59 -7.17 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HE3' ' SG ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -147.6 48.27 1.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.313 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.16 -1.97 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.595 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -13.74 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.958 . . . . 0.0 109.232 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.428 ' SG ' ' HE3' ' A' ' 103' ' ' LYS . 24.0 m -80.01 -55.18 5.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.9 t -50.37 -47.05 56.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.137 -0.977 . . . . 0.0 108.995 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.29 -46.94 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 mp -53.86 -30.87 47.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.144 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.71 -61.49 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -0.824 . . . . 0.0 109.273 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.617 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 58.5 tt0 -51.02 -54.06 27.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.249 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.79 -41.82 71.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.417 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.05 -50.12 38.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -59.68 -39.77 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.454 ' N ' HG22 ' A' ' 114' ' ' ILE . 5.8 tttt -64.46 -46.29 83.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.73 -61.87 2.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.659 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -47.63 -35.64 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.84 -38.53 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 109.553 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.63 -42.32 67.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 109.962 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.33 -39.87 92.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.992 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -68.67 -38.07 80.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.868 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -77.96 -27.45 49.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.19 85.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.575 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.547 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.561 ' OD2' ' CG2' ' A' ' 27' ' ' VAL . 7.2 p-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 m -75.91 8.43 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.398 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.03 12.07 29.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.608 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.561 ' CG2' ' OD2' ' A' ' 24' ' ' ASP . 27.4 t -132.45 101.69 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 109.303 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.29 9.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.97 141.0 51.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -1.092 . . . . 0.0 109.239 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.36 142.97 8.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 ptm -141.31 147.6 38.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -1.201 . . . . 0.0 109.743 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 m -136.0 -179.75 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.025 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.66 163.16 31.12 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.049 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 91.93 42.76 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.368 -1.078 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.25 -27.01 12.17 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.712 2.275 . . . . 0.0 112.44 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.03 -33.95 40.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.1 m -130.13 7.56 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' OD1' ' A' ' 39' ' ' ASP . . . 57.46 71.54 0.73 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.553 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 30.2 m-20 -141.18 131.19 24.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.02 126.65 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.775 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.442 ' HG2' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -110.53 149.17 30.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.442 ' N ' ' HG2' ' A' ' 41' ' ' MET . 4.0 tt0 -124.88 122.99 38.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.63 134.75 54.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -135.83 116.89 14.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.302 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.18 159.07 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -127.03 140.65 52.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.56 150.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.146 -0.971 . . . . 0.0 109.648 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.614 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 9.8 p-10 -75.99 -94.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.614 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -156.26 15.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.67 -7.37 3.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.7 9.88 17.97 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.8 mm -98.41 143.84 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -1.155 . . . . 0.0 109.454 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.2 115.39 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.45 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.92 -37.36 15.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.67 168.09 20.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.23 105.74 3.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -99.88 141.4 32.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.459 ' CD1' HG23 ' A' ' 74' ' ' THR . 13.7 p90 -139.99 179.08 6.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.382 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -164.76 123.75 1.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -137.55 141.51 41.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -158.36 134.26 9.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.42 -69.32 0.54 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.02 128.41 38.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -1.163 . . . . 0.0 109.656 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.45 70.57 0.86 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.99 -17.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -1.112 . . . . 0.0 109.295 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB1' ' SG ' ' A' ' 106' ' ' CYS . . . -105.74 6.33 31.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.431 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 68' ' ' ALA . 41.8 mt -79.05 -53.13 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -44.25 -45.3 8.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -70.85 -38.54 73.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.416 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.8 t -56.21 -39.96 73.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -73.72 -32.77 64.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.323 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.422 ' CD2' ' OE1' ' A' ' 96' ' ' GLU . 10.8 tp -68.96 -59.24 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 tt -52.34 -41.59 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.459 HG23 ' CD1' ' A' ' 58' ' ' PHE . 31.8 p -63.34 -32.33 73.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.331 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.47 -4.77 59.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.288 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.8 -26.44 14.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.57 22.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.298 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -95.49 120.38 35.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.412 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.01 5.48 89.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -87.04 -168.68 2.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -1.17 . . . . 0.0 109.534 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.13 152.47 39.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.369 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -57.82 -28.85 64.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.1 -36.35 79.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 85' ' ' ALA . 63.5 mm-40 -76.84 -56.1 4.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.46 -32.65 1.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.18 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.78 39.3 3.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -159.98 -40.57 0.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 108.781 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 ' O ' ' O ' ' A' ' 87' ' ' ALA . 12.4 pt -45.67 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 109.161 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -150.86 -178.63 6.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.154 -0.966 . . . . 0.0 109.572 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.422 ' HB2' ' HG ' ' A' ' 107' ' ' SER . 25.4 p-10 -90.88 -16.7 27.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.402 -0.811 . . . . 0.0 109.361 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.27 -45.3 65.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.485 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -62.48 -69.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 92' ' ' GLN . 7.9 mt -41.71 -39.96 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.17 -42.12 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.503 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -68.0 -11.41 58.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.443 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' OE1' ' CD2' ' A' ' 72' ' ' LEU . 13.2 tt0 -88.37 -54.77 4.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.413 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mt -81.94 -7.34 59.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 99' ' ' LEU . 6.0 tp10 48.5 23.56 0.62 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -43.97 149.21 0.69 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.67 164.2 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.67 2.246 . . . . 0.0 112.217 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.91 18.4 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.985 2.456 . . . . 0.0 112.638 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.0 t -110.62 0.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 109.727 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.658 ' O ' ' N ' ' A' ' 105' ' ' HIS . 13.0 mtmt -140.33 10.7 2.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.445 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 103' ' ' LYS . 5.0 t -45.11 -10.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.442 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.658 ' N ' ' O ' ' A' ' 103' ' ' LYS . 3.2 m-70 -59.72 -37.92 80.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.435 ' SG ' ' HB1' ' A' ' 66' ' ' ALA . 86.3 m -60.66 -50.68 72.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.422 ' HG ' ' HB2' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -60.85 -52.82 63.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.372 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.5 mt -46.73 -36.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.262 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.445 HD11 ' N ' ' A' ' 109' ' ' LEU . 5.7 mp -75.59 -28.17 58.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.627 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.21 -50.95 71.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.999 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 112' ' ' ASP . 70.9 tt0 -66.55 -63.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.873 . . . . 0.0 109.133 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' GLU . 4.8 t70 -44.1 -35.06 1.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 115' ' ' LYS . . . -58.04 -64.53 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.006 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.8 tp -46.43 -22.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 108.513 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 116' ' ' ALA . 14.5 tttt -74.1 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -40.55 -51.53 2.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.602 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.78 -51.75 67.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.465 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mt -49.73 -43.07 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -55.96 -65.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.537 ' O ' ' C ' ' A' ' 121' ' ' TYR . 27.0 t70 -44.66 -68.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.595 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.537 ' C ' ' O ' ' A' ' 120' ' ' ASP . 54.2 t80 -35.33 -42.99 0.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -68.8 -51.64 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 mttt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.824 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.652 ' C ' HD21 ' A' ' 26' ' ' ASN . 1.0 OUTLIER -72.39 9.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.585 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.652 HD21 ' C ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -125.06 30.01 5.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.9 t -127.1 91.36 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.313 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.42 142.2 16.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -129.17 112.57 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.46 134.93 12.2 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.41 114.41 16.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -1.118 . . . . 0.0 109.524 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.67 174.14 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.19 -178.9 21.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -122.12 89.19 48.58 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 109.367 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -54.46 29.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.95 2.433 . . . . 0.0 112.386 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -105.89 -42.83 5.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.7 -22.0 3.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.601 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.13 51.27 0.52 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.2 m-20 -106.76 140.22 39.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -1.145 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.74 114.54 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.167 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.5 ttt -112.54 140.99 46.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -126.5 128.97 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -0.878 . . . . 0.0 108.986 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -120.64 138.44 53.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.819 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -126.47 132.24 51.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 109.189 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.57 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -128.63 143.24 50.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.61 145.47 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -92.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -161.07 18.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.415 HD21 HG12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -128.36 -21.2 3.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.72 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.55 6.06 6.27 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.415 HG12 HD21 ' A' ' 50' ' ' ASN . 43.1 mm -103.64 130.08 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.641 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.44 97.66 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.299 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.67 -38.39 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.578 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.26 169.44 17.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.136 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 77' ' ' VAL . . . -166.78 118.64 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.131 -0.981 . . . . 0.0 109.593 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -95.97 -177.94 4.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.176 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -168.06 -179.72 4.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.184 -0.947 . . . . 0.0 109.418 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -171.61 113.98 0.36 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.5 p -119.62 131.89 55.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.206 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -140.89 111.27 6.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . 84.88 49.66 4.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.535 ' O ' ' O ' ' A' ' 64' ' ' GLY . 14.5 p -121.5 142.79 49.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.458 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 63' ' ' CYS . . . -38.99 -94.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.3 m -125.68 30.76 5.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.16 -31.51 72.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.497 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.8 mp -38.41 -32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.431 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -86.03 -64.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 109.312 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 m -54.21 -29.48 46.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.54 ' O ' ' OG1' ' A' ' 74' ' ' THR . 78.8 p -62.95 -34.52 77.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.115 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -74.42 -33.24 62.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.83 . . . . 0.0 109.225 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tp -64.34 -60.26 3.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 74' ' ' THR . 12.6 tt -51.95 -51.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.582 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -53.62 -31.15 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.374 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.09 -14.98 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.396 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -89.89 -23.96 21.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 56' ' ' ALA . 17.0 m -97.11 13.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 82.0 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.975 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.7 -9.45 8.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -98.75 -159.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.575 ' HG ' ' N ' ' A' ' 82' ' ' LEU . 41.0 t -128.07 164.49 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 109.709 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.575 ' N ' ' HG ' ' A' ' 81' ' ' SER . 11.0 mt -50.53 -28.68 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.86 -53.01 61.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.351 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.79 -36.3 71.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.829 . . . . 0.0 109.328 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.32 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.255 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 44.4 3.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -161.4 -35.31 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.137 . . . . 0.0 109.404 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.2 pt -40.39 -21.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 mttp 55.51 169.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.973 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.32 -45.32 5.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.553 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 37.1 t -56.19 -22.35 28.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.403 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -67.72 -64.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.369 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -51.35 -30.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.16 90.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.77 -18.32 61.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.372 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -71.14 -51.58 24.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.92 -11.92 56.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.21 19.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 1.7 pt? -59.18 149.2 68.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 109.149 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -37.51 145.39 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.823 2.349 . . . . 0.0 112.23 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.63 8.83 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.671 2.247 . . . . 0.0 112.265 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.77 -30.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -94.09 16.89 13.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.907 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.06 -19.79 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.542 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -54.58 -33.49 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.59 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 90.6 m -58.02 -58.19 9.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.915 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -48.87 -55.77 10.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.441 ' N ' HD21 ' A' ' 90' ' ' ASN . 28.2 mt -47.77 -65.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.313 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 109' ' ' LEU . 6.5 mp -43.79 -27.32 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -69.57 -71.31 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -50.93 -30.78 15.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.911 . . . . 0.0 109.249 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -73.01 -25.08 60.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -75.02 -35.09 61.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.618 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 2.2 tp -75.03 -42.34 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 109.42 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 22.1 tttt -59.94 -40.3 88.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.982 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.61 -54.12 44.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -50.07 -63.48 1.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.227 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 117' ' ' ALA . 67.5 mt -37.77 -44.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.21 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.12 -57.34 12.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -58.75 -45.35 89.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.34 -20.57 44.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -91.36 -29.91 16.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.385 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.97 -7.34 59.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 25' ' ' SER . 5.8 t0 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.522 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.8 OUTLIER 74.41 11.17 4.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' A' ' 25' ' ' SER . 1.7 p-10 174.78 -28.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.96 . . . . 0.0 109.681 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -91.74 114.98 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.09 119.27 5.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.487 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 27.3 m -93.71 136.38 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -1.15 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.67 110.05 0.67 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 ttt -125.63 122.14 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -1.137 . . . . 0.0 109.651 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.55 -169.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.377 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.15 146.83 5.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.11 133.52 20.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.519 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.3 Cg_endo -75.44 -26.38 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.493 2.129 . . . . 0.0 112.256 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.53 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.89 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -98.88 5.32 47.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.04 48.79 10.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -89.66 127.07 35.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.401 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.0 131.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.7 ttt -128.06 130.53 48.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 109.293 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -125.38 142.07 51.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.801 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.56 156.84 43.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.182 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.78 150.56 38.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.78 139.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.316 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -113.38 146.51 39.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.71 147.63 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.485 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 2.2 t0 -88.9 -60.17 2.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 167.27 -23.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.145 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.485 ' ND2' ' OD2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -100.12 22.66 11.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.541 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 15.26 80.14 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.47 HD11 HG21 ' A' ' 52' ' ' ILE . 43.1 mm -104.93 136.66 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.483 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.34 97.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.7 -44.32 57.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.76 157.1 8.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.33 179.31 6.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.351 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -151.29 170.75 18.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.434 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 21.3 p90 -137.35 167.88 20.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 109.384 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -169.71 85.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.17 133.51 55.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -147.18 105.85 3.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.06 -50.66 0.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.1 p -128.9 120.55 26.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.52 66.57 1.02 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.55 -50.93 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.92 -26.4 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.354 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' ALA . 77.8 mt -44.67 -53.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.0 109.217 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.09 60.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 108.921 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.2 -40.37 64.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.34 -0.85 . . . . 0.0 109.024 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 74' ' ' THR . 2.3 t -65.69 -24.55 67.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 109.168 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.7 t -76.12 -46.21 29.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.308 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.05 -59.25 4.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 74' ' ' THR . 17.3 tt -49.21 -43.95 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 71' ' ' SER . 0.9 OUTLIER -54.88 -42.27 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.591 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.19 -18.45 60.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.942 . . . . 0.0 109.729 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -89.35 -21.9 22.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.517 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 4.8 m -107.49 52.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.14 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -142.11 82.43 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.646 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.74 40.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -102.25 -167.44 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -1.189 . . . . 0.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -102.94 139.24 38.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.77 -23.73 60.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.401 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -75.98 -13.97 60.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.35 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.55 -35.05 11.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.49 2.84 42.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.19 25.8 11.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.96 18.66 0.16 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -1.153 . . . . 0.0 109.409 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.05 2.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.847 . . . . 0.0 109.327 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.4 mttt 56.83 167.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.548 ' ND2' ' C ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -86.04 -13.16 48.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.339 -0.851 . . . . 0.0 109.541 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.3 p -75.76 -21.52 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.564 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.443 HE21 ' HA ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -74.79 -56.01 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.423 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.0 mt -59.67 -41.98 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.88 82.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.184 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.35 -46.49 80.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 109.399 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -49.69 -62.45 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.17 -16.65 61.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 52.84 23.52 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.428 HD12 ' SG ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -55.26 146.84 39.36 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.582 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.04 146.78 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.74 2.293 . . . . 0.0 112.239 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 103' ' ' LYS . 57.2 Cg_endo -73.94 -27.59 12.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.762 2.308 . . . . 0.0 112.386 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.9 t -70.5 26.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.739 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.571 ' H ' ' C ' ' A' ' 101' ' ' PRO . 9.6 tttm -165.17 37.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.39 1.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.392 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -58.79 -29.26 66.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -67.59 -41.64 83.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.59 85.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.885 . . . . 0.0 109.177 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -62.56 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.295 -0.878 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.428 HD11 ' N ' ' A' ' 109' ' ' LEU . 7.8 mp -63.23 -25.21 68.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.15 -71.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -50.75 -31.48 16.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.42 -38.77 85.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.138 -0.976 . . . . 0.0 109.158 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -69.9 -58.91 3.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -44.22 -38.09 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 116' ' ' ALA . 4.0 tptt -75.17 -66.13 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -36.61 -39.58 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -64.38 -57.95 7.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -38.01 -49.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.413 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -56.18 -61.15 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.507 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 119' ' ' ALA . 4.3 m-20 -38.83 -62.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -46.42 -57.43 4.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 123' ' ' ALA . 1.0 OUTLIER -47.31 -29.16 2.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -41.25 -47.81 3.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.587 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.419 ' HZ2' ' HB3' ' A' ' 24' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.85 -2.65 43.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -97.13 3.95 51.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.6 96.82 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 155.53 28.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -138.6 117.27 12.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -1.199 . . . . 0.0 109.62 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.06 114.4 4.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.53 108.59 14.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -1.196 . . . . 0.0 109.565 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.67 175.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.11 168.35 41.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.74 80.81 32.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -47.08 -14.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.848 2.366 . . . . 0.0 112.311 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -60.47 2.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -91.55 -8.75 46.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 43.27 9.38 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.2 148.48 25.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.111 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.1 139.89 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ttt -147.0 130.0 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -133.52 118.87 18.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.65 127.46 50.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -106.34 168.82 8.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.728 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -150.11 127.87 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.224 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -98.74 105.15 17.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.58 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.09 144.78 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 109.252 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.617 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 6.6 t70 -78.94 -101.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -148.35 13.6 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.617 ' ND2' ' OD2' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -139.27 2.25 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.68 33.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.405 HD12 ' HG ' ' A' ' 81' ' ' SER . 4.5 mm -83.32 144.06 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -1.187 . . . . 0.0 109.418 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 55' ' ' ASP . 72.1 mt -90.19 91.41 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.85 -54.03 16.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 15.9 t0 -136.59 -177.08 4.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.357 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.91 116.29 1.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.593 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -96.46 141.72 29.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.69 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -117.01 162.63 17.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.403 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -157.16 97.24 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.435 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.52 124.98 50.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -150.78 97.11 2.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.35 -39.7 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 34.3 t -130.12 121.79 27.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.93 47.41 1.89 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.09 2.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -1.16 . . . . 0.0 109.562 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.01 -4.25 20.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.452 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.557 ' O ' ' OG ' ' A' ' 70' ' ' SER . 3.1 mp -62.29 -65.85 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.542 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.5 -71.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.63 ' OG ' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -41.5 -60.32 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.496 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.557 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 84.1 p -46.29 -47.76 18.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.342 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.406 ' C ' ' OG1' ' A' ' 74' ' ' THR . 1.7 m -57.71 -23.95 54.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 74' ' ' THR . 1.4 tp -78.82 -71.54 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.287 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -40.52 -24.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -75.56 -56.17 4.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.252 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.16 -15.52 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -88.63 -32.55 18.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 17.2 m -104.6 55.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.648 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 84.29 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.11 -15.1 23.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -78.25 -174.42 3.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.418 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.405 ' HG ' HD12 ' A' ' 52' ' ' ILE . 73.4 m -109.45 174.39 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.23 -26.03 68.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.633 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -64.61 -17.44 64.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -100.09 -38.87 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.08 -25.29 58.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.73 54.25 0.68 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.17 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -1.169 . . . . 0.0 109.404 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -35.89 -43.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 91' ' ' SER . 0.3 OUTLIER 63.6 119.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.582 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 91' ' ' SER . 43.0 p30 -40.93 -25.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.025 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.535 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.5 m -50.44 -36.9 35.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 93' ' ' ILE . 12.6 tt0 -83.46 -60.31 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.477 ' C ' ' O ' ' A' ' 92' ' ' GLN . 69.6 mt -40.13 -48.1 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 95' ' ' GLU . . . -72.44 -55.2 7.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 94' ' ' ALA . 3.7 tt0 -36.07 -34.06 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 94' ' ' ALA . 1.2 tp10 -81.79 -62.19 1.71 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.619 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.8 OUTLIER -63.29 -16.91 61.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 97' ' ' LEU . 1.1 tp10 37.94 47.43 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.467 ' H ' HD22 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -71.28 150.47 94.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.169 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -36.15 109.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.87 2.38 . . . . 0.0 112.045 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.9 16.41 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.559 2.173 . . . . 0.0 112.477 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 m -82.3 13.64 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' VAL . 4.9 tptt -168.21 -38.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.43 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 103' ' ' LYS . 12.4 t 44.22 57.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.27 -57.85 2.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.63 ' SG ' ' OG ' ' A' ' 69' ' ' SER . 48.0 t -44.46 -60.42 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.807 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.486 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -43.38 -63.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 107' ' ' SER . 27.4 mt -38.1 -62.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.6 mp -48.65 -37.25 17.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.587 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.12 -73.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.637 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.551 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 3.8 tp10 -46.69 -58.54 3.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.9 OUTLIER -43.74 -38.34 3.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.768 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -51.96 65.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.6 tp -61.61 -41.1 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.677 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' HZ2' ' CB ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -62.08 -41.14 97.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 109.511 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.42 67.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.91 63.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.314 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 68.9 mt -69.38 -66.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.851 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -38.69 -46.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.395 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -63.28 -43.85 96.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.394 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 118' ' ' ILE . 59.5 t80 -56.45 -42.25 77.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.452 ' HZ3' HG21 ' A' ' 118' ' ' ILE . 23.6 mttp -72.04 -43.98 64.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.05 -11.91 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 122' ' ' LYS . 6.3 mttt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.31 -1.94 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.58 ' H ' ' C ' ' A' ' 24' ' ' ASP . 1.9 p-10 -167.84 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.59 92.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.8 144.57 18.25 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.567 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 4.8 m -135.43 130.55 34.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.46 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 43' ' ' LEU . . . -116.15 140.52 16.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.21 125.08 21.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 109.575 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.62 170.42 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.08 141.84 7.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -110.67 129.2 24.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.183 . . . . 0.0 109.186 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 36' ' ' ALA . 63.8 Cg_endo -77.14 -45.02 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.515 2.143 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.31 -55.28 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -113.55 29.04 8.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 109.69 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.4 51.67 0.74 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 37' ' ' CYS . 78.8 m-20 -102.24 111.77 24.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.41 ' H ' HG11 ' A' ' 40' ' ' VAL . 3.4 p -99.3 130.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.41 ' HG2' ' N ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -137.05 150.74 48.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.492 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' N ' ' HG2' ' A' ' 41' ' ' MET . 6.3 tt0 -136.76 116.36 12.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.376 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 30' ' ' GLY . 4.3 tt -105.6 143.25 34.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 45' ' ' ILE . 4.8 tt0 -135.51 162.33 32.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.325 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.533 ' N ' ' CG ' ' A' ' 44' ' ' GLN . 1.3 pt -147.41 162.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.426 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 10.6 mmtm -129.52 138.48 51.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.21 155.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.562 ' OD2' ' OD1' ' A' ' 49' ' ' ASP . 38.5 t70 -88.65 -49.7 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.631 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER 160.78 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.234 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -101.39 -11.72 19.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 8.71 7.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.414 HG22 HD13 ' A' ' 52' ' ' ILE . 5.0 mm -96.36 149.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.545 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 53' ' ' ILE . 56.9 mt -90.92 95.55 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' CG ' ' N ' ' A' ' 55' ' ' ASP . 19.9 pt-20 -58.03 -46.24 85.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 54' ' ' GLU . 1.7 t0 -137.53 168.17 20.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.579 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.05 100.51 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.07 159.5 14.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -140.35 -175.0 4.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.58 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -171.35 83.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p -92.9 149.04 21.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -155.06 141.56 18.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.85 -80.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 65' ' ' SER . 0.1 OUTLIER -82.11 136.94 35.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -1.157 . . . . 0.0 109.444 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.83 45.76 3.07 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -154.6 -47.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.392 -1.063 . . . . 0.0 109.336 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.68 -14.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.448 ' H ' ' C ' ' A' ' 65' ' ' SER . 7.2 mt -65.88 -22.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.43 -67.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.556 ' OG ' ' SG ' ' A' ' 106' ' ' CYS . 20.9 p -46.39 -53.41 11.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.166 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.505 ' H ' ' HG ' ' A' ' 69' ' ' SER . 83.9 p -49.88 -33.57 17.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.538 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.3 OUTLIER -71.17 -37.71 72.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.292 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.22 -67.84 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.848 . . . . 0.0 109.441 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 tt -44.42 -40.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.948 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.538 ' OG1' ' O ' ' A' ' 71' ' ' SER . 1.5 p -57.48 -48.31 79.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.894 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.14 -21.57 50.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -11.54 59.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 m -124.67 20.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.253 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -90.54 99.78 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.402 -0.812 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.04 56.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -81.88 171.14 14.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.15 150.68 21.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.532 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.7 mt -54.79 -15.81 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.99 -33.4 74.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.36 -47.48 8.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.871 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.8 -5.58 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.298 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.83 31.54 6.98 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.22 -36.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -1.16 . . . . 0.0 109.184 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.4 pt -44.81 120.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.839 . . . . 0.0 109.545 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.414 ' H ' ' NE2' ' A' ' 92' ' ' GLN . 18.8 mttm -94.3 179.39 5.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -13.9 60.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.462 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -82.75 -43.89 16.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.414 ' NE2' ' H ' ' A' ' 89' ' ' LYS . 58.3 mt-30 -58.28 -36.59 73.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.005 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.15 -33.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.02 -21.08 66.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.899 . . . . 0.0 108.971 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -94.18 -35.32 12.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.179 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -58.74 -36.18 73.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.352 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 mt -106.03 -3.87 21.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 47.12 50.88 13.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.88 146.8 44.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 102' ' ' VAL . 37.0 Cg_endo -69.08 151.99 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.744 2.296 . . . . 0.0 112.053 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.621 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.5 Cg_endo -69.5 19.13 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.887 2.391 . . . . 0.0 112.369 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.532 ' C ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -35.53 -28.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.31 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 101' ' ' PRO . 5.9 tptt -173.35 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.374 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.419 ' CG2' ' C ' ' A' ' 103' ' ' LYS . 1.6 t 69.87 2.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 37.4 p-80 -65.15 -36.76 85.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.556 ' SG ' ' OG ' ' A' ' 69' ' ' SER . 3.9 t -58.7 -56.39 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.06 -44.31 74.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.8 mt -56.53 -41.58 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.39 -32.28 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -63.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.887 . . . . 0.0 109.62 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.1 -49.77 76.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -53.52 -28.03 29.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.973 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -79.3 -64.42 1.19 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.6 tp -44.94 -41.16 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 109.833 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.497 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -73.45 -37.15 65.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.442 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.09 80.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -68.59 -60.34 2.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ALA . 44.4 mt -38.57 -49.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.48 80.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.567 ' OD2' ' O ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -52.67 -66.64 0.35 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.253 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -46.92 -39.02 11.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 109.177 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -59.54 -51.17 70.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.814 . . . . 0.0 109.366 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.72 -6.48 2.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.522 -179.95 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 t0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.359 0.6 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.529 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 3.7 m -101.61 7.24 42.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.529 ' OD1' ' O ' ' A' ' 25' ' ' SER . 56.9 m-20 -144.2 14.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.9 t -118.46 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.192 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.53 153.13 34.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.542 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 7.8 m -127.15 120.7 29.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -1.043 . . . . 0.0 109.108 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.24 106.5 1.81 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.0 ttt -112.33 112.4 23.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -1.216 . . . . 0.0 109.462 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.48 154.44 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.39 -170.1 11.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB2' ' NE2' ' A' ' 105' ' ' HIS . . . -147.31 92.24 4.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 53.7 Cg_exo -48.55 -48.03 18.65 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.689 2.259 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.09 -34.2 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.469 ' O ' ' C ' ' A' ' 38' ' ' GLY . 21.2 m -120.01 12.05 11.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.83 56.89 3.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -124.5 117.6 24.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.29 130.06 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -128.86 137.04 51.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.325 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -121.54 164.01 17.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.689 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tp -158.51 126.19 5.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -117.77 140.55 49.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.54 124.34 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.57 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -101.39 143.6 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.5 t -131.3 156.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.291 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.0 t70 -85.16 -106.12 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.448 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 2.1 p30 -140.02 8.65 2.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.575 HD21 ' H ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -124.75 -29.52 3.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.461 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.402 ' N ' HD21 ' A' ' 50' ' ' ASN . . . 135.66 -5.6 4.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.575 ' H ' HD21 ' A' ' 50' ' ' ASN . 50.0 mm -79.38 137.04 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -1.151 . . . . 0.0 109.487 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mt -91.17 107.01 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -70.93 -16.45 62.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.725 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 15.7 t0 -172.91 151.75 2.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.053 -1.029 . . . . 0.0 109.791 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.556 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -133.12 107.76 8.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.22 154.77 17.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 109.561 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.59 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 2.4 p90 -136.99 -176.5 4.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.58 106.94 0.56 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.349 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.64 ' CG2' ' HG ' ' A' ' 70' ' ' SER . 81.9 p -112.77 145.15 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -154.45 108.79 3.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 109.423 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.84 -58.19 0.3 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.6 t -106.68 136.02 47.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -1.153 . . . . 0.0 109.371 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.63 38.25 2.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.5 20.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -1.185 . . . . 0.0 109.525 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -93.43 -29.49 15.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.724 ' H ' ' CD1' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -42.93 -27.16 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -46.72 -57.59 4.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.852 . . . . 0.0 109.705 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -49.89 29.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.707 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.64 ' HG ' ' CG2' ' A' ' 60' ' ' THR . 0.3 OUTLIER -48.63 -41.62 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.873 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.57 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.15 -45.17 74.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 73' ' ' ILE . 46.3 tp -57.06 -71.22 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.74 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 72' ' ' LEU . 9.5 tt -40.78 -44.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 109.941 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 71' ' ' SER . 1.1 p -59.22 -36.92 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.764 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' LEU . 21.6 tt0 -71.69 -55.65 7.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -31.88 27.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.664 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.595 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 4.2 m -105.37 63.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.7 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -144.58 95.5 2.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.56 -15.47 35.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -76.08 -160.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -1.109 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 t -117.96 159.08 23.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.0 mt -57.11 -19.18 18.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.327 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -67.83 -30.8 70.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.376 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -86.39 -45.86 10.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.608 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.46 60.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.62 46.73 1.13 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -168.33 -33.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.093 . . . . 0.0 108.93 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 87' ' ' ALA . 16.2 pt -50.3 179.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.49 -0.756 . . . . 0.0 109.579 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -143.58 179.98 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.282 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -96.15 -13.22 23.73 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 t -70.84 -41.93 70.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.813 . . . . 0.0 109.268 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -65.86 -52.15 52.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.212 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 mt -57.97 -27.01 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.221 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.67 -42.06 78.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.318 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.51 -22.02 62.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.19 -54.92 5.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.532 ' O ' ' C ' ' A' ' 98' ' ' GLU . 4.4 tp -80.75 -3.47 51.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 97' ' ' LEU . 7.6 tm-20 36.0 70.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.326 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.04 149.76 36.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.373 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 102' ' ' VAL . 39.9 Cg_endo -71.03 151.66 62.03 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.714 2.276 . . . . 0.0 112.112 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.02 19.39 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.797 2.331 . . . . 0.0 112.211 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' A' ' 100' ' ' PRO . 26.8 m -97.31 16.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.493 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.622 ' C ' ' H ' ' A' ' 105' ' ' HIS . 8.8 tttp -176.49 46.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.7 t -65.86 20.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.64 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.622 ' H ' ' C ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -86.24 -30.51 22.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 p -65.85 -44.37 85.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.25 -45.92 89.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.422 HD13 HG22 ' A' ' 108' ' ' ILE . 88.7 mt -68.2 -30.04 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.39 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 mp -73.27 -40.93 64.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.77 53.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.831 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.31 -56.85 8.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.709 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -51.55 -17.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.38 -55.06 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.456 HG21 ' N ' ' A' ' 115' ' ' LYS . 3.6 tp -51.13 -33.07 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.0 109.653 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.503 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -75.39 -61.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -37.47 -35.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 119' ' ' ALA . . . -77.75 -66.34 0.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 117' ' ' ALA . 48.0 mt -37.47 -28.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 117' ' ' ALA . . . -77.9 -52.9 8.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD2' ' O ' ' A' ' 29' ' ' THR . 37.3 m-20 -49.75 -44.19 48.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.71 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.59 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -76.12 -59.17 2.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 109.547 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' TYR . 22.6 tptt -43.11 -33.26 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.8 -20.87 16.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 mttt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.944 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.645 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.286 0.565 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 58.91 -4.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.337 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.645 ' H ' ' C ' ' A' ' 24' ' ' ASP . 8.9 p-10 -146.65 13.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.383 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.06 101.58 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.744 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.19 128.86 9.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.74 152.9 21.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -1.212 . . . . 0.0 109.661 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 43' ' ' LEU . . . -131.51 118.18 2.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.96 95.3 4.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -1.146 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.92 145.56 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.86 177.75 20.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.57 77.15 73.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.171 -1.194 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.03 -6.36 1.8 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.854 2.369 . . . . 0.0 112.107 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.62 -11.08 59.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.588 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.4 -39.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.98 69.63 0.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.1 145.89 44.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -1.157 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.22 117.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.85 . . . . 0.0 109.212 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ttt -120.11 120.24 35.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.893 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.34 142.72 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 108.97 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 tt -150.62 149.39 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 109.886 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.435 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 12.9 pt20 -150.99 123.27 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.787 . . . . 0.0 109.214 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.3 151.12 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -112.68 150.0 32.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.568 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.84 144.52 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.203 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.651 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 36.7 p-10 -85.13 -108.76 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.963 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.651 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 34.0 t0 -131.95 -23.39 2.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.545 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.37 -1.68 57.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 28.83 12.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 52' ' ' ILE . 45.9 mm -108.89 161.43 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 109.373 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.4 mt -100.49 105.47 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.222 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.3 -36.29 20.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.803 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.79 160.31 38.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.707 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.29 112.88 4.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 109.417 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -107.77 146.63 31.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.468 ' CD1' HG22 ' A' ' 74' ' ' THR . 2.9 p90 -140.35 -175.44 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.542 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -170.75 107.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.39 105.87 10.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.474 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.1 122.54 24.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.09 -39.44 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.0 139.06 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -1.099 . . . . 0.0 109.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.52 60.45 1.52 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.622 ' C ' ' H ' ' A' ' 67' ' ' ILE . 2.3 p -175.73 -59.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.02 -1.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.622 ' H ' ' C ' ' A' ' 65' ' ' SER . 4.2 mt -65.76 -8.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.25 -49.75 9.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.09 -52.82 59.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.327 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -43.37 -56.51 3.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -53.21 -30.43 37.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 109.352 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 69' ' ' SER . 11.4 tp -70.53 -67.45 0.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 109.554 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 tt -48.72 -40.35 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.468 HG22 ' CD1' ' A' ' 58' ' ' PHE . 21.0 p -58.66 -47.19 85.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.74 -10.17 58.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.87 -31.37 17.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 m -102.42 64.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -133.93 100.5 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.67 -9.39 77.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -81.45 -171.22 3.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -1.204 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.11 -178.27 3.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.24 -10.32 49.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -71.06 -34.48 71.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.156 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.0 -37.13 13.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.402 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 -29.53 63.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.67 48.29 1.51 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.97 -42.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -1.12 . . . . 0.0 109.027 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.465 ' C ' ' O ' ' A' ' 87' ' ' ALA . 2.3 pt -40.98 151.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.398 -0.814 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -129.53 173.42 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 109.669 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.495 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 4.1 p-10 -86.75 -7.86 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.357 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 -47.38 39.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -60.08 4.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 109.409 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.31 -38.25 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.75 -33.87 76.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.55 -22.31 30.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.486 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.02 -24.85 58.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.4 mt -111.21 -19.26 12.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.242 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.47 62.79 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.684 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.602 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -97.56 153.23 38.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.335 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.0 152.13 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.547 2.164 . . . . 0.0 112.028 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.67 -11.05 22.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.752 2.301 . . . . 0.0 112.229 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -92.01 11.11 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 105' ' ' HIS . 34.7 mttt -139.83 6.56 2.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.454 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.403 ' C ' ' N ' ' A' ' 106' ' ' CYS . 3.8 t -47.09 -17.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -51.4 -14.69 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.514 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.628 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 42.2 t -76.05 -71.12 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.668 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.0 p -48.62 -44.06 36.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.452 HG23 HD12 ' A' ' 108' ' ' ILE . 33.7 mt -57.93 -51.83 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 mp -52.52 -27.91 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.82 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 16.4 tt0 -64.5 -44.92 89.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -35.23 79.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.36 65.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp -58.53 -41.37 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.975 . . . . 0.0 109.567 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.485 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 40.4 tttm -61.27 -28.56 69.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 109.155 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.37 -47.53 19.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.6 -32.41 41.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.92 -41.34 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.42 84.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.11 -52.64 22.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.87 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -49.36 -42.13 41.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.224 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -28.55 63.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.96 4.64 53.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.5 tptt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.37 179.941 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -82.99 9.31 10.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.684 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -118.92 -13.68 9.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.363 -0.836 . . . . 0.0 109.364 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.12 94.08 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.369 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.73 142.5 20.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -120.94 158.88 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -1.089 . . . . 0.0 109.177 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.15 145.4 12.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 ttt -145.62 119.3 9.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -126.17 170.34 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.75 178.29 28.27 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.29 75.34 70.72 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -1.091 . . . . 0.0 109.187 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 75.3 Cg_exo -44.48 -25.74 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 112.434 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.1 -51.2 8.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.8 p -114.79 -24.54 8.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.45 46.11 1.09 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 36.9 t0 -108.09 135.61 49.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 109.488 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.527 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 4.0 m -108.43 137.72 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.9 ttt -137.86 128.56 26.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -117.26 142.91 46.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 109.409 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 tp -149.53 121.09 7.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.67 155.41 29.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.849 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.79 125.48 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.662 ' NZ ' ' OE1' ' A' ' 54' ' ' GLU . 11.2 tttp -100.0 114.71 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -122.39 127.55 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.941 . . . . 0.0 109.495 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.663 ' O ' ' N ' ' A' ' 50' ' ' ASN . 6.3 m-20 -158.02 -32.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.616 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -62.57 50.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.663 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.3 m-80 78.54 54.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.61 18.17 71.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.2 mm -105.73 134.9 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.389 -1.065 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 32.4 mt -63.06 80.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.216 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.662 ' OE1' ' NZ ' ' A' ' 46' ' ' LYS . 35.5 tt0 -49.61 -22.73 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.18 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -169.11 159.57 9.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.034 -1.041 . . . . 0.0 109.808 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.05 134.0 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -116.68 144.59 44.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -143.66 170.64 15.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -171.7 96.54 0.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 0.0 108.975 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.32 148.64 42.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -152.79 147.93 26.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.152 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.73 -74.03 0.45 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.657 ' O ' ' SG ' ' A' ' 63' ' ' CYS . 1.6 p -116.24 122.18 44.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.134 . . . . 0.0 109.348 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.25 -9.68 2.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 63' ' ' CYS . 0.5 OUTLIER -93.27 10.3 32.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.444 ' HB1' ' SG ' ' A' ' 63' ' ' CYS . . . -100.88 -3.49 29.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.86 -24.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.8 65.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -50.78 12.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 74' ' ' THR . 17.1 t -49.34 -38.41 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.1 t -72.21 -39.28 68.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.9 tp -61.0 -59.87 4.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.344 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 76' ' ' TRP . 1.0 OUTLIER -53.13 -59.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 70' ' ' SER . 2.4 p -42.86 -32.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.824 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -91.01 -11.31 39.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.782 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -93.87 -17.31 23.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.975 . . . . 0.0 109.533 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.36 40.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.459 ' C ' ' H ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -95.89 116.93 29.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.43 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.69 5.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -73.74 -173.78 1.6 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.4 m -101.49 158.4 16.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.865 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -70.21 -16.56 63.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.86 -26.22 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.208 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -93.43 -43.4 8.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.376 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.21 67.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.47 33.11 4.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.1 26.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -1.109 . . . . 0.0 109.253 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.57 -25.02 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.832 . . . . 0.0 109.621 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 71.16 156.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.448 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.55 ' OD1' ' OE1' ' A' ' 111' ' ' GLU . 6.6 p-10 -93.48 -41.96 9.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.616 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -35.96 79.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -58.54 -67.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.3 mt -49.8 -33.47 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.751 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.3 -31.08 69.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 109.741 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.4 -36.14 60.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.23 -43.3 82.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.25 -17.15 62.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.404 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 54.24 39.08 30.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 pp -82.27 149.0 60.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.304 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.16 149.31 85.63 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.645 2.23 . . . . 0.0 112.147 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -73.2 20.06 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.926 2.417 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.0 m -85.47 -13.52 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.885 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 105' ' ' HIS . 1.0 OUTLIER -150.12 55.8 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.586 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 74.5 t -73.3 40.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 103' ' ' LYS . 62.4 m80 -97.42 -26.46 14.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.868 . . . . 0.0 109.718 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.642 ' SG ' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -74.94 -45.11 44.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.626 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.642 ' N ' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -53.84 -46.92 71.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 56.2 mt -68.05 -43.65 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.4 mp -58.27 -37.35 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.33 -59.07 5.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.422 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.55 ' OE1' ' OD1' ' A' ' 90' ' ' ASN . 87.1 tt0 -56.09 -60.51 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.362 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 111' ' ' GLU . 1.6 t0 -43.9 -32.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.354 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.89 -61.2 1.9 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.46 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 tp -49.61 -20.68 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -85.26 -57.9 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.353 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.56 5.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.225 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.94 -58.03 3.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.126 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.5 mt -46.72 -31.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.365 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.89 38.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.05 -0.79 12.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.147 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -102.81 -32.05 10.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -95.74 -31.4 13.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.26 -18.18 63.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.484 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.192 0.52 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -71.27 2.4 4.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.277 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 25' ' ' SER . 2.4 p30 165.75 33.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.41 96.76 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.454 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.0 100.95 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 m -86.17 133.16 33.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -1.152 . . . . 0.0 109.657 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.33 145.78 17.57 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.21 110.8 5.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -1.213 . . . . 0.0 109.774 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.77 144.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.34 178.17 21.09 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.93 92.57 49.07 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.139 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.8 Cg_exo -50.15 -40.15 51.28 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.852 2.368 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.43 -44.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 109.671 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.32 -13.03 9.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.599 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.22 57.9 2.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -113.35 110.84 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.5 130.54 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.99 118.96 15.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -111.14 136.23 50.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.707 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.35 141.89 51.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -140.84 135.84 31.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -118.09 136.01 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' CD ' ' OD2' ' A' ' 55' ' ' ASP . 36.8 tttt -105.87 118.92 37.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.25 146.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.661 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.7 m-20 -173.92 -33.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.614 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -62.47 42.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.661 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.8 m-80 80.99 43.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 109.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.13 0.54 82.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.525 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.0 mm -98.23 151.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.494 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -84.39 116.03 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -44.57 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD2' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -130.11 131.2 45.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.561 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.96 121.51 45.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.425 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 115.13 29.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.402 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.744 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -101.78 167.91 9.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 83.74 1.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.545 ' H ' ' HG1' ' A' ' 60' ' ' THR . 0.6 OUTLIER -95.92 127.47 41.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.47 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -151.57 141.56 22.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.596 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.98 -53.06 0.59 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 42.6 t -91.11 172.57 8.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -1.188 . . . . 0.0 109.442 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.495 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -129.92 -10.85 2.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.8 13.65 30.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -1.112 . . . . 0.0 109.368 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.93 -31.37 9.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.845 . . . . 0.0 109.486 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.6 mp -36.7 -35.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.933 . . . . 0.0 109.172 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -75.44 -55.86 5.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.7 m -51.11 -39.87 57.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.05 -66.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.67 -19.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.328 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -79.75 -78.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.937 . . . . 0.0 109.573 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.3 tt -45.95 -36.77 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.7 p -68.76 -39.07 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.82 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -79.78 -12.22 59.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -98.6 -26.36 14.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.539 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.3 -34.76 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -50.73 116.31 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.41 57.49 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -89.22 -177.89 5.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.391 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.525 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 50.6 m -107.17 -178.95 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.9 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.2 mt -77.68 -23.07 49.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 -14.22 60.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.378 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -101.23 -41.95 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.14 1.71 56.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.6 47.07 1.08 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -176.85 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -1.127 . . . . 0.0 109.394 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.498 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -38.16 155.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -116.43 158.6 23.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.539 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.534 ' OD1' ' OE1' ' A' ' 111' ' ' GLU . 1.4 p-10 -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -47.55 -37.06 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.19 -66.97 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 109.555 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -44.95 -44.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.46 -39.76 77.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.105 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -75.86 -10.01 59.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.234 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -79.47 -62.87 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 mt -72.52 -2.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.09 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 46.9 77.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 110.086 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -126.69 148.52 65.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 108.875 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -37.78 148.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.887 2.391 . . . . 0.0 112.358 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.71 -79.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.676 2.251 . . . . 0.0 112.348 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.532 ' CG1' ' H ' ' A' ' 103' ' ' LYS . 3.3 t 47.16 -138.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.195 -0.941 . . . . 0.0 109.298 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.555 ' O ' ' C ' ' A' ' 104' ' ' VAL . 14.6 tttt -78.42 -6.45 55.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.555 ' C ' ' O ' ' A' ' 103' ' ' LYS . 12.0 p 31.97 41.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.485 -0.759 . . . . 0.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 103' ' ' LYS . 16.0 p80 -68.65 -24.4 64.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.8 t -59.48 -71.18 0.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.6 m -46.35 -42.19 14.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.299 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 109' ' ' LEU . 87.5 mt -54.77 -70.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 108' ' ' ILE . 6.4 mp -36.64 -34.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 109.452 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 108' ' ' ILE . . . -61.4 -72.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' OD1' ' A' ' 90' ' ' ASN . 16.9 tt0 -54.49 -38.33 66.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -27.99 68.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.892 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -79.09 -58.26 3.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.529 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.5 tp -44.7 -39.5 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 109.548 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -67.79 -55.9 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.553 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.54 -50.17 13.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.87 -59.98 4.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.506 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.9 mt -52.02 -22.18 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.25 -49.93 25.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.47 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -68.77 -50.85 47.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -48.53 -50.56 31.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 123' ' ' ALA . 3.4 mttm -65.13 -39.36 92.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.626 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -43.16 -42.82 4.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.2 tptt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.928 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 13.13 14.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.888 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -108.83 16.95 22.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.07 116.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.16 140.18 15.6 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.3 m -119.89 120.51 36.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.1 132.94 6.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -136.02 131.43 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -1.141 . . . . 0.0 109.282 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.03 -174.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.23 -169.17 38.71 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -140.31 100.51 6.97 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' CYS . 69.0 Cg_exo -47.06 -60.55 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.52 2.146 . . . . 0.0 112.152 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.71 -20.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 35' ' ' PRO . 3.7 m -118.85 -32.39 4.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 81.0 25.81 54.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.78 132.39 35.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -1.115 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -107.36 115.39 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.7 ttt -113.94 102.15 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -84.92 155.04 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.51 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.89 110.83 2.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -115.26 123.56 49.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.95 153.23 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -126.0 134.38 51.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.75 148.1 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.199 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.58 -94.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.039 -1.038 . . . . 0.0 109.612 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -156.43 20.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.46 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -1.2 3.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.915 . . . . 0.0 109.46 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.11 15.06 31.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mm -105.32 122.35 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -1.147 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.0 mt -67.82 111.93 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.253 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' O ' ' CD ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -88.19 -8.07 55.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.817 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 56' ' ' ALA . 7.0 t70 -171.96 165.86 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 55' ' ' ASP . . . -149.55 139.79 22.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 165.46 24.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -170.61 -174.49 1.63 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.809 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -172.03 111.08 0.28 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.038 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.417 HG22 ' HG ' ' A' ' 70' ' ' SER . 71.1 p -84.32 149.45 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.816 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.7 116.09 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.37 -0.832 . . . . 0.0 109.316 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.49 -87.23 0.14 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 140.32 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -1.11 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.481 ' C ' ' HG ' ' A' ' 65' ' ' SER . . . -91.11 55.37 3.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.481 ' HG ' ' C ' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -143.55 -32.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.378 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -83.6 1.23 43.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.409 HD11 ' HG1' ' A' ' 60' ' ' THR . 5.8 mm -59.07 4.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.614 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -94.09 -38.66 11.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.62 -52.82 18.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.417 ' HG ' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -53.11 -33.67 53.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.514 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.436 ' O ' ' OG1' ' A' ' 74' ' ' THR . 6.2 m -71.51 -35.77 70.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.97 -65.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 tt -46.12 -39.56 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.781 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 71' ' ' SER . 16.6 p -62.89 -40.01 96.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 1.39 51.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.902 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -17.37 14.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.823 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.8 m -114.03 53.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.039 . . . . 0.0 109.648 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HZ2' ' HA ' ' A' ' 55' ' ' ASP . 24.5 tttm -126.26 104.34 8.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.375 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -24.02 33.99 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -65.38 -179.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.405 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.6 159.17 15.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.124 -0.985 . . . . 0.0 109.65 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mt -56.43 -22.29 30.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.888 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.08 -46.47 70.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.138 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.81 -45.58 93.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.132 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.46 72.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.153 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 49.0 4.15 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.98 -32.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -1.075 . . . . 0.0 109.182 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.544 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -34.16 -44.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.45 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 88' ' ' ILE . 49.3 mttt 57.79 145.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.835 . . . . 0.0 109.559 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.35 -28.82 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 0.0 109.37 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.3 p -54.53 -39.86 68.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -53.9 12.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.3 mt -51.49 -40.61 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.447 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.45 -58.82 5.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.392 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.63 -53.01 34.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.214 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -47.24 -50.51 21.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.342 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.5 mp -70.19 -40.34 74.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.357 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 1.8 tp10 81.71 32.6 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.19 146.14 50.6 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 102' ' ' VAL . 20.5 Cg_endo -64.77 152.59 81.5 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.558 2.172 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.11 20.11 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.875 2.383 . . . . 0.0 112.131 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 100' ' ' PRO . 33.0 m -87.93 -21.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.63 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -137.18 47.74 2.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.793 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.45 -9.5 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 108.998 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.28 -27.15 54.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 45.2 t -69.87 -64.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -49.59 -65.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.363 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 107' ' ' SER . 80.0 mt -40.98 -44.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 mp -57.46 -44.23 84.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -57.69 -48.1 80.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.271 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.61 -59.68 5.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 -25.89 3.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.885 . . . . 0.0 109.441 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.9 69.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.454 HG21 ' N ' ' A' ' 115' ' ' LYS . 2.1 tp -70.23 -35.76 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.476 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.454 ' N ' HG21 ' A' ' 114' ' ' ILE . 13.7 mttt -77.92 -30.4 50.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.531 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.86 -43.85 87.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.358 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.14 77.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.273 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.16 -45.72 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.429 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.83 75.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 29' ' ' THR . 4.8 m-20 -66.92 -8.64 30.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -87.22 -52.36 5.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -61.89 -41.78 98.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.633 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.51 -0.59 5.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.429 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.296 0.57 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -92.11 12.31 22.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.333 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.89 19.96 15.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.0 t -139.29 99.42 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.52 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.04 120.87 5.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -82.96 136.69 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 109.52 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.12 85.59 0.32 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mtt -94.69 107.27 19.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -1.103 . . . . 0.0 109.559 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.1 170.78 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.526 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.94 -173.21 34.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.1 87.09 55.97 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.184 . . . . 0.0 109.481 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.94 -12.8 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.736 2.291 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.8 m -120.18 -38.68 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.5 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.12 36.88 0.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.41 115.8 28.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.127 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.72 131.23 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.091 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -134.55 131.5 38.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.801 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 5.4 tt0 -125.41 131.88 52.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.274 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -142.96 111.87 6.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.506 ' NE2' ' OE1' ' A' ' 42' ' ' GLN . 9.2 mt-30 -103.22 143.92 32.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -106.77 147.5 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.574 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 117.94 29.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.8 134.0 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.6 m-20 -170.39 -31.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.575 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 14.0 m-20 -62.7 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.092 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-80 74.49 48.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.488 -0.758 . . . . 0.0 109.067 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.65 -8.54 58.97 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.486 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 45.2 mm -87.71 162.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 53' ' ' ILE . 62.3 mt -79.37 120.33 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.75 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.38 -31.9 21.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.64 157.11 1.99 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.221 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.87 139.09 50.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -103.22 117.66 35.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 15.1 p90 -103.88 166.42 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.5 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -167.05 93.49 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.357 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.78 135.66 50.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.505 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -150.59 139.61 21.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.71 -45.21 0.76 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.6 OUTLIER -119.58 123.71 44.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -1.107 . . . . 0.0 109.389 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 67.19 0.17 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.641 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -174.8 -48.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -1.15 . . . . 0.0 109.633 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.03 -2.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.641 ' H ' ' C ' ' A' ' 65' ' ' SER . 6.2 mm -82.4 -12.05 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.317 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.16 -48.45 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 109.683 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -40.68 97.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.687 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.567 ' O ' ' OG1' ' A' ' 74' ' ' THR . 1.0 OUTLIER -55.25 -47.16 75.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.72 -42.99 99.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.862 . . . . 0.0 109.813 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tp -61.93 -68.25 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.61 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 74' ' ' THR . 17.7 tt -47.99 -49.61 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.754 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.567 ' OG1' ' O ' ' A' ' 70' ' ' SER . 6.5 p -50.49 -46.79 57.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.84 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.52 -5.42 54.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -5.98 26.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.52 -5.85 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.22 114.09 19.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.627 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.21 -6.72 63.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -91.24 165.48 13.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -1.21 . . . . 0.0 109.635 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.486 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 18.1 m -100.42 166.98 10.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.543 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -23.44 67.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.51 -44.82 93.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.83 -59.03 2.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.92 . . . . 0.0 109.387 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.42 -26.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.269 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.17 44.21 1.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.554 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -161.99 -37.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.096 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.554 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.0 pt -41.54 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -136.84 154.49 50.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.54 ' O ' ' C ' ' A' ' 91' ' ' SER . 18.5 p-10 -73.77 -50.71 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.54 ' C ' ' O ' ' A' ' 90' ' ' ASN . 4.0 t -35.01 -46.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.536 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.94 -49.9 72.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.2 mt -55.68 -35.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.221 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.95 -24.3 60.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -81.6 -47.47 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.28 -29.36 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.306 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 99' ' ' LEU . 1.3 mp -98.05 -28.81 13.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.534 ' O ' ' C ' ' A' ' 99' ' ' LEU . 1.6 tt0 64.8 -2.94 0.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.259 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.534 ' C ' ' O ' ' A' ' 98' ' ' GLU . 1.7 pp -34.58 150.23 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.477 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -40.33 108.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.858 2.372 . . . . 0.0 112.097 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.23 8.54 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.536 2.157 . . . . 0.0 112.445 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.84 -14.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -153.11 -38.8 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' CYS . 5.9 t 64.85 5.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.471 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 7.6 p-80 -45.6 -20.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' VAL . 1.8 m -75.41 -75.67 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 106' ' ' CYS . 4.4 m -43.24 -38.78 2.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.8 mt -57.86 -52.65 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.5 mp -59.25 -23.08 62.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.74 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.534 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 6.9 tp10 -60.08 -40.06 88.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -27.69 69.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.177 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -73.44 -65.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.4 tp -43.08 -33.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -67.6 -73.25 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.352 -0.843 . . . . 0.0 109.414 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.544 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -35.48 -36.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' LYS . . . -60.96 -63.93 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.9 mt -47.49 -25.34 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.412 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -59.22 3.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -61.58 -40.28 94.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.313 -0.867 . . . . 0.0 109.093 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -52.43 -57.77 8.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 109.188 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' LYS . 1.7 ttmm -54.44 -47.94 72.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.478 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -44.43 -21.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.51 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 122' ' ' LYS . 42.6 mmtt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.387 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.278 0.561 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.521 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 3.3 m -103.97 -0.41 28.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.659 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.71 11.98 36.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.336 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.37 110.06 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.86 145.68 17.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 m -139.96 137.28 34.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.6 150.73 22.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.9 mtt -144.11 105.0 4.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -1.112 . . . . 0.0 109.209 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.25 -176.15 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.84 157.11 17.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.63 138.4 20.61 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.178 -1.189 . . . . 0.0 109.466 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.99 3.72 4.28 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.609 2.206 . . . . 0.0 112.216 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.17 -79.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -109.37 20.74 17.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.354 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 53.51 16.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.644 ' OD2' ' SG ' ' A' ' 63' ' ' CYS . 1.5 m-20 -86.56 116.93 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -1.105 . . . . 0.0 109.698 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -95.09 121.17 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 109.211 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.34 112.89 20.62 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.168 -0.957 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -99.76 140.15 34.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 109.084 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 tt -151.11 121.31 7.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.727 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -126.49 176.79 6.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.98 157.44 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -131.88 134.93 46.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.582 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 30.0 t -124.9 122.65 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.686 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.3 m-20 -157.78 -32.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.546 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 11.1 t70 -62.22 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.5 m-20 78.89 52.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -0.833 . . . . 0.0 109.535 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.86 9.45 66.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 mm -105.03 155.52 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -1.18 . . . . 0.0 109.476 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.49 HD11 HG21 ' A' ' 53' ' ' ILE . 74.4 mt -75.27 114.46 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -85.37 -35.35 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.73 164.2 31.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.72 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.14 120.36 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.303 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -99.21 122.48 42.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.582 ' CD2' ' CG2' ' A' ' 74' ' ' THR . 11.6 p90 -139.7 160.49 39.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -140.02 120.02 13.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.305 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 p -121.44 137.48 54.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.733 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -162.12 100.73 1.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.8 -50.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.975 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.644 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 11.5 m -122.01 179.1 4.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -1.232 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.418 ' O ' ' CG2' ' A' ' 67' ' ' ILE . . . -102.87 -21.08 10.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . 9.6 t -83.91 -66.68 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -1.164 . . . . 0.0 109.412 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -45.66 -21.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.323 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 65' ' ' SER . 0.6 OUTLIER -64.79 -5.04 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.396 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.19 -55.33 2.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -52.47 -45.55 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.597 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.24 -51.41 44.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.64 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.471 ' HA ' ' HG1' ' A' ' 74' ' ' THR . 0.5 OUTLIER -56.98 -43.52 81.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.754 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.19 -68.5 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.9 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.431 ' CG2' ' H ' ' A' ' 74' ' ' THR . 9.1 tt -50.86 -53.05 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.582 ' CG2' ' CD2' ' A' ' 58' ' ' PHE . 33.4 p -48.01 -28.37 2.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.814 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -101.29 -4.62 26.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -89.84 -18.16 26.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.68 26.18 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -102.75 103.83 14.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.43 0.15 27.9 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -100.38 -176.51 3.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -1.14 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.491 ' HG ' ' H ' ' A' ' 82' ' ' LEU . 22.6 t -108.23 173.85 6.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.594 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.491 ' H ' ' HG ' ' A' ' 81' ' ' SER . 7.8 mt -65.58 -18.04 65.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.594 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.42 -30.57 67.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -86.43 -53.17 5.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.57 -18.89 64.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.351 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.93 40.1 2.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -158.02 -35.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -1.089 . . . . 0.0 109.24 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -44.65 169.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -133.01 -170.4 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.185 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.433 ' O ' ' OG ' ' A' ' 107' ' ' SER . 12.8 p-10 -99.02 -30.33 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.59 -40.83 93.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 95' ' ' GLU . 4.0 mm-40 -58.5 -70.92 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.644 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 92' ' ' GLN . 40.9 mt -44.46 -34.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.99 73.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 92' ' ' GLN . 2.2 tt0 -80.65 -15.49 56.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.193 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -81.24 -51.98 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -78.79 -22.98 45.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 2.4 tt0 73.2 36.15 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.449 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -74.37 146.0 83.45 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.4 155.74 50.64 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.658 2.239 . . . . 0.0 112.261 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.6 Cg_endo -75.31 -2.24 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.852 2.368 . . . . 0.0 112.374 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.87 -2.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.657 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 101' ' ' PRO . 29.4 tttt -166.07 61.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 106' ' ' CYS . 20.4 t -60.63 -25.79 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.422 ' ND1' ' CD1' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -49.15 -17.9 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.159 -0.963 . . . . 0.0 109.287 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -74.01 -62.86 1.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 90' ' ' ASN . 6.9 t -57.19 -36.55 70.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.319 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 109' ' ' LEU . 4.6 mt -61.43 -64.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.268 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 108' ' ' ILE . 2.7 mp -42.61 -41.12 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.92 -63.4 1.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 109.677 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 112' ' ' ASP . 2.1 tm-20 -52.89 -67.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 111' ' ' GLU . 11.4 t70 -37.47 -37.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -60.88 -67.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.81 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.9 tp -41.14 -39.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.9 tmtt? -58.82 -55.3 36.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.98 -56.66 9.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.689 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.96 5.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.587 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 66.7 mt -75.55 -59.63 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -37.02 -51.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 122' ' ' LYS . 27.2 t0 -68.69 -58.09 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 109.701 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.534 ' C ' ' O ' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -33.17 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 109.7 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.633 ' N ' ' O ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -96.93 -34.24 11.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.585 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -78.96 -17.78 54.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 123' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 4' ' ' SER . . . 170.89 76.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.683 ' CD2' ' O ' ' A' ' 3' ' ' TYR . 46.4 t80 -72.27 13.39 0.33 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.4 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 2' ' ' ALA . 11.0 p -120.26 166.89 12.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.435 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -90.96 23.72 3.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.41 121.76 40.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.598 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.529 ' O ' ' C ' ' A' ' 8' ' ' ILE . 28.2 t -104.02 -11.5 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.867 . . . . 0.0 109.34 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.529 ' C ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -35.87 147.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.404 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 74.0 m-20 -83.45 -30.39 27.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.643 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER 178.34 160.7 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 109.463 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -69.68 -38.34 77.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.534 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -133.97 -87.29 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -147.07 149.76 36.38 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 109.549 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.88 7.62 1.95 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.814 2.343 . . . . 0.0 112.257 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -97.87 27.96 4.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER 56.2 77.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.563 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 18' ' ' GLY . 53.6 t 55.76 162.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.485 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . 167.36 -88.02 0.1 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.85 145.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -1.16 . . . . 0.0 109.528 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.42 HD13 ' HZ2' ' A' ' 57' ' ' LYS . 2.5 tp 59.64 107.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.545 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.567 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -178.58 6.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 1.1 mptt 57.46 -0.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.524 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' H ' ' C ' ' A' ' 21' ' ' ASP . 5.6 mtmm -135.01 63.07 1.63 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.204 -0.935 . . . . 0.0 109.504 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -147.08 161.07 41.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -82.21 -12.94 57.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.347 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -92.88 10.77 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.387 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 t -136.55 117.58 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.84 130.34 10.24 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 m -110.44 147.73 33.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.453 -1.028 . . . . 0.0 109.322 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.79 117.6 0.82 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.15 108.41 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.279 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.27 -172.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.33 -171.52 38.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -131.84 74.88 76.76 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.16 . . . . 0.0 109.653 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.27 -2.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.786 2.324 . . . . 0.0 112.148 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -79.48 -7.89 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 3.2 m -149.93 -56.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.927 . . . . 0.0 109.477 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.472 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . 144.03 54.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -124.9 136.64 53.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -1.186 . . . . 0.0 109.347 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.78 135.97 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.9 ttt -133.68 136.96 45.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.504 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -129.63 126.97 39.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 tt -132.47 132.82 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -131.08 133.5 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.153 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -116.16 149.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 14.5 tttm -111.59 136.3 50.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.714 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 t -129.28 116.57 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.168 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.661 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.8 m-20 -159.96 -34.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 109.893 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 51.8 t0 -62.29 50.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.305 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.661 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.9 m-20 81.61 54.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.505 -0.747 . . . . 0.0 109.266 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.64 0.98 9.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 53' ' ' ILE . 3.8 mm -93.01 164.25 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.292 -1.122 . . . . 0.0 109.468 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.453 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 3.3 mt -97.32 114.38 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -97.38 -38.86 9.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -124.39 151.33 44.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 109.783 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.61 99.56 3.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.42 ' HZ2' HD13 ' A' ' 20' ' ' LEU . 1.1 mttt -94.4 175.21 6.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.641 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -165.02 176.91 8.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.474 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -166.31 110.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.7 p -129.13 96.65 4.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.954 . . . . 0.0 109.487 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -115.14 104.21 11.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.48 -41.3 0.28 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.76 ' HG ' ' H ' ' A' ' 66' ' ' ALA . 1.4 t -106.76 105.62 15.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -1.086 . . . . 0.0 109.219 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -67.0 74.44 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 67' ' ' ILE . 1.2 p 162.74 -42.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -1.172 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.76 ' H ' ' HG ' ' A' ' 63' ' ' CYS . . . -56.45 1.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.624 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.5 mp -73.32 -54.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.52 -71.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 t -45.78 -43.03 12.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 109.613 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.551 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.9 OUTLIER -51.0 -36.33 38.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.644 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -31.25 57.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -54.98 7.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 74' ' ' THR . 10.9 tt -58.18 -47.91 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.551 ' OG1' ' O ' ' A' ' 70' ' ' SER . 11.9 p -61.19 -34.19 74.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.08 -7.82 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.13 -0.981 . . . . 0.0 109.623 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -87.13 -36.82 17.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.419 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' GLY . 35.5 m -88.31 -28.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' N ' HG21 ' A' ' 77' ' ' VAL . 6.8 tttp -47.98 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.503 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 77' ' ' VAL . . . 120.38 -26.97 6.81 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.639 ' NZ ' ' OE1' ' A' ' 84' ' ' GLU . 7.1 mtpt -74.13 -165.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.92 163.5 24.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.97 . . . . 0.0 109.596 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.6 mt -55.81 -37.58 68.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.34 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -56.12 -32.56 64.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.3 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE1' ' NZ ' ' A' ' 80' ' ' LYS . 38.7 mt-10 -84.2 -42.96 15.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.83 69.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.15 43.86 3.07 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.04 -35.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.129 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.4 pt -52.52 157.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.455 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -129.23 164.99 22.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -30.08 69.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -60.65 -29.09 69.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -58.99 -56.22 25.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 mp -70.41 -38.97 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.96 55.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.623 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.42 -43.03 15.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.591 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' O ' ' CD ' ' A' ' 96' ' ' GLU . 12.6 tm-20 -63.93 -23.18 67.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.67 -37.9 9.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 67.57 73.44 0.32 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.51 149.17 60.9 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 102' ' ' VAL . 19.7 Cg_endo -61.86 157.71 41.84 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.759 2.306 . . . . 0.0 112.069 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.56 15.01 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.818 2.345 . . . . 0.0 112.315 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 100' ' ' PRO . 4.0 m -104.87 16.75 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -151.73 18.24 0.7 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 t -57.69 -14.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -51.19 -27.13 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 2.1 m -77.63 -75.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.524 ' C ' ' O ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -36.28 -33.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 106' ' ' CYS . 8.5 mt -68.26 -54.97 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.77 -19.64 51.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.46 -64.88 0.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.36 -45.74 86.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -54.64 -35.87 63.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.214 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.22 -57.83 9.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 109.436 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 115' ' ' LYS . 0.4 OUTLIER -50.01 -36.29 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.413 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.446 ' N ' HG23 ' A' ' 114' ' ' ILE . 2.8 tttt -63.24 -37.86 88.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.02 76.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.54 93.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.93 . . . . 0.0 109.501 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.61 -40.86 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.66 88.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.483 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.31 -16.38 60.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.413 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' A' ' 25' ' ' SER . 93.1 t80 -79.39 -31.61 42.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -94.27 -22.63 18.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -76.53 -18.48 58.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 19.03 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.505 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.542 ' H ' ' C ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -161.83 40.65 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.483 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -106.54 -102.83 2.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 mp -81.58 -17.01 49.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -1.161 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 54.32 -133.94 1.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.577 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 129' ' ' HIS . 4.3 p80 -127.79 -176.15 3.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.872 . . . . 0.0 109.406 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.99 -27.1 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.308 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -134.91 140.9 46.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 109.285 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.492 ' O ' ' C ' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -167.52 64.77 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.682 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.492 ' C ' ' O ' ' A' ' 132' ' ' HIS . 8.5 p80 -39.25 135.03 1.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 109.3 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.572 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.72 -65.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.404 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.457 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 14.3 p90 -120.25 125.56 48.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.349 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.35 150.87 5.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.524 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -150.63 -60.35 0.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.333 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -67.16 135.11 53.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.411 -0.805 . . . . 0.0 109.429 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.16 155.07 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 tt -76.54 108.32 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.287 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -112.66 -176.42 2.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 0.0 109.647 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.41 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 1.4 t-80 176.96 70.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.205 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.41 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 11.3 m-85 -150.89 134.84 16.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.971 -1.08 . . . . 0.0 110.067 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.525 ' C ' HD21 ' A' ' 13' ' ' ASN . 0.3 OUTLIER -148.29 153.98 39.4 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.525 HD21 ' C ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -161.14 152.36 15.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.033 -1.042 . . . . 0.0 109.934 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.54 66.04 5.6 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.866 2.377 . . . . 0.0 112.11 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.01 -42.71 8.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -129.99 109.28 10.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.75 -20.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.89 -105.77 0.27 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -93.33 -154.72 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -1.162 . . . . 0.0 109.515 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tp -118.67 152.34 36.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.404 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -46.71 143.82 2.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.435 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -67.53 -5.15 13.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -77.19 29.95 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.93 . . . . 0.0 109.4 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -114.92 151.49 33.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.67 6.14 36.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -120.21 -15.94 8.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.697 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -103.12 128.95 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.353 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -127.05 149.75 17.8 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 120' ' ' ASP . 52.2 m -127.71 149.16 50.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -1.081 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.87 125.37 2.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 ttt -119.74 92.9 3.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -1.205 . . . . 0.0 109.367 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 m -103.56 163.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 109.286 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.27 -176.08 29.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.26 96.07 10.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.337 -1.096 . . . . 0.0 109.386 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.501 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.9 Cg_exo -56.66 -26.37 64.76 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.652 2.235 . . . . 0.0 112.28 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.93 -59.99 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.34 -48.31 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.62 52.78 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -116.34 117.22 29.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.151 . . . . 0.0 109.416 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 m -105.92 141.47 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -135.9 128.82 31.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.28 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.78 HE21 ' NE2' ' A' ' 44' ' ' GLN . 25.4 tt0 -112.68 125.0 53.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.616 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tp -124.01 136.4 54.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.78 ' NE2' HE21 ' A' ' 42' ' ' GLN . 12.8 mt-30 -118.85 145.78 45.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 109.654 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pp -126.31 126.09 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -103.21 109.33 20.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' C ' ' A' ' 48' ' ' ASP . 24.5 t -94.57 110.83 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 47' ' ' VAL . 1.1 t70 -40.16 -77.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.437 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 7.2 t0 -179.71 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 0.0 108.862 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -84.06 -17.09 41.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.458 -0.776 . . . . 0.0 109.352 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.2 12.01 5.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.408 HG23 HD13 ' A' ' 52' ' ' ILE . 17.4 mm -104.87 134.39 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.413 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.452 HD13 HG23 ' A' ' 53' ' ' ILE . 93.2 mt -63.4 88.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.408 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.51 -52.38 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.261 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -143.24 -179.16 6.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 109.141 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.79 144.48 7.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.957 . . . . 0.0 109.743 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -135.32 162.59 32.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.342 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -145.81 167.92 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.368 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -165.83 114.29 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 80.7 p -108.95 141.93 40.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.43 99.65 2.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.9 -54.14 0.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 49.4 t -124.98 173.52 8.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -1.21 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.475 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -121.53 19.06 8.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.7 p -113.83 -8.63 13.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -1.127 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.42 -2.81 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.506 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 68' ' ' ALA . 8.5 mm -61.65 -53.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.402 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -41.4 -53.51 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.457 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 70' ' ' SER . 25.1 p -58.09 -54.26 48.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.531 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.8 OUTLIER -43.94 -38.01 3.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.7 m -71.02 -44.96 64.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.24 -55.62 26.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.61 ' CG2' ' H ' ' A' ' 74' ' ' THR . 2.2 tt -62.33 -61.75 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.61 ' H ' ' CG2' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -35.31 -32.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.78 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -85.57 -30.87 22.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 0.0 109.825 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.606 ' N ' ' O ' ' A' ' 73' ' ' ILE . 10.7 m0 -82.69 0.82 41.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.719 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -123.51 65.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.51 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -148.3 94.35 2.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.31 61.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 76' ' ' TRP . 7.5 mttp -72.17 -168.2 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.421 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -115.69 141.1 48.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mt -48.77 -11.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' SER . 35.1 tt0 -71.08 -55.59 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.235 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -66.36 -30.67 71.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.256 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -24.09 52.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 109.22 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.77 50.24 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.78 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -1.123 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.51 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -36.46 -23.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.744 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 87' ' ' ALA . 10.0 mttm 61.32 173.85 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.304 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.465 HD21 HG12 ' A' ' 108' ' ' ILE . 8.0 p-10 -95.73 -42.55 8.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.439 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 88.9 p -52.76 -50.02 64.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' SER . 4.5 tt0 -44.06 -65.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.194 -0.942 . . . . 0.0 109.779 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.5 mt -59.65 -32.01 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.713 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.58 -32.61 69.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.876 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.84 -33.92 24.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.689 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -55.94 -42.84 76.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.3 mt -83.0 -28.39 29.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 65.64 74.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 148.83 59.88 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.158 -0.963 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.61 148.64 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.58 2.187 . . . . 0.0 112.125 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.54 6.09 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.738 2.292 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.68 -35.88 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -135.52 42.43 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.436 ' CG2' ' HG ' ' A' ' 107' ' ' SER . 9.8 p -58.4 -18.79 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.432 ' CD2' ' C ' ' A' ' 105' ' ' HIS . 8.1 p-80 -45.32 -24.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.338 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -64.87 -47.35 78.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.167 -0.958 . . . . 0.0 109.2 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.436 ' HG ' ' CG2' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -65.28 -50.1 67.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.465 HG12 HD21 ' A' ' 90' ' ' ASN . 4.4 mm -56.0 -33.45 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.883 . . . . 0.0 109.369 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.443 ' O ' ' C ' ' A' ' 110' ' ' ALA . 1.4 mp -63.92 -61.65 2.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -40.36 -53.68 2.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -61.15 -58.25 9.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.3 -34.07 2.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -64.92 -69.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.658 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.1 tp -37.78 -35.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -65.53 -68.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -43.33 -46.22 6.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.307 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.43 -40.72 71.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.456 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.22 -46.89 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.417 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.49 -58.11 7.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.53 ' CG ' ' O ' ' A' ' 29' ' ' THR . 5.2 m-20 -49.0 -59.6 3.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.715 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -51.08 -21.59 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.685 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -96.93 -8.6 30.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.18 -8.4 17.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -15.77 60.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.42 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -48.5 -75.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.474 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 168.61 43.8 0.03 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' GLU . 0.8 OUTLIER -113.59 -6.31 13.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.49 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 127' ' ' LEU . 10.5 mm-40 -42.82 -60.56 1.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -76.12 150.05 37.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.644 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -117.76 -161.64 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.384 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -169.56 33.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.643 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 1.1 p80 -114.62 45.89 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.542 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -158.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.348 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.444 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.553 ' O ' ' O ' ' A' ' 2' ' ' ALA . 5.6 ttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.553 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 55.5 118.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.347 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -79.18 -24.27 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.937 . . . . 0.0 109.45 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -60.54 -160.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.457 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.58 ' N ' ' OG ' ' A' ' 4' ' ' SER . 0.5 OUTLIER -117.84 177.93 4.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 109.519 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 5' ' ' GLU . 20.7 mmtt -47.89 -177.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.309 -0.869 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.3 t -91.79 127.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.405 ' N ' HD11 ' A' ' 8' ' ' ILE . 2.7 mm -78.34 -37.07 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.533 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -77.86 54.82 1.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -113.74 -157.87 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 0.0 109.383 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -133.68 103.52 5.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.501 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.528 ' O ' ' C ' ' A' ' 13' ' ' ASN . 1.6 tt0 -168.83 20.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.474 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.629 ' O ' ' N ' ' A' ' 15' ' ' ARG . 18.5 m-80 36.45 83.09 0.21 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -55.87 35.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.774 2.316 . . . . 0.0 112.133 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.629 ' N ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -150.43 177.33 10.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.454 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 15' ' ' ARG . 5.6 t-20 77.42 -59.43 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.438 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -121.04 158.22 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.424 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.52 -26.13 25.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -174.98 -179.32 1.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.153 . . . . 0.0 109.527 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.507 ' CB ' ' O ' ' A' ' 19' ' ' SER . 11.9 tp 77.27 57.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.386 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -162.17 19.8 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.81 . . . . 0.0 109.482 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt 49.67 11.2 0.05 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 21' ' ' ASP . 9.6 mttt -143.7 62.44 1.36 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.271 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -132.2 137.4 47.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.151 -0.968 . . . . 0.0 109.364 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.44 1.68 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.566 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -117.04 5.59 12.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.5 98.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.59 124.62 8.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -102.7 131.91 49.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -1.155 . . . . 0.0 109.329 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.93 96.44 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.0 ttt -99.52 133.44 43.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.144 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.23 156.11 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.035 -1.041 . . . . 0.0 109.808 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.06 121.61 2.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.13 87.09 28.0 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.263 -1.139 . . . . 0.0 109.428 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.99 36.25 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.893 2.395 . . . . 0.0 112.303 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.67 -39.64 1.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.8 t -177.02 -29.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.394 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.73 71.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.498 ' OD2' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER 62.7 -174.21 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -1.154 . . . . 0.0 109.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 m -95.46 149.45 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.384 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 8.5 ttt -142.34 133.29 25.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.46 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.451 ' HG2' HE21 ' A' ' 44' ' ' GLN . 7.4 tt0 -107.33 127.83 53.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.45 135.56 44.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.557 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.451 HE21 ' HG2' ' A' ' 42' ' ' GLN . 6.5 mp0 -138.19 137.54 37.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.419 ' H ' HG13 ' A' ' 45' ' ' ILE . 1.5 pp -120.64 143.36 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 109.427 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -102.31 152.14 21.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.96 116.72 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 48' ' ' ASP . 33.5 t0 -57.7 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.56 19.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -148.76 24.84 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.502 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.81 30.28 56.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 52' ' ' ILE . 31.5 mm -109.41 134.63 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -1.21 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.6 mt -80.56 81.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.22 -40.49 74.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -137.64 163.51 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.77 102.59 4.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.53 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -97.81 155.49 17.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -166.46 171.29 12.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -163.96 126.04 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.81 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.15 121.8 45.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.028 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 101.53 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.6 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 156.74 -57.25 0.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.8 148.6 26.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -1.117 . . . . 0.0 109.598 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.94 16.97 30.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -125.38 -35.49 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 0.0 109.459 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.11 -3.09 3.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.405 ' H ' ' C ' ' A' ' 65' ' ' SER . 16.9 mm -58.95 -35.32 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.339 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.12 -62.54 1.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' LEU . 3.9 m -58.38 -54.59 45.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.467 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.508 ' C ' ' O ' ' A' ' 69' ' ' SER . 50.6 m -36.98 -66.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.447 ' HG ' ' N ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -51.62 -30.52 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' SER . 12.2 tp -68.93 -73.89 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.578 ' O ' ' N ' ' A' ' 76' ' ' TRP . 0.9 OUTLIER -39.7 -59.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.473 ' H ' HG23 ' A' ' 73' ' ' ILE . 42.4 p -44.21 -44.95 8.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.317 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -73.46 -14.98 61.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.307 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.578 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.07 -11.71 35.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.91 61.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.4 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.09 103.1 7.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.481 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 4.01 89.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -78.55 -161.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -1.155 . . . . 0.0 109.39 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 83' ' ' GLU . 3.7 t -126.69 144.51 50.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -47.78 -15.07 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 0.0 109.24 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -80.71 -23.83 39.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.412 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -95.29 -18.78 20.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.0 -29.95 11.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.96 42.97 2.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -152.14 -37.0 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -1.137 . . . . 0.0 108.602 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -47.22 -175.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -141.38 -177.88 5.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 109.399 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.57 ' CG ' ' N ' ' A' ' 91' ' ' SER . 1.1 p-10 -87.69 -50.93 6.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -54.53 -22.31 12.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.25 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -68.0 -59.18 3.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 109.206 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.69 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 109.272 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.13 -36.49 73.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.245 -0.909 . . . . 0.0 109.196 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.19 -41.97 99.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.271 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.87 -32.9 73.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 0.0 109.047 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.5 mt -93.39 -28.36 16.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.301 -0.875 . . . . 0.0 109.112 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.4 tm-20 51.93 67.09 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.714 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.579 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.4 pt? -117.81 148.46 43.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.272 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -40.51 155.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.792 2.328 . . . . 0.0 112.268 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.08 -0.15 8.12 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.834 2.356 . . . . 0.0 112.177 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.32 -5.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' C ' ' N ' ' A' ' 105' ' ' HIS . 0.6 OUTLIER -125.72 -9.42 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 107' ' ' SER . 8.0 p -45.78 -24.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.489 ' C ' ' O ' ' A' ' 104' ' ' VAL . 15.2 m80 -38.9 -50.0 1.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.63 -36.47 64.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.114 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.628 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.1 p -66.31 -67.23 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.096 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.628 ' N ' ' OG ' ' A' ' 107' ' ' SER . 42.8 mt -45.91 -25.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.088 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 mp -75.98 -44.88 37.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.428 -0.795 . . . . 0.0 109.385 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.36 83.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.723 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.485 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 5.1 tp10 -65.93 -68.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -22.95 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.93 . . . . 0.0 109.641 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.19 -52.87 9.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -55.95 -40.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.59 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.495 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 5.7 tptt -66.14 -51.52 57.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.74 -41.99 64.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.415 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.34 -45.16 95.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 121' ' ' TYR . 61.7 mt -64.49 -61.12 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -40.69 -37.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.185 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -37.71 80.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.052 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 118' ' ' ILE . 7.5 t80 -72.35 -16.99 61.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -88.49 -44.94 10.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.209 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.1 95.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.317 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -72.49 -0.77 13.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -62.26 -20.78 64.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.635 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -142.46 20.47 2.41 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 126' ' ' GLY . 2.0 mp 35.81 48.07 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.235 -1.156 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -108.36 149.69 28.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.545 ' O ' ' CG ' ' A' ' 129' ' ' HIS . 20.7 p-80 -55.36 97.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 109.536 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.478 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -110.87 151.75 27.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 109.421 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER 40.03 83.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.794 ' H ' ' CD2' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -89.25 171.94 9.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.922 . . . . 0.0 109.424 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -75.37 -86.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.4 p80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.43 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 3' ' ' TYR . . . -62.5 -79.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.421 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.8 m-85 -137.93 146.72 43.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 t -74.91 115.64 14.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.252 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.42 -72.9 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.694 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG3' ' H ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.69 -52.86 2.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.809 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.415 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 10.7 p -146.21 155.92 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.827 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 pt -90.3 92.15 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.322 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.17 57.41 1.01 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -97.62 -126.93 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.113 -0.992 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -151.81 -172.02 4.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' H ' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tt0 -154.14 -73.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.644 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.8 t30 -79.71 -43.86 1.56 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 15.7 Cg_exo -65.02 98.52 0.31 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.913 2.408 . . . . 0.0 112.014 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -122.7 -67.75 0.93 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.628 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -112.45 118.6 35.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.21 -3.39 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.306 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.37 57.22 0.47 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -171.3 167.35 6.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -1.14 . . . . 0.0 109.274 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.438 ' CB ' ' O ' ' A' ' 19' ' ' SER . 0.3 OUTLIER 70.14 -17.9 0.25 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.201 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' A' ' 19' ' ' SER . 46.6 m-20 -68.89 147.34 51.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.39 -0.818 . . . . 0.0 109.471 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 10.0 tttt -73.58 16.68 0.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -133.23 27.04 4.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.786 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.5 156.01 20.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.349 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.2 m -85.71 -4.3 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -0.87 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.88 129.69 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.8 147.48 18.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.1 m -130.28 130.32 44.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -1.093 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.45 137.8 10.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.03 120.46 17.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -1.112 . . . . 0.0 109.351 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.75 146.6 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.89 -166.35 10.66 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.628 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -122.12 80.92 43.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.262 -1.14 . . . . 0.0 109.512 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.88 2.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.707 2.271 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.628 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -91.53 -3.73 56.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.41 -58.48 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.38 46.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.01 126.77 54.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 109.507 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 p -107.86 113.45 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -119.47 119.08 32.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HG3' ' N ' ' A' ' 43' ' ' LEU . 7.1 tt0 -103.23 154.93 18.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.198 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.44 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -155.87 119.47 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.487 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -122.23 151.24 41.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.296 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.79 138.01 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 109.565 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -107.57 127.95 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.04 150.66 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.7 t0 -94.21 -103.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -139.45 4.25 2.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.43 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -128.97 17.28 6.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.21 10.2 85.73 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 mm -93.08 132.71 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -1.105 . . . . 0.0 109.529 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 53' ' ' ILE . 17.6 mt -81.54 93.38 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.413 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -53.54 56.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' HA ' ' HZ2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -132.04 139.35 48.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.72 133.31 55.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.67 161.38 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.406 ' CD1' HG22 ' A' ' 74' ' ' THR . 10.7 p90 -169.05 174.32 6.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 109.821 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -165.07 121.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.476 -0.765 . . . . 0.0 109.105 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.661 ' CG2' ' HG ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -124.3 142.57 51.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -158.55 -177.55 6.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.47 -56.82 2.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 66.4 m -120.94 158.64 27.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -1.141 . . . . 0.0 109.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.27 11.49 58.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.98 -39.84 4.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.14 -22.13 66.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.73 -44.96 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -46.73 -62.56 1.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -43.22 -48.05 6.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 109.717 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.661 ' HG ' ' CG2' ' A' ' 60' ' ' THR . 0.6 OUTLIER -49.55 -68.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 109.397 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -37.27 -39.22 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.617 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 73' ' ' ILE . 11.3 tp -66.89 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.536 ' C ' ' O ' ' A' ' 72' ' ' LEU . 4.4 tt -33.74 -48.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 110.054 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.406 HG22 ' CD1' ' A' ' 58' ' ' PHE . 3.2 p -49.8 -46.81 51.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.3 tp10 -86.15 -11.96 51.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.902 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -2.57 57.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.368 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.48 -27.11 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 0.0 109.61 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HZ2' ' HA ' ' A' ' 55' ' ' ASP . 9.8 ttmm -62.1 113.14 2.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.05 58.18 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.44 -164.88 1.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 m -121.02 175.0 6.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.861 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.55 -17.98 64.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.778 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -77.46 -40.6 42.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.73 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -69.16 -44.65 71.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 109.839 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.77 -33.84 52.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.54 52.27 4.68 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -171.9 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.4 pt -36.47 132.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' SER . 50.2 mttt -117.97 142.78 46.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -41.35 -25.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -66.44 -39.41 88.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.568 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -67.73 -55.88 11.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.466 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.74 -30.08 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.09 -60.29 2.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.742 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -55.27 -20.52 11.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -64.53 1.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.12 -14.46 63.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.651 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 52.81 43.62 31.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.894 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.613 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.5 pt? -85.8 151.21 54.84 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -41.52 105.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.559 2.173 . . . . 0.0 111.913 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.87 20.36 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.343 2.028 . . . . 0.0 112.338 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.416 ' H ' HG21 ' A' ' 102' ' ' VAL . 17.6 m -70.47 -40.63 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 104' ' ' VAL . 21.2 mttt -109.94 -23.44 11.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 103' ' ' LYS . 2.5 t 41.43 30.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.421 ' NE2' ' HB1' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -81.16 -35.64 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 60.7 m -59.73 -64.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.563 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 108' ' ' ILE . 2.6 m -51.45 -58.27 6.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.0 mt -42.12 -41.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -63.8 -46.42 85.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.63 -66.7 0.36 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.78 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.2 tm-20 -46.06 -69.64 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.536 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -38.75 -26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -73.87 -63.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.69 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 2.3 tp -46.13 -37.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.579 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 58.6 tttt -66.53 -43.49 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.59 77.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.493 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.25 -54.67 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mt -49.95 -34.85 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 109.256 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -56.86 10.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -11.52 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.415 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -85.0 -43.7 13.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -94.73 3.71 54.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.8 -33.06 10.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.329 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 126' ' ' GLY . 7.4 tttt -75.33 -10.53 59.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 124' ' ' LYS . 8.2 tt0 -45.11 -17.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . 145.81 -39.37 1.15 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 129' ' ' HIS . 5.9 mt -61.71 -37.37 83.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -1.131 . . . . 0.0 109.597 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.26 4.52 0.47 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.89 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 127' ' ' LEU . 4.1 m80 -131.15 176.45 8.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.459 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.456 ' ND1' ' N ' ' A' ' 131' ' ' HIS . 20.6 p80 -112.27 -158.45 0.65 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.456 ' N ' ' ND1' ' A' ' 130' ' ' HIS . 11.1 p-80 -163.57 -154.04 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -144.16 54.29 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.479 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 48.1 m170 46.51 -133.48 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.586 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.598 ' H ' ' CD2' ' A' ' 134' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.535 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -49.53 -55.73 12.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -94.29 42.87 1.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.49 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -19.73 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' LYS . 3.6 pm0 -78.64 -177.29 5.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.663 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 62.6 mttt 54.16 106.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.35 150.62 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.599 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -155.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.273 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.81 -162.43 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 109.296 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.76 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -124.47 126.45 45.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.257 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.51 ' C ' ' O ' ' A' ' 10' ' ' HIS . 95.9 m-85 38.53 75.37 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 108.945 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.35 96.87 3.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -0.838 . . . . 0.0 109.84 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.737 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -86.33 -37.02 0.53 Allowed Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.275 -0.891 . . . . 0.0 109.283 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 27.3 Cg_exo -59.77 -21.58 64.12 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.795 2.33 . . . . 0.0 111.917 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 68.16 135.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -0.858 . . . . 0.0 109.426 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -57.75 117.47 4.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.515 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.45 22.53 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.385 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 64.79 -154.0 49.46 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 18' ' ' GLY . 2.8 p -54.01 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -1.169 . . . . 0.0 109.55 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.1 tp -112.89 -135.32 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 109.538 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' A' ' 23' ' ' LYS . 1.1 p30 -93.64 10.13 34.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.881 . . . . 0.0 109.56 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.566 ' C ' ' H ' ' A' ' 24' ' ' ASP . 26.3 tttt 64.94 -39.98 0.27 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.592 ' H ' ' C ' ' A' ' 21' ' ' ASP . 11.3 mptt -70.64 21.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.977 . . . . 0.0 109.372 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 22' ' ' LYS . 6.8 t0 -98.65 166.24 11.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 14.5 m -101.55 5.36 41.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -117.59 37.39 3.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.476 ' CG1' ' NE2' ' A' ' 44' ' ' GLN . 2.7 t -143.41 98.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.359 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.08 132.55 11.29 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 m -108.85 134.11 51.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -1.111 . . . . 0.0 109.362 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.3 90.77 0.23 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ttm -108.94 128.8 55.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -1.164 . . . . 0.0 109.686 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 m -130.51 165.1 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.392 -0.818 . . . . 0.0 109.173 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.86 121.81 2.1 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.45 93.33 22.48 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.339 -1.095 . . . . 0.0 109.364 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.39 40.7 0.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.665 2.243 . . . . 0.0 112.271 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -144.55 -40.1 0.27 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.7 m -168.11 -32.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.29 -19.01 68.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.44 ' OD2' ' C ' ' A' ' 62' ' ' GLY . 1.6 m-20 61.06 -168.93 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 109.456 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -86.84 140.77 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -142.5 125.77 16.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.318 -0.864 . . . . 0.0 109.599 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.94 113.5 20.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.04 107.17 11.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 109.894 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.476 ' NE2' ' CG1' ' A' ' 27' ' ' VAL . 7.7 tt0 -109.67 129.18 55.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.07 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.56 144.81 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 109.699 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -108.96 138.94 44.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.99 151.5 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 23.5 t0 -81.93 -48.84 11.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.634 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 162.15 -22.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 9.5 p-10 -102.47 25.52 8.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.466 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.37 -4.7 58.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 52' ' ' ILE . 40.8 mm -81.16 146.46 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.348 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.24 108.61 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -44.03 32.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.78 164.41 28.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.273 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.09 118.83 16.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -96.05 133.83 39.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.476 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 10.3 p90 -136.08 168.88 18.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -171.89 104.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.803 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 p -96.42 147.95 23.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.085 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -162.0 111.58 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.701 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.44 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 130.58 -41.11 1.57 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.9 t -103.7 121.26 42.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.636 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 46.72 1.98 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -158.32 -12.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.157 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.88 37.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 67' ' ' ILE . 1.4 mp -48.29 -33.1 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.88 -41.73 74.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 71' ' ' SER . 17.9 p -67.11 -64.15 0.91 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.565 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.8 OUTLIER -38.76 -26.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.33 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 69' ' ' SER . 7.5 t -78.4 -44.7 24.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 69' ' ' SER . 21.4 tp -60.97 -52.14 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.948 . . . . 0.0 109.471 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 74' ' ' THR . 2.3 tt -58.9 -41.46 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.565 ' OG1' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -66.79 -19.35 65.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.663 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 31.4 mm-40 -92.02 -16.35 26.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.49 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.04 -17.0 18.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -109.07 40.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.661 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -118.8 96.44 5.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.97 -27.05 17.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -59.69 -160.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -1.124 . . . . 0.0 109.498 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.09 165.85 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.89 -41.27 82.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -24.72 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.593 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -90.7 -48.48 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.536 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.88 -17.36 56.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.84 11.65 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -148.47 -35.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -41.74 172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.538 -0.726 . . . . 0.0 109.654 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.33 168.44 19.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.55 -32.81 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.749 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.543 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -50.89 -33.22 23.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -73.83 -59.97 2.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.557 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.6 mt -46.02 -42.46 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 -46.71 74.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.355 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.4 -37.92 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -67.58 -45.01 76.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.5 -15.08 61.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.152 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.94 33.87 7.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.16 135.94 72.95 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.532 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -42.22 155.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.512 2.141 . . . . 0.0 112.245 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.24 -11.16 28.41 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.729 2.286 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.8 39.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -176.83 32.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.87 . . . . 0.0 109.189 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 t -74.68 -9.21 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.671 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.33 67.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 18.6 m -73.4 -59.26 2.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.651 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.54 ' HG ' ' H ' ' A' ' 108' ' ' ILE . 1.1 p -48.57 -56.17 9.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 108.974 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.54 ' H ' ' HG ' ' A' ' 107' ' ' SER . 82.3 mt -52.32 -35.58 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.17 -29.3 69.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -51.36 60.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.201 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.402 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 9.6 tp10 -71.73 -32.55 67.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.18 -33.98 75.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.223 -0.923 . . . . 0.0 109.314 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -72.09 -61.55 1.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -46.29 -35.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.129 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.451 ' N ' HG22 ' A' ' 114' ' ' ILE . 11.4 tttt -74.86 -31.38 61.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.853 . . . . 0.0 109.141 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.93 -43.43 83.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.188 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.31 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.2 mt -45.53 -50.76 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.69 -51.68 66.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.88 -21.54 64.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -71.69 -54.88 8.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.364 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -65.55 -34.67 78.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.91 55.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -90.44 46.74 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -121.15 -35.9 3.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.482 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -141.86 6.99 2.4 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tp 38.51 57.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.12 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.07 168.54 10.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.923 . . . . 0.0 109.437 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.505 ' CE1' ' O ' ' A' ' 131' ' ' HIS . 14.2 t-160 -45.39 149.94 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 109.524 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.513 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -133.79 125.04 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.256 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.513 ' C ' ' O ' ' A' ' 130' ' ' HIS . 57.6 m170 38.68 -119.1 0.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.293 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.433 ' C ' ' CG ' ' A' ' 133' ' ' HIS . 0.7 OUTLIER -125.79 27.59 6.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 109.242 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.596 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -148.34 -151.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.855 . . . . 0.0 109.392 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.601 ' O ' ' ND1' ' A' ' 134' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.488 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mtt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.89 -121.25 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.06 82.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.452 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.39 88.08 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -138.73 174.48 10.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.553 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.19 67.1 0.87 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.262 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.6 m -87.45 0.21 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.107 -0.996 . . . . 0.0 109.644 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.0 pt -75.91 9.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.522 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -113.62 -71.56 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 47.03 -155.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 109.475 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -98.25 9.36 43.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.749 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -128.27 128.36 44.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -0.947 . . . . 0.0 109.659 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 12' ' ' GLU . 3.1 m-20 -163.81 89.01 1.16 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.848 . . . . 0.0 109.427 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -51.04 -41.9 54.97 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.909 2.406 . . . . 0.0 112.46 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.719 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -46.58 117.85 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.485 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -80.36 90.86 5.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -57.21 127.94 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.614 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.99 164.09 12.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.5 p -69.82 146.73 51.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -1.13 . . . . 0.0 109.435 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -162.6 -15.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.494 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.642 ' OD1' ' N ' ' A' ' 22' ' ' LYS . 38.3 t0 -110.16 175.32 5.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.642 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 18.4 ttpp -57.33 0.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.423 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.612 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -71.98 10.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -137.13 133.71 35.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.29 8.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.398 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.566 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -115.17 3.26 14.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -122.1 92.45 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.84 155.0 47.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.4 m -131.41 118.56 20.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -1.224 . . . . 0.0 109.817 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.61 93.3 0.56 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -92.5 131.85 37.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.973 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.574 ' O ' ' O ' ' A' ' 41' ' ' MET . 18.5 m -144.53 177.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 108.997 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.62 178.97 41.12 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -118.69 82.31 19.98 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.336 -1.096 . . . . 0.0 109.352 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 37' ' ' CYS . 72.8 Cg_exo -43.97 -10.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.593 2.195 . . . . 0.0 111.99 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.623 ' O ' ' CB ' ' A' ' 37' ' ' CYS . . . -76.07 20.34 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 1.6 t 85.64 -18.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -43.3 -50.3 6.58 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.643 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 153.89 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -1.074 . . . . 0.0 109.424 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 46.9 t -113.56 150.56 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.574 ' O ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -145.73 140.88 27.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.106 -0.996 . . . . 0.0 109.78 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' N ' ' HG2' ' A' ' 41' ' ' MET . 6.0 tt0 -129.49 145.14 51.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.85 138.74 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.591 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -130.84 136.28 48.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.7 132.34 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -115.72 120.01 37.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.276 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.545 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 54.3 t -97.72 126.88 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -56.67 -60.02 4.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.3 OUTLIER 163.85 -22.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 0.0 109.197 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.45 -7.52 47.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.451 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.14 17.59 7.18 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.404 HG23 HD13 ' A' ' 52' ' ' ILE . 46.5 mm -113.36 150.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -1.144 . . . . 0.0 109.504 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.532 ' O ' ' C ' ' A' ' 54' ' ' GLU . 36.1 mt -85.67 77.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 53' ' ' ILE . 2.5 tt0 -34.63 -48.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -153.04 167.68 28.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.94 122.97 13.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -103.99 142.08 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.328 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.468 ' CD1' ' CG2' ' A' ' 74' ' ' THR . 21.8 p90 -137.3 176.06 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.59 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -165.58 132.94 2.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.1 143.66 33.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -159.99 121.16 3.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.77 -61.02 0.29 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.5 t -121.39 140.74 51.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.124 . . . . 0.0 109.677 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.65 -6.98 87.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.6 p -95.13 0.43 54.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -1.15 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.46 2.76 45.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -83.16 -13.86 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.32 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.31 -64.41 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.435 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.465 ' H ' ' HG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -62.97 -30.21 71.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.93 . . . . 0.0 109.453 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.3 t -61.74 -46.14 90.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -64.68 -36.36 84.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.512 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -71.96 -74.54 0.16 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.524 ' C ' ' O ' ' A' ' 72' ' ' LEU . 2.7 tt -34.36 -46.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.873 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' CD1' ' A' ' 58' ' ' PHE . 34.0 p -60.16 -47.24 86.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.0 mt-10 -72.64 -5.92 40.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 109.652 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.63 58.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.477 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -138.1 105.22 5.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.431 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.4 87.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -83.77 -168.5 2.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -1.124 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 t -107.12 146.21 31.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.26 -27.68 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.319 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -61.03 -38.18 85.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.364 -0.835 . . . . 0.0 109.587 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -79.77 -28.91 40.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.648 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.31 -32.7 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.972 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.53 30.2 5.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.89 19.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.351 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.2 pt -91.7 -24.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 88' ' ' ILE . 11.3 mttp 56.72 152.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.581 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -79.55 -22.15 44.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.4 m -60.56 -39.99 89.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.52 -47.65 83.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.08 -36.42 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.19 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.25 -44.15 80.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.266 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.41 -31.83 72.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.79 -41.52 83.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -96.79 -35.36 10.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.646 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 94' ' ' ALA . 9.1 tt0 78.1 32.69 0.36 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.464 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 pp -48.1 147.13 3.84 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 102' ' ' VAL . 30.2 Cg_endo -67.56 147.17 76.09 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.61 2.207 . . . . 0.0 112.066 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.9 15.6 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.679 2.252 . . . . 0.0 112.323 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 100' ' ' PRO . 4.3 m -98.43 6.71 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.295 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -160.03 24.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.346 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' LYS . 26.9 t -38.4 -26.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.854 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.556 ' N ' ' O ' ' A' ' 103' ' ' LYS . 1.8 m-70 -42.95 -28.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 1.9 m -66.36 -37.17 84.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.779 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -68.26 -61.48 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.3 mt -52.29 -33.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.539 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.7 -42.99 94.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.63 -55.31 36.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.499 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -61.52 -56.58 18.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -48.87 -31.13 6.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.26 -65.03 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -49.86 -30.26 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.309 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.407 ' HG3' ' HZ3' ' A' ' 115' ' ' LYS . 63.3 tttp -72.54 -43.3 63.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.439 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.25 69.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.426 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.0 -58.62 3.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.94 . . . . 0.0 109.302 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.2 mt -48.8 -43.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.1 4.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.89 -35.54 15.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.69 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -69.63 -65.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.652 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -24.71 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.652 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.22 -4.74 3.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.415 ' CE ' ' HZ1' ' A' ' 22' ' ' LYS . 5.5 mttm -110.97 -29.19 8.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.636 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -78.52 -11.75 59.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.34 -16.69 49.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.6 tp -80.97 -18.55 46.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -1.144 . . . . 0.0 109.499 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.77 -57.16 2.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -90.04 -161.71 0.82 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -150.82 14.77 0.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.286 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.8 m80 64.39 -132.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.813 . . . . 0.0 109.642 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 56.63 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 109.1 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -130.06 -32.25 1.84 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.672 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.647 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 23.8 p-80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 mtp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 3' ' ' TYR . . . -61.87 108.07 0.96 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.47 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.53 ' C ' ' HG ' ' A' ' 4' ' ' SER . 39.7 m-85 40.68 57.02 2.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.54 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.53 ' HG ' ' C ' ' A' ' 3' ' ' TYR . 25.5 m -158.92 110.87 2.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 109.73 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -111.13 82.3 1.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 109.268 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -73.78 -117.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.708 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.85 -161.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.693 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.8 mt -140.27 -86.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.3 160.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.672 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.528 ' C ' ' H ' ' A' ' 12' ' ' GLU . 28.1 m-70 -137.23 -32.09 0.79 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 109.231 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -74.21 26.28 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.314 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 10' ' ' HIS . 3.4 mp0 -47.65 133.15 13.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 109.697 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.524 ' O ' ' O ' ' A' ' 12' ' ' GLU . 2.7 m120 -35.58 156.17 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 0.0 109.545 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 15' ' ' ARG . 17.8 Cg_endo -63.12 49.6 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.899 2.399 . . . . 0.0 112.264 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 14' ' ' PRO . 2.9 ttp180 60.3 149.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.663 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 18' ' ' GLY . 10.3 t-20 -162.6 -137.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.514 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 16' ' ' ASN . 3.0 p -42.18 95.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.616 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -139.53 80.42 0.27 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -61.09 179.5 0.19 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -1.185 . . . . 0.0 109.454 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.621 ' C ' ' H ' ' A' ' 22' ' ' LYS . 3.6 tp 75.67 14.9 2.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 109.543 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -60.11 5.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.354 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.621 ' H ' ' C ' ' A' ' 20' ' ' LEU . 14.7 mttt 57.12 6.84 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 21' ' ' ASP . 15.9 mttp -135.58 32.31 3.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.326 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -108.2 169.37 8.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.437 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 9.4 t -94.8 -0.62 54.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.55 12.04 22.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.01 107.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.24 150.29 18.64 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -135.75 148.88 48.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.23 103.22 0.29 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 ttp -92.93 129.27 38.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 0.0 109.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' MET . 2.9 m -150.63 -171.75 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.63 -174.52 32.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.94 93.74 26.21 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -1.136 . . . . 0.0 109.485 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.525 ' O ' ' C ' ' A' ' 36' ' ' ALA . 50.6 Cg_exo -50.43 -46.07 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.684 2.256 . . . . 0.0 112.254 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.65 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -37.36 -42.86 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.2 m 159.25 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -35.11 -57.3 0.84 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 153.09 169.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.393 -1.063 . . . . 0.0 109.523 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.563 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 7.6 p -96.12 146.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 108.909 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' VAL . 9.8 ttt -142.3 126.34 17.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 110.002 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -115.6 140.69 48.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.835 . . . . 0.0 108.922 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.24 121.33 13.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.805 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' HG2' ' N ' ' A' ' 45' ' ' ILE . 47.4 tt0 -122.57 152.88 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.21 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.438 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 0.9 OUTLIER -123.17 152.9 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.524 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -124.84 131.03 53.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.7 137.53 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.645 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -175.31 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.8 m-20 -63.2 51.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 0.0 109.108 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.645 ' N ' ' O ' ' A' ' 48' ' ' ASP . 6.3 m-80 72.17 55.15 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.634 -0.666 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.53 77.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 mm -97.61 157.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 109.524 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.442 HG21 HD12 ' A' ' 53' ' ' ILE . 54.0 mt -74.97 99.26 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -59.81 -51.51 69.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -148.98 -174.75 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.797 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.72 122.74 4.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.127 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -95.25 146.92 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 109.9 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.663 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -134.61 165.28 25.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.064 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -162.9 114.18 1.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.049 -1.032 . . . . 0.0 109.999 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 129.0 27.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.197 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.583 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -151.51 118.58 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -0.971 . . . . 0.0 109.759 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.89 -53.37 0.46 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.624 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -107.39 137.23 45.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -1.151 . . . . 0.0 109.392 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.53 26.26 4.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -121.73 -42.42 2.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -1.186 . . . . 0.0 109.493 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.61 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -65.29 -29.01 69.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.1 mm -50.87 -4.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.441 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.61 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -97.67 -56.26 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.547 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.0 -20.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 71' ' ' SER . 8.7 p -70.6 -63.09 1.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.546 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -51.33 -35.23 37.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.802 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 73' ' ' ILE . 6.7 tp -68.74 -79.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.949 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.486 HG21 ' H ' ' A' ' 74' ' ' THR . 3.3 tt -42.33 -48.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 109.915 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.486 ' H ' HG21 ' A' ' 73' ' ' ILE . 56.7 p -54.06 -36.81 63.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.685 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 72' ' ' LEU . 9.1 tt0 -79.38 -12.91 59.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.624 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -100.41 -4.22 29.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.7 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.27 32.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 105.94 14.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.043 -1.035 . . . . 0.0 109.105 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.59 10.62 61.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -90.63 -170.81 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -1.14 . . . . 0.0 109.451 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.37 148.46 35.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.1 -21.97 2.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -83.79 -15.35 48.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.907 . . . . 0.0 109.284 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.46 -28.13 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 0.0 109.253 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.58 -22.38 16.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.63 53.73 4.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.95 -34.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -1.131 . . . . 0.0 109.001 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 2.8 pt -45.45 162.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.42 -0.8 . . . . 0.0 109.364 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.37 -167.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.422 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.84 -24.39 13.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.345 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.8 t -68.98 -36.2 77.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' GLU . 9.1 mt-30 -62.02 -73.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLN . 2.2 mt -43.86 -41.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.68 -37.17 62.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.429 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' GLN . 31.9 tt0 -76.35 -38.34 56.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.401 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -39.42 76.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.81 -22.59 24.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 50.0 70.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.479 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.562 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.3 pt? -117.85 147.67 41.66 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.43 103.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.006 2.47 . . . . 0.0 112.354 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.0 Cg_exo -49.62 -14.86 0.78 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.818 2.345 . . . . 0.0 112.387 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.9 m -62.73 11.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 109.312 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.658 ' H ' ' C ' ' A' ' 101' ' ' PRO . 14.7 ttpp -165.89 64.05 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.055 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 57.6 t -86.54 39.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.808 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -84.68 -24.32 29.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.164 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 m -71.85 -52.83 15.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.96 -52.24 66.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.37 -36.68 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 mp -65.03 -39.49 93.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.913 . . . . 0.0 109.393 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.02 -43.88 94.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 88' ' ' ILE . 15.7 tp10 -66.98 -61.41 1.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -49.27 -22.3 1.03 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.11 -50.66 18.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.75 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.9 tp -56.54 -41.82 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 109.57 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.1 mtpp -62.81 -50.35 71.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 0.0 109.361 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -35.92 32.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.39 -62.06 2.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.379 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.0 mt -52.36 -38.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.404 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.78 -67.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.64 -48.4 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.281 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.563 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 2.9 t80 -49.54 -45.19 47.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -54.97 19.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.596 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.05 -46.41 22.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.693 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -78.1 43.82 0.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 109.737 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -130.07 -21.03 3.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 109.593 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 124.64 18.83 2.63 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 tp -58.36 -24.94 61.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -1.061 . . . . 0.0 109.493 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -123.01 -164.28 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.579 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 0.5 OUTLIER -148.57 160.14 43.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 109.503 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -121.24 -131.85 0.29 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.256 -0.902 . . . . 0.0 109.373 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -159.24 99.02 1.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.426 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.635 ' H ' ' CD2' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -124.62 141.27 52.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.485 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 132' ' ' HIS . 43.8 p-80 -52.17 -175.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.9 p80 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.438 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.637 ' C ' ' H ' ' A' ' 3' ' ' TYR . 12.8 mmt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 3' ' ' TYR . . . 51.64 2.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.56 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.637 ' H ' ' C ' ' A' ' 1' ' ' MET . 25.7 m-85 52.17 178.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.485 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.5 m 54.35 68.93 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.492 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -135.27 137.93 43.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.975 . . . . 0.0 109.406 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -75.19 167.95 20.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.552 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 t -119.53 66.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.297 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.66 ' O ' ' N ' ' A' ' 10' ' ' HIS . 33.9 mt -105.46 -79.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.581 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.527 ' C ' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -34.77 -27.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 109.901 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.66 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -87.51 125.0 34.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 109.669 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.417 ' CD1' ' ND2' ' A' ' 13' ' ' ASN . 1.2 m-85 -44.17 158.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.481 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -125.17 28.39 6.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.51 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.417 ' ND2' ' CD1' ' A' ' 11' ' ' TYR . 9.7 p30 -93.66 151.85 40.34 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.317 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.2 -75.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.75 2.3 . . . . 0.0 112.004 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.734 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -73.69 -152.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.222 -0.924 . . . . 0.0 109.448 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -169.07 -43.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.384 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -89.66 160.03 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 0.0 109.336 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.42 37.82 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.28 97.28 3.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -1.15 . . . . 0.0 109.517 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tp -178.02 -18.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.328 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.641 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -94.99 140.84 29.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -65.77 18.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 109.61 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.641 ' H ' ' C ' ' A' ' 21' ' ' ASP . 5.4 mttp -117.9 -13.39 10.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.314 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -65.78 165.91 11.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 0.0 109.477 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' A' ' 124' ' ' LYS . 3.0 t -101.75 5.57 41.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.369 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.26 -4.18 15.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.5 t -116.41 117.58 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.21 136.72 13.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -115.72 111.88 21.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -1.161 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.86 91.21 0.73 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.37 119.41 27.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.65 171.23 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.43 162.73 36.36 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -123.93 75.99 57.83 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.32 -8.54 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.69 2.26 . . . . 0.0 112.019 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -83.99 -30.22 26.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.88 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 9.9 p -112.66 -17.7 12.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.16 -0.963 . . . . 0.0 109.678 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.53 42.14 6.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.434 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 7.0 t70 -122.38 125.12 45.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.33 146.8 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -148.07 141.99 25.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.687 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -132.87 111.32 10.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.07 145.91 26.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -142.4 114.53 8.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.7 134.83 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HZ1' ' CG ' ' A' ' 57' ' ' LYS . 23.3 mttp -108.16 146.74 32.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.732 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.68 146.32 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.281 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.655 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -179.41 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.893 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.2 m-20 -62.77 44.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.321 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.655 ' N ' ' O ' ' A' ' 48' ' ' ASP . 3.2 m-80 76.98 51.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.13 -0.88 86.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.447 HD11 HG21 ' A' ' 52' ' ' ILE . 34.3 mm -95.12 146.83 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -1.174 . . . . 0.0 109.368 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.445 ' N ' HG22 ' A' ' 52' ' ' ILE . 34.4 mt -75.06 84.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.867 . . . . 0.0 109.259 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -46.85 66.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -142.75 177.59 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.07 123.54 4.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.468 ' CG ' ' HZ1' ' A' ' 46' ' ' LYS . 9.4 mmtt -103.47 154.16 19.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -142.12 175.81 9.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.505 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.37 99.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.253 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.96 130.34 55.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.408 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -144.45 129.33 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 109.581 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.24 -57.65 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.73 150.85 40.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.231 . . . . 0.0 109.543 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.88 56.57 0.51 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -144.06 -11.81 0.65 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.493 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.42 -12.02 17.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.557 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.6 mp -40.87 -54.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.404 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -49.9 -65.95 0.48 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 68' ' ' ALA . 10.9 m -38.94 -54.94 1.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.927 . . . . 0.0 109.533 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 19.4 p -50.57 -46.23 57.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.01 71.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' GLU . 58.8 tp -68.29 -76.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.477 ' C ' ' O ' ' A' ' 72' ' ' LEU . 1.4 tt -40.63 -45.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 70' ' ' SER . 6.8 p -55.81 -35.25 66.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.288 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 72' ' ' LEU . 7.4 mt-10 -93.78 4.16 54.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -106.27 -34.59 7.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.0 109.619 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.88 35.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -111.62 119.28 38.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.382 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.94 -2.92 85.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -85.53 -167.9 2.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.38 149.61 37.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.417 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.32 -20.79 46.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.98 -26.97 67.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -91.78 -38.06 12.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.79 -26.26 65.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.535 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.44 38.73 3.18 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -153.86 -34.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -1.104 . . . . 0.0 109.398 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.579 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.6 pt -40.52 169.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -140.92 161.6 37.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.369 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.617 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 14.7 p-10 -80.97 -28.79 35.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.59 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -57.5 7.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -55.65 -54.92 38.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.424 HD13 HG23 ' A' ' 93' ' ' ILE . 15.0 mt -55.64 -32.57 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.622 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.94 88.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 109.713 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -69.87 -22.69 63.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -74.7 -38.04 62.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -98.27 -15.31 19.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 109.599 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 47.76 68.81 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.334 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.451 ' H ' HD22 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -97.28 149.35 35.62 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.703 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 102' ' ' VAL . 71.6 Cg_exo -41.32 101.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.989 2.459 . . . . 0.0 112.352 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.23 -8.63 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.618 2.212 . . . . 0.0 111.937 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' A' ' 100' ' ' PRO . 18.3 m -77.59 -7.17 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HE3' ' SG ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -147.6 48.27 1.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.313 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.16 -1.97 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.595 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -13.74 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.958 . . . . 0.0 109.232 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.428 ' SG ' ' HE3' ' A' ' 103' ' ' LYS . 24.0 m -80.01 -55.18 5.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.9 t -50.37 -47.05 56.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.137 -0.977 . . . . 0.0 108.995 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.29 -46.94 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 mp -53.86 -30.87 47.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.144 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.71 -61.49 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -0.824 . . . . 0.0 109.273 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.617 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 58.5 tt0 -51.02 -54.06 27.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.249 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.79 -41.82 71.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.417 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.05 -50.12 38.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -59.68 -39.77 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.454 ' N ' HG22 ' A' ' 114' ' ' ILE . 5.8 tttt -64.46 -46.29 83.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.73 -61.87 2.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.659 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -47.63 -35.64 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.84 -38.53 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 109.553 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.63 -42.32 67.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 109.962 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.33 -39.87 92.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.992 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -68.67 -38.07 80.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.868 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -77.96 -27.45 49.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.455 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -66.01 -44.19 85.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.575 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.6 OUTLIER -77.64 25.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.547 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.455 ' H ' ' C ' ' A' ' 123' ' ' ALA . 2.5 tt0 -170.35 54.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.996 . . . . 0.0 109.71 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -143.35 6.02 1.92 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mt -107.39 11.25 29.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -1.204 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.62 -157.44 0.25 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.314 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.33 56.25 1.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.581 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -91.87 30.87 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.47 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.441 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 17.0 m-70 -69.39 -140.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.448 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.441 ' CD2' ' O ' ' A' ' 131' ' ' HIS . 16.1 m80 -151.1 -148.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.452 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 1.6 t-160 -163.05 -55.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.558 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.452 ' CE1' ' HB3' ' A' ' 133' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.476 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.302 0.572 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -51.03 120.62 5.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.54 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.45 ' CD2' ' N ' ' A' ' 4' ' ' SER . 32.5 p90 -100.38 -173.71 2.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.45 ' N ' ' CD2' ' A' ' 3' ' ' TYR . 0.8 OUTLIER -157.53 70.32 0.59 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 109.52 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' O ' ' A' ' 6' ' ' LYS . 35.7 mm-40 -111.66 -4.37 14.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.391 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' O ' ' O ' ' A' ' 5' ' ' GLU . 1.0 OUTLIER 58.01 144.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.554 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.9 134.44 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -86.81 135.25 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.344 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 21.7 p-10 -96.51 -148.4 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.533 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.65 -67.16 0.87 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.337 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -45.87 105.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.415 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -139.34 138.0 36.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' PRO . 1.9 t-20 -176.11 77.44 0.28 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 109.25 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 13' ' ' ASN . 50.4 Cg_exo -48.92 -130.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.848 2.366 . . . . 0.0 112.306 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.699 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -122.45 176.18 6.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.543 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -54.49 109.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.405 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 19' ' ' SER . 16.7 t -64.36 -68.5 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 109.561 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -62.46 57.21 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.6 OUTLIER 169.77 160.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -1.117 . . . . 0.0 109.447 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 19' ' ' SER . 1.8 mm? 39.0 69.8 0.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.461 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.656 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.2 m-20 -157.62 10.98 0.19 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.19 15.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.348 -0.845 . . . . 0.0 109.414 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.656 ' N ' ' O ' ' A' ' 21' ' ' ASP . 15.8 mmtt -139.63 30.96 2.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.561 ' OD2' ' CG2' ' A' ' 27' ' ' VAL . 7.2 p-10 -122.14 141.46 51.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -0.964 . . . . 0.0 109.457 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.463 ' HG ' ' HG3' ' A' ' 125' ' ' GLN . 5.3 m -75.91 8.43 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.398 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.03 12.07 29.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.608 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.561 ' CG2' ' OD2' ' A' ' 24' ' ' ASP . 27.4 t -132.45 101.69 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 109.303 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.29 9.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.97 141.0 51.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -1.092 . . . . 0.0 109.239 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.36 142.97 8.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 ptm -141.31 147.6 38.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -1.201 . . . . 0.0 109.743 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 m -136.0 -179.75 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.025 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.66 163.16 31.12 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.049 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 91.93 42.76 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.368 -1.078 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.25 -27.01 12.17 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.712 2.275 . . . . 0.0 112.44 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.03 -33.95 40.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.1 m -130.13 7.56 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' OD1' ' A' ' 39' ' ' ASP . . . 57.46 71.54 0.73 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.553 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 30.2 m-20 -141.18 131.19 24.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.02 126.65 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.775 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.442 ' HG2' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -110.53 149.17 30.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.442 ' N ' ' HG2' ' A' ' 41' ' ' MET . 4.0 tt0 -124.88 122.99 38.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.63 134.75 54.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -135.83 116.89 14.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.302 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.18 159.07 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -127.03 140.65 52.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.56 150.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.146 -0.971 . . . . 0.0 109.648 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.614 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 9.8 p-10 -75.99 -94.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.614 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -156.26 15.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.67 -7.37 3.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.7 9.88 17.97 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.8 mm -98.41 143.84 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -1.155 . . . . 0.0 109.454 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.2 115.39 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.45 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.92 -37.36 15.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.67 168.09 20.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.23 105.74 3.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -99.88 141.4 32.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.459 ' CD1' HG23 ' A' ' 74' ' ' THR . 13.7 p90 -139.99 179.08 6.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.382 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -164.76 123.75 1.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -137.55 141.51 41.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -158.36 134.26 9.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.42 -69.32 0.54 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.02 128.41 38.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -1.163 . . . . 0.0 109.656 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.45 70.57 0.86 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.99 -17.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -1.112 . . . . 0.0 109.295 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB1' ' SG ' ' A' ' 106' ' ' CYS . . . -105.74 6.33 31.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.431 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 68' ' ' ALA . 41.8 mt -79.05 -53.13 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -44.25 -45.3 8.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -70.85 -38.54 73.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.416 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.8 t -56.21 -39.96 73.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -73.72 -32.77 64.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.323 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.422 ' CD2' ' OE1' ' A' ' 96' ' ' GLU . 10.8 tp -68.96 -59.24 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 tt -52.34 -41.59 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.459 HG23 ' CD1' ' A' ' 58' ' ' PHE . 31.8 p -63.34 -32.33 73.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.331 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.47 -4.77 59.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.288 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.8 -26.44 14.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.57 22.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.298 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -95.49 120.38 35.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.412 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.01 5.48 89.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -87.04 -168.68 2.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -1.17 . . . . 0.0 109.534 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.13 152.47 39.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.369 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -57.82 -28.85 64.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.1 -36.35 79.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 85' ' ' ALA . 63.5 mm-40 -76.84 -56.1 4.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.46 -32.65 1.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.18 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.78 39.3 3.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -159.98 -40.57 0.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 108.781 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 ' O ' ' O ' ' A' ' 87' ' ' ALA . 12.4 pt -45.67 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 109.161 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -150.86 -178.63 6.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.154 -0.966 . . . . 0.0 109.572 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.422 ' HB2' ' HG ' ' A' ' 107' ' ' SER . 25.4 p-10 -90.88 -16.7 27.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.402 -0.811 . . . . 0.0 109.361 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.27 -45.3 65.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.485 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -62.48 -69.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 92' ' ' GLN . 7.9 mt -41.71 -39.96 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.17 -42.12 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.503 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -68.0 -11.41 58.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.443 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' OE1' ' CD2' ' A' ' 72' ' ' LEU . 13.2 tt0 -88.37 -54.77 4.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.413 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mt -81.94 -7.34 59.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 99' ' ' LEU . 6.0 tp10 48.5 23.56 0.62 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -43.97 149.21 0.69 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.67 164.2 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.67 2.246 . . . . 0.0 112.217 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.91 18.4 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.985 2.456 . . . . 0.0 112.638 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.0 t -110.62 0.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 109.727 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.658 ' O ' ' N ' ' A' ' 105' ' ' HIS . 13.0 mtmt -140.33 10.7 2.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.445 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 103' ' ' LYS . 5.0 t -45.11 -10.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.442 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.658 ' N ' ' O ' ' A' ' 103' ' ' LYS . 3.2 m-70 -59.72 -37.92 80.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.435 ' SG ' ' HB1' ' A' ' 66' ' ' ALA . 86.3 m -60.66 -50.68 72.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.422 ' HG ' ' HB2' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -60.85 -52.82 63.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.372 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.5 mt -46.73 -36.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.262 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.445 HD11 ' N ' ' A' ' 109' ' ' LEU . 5.7 mp -75.59 -28.17 58.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.627 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.21 -50.95 71.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.999 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 112' ' ' ASP . 70.9 tt0 -66.55 -63.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.873 . . . . 0.0 109.133 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' GLU . 4.8 t70 -44.1 -35.06 1.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 115' ' ' LYS . . . -58.04 -64.53 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.006 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.8 tp -46.43 -22.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 108.513 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 116' ' ' ALA . 14.5 tttt -74.1 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -40.55 -51.53 2.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.602 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.78 -51.75 67.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.465 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mt -49.73 -43.07 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -55.96 -65.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.537 ' O ' ' C ' ' A' ' 121' ' ' TYR . 27.0 t70 -44.66 -68.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.595 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.537 ' C ' ' O ' ' A' ' 120' ' ' ASP . 54.2 t80 -35.33 -42.99 0.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -68.8 -51.64 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -65.29 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -53.3 -7.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 123' ' ' ALA . 6.8 tt0 -136.32 50.78 2.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -152.95 -44.22 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.27 -32.77 57.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -1.175 . . . . 0.0 109.446 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -68.68 -179.01 1.28 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.898 . . . . 0.0 109.478 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.81 175.72 8.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.414 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.572 ' ND1' ' O ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -97.03 -144.45 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.612 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.623 ' H ' ' CD2' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -75.24 158.62 32.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.513 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -101.04 137.57 39.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.331 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 134' ' ' HIS . 20.6 p80 -145.4 -135.2 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 109.521 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.433 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 4.0 p-80 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.506 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.26 0.552 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 4' ' ' SER . . . -98.8 -10.63 22.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -63.61 60.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.511 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 2' ' ' ALA . 0.7 OUTLIER -75.17 -12.22 60.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.37 -0.831 . . . . 0.0 109.465 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.9 -48.17 5.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 tptm 51.23 75.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.644 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.42 141.96 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.328 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.8 tt -143.43 159.95 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 109.565 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 10' ' ' HIS . 1.0 OUTLIER -60.47 144.44 51.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.5 ' C ' ' O ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -38.64 153.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.112 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.87 117.86 8.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 109.74 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -108.54 -166.73 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.13 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 15' ' ' ARG . 7.4 t-20 -165.58 86.25 0.99 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.064 -1.023 . . . . 0.0 109.781 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.53 66.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.846 2.364 . . . . 0.0 111.973 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.712 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -97.44 92.2 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.816 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 16' ' ' ASN . 1.3 m-80 56.91 14.3 1.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.882 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.436 ' CG2' ' H ' ' A' ' 18' ' ' GLY . 8.6 p -113.34 175.22 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.53 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' H ' ' CG2' ' A' ' 17' ' ' VAL . . . 87.25 10.42 71.28 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 21' ' ' ASP . 3.6 p -143.67 -164.03 1.79 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mp 58.72 0.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.878 . . . . 0.0 109.327 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.575 ' H ' ' C ' ' A' ' 19' ' ' SER . 1.3 m-20 -103.89 148.21 26.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.52 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.59 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -64.96 -25.16 67.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -63.82 7.98 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.406 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.59 ' H ' ' C ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -111.54 119.39 38.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 109.358 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.652 ' C ' HD21 ' A' ' 26' ' ' ASN . 1.0 OUTLIER -72.39 9.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.585 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.652 HD21 ' C ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -125.06 30.01 5.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.9 t -127.1 91.36 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.313 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.42 142.2 16.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -129.17 112.57 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.46 134.93 12.2 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.41 114.41 16.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -1.118 . . . . 0.0 109.524 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.67 174.14 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.19 -178.9 21.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -122.12 89.19 48.58 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 109.367 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -54.46 29.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.95 2.433 . . . . 0.0 112.386 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -105.89 -42.83 5.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.7 -22.0 3.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.601 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.13 51.27 0.52 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.2 m-20 -106.76 140.22 39.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -1.145 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.74 114.54 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.167 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.5 ttt -112.54 140.99 46.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -126.5 128.97 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -0.878 . . . . 0.0 108.986 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -120.64 138.44 53.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.819 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -126.47 132.24 51.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 109.189 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.57 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -128.63 143.24 50.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.61 145.47 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -92.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -161.07 18.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.415 HD21 HG12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -128.36 -21.2 3.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.72 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.55 6.06 6.27 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.415 HG12 HD21 ' A' ' 50' ' ' ASN . 43.1 mm -103.64 130.08 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.641 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.44 97.66 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.299 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.67 -38.39 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.578 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.26 169.44 17.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.136 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 77' ' ' VAL . . . -166.78 118.64 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.131 -0.981 . . . . 0.0 109.593 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -95.97 -177.94 4.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.176 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -168.06 -179.72 4.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.184 -0.947 . . . . 0.0 109.418 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -171.61 113.98 0.36 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.5 p -119.62 131.89 55.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.206 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -140.89 111.27 6.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . 84.88 49.66 4.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.535 ' O ' ' O ' ' A' ' 64' ' ' GLY . 14.5 p -121.5 142.79 49.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.458 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 63' ' ' CYS . . . -38.99 -94.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.3 m -125.68 30.76 5.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.16 -31.51 72.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.497 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.8 mp -38.41 -32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.431 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -86.03 -64.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 109.312 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 m -54.21 -29.48 46.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.54 ' O ' ' OG1' ' A' ' 74' ' ' THR . 78.8 p -62.95 -34.52 77.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.115 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -74.42 -33.24 62.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.83 . . . . 0.0 109.225 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tp -64.34 -60.26 3.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 74' ' ' THR . 12.6 tt -51.95 -51.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.582 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -53.62 -31.15 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.374 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.09 -14.98 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.396 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -89.89 -23.96 21.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 56' ' ' ALA . 17.0 m -97.11 13.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 82.0 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.975 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.7 -9.45 8.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -98.75 -159.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.575 ' HG ' ' N ' ' A' ' 82' ' ' LEU . 41.0 t -128.07 164.49 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 109.709 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.575 ' N ' ' HG ' ' A' ' 81' ' ' SER . 11.0 mt -50.53 -28.68 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.86 -53.01 61.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.351 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.79 -36.3 71.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.829 . . . . 0.0 109.328 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.32 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.255 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 44.4 3.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -161.4 -35.31 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.137 . . . . 0.0 109.404 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.2 pt -40.39 -21.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 mttp 55.51 169.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.973 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.32 -45.32 5.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.553 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 37.1 t -56.19 -22.35 28.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.403 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -67.72 -64.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.369 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -51.35 -30.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.16 90.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.77 -18.32 61.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.372 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -71.14 -51.58 24.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.92 -11.92 56.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.21 19.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 1.7 pt? -59.18 149.2 68.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 109.149 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -37.51 145.39 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.823 2.349 . . . . 0.0 112.23 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.63 8.83 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.671 2.247 . . . . 0.0 112.265 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.77 -30.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -94.09 16.89 13.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.907 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.06 -19.79 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.542 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -54.58 -33.49 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.59 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 90.6 m -58.02 -58.19 9.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.915 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -48.87 -55.77 10.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.441 ' N ' HD21 ' A' ' 90' ' ' ASN . 28.2 mt -47.77 -65.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.313 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 109' ' ' LEU . 6.5 mp -43.79 -27.32 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -69.57 -71.31 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -50.93 -30.78 15.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.911 . . . . 0.0 109.249 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -73.01 -25.08 60.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -75.02 -35.09 61.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.618 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 2.2 tp -75.03 -42.34 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 109.42 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 22.1 tttt -59.94 -40.3 88.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.982 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.61 -54.12 44.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -50.07 -63.48 1.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.227 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 117' ' ' ALA . 67.5 mt -37.77 -44.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.21 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.12 -57.34 12.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -58.75 -45.35 89.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.34 -20.57 44.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -91.36 -29.91 16.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.385 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.97 -7.34 59.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.07 21.84 1.29 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -160.91 55.45 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -129.74 -69.86 0.12 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 129' ' ' HIS . 10.0 mp -55.43 -37.3 67.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -1.139 . . . . 0.0 109.446 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.46 ' C ' ' CD2' ' A' ' 129' ' ' HIS . 13.8 mt-10 -73.04 36.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 131' ' ' HIS . 55.4 m-70 -147.95 130.42 15.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -67.1 44.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 0.0 109.369 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.527 ' N ' ' O ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -73.05 86.52 1.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 109.422 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.24 7.73 1.37 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.346 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.608 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 2.8 p-80 -120.45 50.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.408 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.409 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.69 98.8 6.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 4' ' ' SER . 54.5 t80 -118.62 76.25 1.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.3 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 3' ' ' TYR . 6.9 t -53.95 -161.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -130.86 85.77 2.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.907 . . . . 0.0 109.54 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -139.05 159.21 42.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.364 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 m -119.71 52.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.218 -0.926 . . . . 0.0 109.954 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.6 mt -95.81 57.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.131 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.2 -163.71 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.728 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -107.27 -167.78 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -143.71 28.75 1.42 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.16 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.73 120.67 15.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 109.661 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.635 ' O ' ' N ' ' A' ' 15' ' ' ARG . 63.1 m-20 -59.38 155.14 38.76 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.28 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -40.64 -11.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.768 2.312 . . . . 0.0 112.231 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.706 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -73.18 137.89 45.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 -11.24 15.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.385 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.508 ' CG1' ' H ' ' A' ' 18' ' ' GLY . 57.9 t -92.12 173.6 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.607 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.641 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . 150.82 -14.55 0.9 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 1.5 t 153.7 162.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.545 -0.973 . . . . 0.0 109.166 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.458 HD11 ' HZ2' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -111.75 88.55 2.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.696 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.653 ' C ' ' H ' ' A' ' 23' ' ' LYS . 6.1 m-20 58.46 109.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 109.524 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -58.1 4.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.388 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.653 ' H ' ' C ' ' A' ' 21' ' ' ASP . 8.8 tttm -50.95 -28.59 10.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 109.692 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 23' ' ' LYS . 5.8 t0 80.16 -146.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.522 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.8 OUTLIER 74.41 11.17 4.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' A' ' 25' ' ' SER . 1.7 p-10 174.78 -28.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.96 . . . . 0.0 109.681 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -91.74 114.98 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.09 119.27 5.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.487 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 27.3 m -93.71 136.38 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -1.15 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.67 110.05 0.67 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 ttt -125.63 122.14 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -1.137 . . . . 0.0 109.651 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.55 -169.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.377 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.15 146.83 5.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.11 133.52 20.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.3 Cg_endo -75.44 -26.38 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.493 2.129 . . . . 0.0 112.256 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.53 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.89 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -98.88 5.32 47.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.04 48.79 10.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -89.66 127.07 35.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.401 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.0 131.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.7 ttt -128.06 130.53 48.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 109.293 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -125.38 142.07 51.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.801 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.56 156.84 43.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.182 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.78 150.56 38.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.78 139.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.316 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.458 ' HZ2' HD11 ' A' ' 20' ' ' LEU . 35.5 ttmt -113.38 146.51 39.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.71 147.63 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.485 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 2.2 t0 -88.9 -60.17 2.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 167.27 -23.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.145 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.485 ' ND2' ' OD2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -100.12 22.66 11.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.541 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 15.26 80.14 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.47 HD11 HG21 ' A' ' 52' ' ' ILE . 43.1 mm -104.93 136.66 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.483 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.34 97.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.7 -44.32 57.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.76 157.1 8.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.33 179.31 6.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.351 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -151.29 170.75 18.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.434 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 21.3 p90 -137.35 167.88 20.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 109.384 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -169.71 85.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.17 133.51 55.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -147.18 105.85 3.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.06 -50.66 0.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.1 p -128.9 120.55 26.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.52 66.57 1.02 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.55 -50.93 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.92 -26.4 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.354 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' ALA . 77.8 mt -44.67 -53.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.0 109.217 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.09 60.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 108.921 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.2 -40.37 64.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.34 -0.85 . . . . 0.0 109.024 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 74' ' ' THR . 2.3 t -65.69 -24.55 67.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 109.168 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.7 t -76.12 -46.21 29.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.308 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.05 -59.25 4.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 74' ' ' THR . 17.3 tt -49.21 -43.95 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 71' ' ' SER . 0.9 OUTLIER -54.88 -42.27 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.591 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.19 -18.45 60.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.942 . . . . 0.0 109.729 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -89.35 -21.9 22.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.517 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 4.8 m -107.49 52.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.14 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -142.11 82.43 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.646 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.74 40.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -102.25 -167.44 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -1.189 . . . . 0.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -102.94 139.24 38.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.77 -23.73 60.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.401 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -75.98 -13.97 60.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.35 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.55 -35.05 11.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.49 2.84 42.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.19 25.8 11.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.96 18.66 0.16 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -1.153 . . . . 0.0 109.409 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.05 2.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.847 . . . . 0.0 109.327 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.4 mttt 56.83 167.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.548 ' ND2' ' C ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -86.04 -13.16 48.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.339 -0.851 . . . . 0.0 109.541 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.3 p -75.76 -21.52 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.564 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.443 HE21 ' HA ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -74.79 -56.01 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.423 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.0 mt -59.67 -41.98 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.88 82.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.184 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.35 -46.49 80.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 109.399 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -49.69 -62.45 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.17 -16.65 61.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 52.84 23.52 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.428 HD12 ' SG ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -55.26 146.84 39.36 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.582 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -42.04 146.78 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.74 2.293 . . . . 0.0 112.239 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 103' ' ' LYS . 57.2 Cg_endo -73.94 -27.59 12.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.762 2.308 . . . . 0.0 112.386 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.9 t -70.5 26.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.739 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.571 ' H ' ' C ' ' A' ' 101' ' ' PRO . 9.6 tttm -165.17 37.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.39 1.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.392 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -58.79 -29.26 66.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -67.59 -41.64 83.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.59 85.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.885 . . . . 0.0 109.177 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -62.56 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.295 -0.878 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.428 HD11 ' N ' ' A' ' 109' ' ' LEU . 7.8 mp -63.23 -25.21 68.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.15 -71.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -50.75 -31.48 16.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.42 -38.77 85.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.138 -0.976 . . . . 0.0 109.158 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -69.9 -58.91 3.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -44.22 -38.09 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 116' ' ' ALA . 4.0 tptt -75.17 -66.13 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -36.61 -39.58 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -64.38 -57.95 7.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -38.01 -49.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.413 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -56.18 -61.15 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.507 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 119' ' ' ALA . 4.3 m-20 -38.83 -62.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -46.42 -57.43 4.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 125' ' ' GLN . 1.0 OUTLIER -47.31 -29.16 2.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -41.25 -47.81 3.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.587 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -90.82 23.81 2.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 122' ' ' LYS . 14.1 tp60 -165.98 39.93 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.15 -0.969 . . . . 0.0 109.467 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.43 -100.26 0.47 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.664 ' O ' ' N ' ' A' ' 129' ' ' HIS . 0.5 OUTLIER -117.52 -32.73 4.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.714 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -46.64 -6.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.621 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.664 ' N ' ' O ' ' A' ' 127' ' ' LEU . 73.8 t60 -112.68 -95.91 0.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.933 . . . . 0.0 109.585 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.636 ' C ' ' ND1' ' A' ' 131' ' ' HIS . 0.8 OUTLIER 177.47 -164.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.275 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.636 ' ND1' ' C ' ' A' ' 130' ' ' HIS . 2.0 p-80 -179.86 115.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.14 -0.975 . . . . 0.0 109.624 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.564 ' C ' ' H ' ' A' ' 134' ' ' HIS . 2.0 t60 178.12 -81.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.766 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -70.87 23.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.897 . . . . 0.0 109.849 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.564 ' H ' ' C ' ' A' ' 132' ' ' HIS . 1.6 p-80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.362 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.276 0.56 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -49.64 126.27 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.566 ' O ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -81.41 157.3 25.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.627 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER 55.43 119.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.9 . . . . 0.0 109.501 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -72.02 172.33 10.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.292 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -149.82 61.17 1.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 109.54 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t 60.74 86.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.677 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 9' ' ' ASP . 1.9 pt -144.36 160.61 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.3 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 8' ' ' ILE . 45.3 t0 40.74 85.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.402 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 9' ' ' ASP . 4.8 m-70 -43.97 131.02 5.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.31 109.51 19.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.66 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 63.83 123.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.342 -0.849 . . . . 0.0 109.567 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.417 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 1.2 t-20 -147.8 57.25 3.18 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.191 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 33.2 Cg_endo -67.89 4.29 1.53 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.884 2.389 . . . . 0.0 112.327 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 58.86 -92.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.167 -0.958 . . . . 0.0 109.515 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.689 HD21 ' N ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -173.07 -4.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.689 ' N ' HD21 ' A' ' 16' ' ' ASN . 77.1 t -56.56 127.71 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.372 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.27 80.35 0.67 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 20' ' ' LEU . 8.9 p -174.23 113.15 0.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -1.119 . . . . 0.0 109.393 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.606 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 5.7 tp 72.61 -3.27 2.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.383 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.62 ' C ' ' H ' ' A' ' 23' ' ' LYS . 2.3 m-20 -69.7 16.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 20' ' ' LEU . 3.5 mtpp 63.5 -9.36 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' H ' ' C ' ' A' ' 21' ' ' ASP . 2.6 ttmm -132.17 62.29 1.64 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.538 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.606 ' OD2' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -123.93 156.34 36.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.85 -2.65 43.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -97.13 3.95 51.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.6 96.82 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 155.53 28.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -138.6 117.27 12.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -1.199 . . . . 0.0 109.62 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.06 114.4 4.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.53 108.59 14.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -1.196 . . . . 0.0 109.565 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.67 175.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.11 168.35 41.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.74 80.81 32.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -47.08 -14.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.848 2.366 . . . . 0.0 112.311 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -60.47 2.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -91.55 -8.75 46.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 43.27 9.38 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.2 148.48 25.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.111 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.1 139.89 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ttt -147.0 130.0 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -133.52 118.87 18.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.65 127.46 50.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -106.34 168.82 8.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.728 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -150.11 127.87 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.224 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -98.74 105.15 17.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.58 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.09 144.78 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 109.252 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.617 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 6.6 t70 -78.94 -101.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -148.35 13.6 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.617 ' ND2' ' OD2' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -139.27 2.25 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.68 33.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.405 HD12 ' HG ' ' A' ' 81' ' ' SER . 4.5 mm -83.32 144.06 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -1.187 . . . . 0.0 109.418 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 55' ' ' ASP . 72.1 mt -90.19 91.41 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.85 -54.03 16.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 15.9 t0 -136.59 -177.08 4.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.357 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.91 116.29 1.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.593 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -96.46 141.72 29.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.69 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -117.01 162.63 17.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.403 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -157.16 97.24 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.435 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.52 124.98 50.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -150.78 97.11 2.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.35 -39.7 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 34.3 t -130.12 121.79 27.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.93 47.41 1.89 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.09 2.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -1.16 . . . . 0.0 109.562 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.01 -4.25 20.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.452 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.557 ' O ' ' OG ' ' A' ' 70' ' ' SER . 3.1 mp -62.29 -65.85 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.542 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.5 -71.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.63 ' OG ' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -41.5 -60.32 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.496 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.557 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 84.1 p -46.29 -47.76 18.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.342 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.406 ' C ' ' OG1' ' A' ' 74' ' ' THR . 1.7 m -57.71 -23.95 54.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 74' ' ' THR . 1.4 tp -78.82 -71.54 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.287 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -40.52 -24.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -75.56 -56.17 4.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.252 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.16 -15.52 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -88.63 -32.55 18.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 17.2 m -104.6 55.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.648 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 84.29 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.11 -15.1 23.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -78.25 -174.42 3.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.418 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.405 ' HG ' HD12 ' A' ' 52' ' ' ILE . 73.4 m -109.45 174.39 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.23 -26.03 68.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.633 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -64.61 -17.44 64.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -100.09 -38.87 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.08 -25.29 58.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.73 54.25 0.68 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.17 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -1.169 . . . . 0.0 109.404 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -35.89 -43.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 91' ' ' SER . 0.3 OUTLIER 63.6 119.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.582 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 91' ' ' SER . 43.0 p30 -40.93 -25.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.025 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.535 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.5 m -50.44 -36.9 35.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 93' ' ' ILE . 12.6 tt0 -83.46 -60.31 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.477 ' C ' ' O ' ' A' ' 92' ' ' GLN . 69.6 mt -40.13 -48.1 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 95' ' ' GLU . . . -72.44 -55.2 7.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 94' ' ' ALA . 3.7 tt0 -36.07 -34.06 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 94' ' ' ALA . 1.2 tp10 -81.79 -62.19 1.71 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.619 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.8 OUTLIER -63.29 -16.91 61.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 97' ' ' LEU . 1.1 tp10 37.94 47.43 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.467 ' H ' HD22 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -71.28 150.47 94.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.169 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -36.15 109.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.87 2.38 . . . . 0.0 112.045 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.9 16.41 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.559 2.173 . . . . 0.0 112.477 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 m -82.3 13.64 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' VAL . 4.9 tptt -168.21 -38.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.43 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 103' ' ' LYS . 12.4 t 44.22 57.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.27 -57.85 2.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.63 ' SG ' ' OG ' ' A' ' 69' ' ' SER . 48.0 t -44.46 -60.42 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.807 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.486 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -43.38 -63.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 107' ' ' SER . 27.4 mt -38.1 -62.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.6 mp -48.65 -37.25 17.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.587 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.12 -73.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.637 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.551 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 3.8 tp10 -46.69 -58.54 3.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.9 OUTLIER -43.74 -38.34 3.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.768 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -51.96 65.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.6 tp -61.61 -41.1 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.677 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' HZ2' ' CB ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -62.08 -41.14 97.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 109.511 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.42 67.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.02 -33.91 63.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.314 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 68.9 mt -69.38 -66.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.851 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -38.69 -46.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.395 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -63.28 -43.85 96.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.394 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 118' ' ' ILE . 59.5 t80 -56.45 -42.25 77.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 126' ' ' GLY . 23.6 mttp -72.04 -43.98 64.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.05 -11.91 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 122' ' ' LYS . 6.3 mttt -108.47 -65.87 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.488 ' O ' ' CG ' ' A' ' 125' ' ' GLN . 5.1 tt0 -85.05 14.67 4.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -49.16 -88.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 mt -125.71 -8.92 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -1.146 . . . . 0.0 109.366 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -170.4 -152.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.646 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 0.3 OUTLIER -94.44 55.24 1.94 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.66 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 131' ' ' HIS . 7.6 t-80 -62.39 -158.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.957 . . . . 0.0 109.237 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.502 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 7.0 p80 -163.27 150.89 13.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.674 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 134' ' ' HIS . 33.7 t-80 -54.24 108.52 0.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.89 . . . . 0.0 109.381 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -53.65 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 132' ' ' HIS . 4.6 t60 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.562 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' O ' ' C ' ' A' ' 2' ' ' ALA . 5.2 tpt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 43.98 75.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.422 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 4' ' ' SER . 2.4 t80 -165.83 -21.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.58 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.57 ' O ' ' OG ' ' A' ' 4' ' ' SER . 1.0 OUTLIER 45.15 62.6 2.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.953 . . . . 0.0 109.532 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.53 -79.88 0.47 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.21 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 7' ' ' VAL . 8.2 tttp -101.15 162.18 13.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 6' ' ' LYS . 2.5 m -56.6 154.7 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.488 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.0 mt -149.28 151.39 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.46 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 p30 176.86 34.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.618 ' O ' ' CG ' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -117.66 36.15 4.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.44 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER 53.8 72.08 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -83.15 -20.18 35.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 0.0 109.374 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -123.94 97.25 41.32 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 109.346 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -48.73 149.59 7.26 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.585 2.19 . . . . 0.0 112.185 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.721 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -105.23 -62.11 1.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.9 . . . . 0.0 109.575 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.89 91.78 8.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.927 . . . . 0.0 109.515 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -129.66 137.14 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.91 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 19' ' ' SER . . . 76.09 97.44 0.15 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 18' ' ' GLY . 4.6 t 40.32 -141.07 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -1.14 . . . . 0.0 109.474 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.02 133.89 55.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.0 106.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.392 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.8 -2.15 4.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.579 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -50.22 -28.89 8.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.942 . . . . 0.0 109.431 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.9 OUTLIER 45.75 -165.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.31 -1.94 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.58 ' H ' ' C ' ' A' ' 24' ' ' ASP . 1.9 p-10 -167.84 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.59 92.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.8 144.57 18.25 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.567 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 4.8 m -135.43 130.55 34.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.46 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 43' ' ' LEU . . . -116.15 140.52 16.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.21 125.08 21.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 109.575 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.62 170.42 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.08 141.84 7.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -110.67 129.2 24.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.183 . . . . 0.0 109.186 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 36' ' ' ALA . 63.8 Cg_endo -77.14 -45.02 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.515 2.143 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.31 -55.28 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -113.55 29.04 8.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 109.69 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.4 51.67 0.74 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 37' ' ' CYS . 78.8 m-20 -102.24 111.77 24.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.41 ' H ' HG11 ' A' ' 40' ' ' VAL . 3.4 p -99.3 130.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.41 ' HG2' ' N ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -137.05 150.74 48.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.492 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' N ' ' HG2' ' A' ' 41' ' ' MET . 6.3 tt0 -136.76 116.36 12.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.376 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 30' ' ' GLY . 4.3 tt -105.6 143.25 34.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 45' ' ' ILE . 4.8 tt0 -135.51 162.33 32.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.325 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.533 ' N ' ' CG ' ' A' ' 44' ' ' GLN . 1.3 pt -147.41 162.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.426 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 10.6 mmtm -129.52 138.48 51.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.21 155.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.562 ' OD2' ' OD1' ' A' ' 49' ' ' ASP . 38.5 t70 -88.65 -49.7 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.631 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER 160.78 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.234 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -101.39 -11.72 19.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 8.71 7.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.414 HG22 HD13 ' A' ' 52' ' ' ILE . 5.0 mm -96.36 149.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.545 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 53' ' ' ILE . 56.9 mt -90.92 95.55 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' CG ' ' N ' ' A' ' 55' ' ' ASP . 19.9 pt-20 -58.03 -46.24 85.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 54' ' ' GLU . 1.7 t0 -137.53 168.17 20.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.579 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.05 100.51 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.07 159.5 14.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -140.35 -175.0 4.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.58 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -171.35 83.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p -92.9 149.04 21.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -155.06 141.56 18.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.85 -80.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 65' ' ' SER . 0.1 OUTLIER -82.11 136.94 35.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -1.157 . . . . 0.0 109.444 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.83 45.76 3.07 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -154.6 -47.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.392 -1.063 . . . . 0.0 109.336 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.68 -14.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.448 ' H ' ' C ' ' A' ' 65' ' ' SER . 7.2 mt -65.88 -22.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.43 -67.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.556 ' OG ' ' SG ' ' A' ' 106' ' ' CYS . 20.9 p -46.39 -53.41 11.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.166 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.505 ' H ' ' HG ' ' A' ' 69' ' ' SER . 83.9 p -49.88 -33.57 17.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.538 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.3 OUTLIER -71.17 -37.71 72.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.292 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.22 -67.84 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.848 . . . . 0.0 109.441 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 tt -44.42 -40.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.948 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.538 ' OG1' ' O ' ' A' ' 71' ' ' SER . 1.5 p -57.48 -48.31 79.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.894 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.14 -21.57 50.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -11.54 59.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 m -124.67 20.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.253 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -90.54 99.78 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.402 -0.812 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.04 56.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -81.88 171.14 14.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.15 150.68 21.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.532 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.7 mt -54.79 -15.81 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.99 -33.4 74.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.36 -47.48 8.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.871 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.8 -5.58 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.298 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.83 31.54 6.98 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.22 -36.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -1.16 . . . . 0.0 109.184 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.4 pt -44.81 120.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.839 . . . . 0.0 109.545 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.414 ' H ' ' NE2' ' A' ' 92' ' ' GLN . 18.8 mttm -94.3 179.39 5.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -13.9 60.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.462 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -82.75 -43.89 16.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.414 ' NE2' ' H ' ' A' ' 89' ' ' LYS . 58.3 mt-30 -58.28 -36.59 73.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.005 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.15 -33.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.02 -21.08 66.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.899 . . . . 0.0 108.971 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -94.18 -35.32 12.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.179 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -58.74 -36.18 73.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.352 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 mt -106.03 -3.87 21.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 47.12 50.88 13.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.88 146.8 44.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 102' ' ' VAL . 37.0 Cg_endo -69.08 151.99 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.744 2.296 . . . . 0.0 112.053 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.621 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.5 Cg_endo -69.5 19.13 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.887 2.391 . . . . 0.0 112.369 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.532 ' C ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -35.53 -28.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.31 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 101' ' ' PRO . 5.9 tptt -173.35 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.374 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.419 ' CG2' ' C ' ' A' ' 103' ' ' LYS . 1.6 t 69.87 2.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 37.4 p-80 -65.15 -36.76 85.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.556 ' SG ' ' OG ' ' A' ' 69' ' ' SER . 3.9 t -58.7 -56.39 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.06 -44.31 74.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.8 mt -56.53 -41.58 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.39 -32.28 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -63.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.887 . . . . 0.0 109.62 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.1 -49.77 76.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -53.52 -28.03 29.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.973 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -79.3 -64.42 1.19 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.6 tp -44.94 -41.16 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 109.833 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.497 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -73.45 -37.15 65.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.442 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.09 80.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -68.59 -60.34 2.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ALA . 44.4 mt -38.57 -49.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.48 80.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.567 ' OD2' ' O ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -52.67 -66.64 0.35 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.253 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -46.92 -39.02 11.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 109.177 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -59.54 -51.17 70.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.814 . . . . 0.0 109.366 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.72 -6.48 2.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -97.21 40.21 1.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -117.85 -74.77 0.59 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 128' ' ' GLU . . . -176.38 -49.97 0.06 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 126' ' ' GLY . 6.8 tp -45.64 -11.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -1.124 . . . . 0.0 109.447 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 126' ' ' GLY . 2.5 tm-20 -56.78 -55.06 39.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.347 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.419 ' C ' ' ND1' ' A' ' 129' ' ' HIS . 0.5 OUTLIER 57.45 86.23 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.76 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 154.64 40.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.06 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -175.79 80.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.084 -1.01 . . . . 0.0 109.681 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.558 ' CG ' ' H ' ' A' ' 133' ' ' HIS . 4.8 t60 -57.97 -177.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 109.087 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.558 ' H ' ' CG ' ' A' ' 132' ' ' HIS . 4.3 m80 -129.09 159.36 36.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.105 -0.997 . . . . 0.0 109.566 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.449 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 4' ' ' SER . . . -70.28 170.6 11.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.55 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -47.45 82.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.548 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 2' ' ' ALA . 14.0 t -166.69 10.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.657 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.522 ' CD ' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -112.34 113.2 25.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.162 -0.962 . . . . 0.0 109.46 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -59.36 163.94 3.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -18.61 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.717 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.3 mt -95.31 83.83 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -145.62 66.28 1.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 10' ' ' HIS . 1.4 m170 -77.41 115.81 17.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.448 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.62 26.55 6.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.452 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.04 70.32 0.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -134.28 60.33 43.14 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.476 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -65.33 -152.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.758 2.305 . . . . 0.0 112.349 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.14 -170.14 0.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.215 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -154.74 -105.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.669 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.91 87.62 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.131 -0.981 . . . . 0.0 109.594 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' SER . . . -50.57 176.12 0.05 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' GLY . 1.8 t -42.57 148.43 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -1.217 . . . . 0.0 109.377 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.567 ' O ' ' O ' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -92.25 51.57 1.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.442 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.624 ' C ' ' H ' ' A' ' 23' ' ' LYS . 9.4 m-20 53.73 159.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 15.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.124 -0.985 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 21' ' ' ASP . 11.5 mmtm -95.99 23.62 6.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.838 . . . . 0.0 109.335 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -96.11 167.42 11.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.538 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.529 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 3.7 m -101.61 7.24 42.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.529 ' OD1' ' O ' ' A' ' 25' ' ' SER . 56.9 m-20 -144.2 14.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.9 t -118.46 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.192 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.53 153.13 34.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.542 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 7.8 m -127.15 120.7 29.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -1.043 . . . . 0.0 109.108 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.24 106.5 1.81 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.0 ttt -112.33 112.4 23.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -1.216 . . . . 0.0 109.462 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.48 154.44 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.39 -170.1 11.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB2' ' NE2' ' A' ' 105' ' ' HIS . . . -147.31 92.24 4.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 53.7 Cg_exo -48.55 -48.03 18.65 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.689 2.259 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.09 -34.2 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.469 ' O ' ' C ' ' A' ' 38' ' ' GLY . 21.2 m -120.01 12.05 11.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.83 56.89 3.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -124.5 117.6 24.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.29 130.06 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -128.86 137.04 51.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.325 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -121.54 164.01 17.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.689 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tp -158.51 126.19 5.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -117.77 140.55 49.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.54 124.34 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.57 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -101.39 143.6 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.5 t -131.3 156.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.291 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.0 t70 -85.16 -106.12 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.448 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 2.1 p30 -140.02 8.65 2.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.575 HD21 ' H ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -124.75 -29.52 3.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.461 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.402 ' N ' HD21 ' A' ' 50' ' ' ASN . . . 135.66 -5.6 4.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.575 ' H ' HD21 ' A' ' 50' ' ' ASN . 50.0 mm -79.38 137.04 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -1.151 . . . . 0.0 109.487 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mt -91.17 107.01 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -70.93 -16.45 62.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.725 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 15.7 t0 -172.91 151.75 2.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.053 -1.029 . . . . 0.0 109.791 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.556 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -133.12 107.76 8.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.22 154.77 17.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 109.561 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.59 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 2.4 p90 -136.99 -176.5 4.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.58 106.94 0.56 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.349 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.64 ' CG2' ' HG ' ' A' ' 70' ' ' SER . 81.9 p -112.77 145.15 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -154.45 108.79 3.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 109.423 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.84 -58.19 0.3 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.6 t -106.68 136.02 47.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -1.153 . . . . 0.0 109.371 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.63 38.25 2.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.5 20.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -1.185 . . . . 0.0 109.525 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -93.43 -29.49 15.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.724 ' H ' ' CD1' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -42.93 -27.16 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -46.72 -57.59 4.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.852 . . . . 0.0 109.705 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -49.89 29.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.707 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.64 ' HG ' ' CG2' ' A' ' 60' ' ' THR . 0.3 OUTLIER -48.63 -41.62 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.873 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.57 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.15 -45.17 74.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 73' ' ' ILE . 46.3 tp -57.06 -71.22 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.74 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 72' ' ' LEU . 9.5 tt -40.78 -44.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 109.941 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 71' ' ' SER . 1.1 p -59.22 -36.92 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.764 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' LEU . 21.6 tt0 -71.69 -55.65 7.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -31.88 27.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.664 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.595 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 4.2 m -105.37 63.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.7 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -144.58 95.5 2.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.56 -15.47 35.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -76.08 -160.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -1.109 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 t -117.96 159.08 23.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.0 mt -57.11 -19.18 18.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.327 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -67.83 -30.8 70.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.376 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -86.39 -45.86 10.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.608 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.46 60.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.62 46.73 1.13 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -168.33 -33.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.093 . . . . 0.0 108.93 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 87' ' ' ALA . 16.2 pt -50.3 179.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.49 -0.756 . . . . 0.0 109.579 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -143.58 179.98 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.282 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -96.15 -13.22 23.73 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 t -70.84 -41.93 70.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.813 . . . . 0.0 109.268 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -65.86 -52.15 52.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.212 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 mt -57.97 -27.01 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.221 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.67 -42.06 78.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.318 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.51 -22.02 62.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.19 -54.92 5.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.532 ' O ' ' C ' ' A' ' 98' ' ' GLU . 4.4 tp -80.75 -3.47 51.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 97' ' ' LEU . 7.6 tm-20 36.0 70.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.326 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.04 149.76 36.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.373 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 102' ' ' VAL . 39.9 Cg_endo -71.03 151.66 62.03 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.714 2.276 . . . . 0.0 112.112 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.02 19.39 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.797 2.331 . . . . 0.0 112.211 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' A' ' 100' ' ' PRO . 26.8 m -97.31 16.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.493 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.622 ' C ' ' H ' ' A' ' 105' ' ' HIS . 8.8 tttp -176.49 46.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.7 t -65.86 20.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.64 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.622 ' H ' ' C ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -86.24 -30.51 22.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 p -65.85 -44.37 85.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.25 -45.92 89.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.422 HD13 HG22 ' A' ' 108' ' ' ILE . 88.7 mt -68.2 -30.04 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.39 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 mp -73.27 -40.93 64.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.77 53.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.831 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.31 -56.85 8.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.709 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -51.55 -17.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.38 -55.06 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.456 HG21 ' N ' ' A' ' 115' ' ' LYS . 3.6 tp -51.13 -33.07 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.0 109.653 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.503 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -75.39 -61.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -37.47 -35.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 119' ' ' ALA . . . -77.75 -66.34 0.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 117' ' ' ALA . 48.0 mt -37.47 -28.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 117' ' ' ALA . . . -77.9 -52.9 8.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD2' ' O ' ' A' ' 29' ' ' THR . 37.3 m-20 -49.75 -44.19 48.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.71 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.59 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -76.12 -59.17 2.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 109.547 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' TYR . 22.6 tptt -43.11 -33.26 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.8 -20.87 16.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -111.23 24.12 13.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -154.5 44.15 0.52 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.656 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.08 -36.43 0.13 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -96.05 -14.2 23.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -1.194 . . . . 0.0 109.697 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -152.9 164.94 36.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.583 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -167.13 49.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.487 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 4.5 p80 -134.08 132.27 39.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.565 ' N ' ' ND1' ' A' ' 131' ' ' HIS . 1.0 OUTLIER -178.84 87.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.379 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' HIS . 31.2 m80 -40.18 -80.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.452 ' CD2' ' H ' ' A' ' 134' ' ' HIS . 1.7 t-160 -124.27 -143.47 0.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.552 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.452 ' H ' ' CD2' ' A' ' 133' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.454 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.09 172.17 13.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 109.432 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.74 131.89 52.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 t -124.48 137.84 54.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.4 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -90.61 -74.36 0.5 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.339 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -151.8 -57.54 0.15 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.427 -0.795 . . . . 0.0 109.121 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.548 ' O ' ' C ' ' A' ' 8' ' ' ILE . 15.9 m -87.47 160.96 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.358 -0.838 . . . . 0.0 109.139 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.548 ' C ' ' O ' ' A' ' 7' ' ' VAL . 26.1 mm -36.13 143.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.31 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -100.35 161.97 13.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.09 -1.006 . . . . 0.0 109.734 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -107.39 141.68 38.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.399 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -87.42 -15.84 36.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 63.07 -122.43 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.657 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.49 146.47 86.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.608 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.679 ' O ' ' N ' ' A' ' 16' ' ' ASN . 57.4 Cg_endo -74.44 8.24 2.29 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.836 2.357 . . . . 0.0 112.408 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 14' ' ' PRO . 14.4 ptm180 -42.81 -13.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 109.57 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' PRO . 4.0 m-80 -64.14 86.85 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.534 ' C ' ' O ' ' A' ' 16' ' ' ASN . 3.0 m -36.18 118.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -162.72 -177.1 35.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 0.9 OUTLIER 77.11 177.58 0.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.144 -1.209 . . . . 0.0 109.428 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.523 ' N ' ' HG ' ' A' ' 19' ' ' SER . 1.2 mt -97.91 -49.13 4.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 47.22 32.23 2.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.836 . . . . 0.0 109.524 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 21' ' ' ASP . 21.5 tptp -45.3 -43.91 11.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.321 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.582 ' O ' ' O ' ' A' ' 24' ' ' ASP . 3.1 tttt -155.11 13.91 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.588 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.645 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 48.95 172.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.538 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 58.91 -4.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.337 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.645 ' H ' ' C ' ' A' ' 24' ' ' ASP . 8.9 p-10 -146.65 13.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.383 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.06 101.58 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.744 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.19 128.86 9.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.74 152.9 21.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -1.212 . . . . 0.0 109.661 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 43' ' ' LEU . . . -131.51 118.18 2.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.96 95.3 4.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -1.146 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.92 145.56 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.86 177.75 20.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.57 77.15 73.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.171 -1.194 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.03 -6.36 1.8 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.854 2.369 . . . . 0.0 112.107 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.62 -11.08 59.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.588 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.4 -39.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.98 69.63 0.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.1 145.89 44.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -1.157 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.22 117.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.85 . . . . 0.0 109.212 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ttt -120.11 120.24 35.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.893 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.34 142.72 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 108.97 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 tt -150.62 149.39 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 109.886 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.435 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 12.9 pt20 -150.99 123.27 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.787 . . . . 0.0 109.214 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.3 151.12 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -112.68 150.0 32.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.568 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.84 144.52 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.203 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.651 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 36.7 p-10 -85.13 -108.76 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.963 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.651 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 34.0 t0 -131.95 -23.39 2.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.545 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.37 -1.68 57.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 28.83 12.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 52' ' ' ILE . 45.9 mm -108.89 161.43 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 109.373 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.4 mt -100.49 105.47 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.222 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.3 -36.29 20.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.803 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.79 160.31 38.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.707 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.29 112.88 4.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 109.417 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -107.77 146.63 31.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.468 ' CD1' HG22 ' A' ' 74' ' ' THR . 2.9 p90 -140.35 -175.44 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.542 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -170.75 107.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.39 105.87 10.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.474 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.1 122.54 24.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.09 -39.44 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.0 139.06 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -1.099 . . . . 0.0 109.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.52 60.45 1.52 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.622 ' C ' ' H ' ' A' ' 67' ' ' ILE . 2.3 p -175.73 -59.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.02 -1.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.532 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.622 ' H ' ' C ' ' A' ' 65' ' ' SER . 4.2 mt -65.76 -8.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.25 -49.75 9.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.09 -52.82 59.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.327 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -43.37 -56.51 3.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -53.21 -30.43 37.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 109.352 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 69' ' ' SER . 11.4 tp -70.53 -67.45 0.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 109.554 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 tt -48.72 -40.35 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.468 HG22 ' CD1' ' A' ' 58' ' ' PHE . 21.0 p -58.66 -47.19 85.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.74 -10.17 58.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.87 -31.37 17.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 m -102.42 64.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -133.93 100.5 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.67 -9.39 77.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -81.45 -171.22 3.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -1.204 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.11 -178.27 3.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.24 -10.32 49.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -71.06 -34.48 71.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.156 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.0 -37.13 13.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.402 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 -29.53 63.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.67 48.29 1.51 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.97 -42.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -1.12 . . . . 0.0 109.027 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.465 ' C ' ' O ' ' A' ' 87' ' ' ALA . 2.3 pt -40.98 151.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.398 -0.814 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -129.53 173.42 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 109.669 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.495 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 4.1 p-10 -86.75 -7.86 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.357 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 -47.38 39.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -60.08 4.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 109.409 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.31 -38.25 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.75 -33.87 76.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.55 -22.31 30.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.486 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.02 -24.85 58.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.4 mt -111.21 -19.26 12.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.242 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.47 62.79 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.684 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.602 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -97.56 153.23 38.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.335 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.0 152.13 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.547 2.164 . . . . 0.0 112.028 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.67 -11.05 22.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.752 2.301 . . . . 0.0 112.229 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -92.01 11.11 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 105' ' ' HIS . 34.7 mttt -139.83 6.56 2.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.454 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.403 ' C ' ' N ' ' A' ' 106' ' ' CYS . 3.8 t -47.09 -17.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -51.4 -14.69 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.514 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.628 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 42.2 t -76.05 -71.12 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.668 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.0 p -48.62 -44.06 36.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.452 HG23 HD12 ' A' ' 108' ' ' ILE . 33.7 mt -57.93 -51.83 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 mp -52.52 -27.91 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.82 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 16.4 tt0 -64.5 -44.92 89.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -35.23 79.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.36 65.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp -58.53 -41.37 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.975 . . . . 0.0 109.567 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.485 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 40.4 tttm -61.27 -28.56 69.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 109.155 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.37 -47.53 19.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.6 -32.41 41.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.92 -41.34 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.42 84.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.11 -52.64 22.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.87 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -49.36 -42.13 41.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.224 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -28.55 63.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.96 4.64 53.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -79.05 -58.45 3.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.37 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -99.22 54.93 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.547 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -161.82 -50.4 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.547 ' C ' ' O ' ' A' ' 126' ' ' GLY . 1.2 mp -35.28 -51.3 0.58 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -1.124 . . . . 0.0 109.423 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -155.5 -141.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.572 ' C ' ' ND1' ' A' ' 129' ' ' HIS . 0.2 OUTLIER -146.31 -83.86 0.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.482 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -155.34 -63.32 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.406 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.414 ' CD2' ' O ' ' A' ' 131' ' ' HIS . 32.0 p-80 -86.55 134.08 33.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.908 . . . . 0.0 109.347 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -140.52 -58.1 0.53 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.647 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -110.27 146.27 35.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.631 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.48 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.607 ' O ' ' NZ ' ' A' ' 6' ' ' LYS . 3.7 ttm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.555 ' O ' ' CB ' ' A' ' 3' ' ' TYR . . . -97.34 105.81 18.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER 78.44 98.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.16 -80.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -126.29 29.1 5.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.607 ' NZ ' ' O ' ' A' ' 1' ' ' MET . 6.8 mttt -76.22 -75.35 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.882 . . . . 0.0 109.426 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -178.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.183 -0.948 . . . . 0.0 109.367 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mt 46.56 78.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.502 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.09 -99.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.303 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.467 ' O ' ' C ' ' A' ' 11' ' ' TYR . 2.0 t60 -90.07 -64.88 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.181 -0.949 . . . . 0.0 109.304 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 10' ' ' HIS . 3.8 m-85 -42.09 134.24 2.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 109.254 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.7 62.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.581 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.675 ' O ' ' N ' ' A' ' 15' ' ' ARG . 4.0 m-20 177.31 72.09 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -55.91 31.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.761 2.307 . . . . 0.0 112.036 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.675 ' N ' ' O ' ' A' ' 13' ' ' ASN . 9.5 mtt180 52.2 67.93 0.9 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.296 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.51 ' CG ' ' O ' ' A' ' 16' ' ' ASN . 5.8 p30 -161.96 116.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.54 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -54.22 -67.97 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.557 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 136.43 112.24 1.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER 52.11 165.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -1.116 . . . . 0.0 109.574 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 22' ' ' LYS . 87.8 mt -82.13 88.51 6.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 3.1 t0 73.71 -40.53 0.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 109.525 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 5.5 tttt 74.41 -9.07 1.36 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -0.833 . . . . 0.0 109.731 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -131.0 48.7 2.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -114.92 161.23 18.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.424 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -82.99 9.31 10.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.684 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -118.92 -13.68 9.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.363 -0.836 . . . . 0.0 109.364 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.12 94.08 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.369 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.73 142.5 20.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -120.94 158.88 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -1.089 . . . . 0.0 109.177 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.15 145.4 12.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 ttt -145.62 119.3 9.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -126.17 170.34 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.75 178.29 28.27 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.29 75.34 70.72 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -1.091 . . . . 0.0 109.187 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 75.3 Cg_exo -44.48 -25.74 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 112.434 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.1 -51.2 8.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.8 p -114.79 -24.54 8.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.45 46.11 1.09 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 36.9 t0 -108.09 135.61 49.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 109.488 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 4.0 m -108.43 137.72 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.9 ttt -137.86 128.56 26.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -117.26 142.91 46.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 109.409 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 tp -149.53 121.09 7.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.67 155.41 29.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.849 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.79 125.48 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.662 ' NZ ' ' OE1' ' A' ' 54' ' ' GLU . 11.2 tttp -100.0 114.71 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -122.39 127.55 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.941 . . . . 0.0 109.495 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.663 ' O ' ' N ' ' A' ' 50' ' ' ASN . 6.3 m-20 -158.02 -32.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.616 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -62.57 50.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.663 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.3 m-80 78.54 54.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.61 18.17 71.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.2 mm -105.73 134.9 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.389 -1.065 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 32.4 mt -63.06 80.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.216 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.662 ' OE1' ' NZ ' ' A' ' 46' ' ' LYS . 35.5 tt0 -49.61 -22.73 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.18 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -169.11 159.57 9.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.034 -1.041 . . . . 0.0 109.808 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.05 134.0 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -116.68 144.59 44.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -143.66 170.64 15.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -171.7 96.54 0.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 0.0 108.975 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.32 148.64 42.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -152.79 147.93 26.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.152 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.73 -74.03 0.45 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.657 ' O ' ' SG ' ' A' ' 63' ' ' CYS . 1.6 p -116.24 122.18 44.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.134 . . . . 0.0 109.348 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.25 -9.68 2.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 63' ' ' CYS . 0.5 OUTLIER -93.27 10.3 32.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.444 ' HB1' ' SG ' ' A' ' 63' ' ' CYS . . . -100.88 -3.49 29.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.86 -24.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.8 65.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -50.78 12.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 74' ' ' THR . 17.1 t -49.34 -38.41 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.1 t -72.21 -39.28 68.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.9 tp -61.0 -59.87 4.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.344 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 76' ' ' TRP . 1.0 OUTLIER -53.13 -59.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 70' ' ' SER . 2.4 p -42.86 -32.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.824 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -91.01 -11.31 39.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.782 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -93.87 -17.31 23.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.975 . . . . 0.0 109.533 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.36 40.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.459 ' C ' ' H ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -95.89 116.93 29.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.43 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.69 5.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -73.74 -173.78 1.6 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.4 m -101.49 158.4 16.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.865 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -70.21 -16.56 63.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.86 -26.22 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.208 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -93.43 -43.4 8.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.376 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.21 67.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.47 33.11 4.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.1 26.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -1.109 . . . . 0.0 109.253 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.57 -25.02 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.832 . . . . 0.0 109.621 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 71.16 156.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.448 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.55 ' OD1' ' OE1' ' A' ' 111' ' ' GLU . 6.6 p-10 -93.48 -41.96 9.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.616 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -35.96 79.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -58.54 -67.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.3 mt -49.8 -33.47 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.751 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.3 -31.08 69.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 109.741 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.4 -36.14 60.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.23 -43.3 82.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.25 -17.15 62.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.404 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 54.24 39.08 30.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 pp -82.27 149.0 60.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.304 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.16 149.31 85.63 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.645 2.23 . . . . 0.0 112.147 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -73.2 20.06 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.926 2.417 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.0 m -85.47 -13.52 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.885 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 105' ' ' HIS . 1.0 OUTLIER -150.12 55.8 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.586 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 74.5 t -73.3 40.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 103' ' ' LYS . 62.4 m80 -97.42 -26.46 14.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.868 . . . . 0.0 109.718 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.642 ' SG ' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -74.94 -45.11 44.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.626 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.642 ' N ' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -53.84 -46.92 71.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 56.2 mt -68.05 -43.65 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.4 mp -58.27 -37.35 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.33 -59.07 5.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.422 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.55 ' OE1' ' OD1' ' A' ' 90' ' ' ASN . 87.1 tt0 -56.09 -60.51 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.362 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 111' ' ' GLU . 1.6 t0 -43.9 -32.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.354 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.89 -61.2 1.9 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.46 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 tp -49.61 -20.68 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -85.26 -57.9 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.353 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.56 5.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.225 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.94 -58.03 3.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.126 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.5 mt -46.72 -31.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.365 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.89 38.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.05 -0.79 12.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.147 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -102.81 -32.05 10.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -95.74 -31.4 13.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.26 -18.18 63.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.484 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.49 5.61 30.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -100.99 -21.66 14.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 109.287 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -87.21 -18.75 56.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 128' ' ' GLU . 3.5 tp -69.66 -15.13 63.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.425 -1.044 . . . . 0.0 109.223 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' A' ' 130' ' ' HIS . 1.6 tt0 41.92 87.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.328 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.45 ' C ' ' O ' ' A' ' 128' ' ' GLU . 1.9 m-70 -41.24 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 109.643 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.652 ' N ' ' O ' ' A' ' 128' ' ' GLU . 0.9 OUTLIER -102.89 -139.44 0.35 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.207 -0.933 . . . . 0.0 109.141 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.565 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 48.9 t-80 -45.11 156.23 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.31 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.461 ' N ' ' ND1' ' A' ' 131' ' ' HIS . 40.1 m80 -123.15 167.99 12.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.501 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.13 146.62 32.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.69 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 1.9 t60 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.522 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.59 139.29 30.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.425 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -89.14 79.94 7.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -123.56 38.69 4.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.319 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.85 73.68 3.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -83.93 19.36 1.76 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.301 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.7 m -89.22 62.47 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.469 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 mt -83.69 21.26 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.267 -0.895 . . . . 0.0 109.474 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -119.51 -72.19 0.7 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.61 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.512 ' C ' ' O ' ' A' ' 9' ' ' ASP . 37.7 t60 36.69 63.75 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -106.58 58.47 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 109.59 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -127.85 -51.23 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.624 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 12' ' ' GLU . 2.4 m120 -42.33 157.88 0.22 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.51 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 15' ' ' ARG . 53.6 Cg_endo -73.93 -0.08 9.01 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.883 2.389 . . . . 0.0 112.314 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.545 ' O ' ' O ' ' A' ' 14' ' ' PRO . 16.2 mmm180 57.94 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.313 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -100.17 59.56 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.963 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.55 165.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.368 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.66 -65.38 0.48 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 160.54 22.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.3 mt -124.88 142.01 51.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.509 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER 53.2 90.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.35 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 1.47 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 21' ' ' ASP . 11.7 ttmt -60.36 -22.65 63.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.951 . . . . 0.0 109.015 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 57.23 25.26 10.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -71.27 2.4 4.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.277 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 25' ' ' SER . 2.4 p30 165.75 33.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.41 96.76 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.454 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.0 100.95 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 m -86.17 133.16 33.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -1.152 . . . . 0.0 109.657 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.33 145.78 17.57 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.21 110.8 5.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -1.213 . . . . 0.0 109.774 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.77 144.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.34 178.17 21.09 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.93 92.57 49.07 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.139 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.8 Cg_exo -50.15 -40.15 51.28 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.852 2.368 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.43 -44.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 109.671 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.32 -13.03 9.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.599 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.22 57.9 2.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -113.35 110.84 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.5 130.54 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.99 118.96 15.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -111.14 136.23 50.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.707 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.35 141.89 51.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -140.84 135.84 31.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -118.09 136.01 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' CD ' ' OD2' ' A' ' 55' ' ' ASP . 36.8 tttt -105.87 118.92 37.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.25 146.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.661 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.7 m-20 -173.92 -33.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.614 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -62.47 42.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.661 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.8 m-80 80.99 43.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 109.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.13 0.54 82.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.525 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.0 mm -98.23 151.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.494 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -84.39 116.03 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -44.57 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD2' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -130.11 131.2 45.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.561 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.96 121.51 45.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.425 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 115.13 29.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.402 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.744 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -101.78 167.91 9.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 83.74 1.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.545 ' H ' ' HG1' ' A' ' 60' ' ' THR . 0.6 OUTLIER -95.92 127.47 41.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.47 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -151.57 141.56 22.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.596 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.98 -53.06 0.59 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 42.6 t -91.11 172.57 8.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -1.188 . . . . 0.0 109.442 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.495 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -129.92 -10.85 2.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.8 13.65 30.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -1.112 . . . . 0.0 109.368 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.93 -31.37 9.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.845 . . . . 0.0 109.486 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.6 mp -36.7 -35.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.933 . . . . 0.0 109.172 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -75.44 -55.86 5.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.7 m -51.11 -39.87 57.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.05 -66.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.67 -19.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.328 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -79.75 -78.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.937 . . . . 0.0 109.573 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.3 tt -45.95 -36.77 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.7 p -68.76 -39.07 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.82 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -79.78 -12.22 59.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -98.6 -26.36 14.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.539 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.3 -34.76 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -50.73 116.31 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.41 57.49 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -89.22 -177.89 5.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.391 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.525 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 50.6 m -107.17 -178.95 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.9 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.2 mt -77.68 -23.07 49.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 -14.22 60.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.378 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -101.23 -41.95 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.14 1.71 56.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.6 47.07 1.08 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -176.85 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -1.127 . . . . 0.0 109.394 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.498 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -38.16 155.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -116.43 158.6 23.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.539 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.534 ' OD1' ' OE1' ' A' ' 111' ' ' GLU . 1.4 p-10 -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -47.55 -37.06 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.19 -66.97 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 109.555 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -44.95 -44.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.46 -39.76 77.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.105 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -75.86 -10.01 59.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.234 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -79.47 -62.87 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 mt -72.52 -2.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.09 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 46.9 77.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 110.086 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -126.69 148.52 65.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 108.875 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -37.78 148.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.887 2.391 . . . . 0.0 112.358 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.71 -79.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.676 2.251 . . . . 0.0 112.348 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.532 ' CG1' ' H ' ' A' ' 103' ' ' LYS . 3.3 t 47.16 -138.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.195 -0.941 . . . . 0.0 109.298 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.555 ' O ' ' C ' ' A' ' 104' ' ' VAL . 14.6 tttt -78.42 -6.45 55.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.555 ' C ' ' O ' ' A' ' 103' ' ' LYS . 12.0 p 31.97 41.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.485 -0.759 . . . . 0.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 103' ' ' LYS . 16.0 p80 -68.65 -24.4 64.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.8 t -59.48 -71.18 0.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.6 m -46.35 -42.19 14.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.299 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.535 ' O ' ' C ' ' A' ' 109' ' ' LEU . 87.5 mt -54.77 -70.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 108' ' ' ILE . 6.4 mp -36.64 -34.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 109.452 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 108' ' ' ILE . . . -61.4 -72.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' OD1' ' A' ' 90' ' ' ASN . 16.9 tt0 -54.49 -38.33 66.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -27.99 68.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.892 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -79.09 -58.26 3.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.529 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.5 tp -44.7 -39.5 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 109.548 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -67.79 -55.9 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.553 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.54 -50.17 13.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.87 -59.98 4.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.506 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.9 mt -52.02 -22.18 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.25 -49.93 25.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.47 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -68.77 -50.85 47.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -48.53 -50.56 31.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 123' ' ' ALA . 3.4 mttm -65.13 -39.36 92.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.626 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -43.16 -42.82 4.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -53.61 -43.96 69.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.928 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -51.22 -21.78 2.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 109.666 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.94 28.96 11.04 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.6 mt 54.28 14.98 0.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -1.197 . . . . 0.0 109.54 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.575 ' C ' ' CG ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER 61.63 -173.97 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.433 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER 179.1 81.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.586 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 2.1 t60 -138.06 13.34 2.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.319 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -50.7 161.89 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.559 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.661 ' N ' ' ND1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -173.76 69.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.376 -0.827 . . . . 0.0 109.497 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.528 ' O ' ' C ' ' A' ' 134' ' ' HIS . 9.8 m-70 -101.74 -117.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.528 ' C ' ' O ' ' A' ' 133' ' ' HIS . 35.5 m170 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.455 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.258 0.552 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.91 -159.24 0.29 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.945 . . . . 0.0 109.524 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -100.31 -5.7 27.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.409 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -132.49 163.1 29.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 4' ' ' SER . 3.3 tp10 75.05 55.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 109.517 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.35 -56.15 4.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 t -58.19 151.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.346 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 mt -66.9 -57.92 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -148.68 153.27 38.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.384 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.717 ' CD2' ' H ' ' A' ' 10' ' ' HIS . 1.8 p80 -94.61 60.66 2.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 0.0 109.496 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -164.06 147.67 9.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.537 ' C ' ' OD1' ' A' ' 13' ' ' ASN . 72.7 mt-10 -145.14 -120.6 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.2 -0.937 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.537 ' OD1' ' C ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -148.9 162.23 30.05 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.37 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.18 -28.45 28.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.757 2.304 . . . . 0.0 112.013 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.715 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -73.19 124.75 26.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -136.81 6.59 2.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.109 -0.994 . . . . 0.0 109.627 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.89 29.07 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.516 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.53 158.9 23.22 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.769 ' HG ' ' H ' ' A' ' 20' ' ' LEU . 26.7 p -144.06 -129.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.165 . . . . 0.0 109.438 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.769 ' H ' ' HG ' ' A' ' 19' ' ' SER . 3.0 tp 77.15 -28.26 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.553 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -46.43 -15.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.501 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 22.3 tttt 78.13 -21.64 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 21' ' ' ASP . 3.2 pttt -117.04 36.03 4.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.878 . . . . 0.0 109.391 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -102.89 158.55 16.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.439 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 13.13 14.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.888 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -108.83 16.95 22.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.07 116.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.16 140.18 15.6 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.3 m -119.89 120.51 36.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.1 132.94 6.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -136.02 131.43 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -1.141 . . . . 0.0 109.282 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.03 -174.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.23 -169.17 38.71 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -140.31 100.51 6.97 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' CYS . 69.0 Cg_exo -47.06 -60.55 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.52 2.146 . . . . 0.0 112.152 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.71 -20.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 35' ' ' PRO . 3.7 m -118.85 -32.39 4.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 81.0 25.81 54.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.78 132.39 35.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -1.115 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -107.36 115.39 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.7 ttt -113.94 102.15 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -84.92 155.04 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.51 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.89 110.83 2.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -115.26 123.56 49.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.95 153.23 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' NZ ' HD11 ' A' ' 20' ' ' LEU . 26.0 mttt -126.0 134.38 51.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.75 148.1 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.199 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.58 -94.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.039 -1.038 . . . . 0.0 109.612 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -156.43 20.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.46 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -1.2 3.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.915 . . . . 0.0 109.46 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.11 15.06 31.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mm -105.32 122.35 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -1.147 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.0 mt -67.82 111.93 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.253 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' O ' ' CD ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -88.19 -8.07 55.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.817 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 56' ' ' ALA . 7.0 t70 -171.96 165.86 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 55' ' ' ASP . . . -149.55 139.79 22.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 165.46 24.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -170.61 -174.49 1.63 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.809 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -172.03 111.08 0.28 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.038 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.417 HG22 ' HG ' ' A' ' 70' ' ' SER . 71.1 p -84.32 149.45 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.816 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.7 116.09 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.37 -0.832 . . . . 0.0 109.316 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.49 -87.23 0.14 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 140.32 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -1.11 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.481 ' C ' ' HG ' ' A' ' 65' ' ' SER . . . -91.11 55.37 3.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.481 ' HG ' ' C ' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -143.55 -32.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.378 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -83.6 1.23 43.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.409 HD11 ' HG1' ' A' ' 60' ' ' THR . 5.8 mm -59.07 4.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.614 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -94.09 -38.66 11.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.62 -52.82 18.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.417 ' HG ' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -53.11 -33.67 53.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.514 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.436 ' O ' ' OG1' ' A' ' 74' ' ' THR . 6.2 m -71.51 -35.77 70.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.97 -65.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.2 tt -46.12 -39.56 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.781 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 71' ' ' SER . 16.6 p -62.89 -40.01 96.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 1.39 51.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.902 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -17.37 14.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.823 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.8 m -114.03 53.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.039 . . . . 0.0 109.648 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HZ2' ' HA ' ' A' ' 55' ' ' ASP . 24.5 tttm -126.26 104.34 8.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.375 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -24.02 33.99 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -65.38 -179.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.405 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.6 159.17 15.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.124 -0.985 . . . . 0.0 109.65 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mt -56.43 -22.29 30.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.888 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.08 -46.47 70.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.138 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.81 -45.58 93.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.132 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.46 72.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.153 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 49.0 4.15 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.98 -32.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -1.075 . . . . 0.0 109.182 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.544 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -34.16 -44.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.45 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 88' ' ' ILE . 49.3 mttt 57.79 145.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.835 . . . . 0.0 109.559 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.35 -28.82 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 0.0 109.37 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.3 p -54.53 -39.86 68.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -53.9 12.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.3 mt -51.49 -40.61 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.447 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.45 -58.82 5.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.392 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.63 -53.01 34.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.214 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -47.24 -50.51 21.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.342 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.5 mp -70.19 -40.34 74.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.357 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 1.8 tp10 81.71 32.6 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.19 146.14 50.6 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 102' ' ' VAL . 20.5 Cg_endo -64.77 152.59 81.5 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.558 2.172 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.11 20.11 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.875 2.383 . . . . 0.0 112.131 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 100' ' ' PRO . 33.0 m -87.93 -21.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.63 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -137.18 47.74 2.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.793 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.45 -9.5 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 108.998 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.28 -27.15 54.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 45.2 t -69.87 -64.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -49.59 -65.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.363 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 107' ' ' SER . 80.0 mt -40.98 -44.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 mp -57.46 -44.23 84.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -57.69 -48.1 80.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.271 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.61 -59.68 5.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 -25.89 3.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.885 . . . . 0.0 109.441 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.1 -38.9 69.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.454 HG21 ' N ' ' A' ' 115' ' ' LYS . 2.1 tp -70.23 -35.76 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.476 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.454 ' N ' HG21 ' A' ' 114' ' ' ILE . 13.7 mttt -77.92 -30.4 50.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.531 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.86 -43.85 87.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.358 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.14 77.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.273 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.16 -45.72 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.429 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.83 75.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 29' ' ' THR . 4.8 m-20 -66.92 -8.64 30.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -87.22 -52.36 5.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -61.89 -41.78 98.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.633 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.51 -0.59 5.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.7 18.1 22.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.429 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -90.16 -69.58 0.72 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -89.41 -10.88 65.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.56 ' N ' ' OE2' ' A' ' 128' ' ' GLU . 11.4 mt 61.44 41.27 12.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -1.16 . . . . 0.0 109.384 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 128' ' ' GLU . 2.4 pm0 -89.16 166.99 13.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.279 -0.888 . . . . 0.0 109.45 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 128' ' ' GLU . 51.3 m80 -155.68 -137.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.862 . . . . 0.0 109.383 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -135.92 -29.4 1.02 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -0.98 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.623 ' CD2' ' HE2' ' A' ' 133' ' ' HIS . 3.2 t60 -162.48 97.7 0.99 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 109.698 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.708 ' N ' ' ND1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -134.21 109.92 9.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.932 . . . . 0.0 109.307 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.623 ' HE2' ' CD2' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -111.17 11.14 21.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.973 . . . . 0.0 109.491 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.438 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' H2 ' ' H ' ' A' ' 2' ' ' ALA . 3.5 ttm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.313 0.578 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' H ' ' H2 ' ' A' ' 1' ' ' MET . . . -85.5 150.33 24.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.512 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 1' ' ' MET . 39.5 m-85 -134.28 -18.54 1.99 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.466 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -48.52 73.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.97 -129.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.723 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.85 87.99 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.516 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -106.86 -56.86 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.524 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.518 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 3.7 mp 53.97 109.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.433 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 3.7 p30 -143.35 -13.62 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 0.0 109.638 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.661 ' ND1' ' N ' ' A' ' 11' ' ' TYR . 3.3 p80 -70.99 -106.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.661 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 50.8 t80 44.6 53.38 7.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.611 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 3.5 pm0 -65.91 142.67 57.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.466 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.709 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -82.64 155.93 68.25 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.614 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.92 140.25 37.9 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.881 2.387 . . . . 0.0 112.442 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -100.14 -177.24 3.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 17' ' ' VAL . 17.1 p-10 -166.85 -50.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 109.684 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -92.0 120.87 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.623 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.598 ' C ' ' HG ' ' A' ' 19' ' ' SER . . . -111.91 -109.95 3.08 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.598 ' HG ' ' C ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER 44.36 77.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -1.153 . . . . 0.0 109.633 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 21' ' ' ASP . 12.3 mt -64.94 160.84 19.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.445 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 20' ' ' LEU . 2.8 m-20 -49.72 174.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.355 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -81.01 16.16 1.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.142 -0.974 . . . . 0.0 109.403 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 23' ' ' LYS . 19.8 ttpt -83.37 -11.93 57.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.516 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.95 156.59 16.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.527 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -92.11 12.31 22.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.333 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.89 19.96 15.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.0 t -139.29 99.42 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.52 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.04 120.87 5.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -82.96 136.69 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 109.52 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.12 85.59 0.32 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mtt -94.69 107.27 19.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -1.103 . . . . 0.0 109.559 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.1 170.78 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.526 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.94 -173.21 34.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.1 87.09 55.97 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.184 . . . . 0.0 109.481 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.94 -12.8 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.736 2.291 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.8 m -120.18 -38.68 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.5 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.12 36.88 0.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.41 115.8 28.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.127 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.72 131.23 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.091 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -134.55 131.5 38.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.801 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 5.4 tt0 -125.41 131.88 52.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.274 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -142.96 111.87 6.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.506 ' NE2' ' OE1' ' A' ' 42' ' ' GLN . 9.2 mt-30 -103.22 143.92 32.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -106.77 147.5 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.574 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 117.94 29.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.8 134.0 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.6 m-20 -170.39 -31.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.575 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 14.0 m-20 -62.7 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.092 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-80 74.49 48.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.488 -0.758 . . . . 0.0 109.067 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.65 -8.54 58.97 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.486 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 45.2 mm -87.71 162.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 53' ' ' ILE . 62.3 mt -79.37 120.33 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.75 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.38 -31.9 21.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.64 157.11 1.99 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.221 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.87 139.09 50.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -103.22 117.66 35.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 15.1 p90 -103.88 166.42 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.5 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -167.05 93.49 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.357 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.78 135.66 50.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.505 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -150.59 139.61 21.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.71 -45.21 0.76 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.6 OUTLIER -119.58 123.71 44.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -1.107 . . . . 0.0 109.389 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 67.19 0.17 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.641 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -174.8 -48.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -1.15 . . . . 0.0 109.633 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.03 -2.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.641 ' H ' ' C ' ' A' ' 65' ' ' SER . 6.2 mm -82.4 -12.05 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.317 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.16 -48.45 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 109.683 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -40.68 97.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.687 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.567 ' O ' ' OG1' ' A' ' 74' ' ' THR . 1.0 OUTLIER -55.25 -47.16 75.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.72 -42.99 99.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.862 . . . . 0.0 109.813 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tp -61.93 -68.25 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.61 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 74' ' ' THR . 17.7 tt -47.99 -49.61 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.754 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.567 ' OG1' ' O ' ' A' ' 70' ' ' SER . 6.5 p -50.49 -46.79 57.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.84 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.52 -5.42 54.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -5.98 26.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.52 -5.85 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.22 114.09 19.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.627 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.21 -6.72 63.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -91.24 165.48 13.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -1.21 . . . . 0.0 109.635 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.486 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 18.1 m -100.42 166.98 10.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.543 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -23.44 67.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.51 -44.82 93.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.83 -59.03 2.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.92 . . . . 0.0 109.387 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.42 -26.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.269 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.17 44.21 1.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.554 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -161.99 -37.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.096 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.554 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.0 pt -41.54 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -136.84 154.49 50.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.54 ' O ' ' C ' ' A' ' 91' ' ' SER . 18.5 p-10 -73.77 -50.71 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.54 ' C ' ' O ' ' A' ' 90' ' ' ASN . 4.0 t -35.01 -46.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.536 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.94 -49.9 72.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.2 mt -55.68 -35.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.221 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.95 -24.3 60.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -81.6 -47.47 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.28 -29.36 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.306 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 99' ' ' LEU . 1.3 mp -98.05 -28.81 13.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.534 ' O ' ' C ' ' A' ' 99' ' ' LEU . 1.6 tt0 64.8 -2.94 0.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.259 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.534 ' C ' ' O ' ' A' ' 98' ' ' GLU . 1.7 pp -34.58 150.23 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.477 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -40.33 108.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.858 2.372 . . . . 0.0 112.097 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.23 8.54 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.536 2.157 . . . . 0.0 112.445 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.84 -14.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -153.11 -38.8 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' CYS . 5.9 t 64.85 5.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.471 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 7.6 p-80 -45.6 -20.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' VAL . 1.8 m -75.41 -75.67 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 106' ' ' CYS . 4.4 m -43.24 -38.78 2.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.8 mt -57.86 -52.65 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.5 mp -59.25 -23.08 62.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.74 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.534 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 6.9 tp10 -60.08 -40.06 88.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -27.69 69.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.177 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -73.44 -65.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.4 tp -43.08 -33.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -67.6 -73.25 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.352 -0.843 . . . . 0.0 109.414 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.544 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -35.48 -36.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' LYS . . . -60.96 -63.93 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.9 mt -47.49 -25.34 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.412 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -59.22 3.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -61.58 -40.28 94.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.313 -0.867 . . . . 0.0 109.093 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -52.43 -57.77 8.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 109.188 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' LYS . 1.7 ttmm -54.44 -47.94 72.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.478 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -44.43 -21.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.51 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 122' ' ' LYS . 42.6 mmtt -98.4 -49.64 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.387 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -119.27 68.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.602 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -95.29 -93.28 1.72 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mt -114.51 -17.51 11.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -1.145 . . . . 0.0 109.175 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 58.15 175.54 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.847 . . . . 0.0 109.609 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.75 25.1 11.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 109.298 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -153.1 106.4 3.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' A' ' 132' ' ' HIS . 6.8 t-80 -129.42 118.0 21.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.68 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.59 ' O ' ' CE1' ' A' ' 131' ' ' HIS . 23.9 t60 -84.65 149.52 25.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.421 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 132' ' ' HIS . 2.2 m-70 -42.75 -48.9 5.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.411 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 2' ' ' ALA . 16.2 mtp . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -42.57 -72.89 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.78 124.99 22.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.193 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -120.33 -9.39 9.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 109.679 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.5 ' C ' ' CD ' ' A' ' 5' ' ' GLU . 3.0 tm-20 -74.85 101.44 4.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.404 ' HZ3' ' HG3' ' A' ' 6' ' ' LYS . 2.9 tmtp? -153.24 53.0 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.539 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.4 157.41 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.5 mt -99.79 146.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.55 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.635 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -120.53 -87.36 0.64 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.39 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -60.49 -175.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.432 ' C ' ' CD ' ' A' ' 12' ' ' GLU . 60.6 m-85 -109.98 -116.87 0.29 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 109.368 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.432 ' CD ' ' C ' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -131.34 -176.15 3.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.922 . . . . 0.0 109.385 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.711 ' N ' HD21 ' A' ' 13' ' ' ASN . 0.0 OUTLIER -144.34 80.06 12.32 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.955 . . . . 0.0 109.423 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 15' ' ' ARG . 50.1 Cg_exo -48.8 -179.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.762 2.308 . . . . 0.0 112.188 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.563 ' O ' ' O ' ' A' ' 14' ' ' PRO . 11.1 mtp180 36.1 95.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.7 127.65 56.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.344 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 t -120.34 126.96 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.403 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.83 145.7 10.93 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.682 ' C ' ' H ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -70.48 -169.37 0.31 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -1.124 . . . . 0.0 109.464 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 mt 61.58 -33.94 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 109.68 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.682 ' H ' ' C ' ' A' ' 19' ' ' SER . 9.5 t0 -82.42 168.42 17.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.587 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -85.39 23.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.445 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -115.39 22.45 13.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.96 165.06 18.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.521 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 3.3 m -103.97 -0.41 28.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.659 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.71 11.98 36.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.336 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.37 110.06 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.86 145.68 17.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 m -139.96 137.28 34.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.6 150.73 22.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.9 mtt -144.11 105.0 4.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -1.112 . . . . 0.0 109.209 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.25 -176.15 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.84 157.11 17.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.63 138.4 20.61 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.178 -1.189 . . . . 0.0 109.466 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.99 3.72 4.28 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.609 2.206 . . . . 0.0 112.216 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.17 -79.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -109.37 20.74 17.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.354 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 53.51 16.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.644 ' OD2' ' SG ' ' A' ' 63' ' ' CYS . 1.5 m-20 -86.56 116.93 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -1.105 . . . . 0.0 109.698 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -95.09 121.17 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 109.211 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.34 112.89 20.62 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.168 -0.957 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -99.76 140.15 34.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 109.084 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 tt -151.11 121.31 7.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.727 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -126.49 176.79 6.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.98 157.44 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -131.88 134.93 46.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.582 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 30.0 t -124.9 122.65 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.686 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.3 m-20 -157.78 -32.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.546 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 11.1 t70 -62.22 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.5 m-20 78.89 52.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -0.833 . . . . 0.0 109.535 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.86 9.45 66.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 mm -105.03 155.52 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -1.18 . . . . 0.0 109.476 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.49 HD11 HG21 ' A' ' 53' ' ' ILE . 74.4 mt -75.27 114.46 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -85.37 -35.35 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.73 164.2 31.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.72 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.14 120.36 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.303 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -99.21 122.48 42.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.582 ' CD2' ' CG2' ' A' ' 74' ' ' THR . 11.6 p90 -139.7 160.49 39.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -140.02 120.02 13.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.305 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 p -121.44 137.48 54.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.733 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -162.12 100.73 1.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.8 -50.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.975 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.644 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 11.5 m -122.01 179.1 4.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -1.232 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.418 ' O ' ' CG2' ' A' ' 67' ' ' ILE . . . -102.87 -21.08 10.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . 9.6 t -83.91 -66.68 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -1.164 . . . . 0.0 109.412 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -45.66 -21.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.323 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 65' ' ' SER . 0.6 OUTLIER -64.79 -5.04 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.396 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.19 -55.33 2.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -52.47 -45.55 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.597 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.24 -51.41 44.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.64 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.471 ' HA ' ' HG1' ' A' ' 74' ' ' THR . 0.5 OUTLIER -56.98 -43.52 81.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.754 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.19 -68.5 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.9 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.431 ' CG2' ' H ' ' A' ' 74' ' ' THR . 9.1 tt -50.86 -53.05 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.582 ' CG2' ' CD2' ' A' ' 58' ' ' PHE . 33.4 p -48.01 -28.37 2.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.814 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -101.29 -4.62 26.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -89.84 -18.16 26.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.68 26.18 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -102.75 103.83 14.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.43 0.15 27.9 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -100.38 -176.51 3.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -1.14 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.491 ' HG ' ' H ' ' A' ' 82' ' ' LEU . 22.6 t -108.23 173.85 6.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.594 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.491 ' H ' ' HG ' ' A' ' 81' ' ' SER . 7.8 mt -65.58 -18.04 65.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.594 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.42 -30.57 67.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -86.43 -53.17 5.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.57 -18.89 64.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.351 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.93 40.1 2.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -158.02 -35.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -1.089 . . . . 0.0 109.24 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -44.65 169.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -133.01 -170.4 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.185 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.433 ' O ' ' OG ' ' A' ' 107' ' ' SER . 12.8 p-10 -99.02 -30.33 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.59 -40.83 93.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 95' ' ' GLU . 4.0 mm-40 -58.5 -70.92 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.644 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 92' ' ' GLN . 40.9 mt -44.46 -34.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.99 73.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 92' ' ' GLN . 2.2 tt0 -80.65 -15.49 56.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.193 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -81.24 -51.98 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -78.79 -22.98 45.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 2.4 tt0 73.2 36.15 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.449 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -74.37 146.0 83.45 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.4 155.74 50.64 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.658 2.239 . . . . 0.0 112.261 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.6 Cg_endo -75.31 -2.24 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.852 2.368 . . . . 0.0 112.374 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.87 -2.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.657 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 101' ' ' PRO . 29.4 tttt -166.07 61.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 106' ' ' CYS . 20.4 t -60.63 -25.79 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.422 ' ND1' ' CD1' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -49.15 -17.9 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.159 -0.963 . . . . 0.0 109.287 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -74.01 -62.86 1.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 90' ' ' ASN . 6.9 t -57.19 -36.55 70.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.319 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 109' ' ' LEU . 4.6 mt -61.43 -64.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.268 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 108' ' ' ILE . 2.7 mp -42.61 -41.12 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.92 -63.4 1.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 109.677 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 112' ' ' ASP . 2.1 tm-20 -52.89 -67.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 111' ' ' GLU . 11.4 t70 -37.47 -37.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -60.88 -67.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.81 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.9 tp -41.14 -39.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.9 tmtt? -58.82 -55.3 36.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.98 -56.66 9.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.689 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.96 5.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.587 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 66.7 mt -75.55 -59.63 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -37.02 -51.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 122' ' ' LYS . 27.2 t0 -68.69 -58.09 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 109.701 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.534 ' C ' ' O ' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -33.17 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 109.7 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.633 ' N ' ' O ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -96.93 -34.24 11.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.585 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -78.96 -17.78 54.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 123' ' ' ALA . 0.2 OUTLIER -41.99 -41.64 2.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.406 ' CD ' ' HG ' ' A' ' 25' ' ' SER . 30.4 mt-30 -84.15 -32.45 24.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.563 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.43 3.35 55.41 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 128' ' ' GLU . 2.9 mm? -61.54 -42.05 98.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -1.104 . . . . 0.0 109.553 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 127' ' ' LEU . 5.7 mt-10 39.06 86.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 109.367 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -144.57 119.38 9.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 109.604 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -154.15 -54.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.667 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 1.7 t60 -151.11 -129.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.365 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.667 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 95.4 m-70 -141.42 -56.41 0.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -46.93 -72.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.458 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.63 ' OXT' ' CG ' ' A' ' 134' ' ' HIS . 4.1 p80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.586 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.313 0.578 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -82.21 -12.94 57.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.347 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -92.88 10.77 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.387 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 t -136.55 117.58 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.84 130.34 10.24 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 m -110.44 147.73 33.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.453 -1.028 . . . . 0.0 109.322 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.79 117.6 0.82 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.15 108.41 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.279 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.27 -172.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.33 -171.52 38.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -131.84 74.88 76.76 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.16 . . . . 0.0 109.653 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.27 -2.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.786 2.324 . . . . 0.0 112.148 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -79.48 -7.89 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 3.2 m -149.93 -56.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.927 . . . . 0.0 109.477 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.472 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . 144.03 54.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -124.9 136.64 53.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -1.186 . . . . 0.0 109.347 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.78 135.97 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.66 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.9 ttt -133.68 136.96 45.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.504 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -129.63 126.97 39.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 tt -132.47 132.82 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -131.08 133.5 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.153 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -116.16 149.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 14.5 tttm -111.59 136.3 50.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.714 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 82' ' ' LEU . 24.7 t -129.28 116.57 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.168 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.691 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.8 m-20 -159.96 -34.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 109.893 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 51.8 t0 -62.29 50.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.305 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.1 m120 81.61 54.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.505 -0.747 . . . . 0.0 109.266 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.64 0.98 9.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 53' ' ' ILE . 3.8 mm -93.01 164.25 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.292 -1.122 . . . . 0.0 109.468 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.581 ' N ' HG22 ' A' ' 52' ' ' ILE . 3.3 mt -97.32 114.38 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -97.38 -38.86 9.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -124.39 151.33 44.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 109.783 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.61 99.56 3.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -94.4 175.21 6.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.641 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' A' ' 74' ' ' THR . 45.4 p90 -165.02 176.91 8.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.474 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -166.31 110.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 41' ' ' MET . 10.7 p -129.13 96.65 4.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.954 . . . . 0.0 109.487 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -115.14 104.21 11.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.48 -41.3 0.28 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' SER . 1.4 t -106.76 105.62 15.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -1.086 . . . . 0.0 109.219 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -67.0 74.44 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 67' ' ' ILE . 1.2 p 162.74 -42.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -1.172 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.45 1.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.582 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.5 mp -73.32 -54.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.52 -71.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 73' ' ' ILE . 7.4 t -45.78 -43.03 12.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 109.613 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.0 -36.33 38.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.644 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -31.25 57.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -54.98 7.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 74' ' ' THR . 10.9 tt -58.18 -47.91 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.598 ' N ' HG23 ' A' ' 73' ' ' ILE . 11.9 p -61.19 -34.19 74.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.08 -7.82 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.13 -0.981 . . . . 0.0 109.623 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -87.13 -36.82 17.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.419 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' GLY . 35.5 m -88.31 -28.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -47.98 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 77' ' ' VAL . . . 120.38 -26.97 6.81 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.639 ' NZ ' ' OE1' ' A' ' 84' ' ' GLU . 7.1 mtpt -74.13 -165.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.92 163.5 24.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.97 . . . . 0.0 109.596 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 47' ' ' VAL . 17.6 mt -55.81 -37.58 68.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.34 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -56.12 -32.56 64.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.3 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE1' ' NZ ' ' A' ' 80' ' ' LYS . 38.7 mt-10 -84.2 -42.96 15.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -60.45 -30.83 69.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.15 43.86 3.07 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.04 -35.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.129 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 88' ' ' ILE . 2.4 pt -52.52 157.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.455 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -129.23 164.99 22.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -30.08 69.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -60.65 -29.09 69.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -58.99 -56.22 25.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 mp -70.41 -38.97 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.96 55.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.623 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.42 -43.03 15.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.591 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' O ' ' CD ' ' A' ' 96' ' ' GLU . 12.6 tm-20 -63.93 -23.18 67.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.67 -37.9 9.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 67.57 73.44 0.32 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.51 149.17 60.9 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.86 157.71 41.84 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.759 2.306 . . . . 0.0 112.069 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.56 15.01 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.818 2.345 . . . . 0.0 112.315 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.0 m -104.87 16.75 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -151.73 18.24 0.7 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 104' ' ' VAL . 10.6 t -57.69 -14.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -51.19 -27.13 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 2.1 m -77.63 -75.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.524 ' C ' ' O ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -36.28 -33.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 106' ' ' CYS . 8.5 mt -68.26 -54.97 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 6.3 mp -59.77 -19.64 51.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.57 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -72.46 -64.88 0.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 114' ' ' ILE . 3.1 tm-20 -64.36 -45.74 86.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -54.64 -35.87 63.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.214 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 109' ' ' LEU . . . -63.22 -57.83 9.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 111' ' ' GLU . 0.4 OUTLIER -50.01 -36.29 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.413 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.401 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.8 tttt -63.24 -37.86 88.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.02 76.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.54 93.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.93 . . . . 0.0 109.501 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.61 -40.86 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.66 88.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.483 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.31 -16.38 60.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.413 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' A' ' 25' ' ' SER . 93.1 t80 -79.39 -31.61 42.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -94.27 -22.63 18.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.53 -18.48 58.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.468 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.505 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.67 6.14 36.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -120.21 -15.94 8.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.697 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -103.12 128.95 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.353 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -127.05 149.75 17.8 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 120' ' ' ASP . 52.2 m -127.71 149.16 50.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -1.081 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.87 125.37 2.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 ttt -119.74 92.9 3.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -1.205 . . . . 0.0 109.367 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 m -103.56 163.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 109.286 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.27 -176.08 29.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -138.26 96.07 10.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.337 -1.096 . . . . 0.0 109.386 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.501 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.9 Cg_exo -56.66 -26.37 64.76 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.652 2.235 . . . . 0.0 112.28 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.93 -59.99 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.34 -48.31 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.62 52.78 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -116.34 117.22 29.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.151 . . . . 0.0 109.416 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 m -105.92 141.47 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.495 ' SD ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -135.9 128.82 31.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.28 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -112.68 125.0 53.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.616 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tp -124.01 136.4 54.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.411 HE21 ' HB2' ' A' ' 44' ' ' GLN . 2.3 mt-30 -118.85 145.78 45.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 109.654 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.667 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.1 pp -126.31 126.09 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -103.21 109.33 20.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.466 HG23 HD12 ' A' ' 45' ' ' ILE . 24.5 t -94.57 110.83 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 47' ' ' VAL . 1.1 t70 -40.16 -77.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.437 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 7.2 t0 -179.71 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 0.0 108.862 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -84.06 -17.09 41.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.458 -0.776 . . . . 0.0 109.352 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.2 12.01 5.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.4 mm -104.87 134.39 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.413 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.4 88.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.408 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.51 -52.38 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.261 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -143.24 -179.16 6.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 109.141 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.79 144.48 7.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.957 . . . . 0.0 109.743 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -135.32 162.59 32.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.342 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.64 ' CD1' HG21 ' A' ' 74' ' ' THR . 5.9 p90 -145.81 167.92 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.368 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -165.83 114.29 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.495 HG22 ' SD ' ' A' ' 41' ' ' MET . 80.7 p -108.95 141.93 40.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.43 99.65 2.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.9 -54.14 0.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 49.4 t -124.98 173.52 8.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -1.21 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.476 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -121.53 19.06 8.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.7 p -113.83 -8.63 13.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -1.127 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.42 -2.81 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.506 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 68' ' ' ALA . 8.5 mm -61.65 -53.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.402 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -41.4 -53.51 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.457 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 70' ' ' SER . 25.1 p -58.09 -54.26 48.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -43.94 -38.01 3.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.7 m -71.02 -44.96 64.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.24 -55.62 26.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.866 HG23 ' H ' ' A' ' 74' ' ' THR . 2.2 tt -62.33 -61.75 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.866 ' H ' HG23 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -35.31 -32.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.78 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -85.57 -30.87 22.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 0.0 109.825 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.606 ' N ' ' O ' ' A' ' 73' ' ' ILE . 10.7 m0 -82.69 0.82 41.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.719 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 73' ' ' ILE . 6.4 m -123.51 65.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.51 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -148.3 94.35 2.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.31 61.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -72.17 -168.2 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.421 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -115.69 141.1 48.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mt -48.77 -11.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' SER . 35.1 tt0 -71.08 -55.59 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.235 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -66.36 -30.67 71.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.256 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -24.09 52.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 109.22 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.77 50.24 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.78 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -1.123 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.51 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -36.46 -23.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.744 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 87' ' ' ALA . 10.0 mttm 61.32 173.85 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.304 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.484 HD22 HG12 ' A' ' 108' ' ' ILE . 8.0 p-10 -95.73 -42.55 8.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.444 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 88.9 p -52.76 -50.02 64.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' SER . 4.5 tt0 -44.06 -65.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.194 -0.942 . . . . 0.0 109.779 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.5 mt -59.65 -32.01 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.713 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.58 -32.61 69.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.876 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.84 -33.92 24.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.689 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -55.94 -42.84 76.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.3 mt -83.0 -28.39 29.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 65.64 74.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 148.83 59.88 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.158 -0.963 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.61 148.64 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.58 2.187 . . . . 0.0 112.125 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.54 6.09 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.738 2.292 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.68 -35.88 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -135.52 42.43 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.402 ' C ' ' N ' ' A' ' 106' ' ' CYS . 9.8 p -58.4 -18.79 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -45.32 -24.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.338 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -64.87 -47.35 78.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.167 -0.958 . . . . 0.0 109.2 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -50.1 67.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.484 HG12 HD22 ' A' ' 90' ' ' ASN . 4.4 mm -56.0 -33.45 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.883 . . . . 0.0 109.369 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 34' ' ' ALA . 1.4 mp -63.92 -61.65 2.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -40.36 -53.68 2.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -61.15 -58.25 9.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.3 -34.07 2.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -64.92 -69.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.658 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.1 tp -37.78 -35.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -65.53 -68.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -43.33 -46.22 6.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.307 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.667 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -55.43 -40.72 71.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.22 -46.89 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.417 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.49 -58.11 7.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.53 ' CG ' ' O ' ' A' ' 29' ' ' THR . 5.2 m-20 -49.0 -59.6 3.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.715 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -51.08 -21.59 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.685 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -96.93 -8.6 30.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.18 -8.4 17.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.42 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.44 1.68 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -117.04 5.59 12.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.5 98.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.59 124.62 8.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -102.7 131.91 49.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -1.155 . . . . 0.0 109.329 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.93 96.44 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.0 ttt -99.52 133.44 43.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.144 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 41' ' ' MET . 30.4 m -125.23 156.11 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.035 -1.041 . . . . 0.0 109.808 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' A' ' 40' ' ' VAL . . . -138.06 121.61 2.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 39' ' ' ASP . . . -118.13 87.09 28.0 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.263 -1.139 . . . . 0.0 109.428 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.99 36.25 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.893 2.395 . . . . 0.0 112.303 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.67 -39.64 1.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.8 t -177.02 -29.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.394 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.73 71.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 0.8 OUTLIER 62.7 -174.21 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -1.154 . . . . 0.0 109.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.472 HG12 ' HA2' ' A' ' 33' ' ' GLY . 8.5 m -95.46 149.45 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.384 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 32' ' ' VAL . 8.5 ttt -142.34 133.29 25.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.46 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -107.33 127.83 53.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.45 135.56 44.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.557 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.19 137.54 37.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 45' ' ' ILE . 1.5 pp -120.64 143.36 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 109.427 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -102.31 152.14 21.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.96 116.72 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 48' ' ' ASP . 33.5 t0 -57.7 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.56 19.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -148.76 24.84 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.502 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.81 30.28 56.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.5 mm -109.41 134.63 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -1.21 . . . . 0.0 109.414 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.6 mt -80.56 81.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.22 -40.49 74.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -137.64 163.51 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.77 102.59 4.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.53 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -97.81 155.49 17.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.502 ' CD1' HG21 ' A' ' 74' ' ' THR . 27.0 p90 -166.46 171.29 12.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -163.96 126.04 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.81 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.15 121.8 45.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.028 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 101.53 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.6 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 156.74 -57.25 0.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.8 148.6 26.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -1.117 . . . . 0.0 109.598 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.94 16.97 30.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.38 -35.49 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 0.0 109.459 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.11 -3.09 3.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.9 mm -58.95 -35.32 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.339 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.12 -62.54 1.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' LEU . 3.9 m -58.38 -54.59 45.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.467 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.508 ' C ' ' O ' ' A' ' 69' ' ' SER . 50.6 m -36.98 -66.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.62 -30.52 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' SER . 12.2 tp -68.93 -73.89 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.723 HG23 ' H ' ' A' ' 74' ' ' THR . 0.9 OUTLIER -39.7 -59.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.723 ' H ' HG23 ' A' ' 73' ' ' ILE . 42.4 p -44.21 -44.95 8.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.317 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -73.46 -14.98 61.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.307 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.553 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.07 -11.71 35.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 77' ' ' VAL . 33.5 m -123.91 61.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.4 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.09 103.1 7.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.481 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 4.01 89.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -78.55 -161.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -1.155 . . . . 0.0 109.39 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 83' ' ' GLU . 3.7 t -126.69 144.51 50.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -47.78 -15.07 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 0.0 109.24 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -80.71 -23.83 39.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.412 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -95.29 -18.78 20.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.0 -29.95 11.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.96 42.97 2.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -152.14 -37.0 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -1.137 . . . . 0.0 108.602 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -47.22 -175.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -141.38 -177.88 5.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 109.399 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.57 ' CG ' ' N ' ' A' ' 91' ' ' SER . 1.1 p-10 -87.69 -50.93 6.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -54.53 -22.31 12.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.25 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -68.0 -59.18 3.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 109.206 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.69 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 109.272 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.13 -36.49 73.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.245 -0.909 . . . . 0.0 109.196 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.19 -41.97 99.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.271 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.87 -32.9 73.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 0.0 109.047 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.5 mt -93.39 -28.36 16.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.301 -0.875 . . . . 0.0 109.112 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.4 tm-20 51.93 67.09 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.714 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.003 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.4 pt? -117.81 148.46 43.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.272 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.596 ' HB2' HG22 ' A' ' 102' ' ' VAL . 71.4 Cg_exo -40.51 155.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.792 2.328 . . . . 0.0 112.268 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.08 -0.15 8.12 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.834 2.356 . . . . 0.0 112.177 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 100' ' ' PRO . 34.3 m -88.32 -5.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.404 ' C ' ' N ' ' A' ' 105' ' ' HIS . 0.6 OUTLIER -125.72 -9.42 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 107' ' ' SER . 8.0 p -45.78 -24.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.489 ' C ' ' O ' ' A' ' 104' ' ' VAL . 15.2 m80 -38.9 -50.0 1.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.63 -36.47 64.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.114 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.628 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.1 p -66.31 -67.23 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.096 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.628 ' N ' ' OG ' ' A' ' 107' ' ' SER . 42.8 mt -45.91 -25.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.088 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 mp -75.98 -44.88 37.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.428 -0.795 . . . . 0.0 109.385 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.36 83.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.723 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.485 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 5.1 tp10 -65.93 -68.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -22.95 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.93 . . . . 0.0 109.641 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.19 -52.87 9.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -55.95 -40.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.59 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.495 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 5.7 tptt -66.14 -51.52 57.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.74 -41.99 64.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.415 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.34 -45.16 95.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 121' ' ' TYR . 61.7 mt -64.49 -61.12 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -40.69 -37.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.185 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -37.71 80.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.052 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 118' ' ' ILE . 7.5 t80 -72.35 -16.99 61.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -88.49 -44.94 10.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.209 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.1 95.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.317 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 179.899 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.2 m -85.71 -4.3 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -0.87 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.88 129.69 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.8 147.48 18.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.1 m -130.28 130.32 44.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -1.093 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.45 137.8 10.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.03 120.46 17.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -1.112 . . . . 0.0 109.351 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.75 146.6 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.89 -166.35 10.66 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -122.12 80.92 43.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.262 -1.14 . . . . 0.0 109.512 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.88 2.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.707 2.271 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.6 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -91.53 -3.73 56.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.41 -58.48 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.38 46.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.01 126.77 54.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 109.507 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 40' ' ' VAL . 3.1 p -107.86 113.45 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -119.47 119.08 32.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 43' ' ' LEU . 7.9 tt0 -103.23 154.93 18.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.198 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.46 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -155.87 119.47 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.487 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -122.23 151.24 41.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.296 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.79 138.01 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 109.565 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -107.57 127.95 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.04 150.66 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.7 t0 -94.21 -103.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -139.45 4.25 2.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.43 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -128.97 17.28 6.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.21 10.2 85.73 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 mm -93.08 132.71 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -1.105 . . . . 0.0 109.529 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 53' ' ' ILE . 17.6 mt -81.54 93.38 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.413 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -53.54 56.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.446 ' HA ' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -132.04 139.35 48.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.72 133.31 55.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.67 161.38 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.526 ' CD1' HG21 ' A' ' 74' ' ' THR . 10.7 p90 -169.05 174.32 6.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 109.821 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -165.07 121.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.476 -0.765 . . . . 0.0 109.105 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.3 142.57 51.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -158.55 -177.55 6.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.47 -56.82 2.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 66.4 m -120.94 158.64 27.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -1.141 . . . . 0.0 109.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.27 11.49 58.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.98 -39.84 4.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.14 -22.13 66.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.73 -44.96 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -46.73 -62.56 1.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -43.22 -48.05 6.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 109.717 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.519 ' O ' ' C ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -49.55 -68.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 109.397 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -37.27 -39.22 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.617 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 73' ' ' ILE . 11.3 tp -66.89 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.615 ' O ' HG22 ' A' ' 77' ' ' VAL . 4.4 tt -33.74 -48.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 110.054 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.526 HG21 ' CD1' ' A' ' 58' ' ' PHE . 3.2 p -49.8 -46.81 51.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.3 tp10 -86.15 -11.96 51.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.902 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -2.57 57.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.368 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 73' ' ' ILE . 28.8 m -123.48 -27.11 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 0.0 109.61 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' NZ ' ' HA ' ' A' ' 55' ' ' ASP . 9.8 ttmm -62.1 113.14 2.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.05 58.18 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.44 -164.88 1.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 m -121.02 175.0 6.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.861 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.55 -17.98 64.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.778 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -77.46 -40.6 42.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.73 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -69.16 -44.65 71.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 109.839 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.77 -33.84 52.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.54 52.27 4.68 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -171.9 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.4 pt -36.47 132.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' SER . 50.2 mttt -117.97 142.78 46.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -41.35 -25.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -66.44 -39.41 88.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.568 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -67.73 -55.88 11.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.466 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 93' ' ' ILE . 1.6 mp -58.74 -30.08 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.592 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.09 -60.29 2.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.742 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -55.27 -20.52 11.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -64.53 1.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.5 OUTLIER -69.12 -14.46 63.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.651 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 52.81 43.62 31.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.894 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.698 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.5 pt? -85.8 151.21 54.84 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -41.52 105.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.559 2.173 . . . . 0.0 111.913 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.87 20.36 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.343 2.028 . . . . 0.0 112.338 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.435 HG23 ' N ' ' A' ' 103' ' ' LYS . 17.6 m -70.47 -40.63 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 104' ' ' VAL . 21.2 mttt -109.94 -23.44 11.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 103' ' ' LYS . 2.5 t 41.43 30.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.5 ' NE2' ' HB1' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -81.16 -35.64 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 60.7 m -59.73 -64.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.563 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 108' ' ' ILE . 2.6 m -51.45 -58.27 6.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.0 mt -42.12 -41.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -63.8 -46.42 85.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -54.63 -66.7 0.36 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.78 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.2 tm-20 -46.06 -69.64 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.536 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -38.75 -26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -73.87 -63.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.69 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 2.3 tp -46.13 -37.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.579 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 58.6 tttt -66.53 -43.49 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.59 77.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.493 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.25 -54.67 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mt -49.95 -34.85 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 109.256 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -56.86 10.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -11.52 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.415 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -85.0 -43.7 13.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -94.73 3.71 54.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.8 -33.06 10.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.329 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 tttt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 25' ' ' SER . 6.8 t0 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 14.5 m -101.55 5.36 41.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -117.59 37.39 3.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.625 ' O ' HG12 ' A' ' 27' ' ' VAL . 2.7 t -143.41 98.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.359 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.08 132.55 11.29 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 m -108.85 134.11 51.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -1.111 . . . . 0.0 109.362 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.3 90.77 0.23 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ttm -108.94 128.8 55.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -1.164 . . . . 0.0 109.686 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.533 HG21 ' HG ' ' A' ' 109' ' ' LEU . 2.0 m -130.51 165.1 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.392 -0.818 . . . . 0.0 109.173 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.86 121.81 2.1 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HB3' ' N ' ' A' ' 39' ' ' ASP . . . -112.45 93.33 22.48 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.339 -1.095 . . . . 0.0 109.364 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.39 40.7 0.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.665 2.243 . . . . 0.0 112.271 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.543 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -144.55 -40.1 0.27 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.7 m -168.11 -32.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' C ' ' HB3' ' A' ' 34' ' ' ALA . . . -66.29 -19.01 68.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.513 ' N ' ' HB3' ' A' ' 34' ' ' ALA . 1.6 m-20 61.06 -168.93 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 109.456 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -86.84 140.77 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -142.5 125.77 16.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.318 -0.864 . . . . 0.0 109.599 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.94 113.5 20.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.04 107.17 11.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 109.894 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -109.67 129.18 55.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.07 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.56 144.81 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 109.699 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -108.96 138.94 44.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.99 151.5 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 23.5 t0 -81.93 -48.84 11.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.634 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 162.15 -22.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 9.5 p-10 -102.47 25.52 8.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.466 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.37 -4.7 58.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.16 146.46 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.348 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.24 108.61 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -44.03 32.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.78 164.41 28.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.273 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.09 118.83 16.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -96.05 133.83 39.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.476 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 10.3 p90 -136.08 168.88 18.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -171.89 104.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.803 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 p -96.42 147.95 23.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.085 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -162.0 111.58 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.701 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.44 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 130.58 -41.11 1.57 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.9 t -103.7 121.26 42.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.636 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 46.72 1.98 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -158.32 -12.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.157 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.88 37.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.29 -33.1 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.88 -41.73 74.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 71' ' ' SER . 17.9 p -67.11 -64.15 0.91 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.511 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.8 OUTLIER -38.76 -26.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.33 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 69' ' ' SER . 7.5 t -78.4 -44.7 24.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 69' ' ' SER . 21.4 tp -60.97 -52.14 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.948 . . . . 0.0 109.471 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.894 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.3 tt -58.9 -41.46 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -66.79 -19.35 65.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -92.02 -16.35 26.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.49 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.04 -17.0 18.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 73' ' ' ILE . 27.8 m -109.07 40.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.661 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -118.8 96.44 5.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.97 -27.05 17.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -59.69 -160.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -1.124 . . . . 0.0 109.498 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.09 165.85 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.89 -41.27 82.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -24.72 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.593 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -90.7 -48.48 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.536 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.556 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -61.88 -17.36 56.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.84 11.65 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -148.47 -35.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -41.74 172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.538 -0.726 . . . . 0.0 109.654 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.33 168.44 19.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.55 -32.81 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.749 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.543 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -50.89 -33.22 23.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -73.83 -59.97 2.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.557 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.6 mt -46.02 -42.46 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 -46.71 74.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.355 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.4 -37.92 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -67.58 -45.01 76.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.5 -15.08 61.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.152 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.94 33.87 7.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.9 pp -75.16 135.94 72.95 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.532 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.659 ' O ' HD12 ' A' ' 99' ' ' LEU . 75.4 Cg_exo -42.22 155.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.512 2.141 . . . . 0.0 112.245 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.24 -11.16 28.41 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.729 2.286 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.8 39.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HG2' ' SG ' ' A' ' 106' ' ' CYS . 2.5 ttmt -176.83 32.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.87 . . . . 0.0 109.189 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 t -74.68 -9.21 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.671 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.33 67.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.42 ' SG ' ' HG2' ' A' ' 103' ' ' LYS . 18.6 m -73.4 -59.26 2.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.651 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.1 p -48.57 -56.17 9.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 108.974 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.46 ' N ' ' OG ' ' A' ' 107' ' ' SER . 82.3 mt -52.32 -35.58 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.533 ' HG ' HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -66.17 -29.3 69.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -51.36 60.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.201 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.402 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 9.6 tp10 -71.73 -32.55 67.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.18 -33.98 75.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.223 -0.923 . . . . 0.0 109.314 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -72.09 -61.55 1.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.556 HG12 ' HB1' ' A' ' 85' ' ' ALA . 0.7 OUTLIER -46.29 -35.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.129 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 11.4 tttt -74.86 -31.38 61.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.853 . . . . 0.0 109.141 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.93 -43.43 83.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.188 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.31 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.2 mt -45.53 -50.76 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.69 -51.68 66.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.88 -21.54 64.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -71.69 -54.88 8.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.364 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -65.55 -34.67 78.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.91 55.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.4 tttt . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.425 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.29 8.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.398 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.657 ' ND2' ' O ' ' A' ' 47' ' ' VAL . 1.2 m120 -115.17 3.26 14.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.9 t -122.1 92.45 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.84 155.0 47.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.4 m -131.41 118.56 20.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -1.224 . . . . 0.0 109.817 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.61 93.3 0.56 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -92.5 131.85 37.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.973 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.574 ' O ' ' O ' ' A' ' 41' ' ' MET . 18.5 m -144.53 177.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 108.997 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.62 178.97 41.12 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -118.69 82.31 19.98 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.336 -1.096 . . . . 0.0 109.352 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 37' ' ' CYS . 72.8 Cg_exo -43.97 -10.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.593 2.195 . . . . 0.0 111.99 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.623 ' O ' ' CB ' ' A' ' 37' ' ' CYS . . . -76.07 20.34 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 1.6 t 85.64 -18.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -43.3 -50.3 6.58 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.643 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 153.89 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -1.074 . . . . 0.0 109.424 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 46.9 t -113.56 150.56 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.574 ' O ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -145.73 140.88 27.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.106 -0.996 . . . . 0.0 109.78 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' A' ' 41' ' ' MET . 39.2 tt0 -129.49 145.14 51.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.85 138.74 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.591 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -130.84 136.28 48.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.526 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -119.7 132.34 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -115.72 120.01 37.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.276 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.657 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 54.3 t -97.72 126.88 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -56.67 -60.02 4.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.3 OUTLIER 163.85 -22.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 0.0 109.197 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.45 -7.52 47.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.451 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.14 17.59 7.18 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -113.36 150.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -1.144 . . . . 0.0 109.504 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.532 ' O ' ' C ' ' A' ' 54' ' ' GLU . 36.1 mt -85.67 77.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 53' ' ' ILE . 2.5 tt0 -34.63 -48.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -153.04 167.68 28.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.94 122.97 13.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -103.99 142.08 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.328 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.587 ' CD1' HG21 ' A' ' 74' ' ' THR . 21.8 p90 -137.3 176.06 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.59 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -165.58 132.94 2.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.1 143.66 33.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -159.99 121.16 3.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.77 -61.02 0.29 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.5 t -121.39 140.74 51.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.124 . . . . 0.0 109.677 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.65 -6.98 87.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.6 p -95.13 0.43 54.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -1.15 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.46 2.76 45.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -83.16 -13.86 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.32 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.31 -64.41 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.435 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.814 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -62.97 -30.21 71.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.93 . . . . 0.0 109.453 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 74' ' ' THR . 2.3 t -61.74 -46.14 90.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -64.68 -36.36 84.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.512 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -71.96 -74.54 0.16 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.824 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.7 tt -34.36 -46.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.873 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.587 HG21 ' CD1' ' A' ' 58' ' ' PHE . 34.0 p -60.16 -47.24 86.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.0 mt-10 -72.64 -5.92 40.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 109.652 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 73' ' ' ILE . 16.3 m -112.63 58.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -138.1 105.22 5.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.431 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.4 87.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -83.77 -168.5 2.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -1.124 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 t -107.12 146.21 31.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.26 -27.68 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.319 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -61.03 -38.18 85.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.364 -0.835 . . . . 0.0 109.587 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 88' ' ' ILE . 16.4 mt-10 -79.77 -28.91 40.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.648 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.31 -32.7 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.972 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.53 30.2 5.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.89 19.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.351 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.2 pt -91.7 -24.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 88' ' ' ILE . 11.3 mttp 56.72 152.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.581 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -79.55 -22.15 44.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.4 m -60.56 -39.99 89.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.52 -47.65 83.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.08 -36.42 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.19 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.25 -44.15 80.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.266 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.41 -31.83 72.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.79 -41.52 83.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -96.79 -35.36 10.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.646 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 94' ' ' ALA . 9.1 tt0 78.1 32.69 0.36 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.464 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 pp -48.1 147.13 3.84 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -67.56 147.17 76.09 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.61 2.207 . . . . 0.0 112.066 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.9 15.6 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.679 2.252 . . . . 0.0 112.323 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 m -98.43 6.71 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.295 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -160.03 24.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.346 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' LYS . 26.9 t -38.4 -26.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.854 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.669 ' O ' HD13 ' A' ' 109' ' ' LEU . 1.8 m-70 -42.95 -28.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 1.9 m -66.36 -37.17 84.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.779 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -68.26 -61.48 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.3 mt -52.29 -33.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.539 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.669 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.1 mp -64.7 -42.99 94.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.63 -55.31 36.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.499 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -61.52 -56.58 18.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -48.87 -31.13 6.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.26 -65.03 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.86 -30.26 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.309 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.54 -43.3 63.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.439 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.25 69.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.426 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.526 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -71.0 -58.62 3.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.94 . . . . 0.0 109.302 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.2 mt -48.8 -43.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.1 4.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.89 -35.54 15.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.69 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -69.63 -65.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.652 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -24.71 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.652 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.22 -4.74 3.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.5 mttm . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.636 -179.875 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.437 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 9.4 t -94.8 -0.62 54.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.55 12.04 22.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.01 107.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.24 150.29 18.64 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -135.75 148.88 48.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.23 103.22 0.29 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 ttp -92.93 129.27 38.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 0.0 109.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' MET . 2.9 m -150.63 -171.75 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.63 -174.52 32.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.94 93.74 26.21 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -1.136 . . . . 0.0 109.485 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.525 ' O ' ' C ' ' A' ' 36' ' ' ALA . 50.6 Cg_exo -50.43 -46.07 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.684 2.256 . . . . 0.0 112.254 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.65 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -37.36 -42.86 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.2 m 159.25 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -35.11 -57.3 0.84 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 153.09 169.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.393 -1.063 . . . . 0.0 109.523 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.563 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 7.6 p -96.12 146.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 108.909 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' VAL . 9.8 ttt -142.3 126.34 17.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 110.002 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -115.6 140.69 48.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.835 . . . . 0.0 108.922 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.24 121.33 13.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.805 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HG2' ' N ' ' A' ' 45' ' ' ILE . 47.4 tt0 -122.57 152.88 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.21 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.662 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -123.17 152.9 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.524 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HB3' ' H ' ' A' ' 55' ' ' ASP . 15.4 tttp -124.84 131.03 53.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.7 137.53 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.682 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -175.31 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.8 m-20 -63.2 51.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 0.0 109.108 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.682 ' N ' ' O ' ' A' ' 48' ' ' ASP . 6.1 m120 72.17 55.15 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.634 -0.666 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.53 77.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 53' ' ' ILE . 4.1 mm -97.61 157.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 109.524 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.459 ' N ' HG22 ' A' ' 52' ' ' ILE . 54.0 mt -74.97 99.26 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -59.81 -51.51 69.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 46' ' ' LYS . 1.6 t70 -148.98 -174.75 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.797 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.72 122.74 4.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.127 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -95.25 146.92 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 109.9 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.663 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -134.61 165.28 25.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.064 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -162.9 114.18 1.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.049 -1.032 . . . . 0.0 109.999 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 129.0 27.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.197 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.583 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -151.51 118.58 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -0.971 . . . . 0.0 109.759 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.89 -53.37 0.46 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.624 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -107.39 137.23 45.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -1.151 . . . . 0.0 109.392 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.53 26.26 4.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -121.73 -42.42 2.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -1.186 . . . . 0.0 109.493 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.585 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -65.29 -29.01 69.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 67' ' ' ILE . 5.1 mm -50.87 -4.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.441 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.585 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -97.67 -56.26 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.547 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.826 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -50.0 -20.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 71' ' ' SER . 8.7 p -70.6 -63.09 1.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.546 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -51.33 -35.23 37.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.802 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 73' ' ' ILE . 6.7 tp -68.74 -79.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.949 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 69' ' ' SER . 3.3 tt -42.33 -48.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 109.915 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.61 ' N ' HG23 ' A' ' 73' ' ' ILE . 56.7 p -54.06 -36.81 63.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.685 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 72' ' ' LEU . 9.1 tt0 -79.38 -12.91 59.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.624 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -100.41 -4.22 29.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.7 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 73' ' ' ILE . 28.0 m -126.27 32.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 105.94 14.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.043 -1.035 . . . . 0.0 109.105 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.59 10.62 61.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -90.63 -170.81 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -1.14 . . . . 0.0 109.451 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.37 148.46 35.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.1 -21.97 2.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -83.79 -15.35 48.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.907 . . . . 0.0 109.284 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.46 -28.13 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 0.0 109.253 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.58 -22.38 16.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.63 53.73 4.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.95 -34.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -1.131 . . . . 0.0 109.001 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 2.8 pt -45.45 162.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.42 -0.8 . . . . 0.0 109.364 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.37 -167.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.422 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -103.84 -24.39 13.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.345 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.8 t -68.98 -36.2 77.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' GLU . 9.1 mt-30 -62.02 -73.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLN . 2.2 mt -43.86 -41.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.68 -37.17 62.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.429 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' GLN . 31.9 tt0 -76.35 -38.34 56.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.401 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -39.42 76.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.81 -22.59 24.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 50.0 70.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.479 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.059 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.3 pt? -117.85 147.67 41.66 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.43 103.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.006 2.47 . . . . 0.0 112.354 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.0 Cg_exo -49.62 -14.86 0.78 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.818 2.345 . . . . 0.0 112.387 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 102' ' ' VAL . 6.9 m -62.73 11.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 109.312 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 101' ' ' PRO . 14.7 ttpp -165.89 64.05 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.055 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.728 ' O ' HG12 ' A' ' 104' ' ' VAL . 57.6 t -86.54 39.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.808 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.819 ' O ' HD13 ' A' ' 109' ' ' LEU . 4.2 m-70 -84.68 -24.32 29.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.164 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 m -71.85 -52.83 15.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.96 -52.24 66.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.37 -36.68 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.2 mp -65.03 -39.49 93.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.913 . . . . 0.0 109.393 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.02 -43.88 94.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 88' ' ' ILE . 15.7 tp10 -66.98 -61.41 1.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -49.27 -22.3 1.03 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.11 -50.66 18.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.75 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.9 tp -56.54 -41.82 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 109.57 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.1 mtpp -62.81 -50.35 71.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 0.0 109.361 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -35.92 32.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -62.39 -62.06 2.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.379 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.0 mt -52.36 -38.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.404 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.78 -67.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.64 -48.4 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.281 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.563 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 2.9 t80 -49.54 -45.19 47.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -54.97 19.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.596 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.05 -46.41 22.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.693 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.1 mttt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 109.737 -179.74 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 124' ' ' LYS . 3.0 t -101.75 5.57 41.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.369 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.26 -4.18 15.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.5 t -116.41 117.58 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.21 136.72 13.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -115.72 111.88 21.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -1.161 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.86 91.21 0.73 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.37 119.41 27.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.65 171.23 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.43 162.73 36.36 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -123.93 75.99 57.83 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.32 -8.54 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.69 2.26 . . . . 0.0 112.019 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -83.99 -30.22 26.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.88 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 9.9 p -112.66 -17.7 12.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.16 -0.963 . . . . 0.0 109.678 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.53 42.14 6.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.46 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 7.0 t70 -122.38 125.12 45.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.33 146.8 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -148.07 141.99 25.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.687 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -132.87 111.32 10.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.07 145.91 26.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -142.4 114.53 8.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.7 134.83 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -108.16 146.74 32.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.732 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.68 146.32 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.281 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -179.41 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.893 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.2 m-20 -62.77 44.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.321 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.685 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.2 m120 76.98 51.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.13 -0.88 86.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 80' ' ' LYS . 34.3 mm -95.12 146.83 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -1.174 . . . . 0.0 109.368 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.641 ' O ' HG22 ' A' ' 53' ' ' ILE . 34.4 mt -75.06 84.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.867 . . . . 0.0 109.259 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -46.85 66.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -142.75 177.59 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.07 123.54 4.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -103.47 154.16 19.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' HG21 ' A' ' 74' ' ' THR . 32.1 p90 -142.12 175.81 9.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.505 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.37 99.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.253 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.96 130.34 55.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.408 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -144.45 129.33 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 109.581 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.24 -57.65 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.73 150.85 40.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.231 . . . . 0.0 109.543 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.88 56.57 0.51 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -144.06 -11.81 0.65 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.493 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.42 -12.02 17.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.557 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 67' ' ' ILE . 1.6 mp -40.87 -54.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.404 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -49.9 -65.95 0.48 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 68' ' ' ALA . 10.9 m -38.94 -54.94 1.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.927 . . . . 0.0 109.533 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' OG1' ' A' ' 74' ' ' THR . 19.4 p -50.57 -46.23 57.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.01 71.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' GLU . 58.8 tp -68.29 -76.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 77' ' ' VAL . 1.4 tt -40.63 -45.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 ' CD1' ' A' ' 58' ' ' PHE . 6.8 p -55.81 -35.25 66.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.288 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 72' ' ' LEU . 7.4 mt-10 -93.78 4.16 54.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -106.27 -34.59 7.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.0 109.619 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 73' ' ' ILE . 35.2 m -103.88 35.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -111.62 119.28 38.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.382 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.94 -2.92 85.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 52' ' ' ILE . 52.7 mmtt -85.53 -167.9 2.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.38 149.61 37.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.417 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.32 -20.79 46.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.98 -26.97 67.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -91.78 -38.06 12.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.449 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -68.79 -26.26 65.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.535 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.44 38.73 3.18 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -153.86 -34.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -1.104 . . . . 0.0 109.398 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.579 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.6 pt -40.52 169.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -140.92 161.6 37.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.369 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.617 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 14.7 p-10 -80.97 -28.79 35.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.59 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -57.5 7.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -55.65 -54.92 38.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.0 mt -55.64 -32.57 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.622 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.94 88.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 109.713 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -69.87 -22.69 63.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -74.7 -38.04 62.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -98.27 -15.31 19.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 109.599 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 47.76 68.81 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.334 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -97.28 149.35 35.62 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.703 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 102' ' ' VAL . 71.6 Cg_exo -41.32 101.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.989 2.459 . . . . 0.0 112.352 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.23 -8.63 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.618 2.212 . . . . 0.0 111.937 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 100' ' ' PRO . 18.3 m -77.59 -7.17 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HE3' ' SG ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -147.6 48.27 1.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.313 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.16 -1.97 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.595 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -13.74 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.958 . . . . 0.0 109.232 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.442 ' SG ' ' HE3' ' A' ' 103' ' ' LYS . 24.0 m -80.01 -55.18 5.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.9 t -50.37 -47.05 56.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.137 -0.977 . . . . 0.0 108.995 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.29 -46.94 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 mp -53.86 -30.87 47.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.144 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.71 -61.49 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -0.824 . . . . 0.0 109.273 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.617 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 58.5 tt0 -51.02 -54.06 27.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.249 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.79 -41.82 71.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.417 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -49.05 -50.12 38.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.449 HG12 ' HB1' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -59.68 -39.77 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 5.8 tttt -64.46 -46.29 83.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.73 -61.87 2.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.659 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -47.63 -35.64 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.84 -38.53 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 109.553 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.63 -42.32 67.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 109.962 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.33 -39.87 92.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.992 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -68.67 -38.07 80.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.868 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -77.96 -27.45 49.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.19 85.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.559 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.547 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.746 ' OD2' HG23 ' A' ' 27' ' ' VAL . 7.2 p-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 m -75.91 8.43 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.398 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.03 12.07 29.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.608 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.746 HG23 ' OD2' ' A' ' 24' ' ' ASP . 27.4 t -132.45 101.69 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 109.303 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.29 9.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.97 141.0 51.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -1.092 . . . . 0.0 109.239 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.36 142.97 8.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 ptm -141.31 147.6 38.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -1.201 . . . . 0.0 109.743 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 m -136.0 -179.75 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.025 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.66 163.16 31.12 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.049 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 91.93 42.76 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.368 -1.078 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.25 -27.01 12.17 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.712 2.275 . . . . 0.0 112.44 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.03 -33.95 40.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.1 m -130.13 7.56 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' OD1' ' A' ' 39' ' ' ASP . . . 57.46 71.54 0.73 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.553 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 30.2 m-20 -141.18 131.19 24.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.02 126.65 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.775 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.43 ' HG2' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -110.53 149.17 30.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.43 ' N ' ' HG2' ' A' ' 41' ' ' MET . 0.6 OUTLIER -124.88 122.99 38.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.63 134.75 54.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -135.83 116.89 14.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.302 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.18 159.07 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -127.03 140.65 52.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.56 150.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.146 -0.971 . . . . 0.0 109.648 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 9.8 p-10 -75.99 -94.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.601 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -156.26 15.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.67 -7.37 3.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.7 9.88 17.97 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.8 mm -98.41 143.84 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -1.155 . . . . 0.0 109.454 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.2 115.39 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.45 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.92 -37.36 15.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.67 168.09 20.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.23 105.74 3.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -99.88 141.4 32.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.766 ' CD1' HG21 ' A' ' 74' ' ' THR . 13.7 p90 -139.99 179.08 6.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.382 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -164.76 123.75 1.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -137.55 141.51 41.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -158.36 134.26 9.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.42 -69.32 0.54 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.02 128.41 38.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -1.163 . . . . 0.0 109.656 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.45 70.57 0.86 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.99 -17.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -1.112 . . . . 0.0 109.295 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . . . -105.74 6.33 31.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.431 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 68' ' ' ALA . 41.8 mt -79.05 -53.13 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -44.25 -45.3 8.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -70.85 -38.54 73.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.416 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.604 ' O ' HG23 ' A' ' 74' ' ' THR . 41.8 t -56.21 -39.96 73.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -73.72 -32.77 64.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.323 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.422 ' CD2' ' OE1' ' A' ' 96' ' ' GLU . 10.8 tp -68.96 -59.24 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 74' ' ' THR . 11.2 tt -52.34 -41.59 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.766 HG21 ' CD1' ' A' ' 58' ' ' PHE . 31.8 p -63.34 -32.33 73.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.331 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.47 -4.77 59.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.288 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.8 -26.44 14.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.57 22.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.298 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -95.49 120.38 35.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.412 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.01 5.48 89.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -87.04 -168.68 2.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -1.17 . . . . 0.0 109.534 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.13 152.47 39.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.369 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -57.82 -28.85 64.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.1 -36.35 79.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 85' ' ' ALA . 63.5 mm-40 -76.84 -56.1 4.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.46 -32.65 1.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.18 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.78 39.3 3.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -159.98 -40.57 0.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 108.781 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.54 ' O ' ' O ' ' A' ' 87' ' ' ALA . 12.4 pt -45.67 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 109.161 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -150.86 -178.63 6.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.154 -0.966 . . . . 0.0 109.572 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -90.88 -16.7 27.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.402 -0.811 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.27 -45.3 65.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.485 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -62.48 -69.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 92' ' ' GLN . 7.9 mt -41.71 -39.96 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HA ' HD21 ' A' ' 99' ' ' LEU . . . -67.17 -42.12 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.503 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -68.0 -11.41 58.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.443 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' OE1' ' CD2' ' A' ' 72' ' ' LEU . 13.2 tt0 -88.37 -54.77 4.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.413 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mt -81.94 -7.34 59.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 99' ' ' LEU . 6.0 tp10 48.5 23.56 0.62 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -43.97 149.21 0.69 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.67 164.2 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.67 2.246 . . . . 0.0 112.217 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 74.5 Cg_endo -79.91 18.4 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.985 2.456 . . . . 0.0 112.638 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.0 t -110.62 0.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 109.727 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.658 ' O ' ' N ' ' A' ' 105' ' ' HIS . 13.0 mtmt -140.33 10.7 2.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.445 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 101' ' ' PRO . 5.0 t -45.11 -10.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.442 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.658 ' N ' ' O ' ' A' ' 103' ' ' LYS . 3.2 m-70 -59.72 -37.92 80.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 86.3 m -60.66 -50.68 72.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -60.85 -52.82 63.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.372 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.5 mt -46.73 -36.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.262 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.59 -28.17 58.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.627 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.21 -50.95 71.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.999 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 112' ' ' ASP . 70.9 tt0 -66.55 -63.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.873 . . . . 0.0 109.133 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' GLU . 4.8 t70 -44.1 -35.06 1.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 115' ' ' LYS . . . -58.04 -64.53 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.006 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.8 tp -46.43 -22.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 108.513 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 116' ' ' ALA . 14.5 tttt -74.1 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -40.55 -51.53 2.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.602 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.78 -51.75 67.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.465 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mt -49.73 -43.07 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -55.96 -65.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.537 ' O ' ' C ' ' A' ' 121' ' ' TYR . 27.0 t70 -44.66 -68.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.595 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.537 ' C ' ' O ' ' A' ' 120' ' ' ASP . 54.2 t80 -35.33 -42.99 0.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -68.8 -51.64 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 mttt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.824 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.39 9.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.585 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 24' ' ' ASP . 4.6 m-20 -125.06 30.01 5.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 27' ' ' VAL . 34.9 t -127.1 91.36 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.313 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.42 142.2 16.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -129.17 112.57 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.46 134.93 12.2 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.41 114.41 16.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -1.118 . . . . 0.0 109.524 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.67 174.14 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.19 -178.9 21.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -122.12 89.19 48.58 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 109.367 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -54.46 29.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.95 2.433 . . . . 0.0 112.386 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -105.89 -42.83 5.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.7 -22.0 3.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.601 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.13 51.27 0.52 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.2 m-20 -106.76 140.22 39.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -1.145 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.74 114.54 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.167 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.5 ttt -112.54 140.99 46.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -126.5 128.97 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -0.878 . . . . 0.0 108.986 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -120.64 138.44 53.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.819 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -126.47 132.24 51.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 109.189 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.57 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -128.63 143.24 50.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.61 145.47 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -92.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -161.07 18.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.36 -21.2 3.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.72 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.55 6.06 6.27 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -103.64 130.08 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.641 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.44 97.66 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.299 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.67 -38.39 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.578 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.26 169.44 17.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.136 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -166.78 118.64 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.131 -0.981 . . . . 0.0 109.593 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -95.97 -177.94 4.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.176 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD1' HG21 ' A' ' 74' ' ' THR . 17.6 p90 -168.06 -179.72 4.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.184 -0.947 . . . . 0.0 109.418 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -171.61 113.98 0.36 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.5 p -119.62 131.89 55.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.206 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -140.89 111.27 6.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . 84.88 49.66 4.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.535 ' O ' ' O ' ' A' ' 64' ' ' GLY . 14.5 p -121.5 142.79 49.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.458 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 63' ' ' CYS . . . -38.99 -94.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.3 m -125.68 30.76 5.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.16 -31.51 72.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.497 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.8 mp -38.41 -32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.431 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -86.03 -64.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 109.312 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 m -54.21 -29.48 46.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.52 ' O ' ' OG1' ' A' ' 74' ' ' THR . 78.8 p -62.95 -34.52 77.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.115 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -74.42 -33.24 62.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.83 . . . . 0.0 109.225 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tp -64.34 -60.26 3.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.661 HG23 ' N ' ' A' ' 74' ' ' THR . 12.6 tt -51.95 -51.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.582 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.661 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -53.62 -31.15 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.374 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.09 -14.98 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.396 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -89.89 -23.96 21.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' ILE . 17.0 m -97.11 13.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 82.0 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.975 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.7 -9.45 8.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -98.75 -159.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -128.07 164.49 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 109.709 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt -50.53 -28.68 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.86 -53.01 61.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.351 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.79 -36.3 71.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.829 . . . . 0.0 109.328 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.649 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -67.97 -40.32 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.255 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 44.4 3.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -161.4 -35.31 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.137 . . . . 0.0 109.404 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.2 pt -40.39 -21.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 mttp 55.51 169.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.973 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.32 -45.32 5.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.553 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 37.1 t -56.19 -22.35 28.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.403 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -67.72 -64.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.369 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -51.35 -30.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.16 90.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.77 -18.32 61.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.372 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -71.14 -51.58 24.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.92 -11.92 56.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.21 19.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.673 ' N ' HD23 ' A' ' 99' ' ' LEU . 1.7 pt? -59.18 149.2 68.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 109.149 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -37.51 145.39 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.823 2.349 . . . . 0.0 112.23 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.63 8.83 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.671 2.247 . . . . 0.0 112.265 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.77 -30.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -94.09 16.89 13.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.907 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.06 -19.79 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.542 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -54.58 -33.49 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.59 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 90.6 m -58.02 -58.19 9.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.915 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -48.87 -55.77 10.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.478 ' N ' HD22 ' A' ' 90' ' ' ASN . 28.2 mt -47.77 -65.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.313 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 34' ' ' ALA . 6.5 mp -43.79 -27.32 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -69.57 -71.31 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -50.93 -30.78 15.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.911 . . . . 0.0 109.249 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -73.01 -25.08 60.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -75.02 -35.09 61.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.618 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.649 HG12 ' HB1' ' A' ' 85' ' ' ALA . 2.2 tp -75.03 -42.34 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 109.42 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 22.1 tttt -59.94 -40.3 88.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.982 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -62.61 -54.12 44.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -50.07 -63.48 1.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.227 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 117' ' ' ALA . 67.5 mt -37.77 -44.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.21 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -55.12 -57.34 12.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -58.75 -45.35 89.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.34 -20.57 44.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -91.36 -29.91 16.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.385 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.97 -7.34 59.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 25' ' ' SER . 5.8 t0 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.522 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.8 OUTLIER 74.41 11.17 4.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' A' ' 25' ' ' SER . 1.7 p-10 174.78 -28.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.96 . . . . 0.0 109.681 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -91.74 114.98 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.09 119.27 5.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.487 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 27.3 m -93.71 136.38 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -1.15 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.67 110.05 0.67 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 ttt -125.63 122.14 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -1.137 . . . . 0.0 109.651 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 41' ' ' MET . 2.1 m -124.55 -169.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.377 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.15 146.83 5.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.11 133.52 20.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.519 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.3 Cg_endo -75.44 -26.38 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.493 2.129 . . . . 0.0 112.256 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.53 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.89 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -98.88 5.32 47.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.04 48.79 10.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -89.66 127.07 35.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.401 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.0 131.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.405 ' HB3' HG23 ' A' ' 32' ' ' VAL . 4.7 ttt -128.06 130.53 48.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 109.293 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -125.38 142.07 51.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.801 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.56 156.84 43.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.182 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.78 150.56 38.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.78 139.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.316 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -113.38 146.51 39.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.71 147.63 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 2.2 t0 -88.9 -60.17 2.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 167.27 -23.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.145 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -100.12 22.66 11.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.541 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 15.26 80.14 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -104.93 136.66 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.483 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.34 97.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.7 -44.32 57.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.76 157.1 8.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.33 179.31 6.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.351 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -151.29 170.75 18.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 74' ' ' THR . 21.3 p90 -137.35 167.88 20.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 109.384 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -169.71 85.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.17 133.51 55.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -147.18 105.85 3.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.06 -50.66 0.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.1 p -128.9 120.55 26.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.52 66.57 1.02 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.55 -50.93 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.92 -26.4 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.354 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' ALA . 77.8 mt -44.67 -53.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.0 109.217 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.09 60.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 108.921 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.2 -40.37 64.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.34 -0.85 . . . . 0.0 109.024 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 74' ' ' THR . 2.3 t -65.69 -24.55 67.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 109.168 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.7 t -76.12 -46.21 29.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.308 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.05 -59.25 4.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 74' ' ' THR . 17.3 tt -49.21 -43.95 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.585 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -54.88 -42.27 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.591 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.19 -18.45 60.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.942 . . . . 0.0 109.729 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -89.35 -21.9 22.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.517 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 77' ' ' VAL . 4.8 m -107.49 52.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.14 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -142.11 82.43 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.646 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.74 40.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -102.25 -167.44 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -1.189 . . . . 0.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -102.94 139.24 38.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.77 -23.73 60.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.401 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -75.98 -13.97 60.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.35 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.55 -35.05 11.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.49 2.84 42.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.19 25.8 11.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.96 18.66 0.16 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -1.153 . . . . 0.0 109.409 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.05 2.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.847 . . . . 0.0 109.327 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.4 mttt 56.83 167.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.04 -13.16 48.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.339 -0.851 . . . . 0.0 109.541 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.3 p -75.76 -21.52 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.564 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -74.79 -56.01 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.423 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.0 mt -59.67 -41.98 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.88 82.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.184 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.35 -46.49 80.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 109.399 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -49.69 -62.45 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.17 -16.65 61.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 52.84 23.52 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.0 OUTLIER -55.26 146.84 39.36 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.582 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.423 ' O ' HD12 ' A' ' 99' ' ' LEU . 73.1 Cg_exo -42.04 146.78 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.74 2.293 . . . . 0.0 112.239 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.664 ' O ' HG23 ' A' ' 104' ' ' VAL . 57.2 Cg_endo -73.94 -27.59 12.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.762 2.308 . . . . 0.0 112.386 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 102' ' ' VAL . 4.9 t -70.5 26.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.739 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 101' ' ' PRO . 9.6 tttm -165.17 37.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 101' ' ' PRO . 3.5 t -71.39 1.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.392 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.583 ' O ' HD13 ' A' ' 109' ' ' LEU . 34.4 m80 -58.79 -29.26 66.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -67.59 -41.64 83.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.59 85.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.885 . . . . 0.0 109.177 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -62.56 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.295 -0.878 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 105' ' ' HIS . 7.8 mp -63.23 -25.21 68.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.428 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -74.15 -71.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 114' ' ' ILE . 12.9 tp10 -50.75 -31.48 16.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.42 -38.77 85.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.138 -0.976 . . . . 0.0 109.158 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -69.9 -58.91 3.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.661 ' O ' HD13 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -44.22 -38.09 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 116' ' ' ALA . 4.0 tptt -75.17 -66.13 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -36.61 -39.58 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -64.38 -57.95 7.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -38.01 -49.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.413 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -56.18 -61.15 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.507 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 119' ' ' ALA . 4.3 m-20 -38.83 -62.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -46.42 -57.43 4.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 123' ' ' ALA . 1.0 OUTLIER -47.31 -29.16 2.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -41.25 -47.81 3.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.587 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.446 ' HZ2' ' HB3' ' A' ' 24' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.85 -2.65 43.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -97.13 3.95 51.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.6 96.82 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 155.53 28.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -138.6 117.27 12.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -1.199 . . . . 0.0 109.62 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.06 114.4 4.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.53 108.59 14.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -1.196 . . . . 0.0 109.565 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.67 175.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.11 168.35 41.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -120.74 80.81 32.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -47.08 -14.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.848 2.366 . . . . 0.0 112.311 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -60.47 2.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -91.55 -8.75 46.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 43.27 9.38 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.2 148.48 25.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.111 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.1 139.89 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ttt -147.0 130.0 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -133.52 118.87 18.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.65 127.46 50.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -106.34 168.82 8.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.728 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.515 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -150.11 127.87 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.224 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -98.74 105.15 17.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.58 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.09 144.78 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 109.252 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.617 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 6.6 t70 -78.94 -101.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -148.35 13.6 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.617 ' ND2' ' OD2' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -139.27 2.25 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.68 33.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.432 HD13 ' OG ' ' A' ' 81' ' ' SER . 4.5 mm -83.32 144.06 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -1.187 . . . . 0.0 109.418 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 55' ' ' ASP . 72.1 mt -90.19 91.41 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.85 -54.03 16.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 15.9 t0 -136.59 -177.08 4.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.357 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.91 116.29 1.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.593 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -96.46 141.72 29.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.69 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -117.01 162.63 17.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.403 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -157.16 97.24 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.435 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.52 124.98 50.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -150.78 97.11 2.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.35 -39.7 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 34.3 t -130.12 121.79 27.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.93 47.41 1.89 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.09 2.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -1.16 . . . . 0.0 109.562 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.01 -4.25 20.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.452 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.542 ' O ' ' C ' ' A' ' 68' ' ' ALA . 3.1 mp -62.29 -65.85 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.542 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.5 -71.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -41.5 -60.32 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.496 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 84.1 p -46.29 -47.76 18.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.342 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.406 ' C ' ' OG1' ' A' ' 74' ' ' THR . 1.7 m -57.71 -23.95 54.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 74' ' ' THR . 1.4 tp -78.82 -71.54 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.287 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.577 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -40.52 -24.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -75.56 -56.17 4.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.252 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.16 -15.52 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -88.63 -32.55 18.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 77' ' ' VAL . 17.2 m -104.6 55.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.648 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 84.29 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.11 -15.1 23.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -78.25 -174.42 3.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.418 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.432 ' OG ' HD13 ' A' ' 52' ' ' ILE . 73.4 m -109.45 174.39 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.23 -26.03 68.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.633 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -64.61 -17.44 64.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -100.09 -38.87 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.08 -25.29 58.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.73 54.25 0.68 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.17 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -1.169 . . . . 0.0 109.404 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.54 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -35.89 -43.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 91' ' ' SER . 0.3 OUTLIER 63.6 119.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.582 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 91' ' ' SER . 43.0 p30 -40.93 -25.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.025 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.535 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.5 m -50.44 -36.9 35.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 93' ' ' ILE . 12.6 tt0 -83.46 -60.31 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.477 ' C ' ' O ' ' A' ' 92' ' ' GLN . 69.6 mt -40.13 -48.1 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 95' ' ' GLU . . . -72.44 -55.2 7.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 94' ' ' ALA . 3.7 tt0 -36.07 -34.06 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 94' ' ' ALA . 1.2 tp10 -81.79 -62.19 1.71 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.619 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.8 OUTLIER -63.29 -16.91 61.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 97' ' ' LEU . 1.1 tp10 37.94 47.43 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -71.28 150.47 94.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.169 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -36.15 109.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.87 2.38 . . . . 0.0 112.045 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.9 16.41 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.559 2.173 . . . . 0.0 112.477 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 102' ' ' VAL . 10.9 m -82.3 13.64 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' VAL . 4.9 tptt -168.21 -38.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.43 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 103' ' ' LYS . 12.4 t 44.22 57.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.27 -57.85 2.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' A' ' 107' ' ' SER . 48.0 t -44.46 -60.42 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.807 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.486 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -43.38 -63.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 107' ' ' SER . 27.4 mt -38.1 -62.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 34' ' ' ALA . 8.6 mp -48.65 -37.25 17.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.587 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.12 -73.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.637 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.551 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 3.8 tp10 -46.69 -58.54 3.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.9 OUTLIER -43.74 -38.34 3.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.768 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -51.96 65.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.6 tp -61.61 -41.1 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.677 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.479 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -62.08 -41.14 97.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 109.511 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.42 67.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -55.02 -33.91 63.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.314 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 68.9 mt -69.38 -66.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.851 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -38.69 -46.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.395 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -63.28 -43.85 96.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.394 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 118' ' ' ILE . 59.5 t80 -56.45 -42.25 77.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.449 ' NZ ' ' CG2' ' A' ' 118' ' ' ILE . 23.6 mttp -72.04 -43.98 64.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.05 -11.91 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.417 ' N ' ' C ' ' A' ' 122' ' ' LYS . 6.3 mttt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.31 -1.94 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 24' ' ' ASP . 1.9 p-10 -167.84 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.59 92.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.8 144.57 18.25 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.567 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 4.8 m -135.43 130.55 34.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.46 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.15 140.52 16.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.21 125.08 21.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 109.575 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.62 170.42 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.08 141.84 7.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -110.67 129.2 24.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.183 . . . . 0.0 109.186 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 36' ' ' ALA . 63.8 Cg_endo -77.14 -45.02 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.515 2.143 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.31 -55.28 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -113.55 29.04 8.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 109.69 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.4 51.67 0.74 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 37' ' ' CYS . 78.8 m-20 -102.24 111.77 24.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -99.3 130.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.759 ' HG3' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -137.05 150.74 48.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.492 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -136.76 116.36 12.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.376 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 tt -105.6 143.25 34.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 45' ' ' ILE . 4.8 tt0 -135.51 162.33 32.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.325 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.533 ' N ' ' CG ' ' A' ' 44' ' ' GLN . 1.3 pt -147.41 162.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.426 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 10.6 mmtm -129.52 138.48 51.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.21 155.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.562 ' OD2' ' OD1' ' A' ' 49' ' ' ASP . 38.5 t70 -88.65 -49.7 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.631 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER 160.78 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.234 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -101.39 -11.72 19.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 8.71 7.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.36 149.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.9 mt -90.92 95.55 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' CG ' ' N ' ' A' ' 55' ' ' ASP . 19.9 pt-20 -58.03 -46.24 85.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 54' ' ' GLU . 1.7 t0 -137.53 168.17 20.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.579 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.05 100.51 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.07 159.5 14.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.509 ' CD1' HG21 ' A' ' 74' ' ' THR . 34.6 p90 -140.35 -175.0 4.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.58 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -171.35 83.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.759 HG22 ' HG3' ' A' ' 41' ' ' MET . 59.6 p -92.9 149.04 21.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -155.06 141.56 18.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.85 -80.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 65' ' ' SER . 0.1 OUTLIER -82.11 136.94 35.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -1.157 . . . . 0.0 109.444 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.83 45.76 3.07 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -154.6 -47.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.392 -1.063 . . . . 0.0 109.336 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.68 -14.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' SER . 7.2 mt -65.88 -22.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.43 -67.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 73' ' ' ILE . 20.9 p -46.39 -53.41 11.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.166 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 74' ' ' THR . 83.9 p -49.88 -33.57 17.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.524 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.3 OUTLIER -71.17 -37.71 72.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.292 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.22 -67.84 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.848 . . . . 0.0 109.441 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' VAL . 5.3 tt -44.42 -40.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.948 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 71' ' ' SER . 1.5 p -57.48 -48.31 79.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.894 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.14 -21.57 50.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -11.54 59.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 73' ' ' ILE . 16.4 m -124.67 20.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.253 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -90.54 99.78 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.402 -0.812 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.04 56.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -81.88 171.14 14.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.15 150.68 21.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.532 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.7 mt -54.79 -15.81 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.99 -33.4 74.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.36 -47.48 8.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.871 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.8 -5.58 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.298 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.83 31.54 6.98 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.22 -36.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -1.16 . . . . 0.0 109.184 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.4 pt -44.81 120.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.839 . . . . 0.0 109.545 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -94.3 179.39 5.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -13.9 60.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.462 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -82.75 -43.89 16.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -58.28 -36.59 73.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.005 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.15 -33.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.02 -21.08 66.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.899 . . . . 0.0 108.971 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -94.18 -35.32 12.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.179 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -58.74 -36.18 73.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.352 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 mt -106.03 -3.87 21.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 47.12 50.88 13.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 99' ' ' LEU . 3.5 pp -85.88 146.8 44.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.427 ' O ' HG12 ' A' ' 102' ' ' VAL . 37.0 Cg_endo -69.08 151.99 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.744 2.296 . . . . 0.0 112.053 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.621 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.5 Cg_endo -69.5 19.13 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.887 2.391 . . . . 0.0 112.369 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.532 ' C ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -35.53 -28.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.31 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.649 ' C ' HG23 ' A' ' 104' ' ' VAL . 5.9 tptt -173.35 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.374 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 ' C ' ' A' ' 103' ' ' LYS . 1.6 t 69.87 2.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 37.4 p-80 -65.15 -36.76 85.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 3.9 t -58.7 -56.39 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.06 -44.31 74.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.8 mt -56.53 -41.58 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.39 -32.28 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -63.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.887 . . . . 0.0 109.62 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.1 -49.77 76.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -53.52 -28.03 29.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.973 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -79.3 -64.42 1.19 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.6 tp -44.94 -41.16 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 109.833 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.497 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -73.45 -37.15 65.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.442 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.09 80.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -68.59 -60.34 2.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ALA . 44.4 mt -38.57 -49.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.48 80.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.567 ' OD2' ' O ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -52.67 -66.64 0.35 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.253 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -46.92 -39.02 11.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 109.177 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -59.54 -51.17 70.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.814 . . . . 0.0 109.366 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.72 -6.48 2.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.522 -179.95 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' HG23 ' A' ' 27' ' ' VAL . 4.2 t0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.359 0.6 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.529 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 3.7 m -101.61 7.24 42.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.529 ' OD1' ' O ' ' A' ' 25' ' ' SER . 56.9 m-20 -144.2 14.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.435 HG23 ' OD2' ' A' ' 24' ' ' ASP . 32.9 t -118.46 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.192 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.53 153.13 34.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.542 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 7.8 m -127.15 120.7 29.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -1.043 . . . . 0.0 109.108 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.24 106.5 1.81 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.0 ttt -112.33 112.4 23.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -1.216 . . . . 0.0 109.462 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.48 154.44 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.39 -170.1 11.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.31 92.24 4.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 53.7 Cg_exo -48.55 -48.03 18.65 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.689 2.259 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.09 -34.2 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.469 ' O ' ' C ' ' A' ' 38' ' ' GLY . 21.2 m -120.01 12.05 11.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.83 56.89 3.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -124.5 117.6 24.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.29 130.06 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -128.86 137.04 51.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.325 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -121.54 164.01 17.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.689 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tp -158.51 126.19 5.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -117.77 140.55 49.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.426 HD11 ' HB1' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -129.54 124.34 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.57 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -101.39 143.6 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 48' ' ' ASP . 92.5 t -131.3 156.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.291 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.0 t70 -85.16 -106.12 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.448 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 2.1 p30 -140.02 8.65 2.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.75 -29.52 3.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.461 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.66 -5.6 4.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.38 137.04 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -1.151 . . . . 0.0 109.487 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 53' ' ' ILE . 8.1 mt -91.17 107.01 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -70.93 -16.45 62.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.725 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 15.7 t0 -172.91 151.75 2.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.053 -1.029 . . . . 0.0 109.791 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.556 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -133.12 107.76 8.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.22 154.77 17.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 109.561 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 74' ' ' THR . 2.4 p90 -136.99 -176.5 4.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.58 106.94 0.56 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.349 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.43 ' CG2' ' OG ' ' A' ' 70' ' ' SER . 81.9 p -112.77 145.15 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -154.45 108.79 3.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 109.423 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.84 -58.19 0.3 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.6 t -106.68 136.02 47.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -1.153 . . . . 0.0 109.371 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.63 38.25 2.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.5 20.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -1.185 . . . . 0.0 109.525 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -93.43 -29.49 15.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.805 ' H ' ' CD1' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -42.93 -27.16 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -46.72 -57.59 4.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.852 . . . . 0.0 109.705 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -49.89 29.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.707 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.43 ' OG ' ' CG2' ' A' ' 60' ' ' THR . 0.3 OUTLIER -48.63 -41.62 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.873 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.57 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.15 -45.17 74.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 73' ' ' ILE . 46.3 tp -57.06 -71.22 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.74 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.641 ' O ' HG22 ' A' ' 77' ' ' VAL . 9.5 tt -40.78 -44.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 109.941 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.824 HG21 ' CD1' ' A' ' 58' ' ' PHE . 1.1 p -59.22 -36.92 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.764 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' LEU . 21.6 tt0 -71.69 -55.65 7.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -31.88 27.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.664 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 77' ' ' VAL . 4.2 m -105.37 63.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.7 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -144.58 95.5 2.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.56 -15.47 35.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -76.08 -160.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -1.109 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 t -117.96 159.08 23.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 82' ' ' LEU . 14.0 mt -57.11 -19.18 18.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.327 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -67.83 -30.8 70.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.376 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.7 tp10 -86.39 -45.86 10.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.608 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.46 60.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.62 46.73 1.13 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -168.33 -33.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.093 . . . . 0.0 108.93 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 84' ' ' GLU . 16.2 pt -50.3 179.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.49 -0.756 . . . . 0.0 109.579 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -143.58 179.98 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.282 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -96.15 -13.22 23.73 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 t -70.84 -41.93 70.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.813 . . . . 0.0 109.268 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -65.86 -52.15 52.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.212 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 mt -57.97 -27.01 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.221 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.67 -42.06 78.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.318 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.51 -22.02 62.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.19 -54.92 5.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.532 ' O ' ' C ' ' A' ' 98' ' ' GLU . 4.4 tp -80.75 -3.47 51.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 97' ' ' LEU . 7.6 tm-20 36.0 70.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.326 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.04 149.76 36.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.373 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -71.03 151.66 62.03 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.714 2.276 . . . . 0.0 112.112 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.02 19.39 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.797 2.331 . . . . 0.0 112.211 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.31 16.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.493 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 105' ' ' HIS . 8.8 tttp -176.49 46.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 104' ' ' VAL . 18.7 t -65.86 20.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.64 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.611 ' H ' ' C ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -86.24 -30.51 22.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 p -65.85 -44.37 85.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.25 -45.92 89.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.7 mt -68.2 -30.04 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 mp -73.27 -40.93 64.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.641 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -60.15 -53.77 53.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.831 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.31 -56.85 8.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.709 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -51.55 -17.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.38 -55.06 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 tp -51.13 -33.07 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.0 109.653 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.503 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -75.39 -61.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -37.47 -35.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 119' ' ' ALA . . . -77.75 -66.34 0.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 117' ' ' ALA . 48.0 mt -37.47 -28.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 117' ' ' ALA . . . -77.9 -52.9 8.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD2' ' O ' ' A' ' 29' ' ' THR . 37.3 m-20 -49.75 -44.19 48.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.71 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.59 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -76.12 -59.17 2.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 109.547 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' TYR . 22.6 tptt -43.11 -33.26 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.8 -20.87 16.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 mttt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.944 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.286 0.565 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 58.91 -4.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.337 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -146.65 13.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.383 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.06 101.58 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.744 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.19 128.86 9.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.74 152.9 21.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -1.212 . . . . 0.0 109.661 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 43' ' ' LEU . . . -131.51 118.18 2.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.96 95.3 4.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -1.146 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.92 145.56 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.86 177.75 20.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.57 77.15 73.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.171 -1.194 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.03 -6.36 1.8 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.854 2.369 . . . . 0.0 112.107 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.62 -11.08 59.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.588 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.4 -39.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.98 69.63 0.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.1 145.89 44.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -1.157 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.22 117.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.85 . . . . 0.0 109.212 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ttt -120.11 120.24 35.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.893 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -113.34 142.72 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 108.97 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 tt -150.62 149.39 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 109.886 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 6.7 pt20 -150.99 123.27 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.787 . . . . 0.0 109.214 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.3 151.12 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -112.68 150.0 32.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.568 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.84 144.52 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.203 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.605 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 36.7 p-10 -85.13 -108.76 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.963 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.605 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 34.0 t0 -131.95 -23.39 2.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.545 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.37 -1.68 57.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 28.83 12.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 53' ' ' ILE . 45.9 mm -108.89 161.43 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 109.373 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.463 ' N ' HG22 ' A' ' 52' ' ' ILE . 8.4 mt -100.49 105.47 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.222 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.3 -36.29 20.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.803 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.79 160.31 38.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.707 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.29 112.88 4.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 109.417 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -107.77 146.63 31.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -140.35 -175.44 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.542 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -170.75 107.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.433 HG21 ' CB ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -121.39 105.87 10.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.474 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.1 122.54 24.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.09 -39.44 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.0 139.06 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -1.099 . . . . 0.0 109.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.52 60.45 1.52 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.565 ' C ' ' H ' ' A' ' 67' ' ' ILE . 2.3 p -175.73 -59.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 106' ' ' CYS . . . -54.02 -1.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.532 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.565 ' H ' ' C ' ' A' ' 65' ' ' SER . 4.2 mt -65.76 -8.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.25 -49.75 9.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.09 -52.82 59.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.327 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -43.37 -56.51 3.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -53.21 -30.43 37.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 109.352 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 69' ' ' SER . 11.4 tp -70.53 -67.45 0.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 109.554 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.651 ' O ' HG22 ' A' ' 77' ' ' VAL . 3.9 tt -48.72 -40.35 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.458 ' N ' HG23 ' A' ' 73' ' ' ILE . 21.0 p -58.66 -47.19 85.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.74 -10.17 58.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.87 -31.37 17.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 73' ' ' ILE . 4.2 m -102.42 64.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -133.93 100.5 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.67 -9.39 77.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -81.45 -171.22 3.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -1.204 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.11 -178.27 3.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.24 -10.32 49.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -71.06 -34.48 71.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.156 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.0 -37.13 13.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.402 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 -29.53 63.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.67 48.29 1.51 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.97 -42.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -1.12 . . . . 0.0 109.027 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.465 ' C ' ' O ' ' A' ' 87' ' ' ALA . 2.3 pt -40.98 151.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.398 -0.814 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -129.53 173.42 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 109.669 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.495 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 4.1 p-10 -86.75 -7.86 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.357 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 -47.38 39.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -60.08 4.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 109.409 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.31 -38.25 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 90' ' ' ASN . . . -62.75 -33.87 76.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.55 -22.31 30.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.486 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.02 -24.85 58.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.4 mt -111.21 -19.26 12.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.242 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.47 62.79 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.684 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -97.56 153.23 38.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.335 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.0 152.13 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.547 2.164 . . . . 0.0 112.028 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.41 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 57.6 Cg_endo -74.67 -11.05 22.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.752 2.301 . . . . 0.0 112.229 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -92.01 11.11 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 105' ' ' HIS . 34.7 mttt -139.83 6.56 2.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.454 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 104' ' ' VAL . 3.8 t -47.09 -17.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -51.4 -14.69 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.514 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.628 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 42.2 t -76.05 -71.12 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.668 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.0 p -48.62 -44.06 36.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.7 mt -57.93 -51.83 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp -52.52 -27.91 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.82 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 16.4 tt0 -64.5 -44.92 89.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -35.23 79.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.36 65.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp -58.53 -41.37 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.975 . . . . 0.0 109.567 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.485 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 40.4 tttm -61.27 -28.56 69.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 109.155 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.37 -47.53 19.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.6 -32.41 41.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.92 -41.34 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.42 84.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.11 -52.64 22.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.87 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -49.36 -42.13 41.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.224 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -28.55 63.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.96 4.64 53.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.5 tptt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.37 179.941 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -82.99 9.31 10.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.684 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -118.92 -13.68 9.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.363 -0.836 . . . . 0.0 109.364 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.12 94.08 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.369 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.73 142.5 20.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -120.94 158.88 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -1.089 . . . . 0.0 109.177 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.15 145.4 12.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 ttt -145.62 119.3 9.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -126.17 170.34 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.75 178.29 28.27 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.29 75.34 70.72 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -1.091 . . . . 0.0 109.187 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 75.3 Cg_exo -44.48 -25.74 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 112.434 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.1 -51.2 8.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.8 p -114.79 -24.54 8.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.45 46.11 1.09 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 36.9 t0 -108.09 135.61 49.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 109.488 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.527 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 4.0 m -108.43 137.72 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.9 ttt -137.86 128.56 26.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -117.26 142.91 46.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 109.409 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 tp -149.53 121.09 7.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.67 155.41 29.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.849 . . . . 0.0 109.371 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.79 125.48 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.66 ' NZ ' ' OE1' ' A' ' 54' ' ' GLU . 11.2 tttp -100.0 114.71 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -122.39 127.55 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.941 . . . . 0.0 109.495 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 50' ' ' ASN . 6.3 m-20 -158.02 -32.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -62.57 50.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER 78.54 54.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' C ' HG12 ' A' ' 47' ' ' VAL . . . 68.61 18.17 71.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.2 mm -105.73 134.9 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.389 -1.065 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.703 ' O ' HG22 ' A' ' 53' ' ' ILE . 32.4 mt -63.06 80.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.216 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.66 ' OE1' ' NZ ' ' A' ' 46' ' ' LYS . 35.5 tt0 -49.61 -22.73 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.18 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -169.11 159.57 9.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.034 -1.041 . . . . 0.0 109.808 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.05 134.0 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -116.68 144.59 44.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -143.66 170.64 15.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -171.7 96.54 0.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 0.0 108.975 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.32 148.64 42.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -152.79 147.93 26.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.152 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.73 -74.03 0.45 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 1.6 p -116.24 122.18 44.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.134 . . . . 0.0 109.348 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.25 -9.68 2.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 63' ' ' CYS . 0.5 OUTLIER -93.27 10.3 32.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.711 ' HB2' ' SG ' ' A' ' 63' ' ' CYS . . . -100.88 -3.49 29.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.86 -24.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.8 65.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.622 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -76.91 -50.78 12.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.1 t -49.34 -38.41 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.359 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.1 t -72.21 -39.28 68.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 HG23 ' A' ' 93' ' ' ILE . 49.9 tp -61.0 -59.87 4.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.344 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.727 HG23 ' H ' ' A' ' 74' ' ' THR . 1.0 OUTLIER -53.13 -59.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.727 ' H ' HG23 ' A' ' 73' ' ' ILE . 2.4 p -42.86 -32.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.824 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -91.01 -11.31 39.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.782 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -93.87 -17.31 23.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.975 . . . . 0.0 109.533 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.36 40.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -95.89 116.93 29.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.43 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.69 5.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -73.74 -173.78 1.6 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.4 m -101.49 158.4 16.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.865 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -70.21 -16.56 63.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.86 -26.22 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.208 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -93.43 -43.4 8.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.376 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.21 67.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.47 33.11 4.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.1 26.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -1.109 . . . . 0.0 109.253 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.57 -25.02 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.832 . . . . 0.0 109.621 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 71.16 156.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.448 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.684 ' ND2' ' OE1' ' A' ' 111' ' ' GLU . 2.6 p30 -93.48 -41.96 9.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.616 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -35.96 79.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -58.54 -67.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.408 HG23 HD23 ' A' ' 72' ' ' LEU . 4.3 mt -49.8 -33.47 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.751 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 107' ' ' SER . . . -69.3 -31.08 69.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 109.741 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.4 -36.14 60.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.23 -43.3 82.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.25 -17.15 62.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.404 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 54.24 39.08 30.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.3 pp -82.27 149.0 60.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.304 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.404 ' O ' HD12 ' A' ' 99' ' ' LEU . 29.3 Cg_endo -66.16 149.31 85.63 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.645 2.23 . . . . 0.0 112.147 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -73.2 20.06 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.926 2.417 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.0 m -85.47 -13.52 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.885 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 105' ' ' HIS . 1.0 OUTLIER -150.12 55.8 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.849 ' O ' HG12 ' A' ' 104' ' ' VAL . 74.5 t -73.3 40.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.467 ' H ' ' C ' ' A' ' 103' ' ' LYS . 62.4 m80 -97.42 -26.46 14.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.868 . . . . 0.0 109.718 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.642 ' SG ' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -74.94 -45.11 44.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.626 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.642 ' N ' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -53.84 -46.92 71.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 56.2 mt -68.05 -43.65 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.4 mp -58.27 -37.35 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -63.33 -59.07 5.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.422 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.684 ' OE1' ' ND2' ' A' ' 90' ' ' ASN . 87.1 tt0 -56.09 -60.51 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.362 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 111' ' ' GLU . 1.6 t0 -43.9 -32.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.354 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -68.89 -61.2 1.9 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.46 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 tp -49.61 -20.68 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -85.26 -57.9 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.353 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.56 5.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.225 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.94 -58.03 3.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.126 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.5 mt -46.72 -31.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.365 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.89 38.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.05 -0.79 12.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.147 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -102.81 -32.05 10.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -95.74 -31.4 13.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.26 -18.18 63.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.484 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.192 0.52 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -71.27 2.4 4.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.277 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 25' ' ' SER . 2.4 p30 165.75 33.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.41 96.76 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.454 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.0 100.95 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 m -86.17 133.16 33.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -1.152 . . . . 0.0 109.657 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.33 145.78 17.57 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.21 110.8 5.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -1.213 . . . . 0.0 109.774 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.77 144.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.34 178.17 21.09 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.93 92.57 49.07 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.139 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.8 Cg_exo -50.15 -40.15 51.28 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.852 2.368 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.43 -44.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 109.671 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.32 -13.03 9.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.599 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.22 57.9 2.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -113.35 110.84 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.5 130.54 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.99 118.96 15.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -111.14 136.23 50.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.707 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' CB ' ' HB1' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -126.35 141.89 51.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -140.84 135.84 31.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -118.09 136.01 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' CD ' ' OD2' ' A' ' 55' ' ' ASP . 36.8 tttt -105.87 118.92 37.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.25 146.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.7 m-20 -173.92 -33.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -62.47 42.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.672 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.1 m120 80.99 43.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 109.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.13 0.54 82.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.525 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.0 mm -98.23 151.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.494 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -84.39 116.03 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -44.57 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD2' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -130.11 131.2 45.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.561 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.96 121.51 45.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.425 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 115.13 29.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.402 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.744 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -101.78 167.91 9.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 83.74 1.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.92 127.47 41.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.47 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -151.57 141.56 22.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.596 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.98 -53.06 0.59 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 42.6 t -91.11 172.57 8.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -1.188 . . . . 0.0 109.442 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.495 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -129.92 -10.85 2.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.8 13.65 30.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -1.112 . . . . 0.0 109.368 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.93 -31.37 9.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.845 . . . . 0.0 109.486 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.6 mp -36.7 -35.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.933 . . . . 0.0 109.172 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -75.44 -55.86 5.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.7 m -51.11 -39.87 57.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -70.05 -66.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.67 -19.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.328 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -79.75 -78.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.937 . . . . 0.0 109.573 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 74' ' ' THR . 11.3 tt -45.95 -36.77 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.57 HG21 ' CG ' ' A' ' 58' ' ' PHE . 43.7 p -68.76 -39.07 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.82 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -79.78 -12.22 59.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -98.6 -26.36 14.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.539 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.3 -34.76 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -50.73 116.31 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.41 57.49 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -89.22 -177.89 5.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.391 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.525 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 50.6 m -107.17 -178.95 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.9 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.2 mt -77.68 -23.07 49.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 -14.22 60.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.378 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -101.23 -41.95 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.14 1.71 56.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.6 47.07 1.08 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -176.85 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -1.127 . . . . 0.0 109.394 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.498 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -38.16 155.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -116.43 158.6 23.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.539 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.534 ' OD1' ' OE1' ' A' ' 111' ' ' GLU . 1.4 p-10 -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -47.55 -37.06 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.19 -66.97 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 109.555 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -44.95 -44.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.46 -39.76 77.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.105 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -75.86 -10.01 59.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.234 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -79.47 -62.87 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 97' ' ' LEU . 6.2 mt -72.52 -2.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.09 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 46.9 77.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 110.086 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.608 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.4 OUTLIER -126.69 148.52 65.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 108.875 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -37.78 148.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.887 2.391 . . . . 0.0 112.358 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.71 -79.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.676 2.251 . . . . 0.0 112.348 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 103' ' ' LYS . 3.3 t 47.16 -138.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.195 -0.941 . . . . 0.0 109.298 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.69 ' H ' HG12 ' A' ' 102' ' ' VAL . 14.6 tttt -78.42 -6.45 55.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 104' ' ' VAL . 12.0 p 31.97 41.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.485 -0.759 . . . . 0.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.666 ' HA ' HD12 ' A' ' 108' ' ' ILE . 16.0 p80 -68.65 -24.4 64.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.8 t -59.48 -71.18 0.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 69.6 m -46.35 -42.19 14.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.299 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 105' ' ' HIS . 87.5 mt -54.77 -70.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 108' ' ' ILE . 6.4 mp -36.64 -34.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 109.452 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -61.4 -72.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' OD1' ' A' ' 90' ' ' ASN . 16.9 tt0 -54.49 -38.33 66.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -27.99 68.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.892 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 43' ' ' LEU . . . -79.09 -58.26 3.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.529 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.5 tp -44.7 -39.5 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 109.548 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -67.79 -55.9 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.553 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -45.54 -50.17 13.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.87 -59.98 4.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.506 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.9 mt -52.02 -22.18 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -73.25 -49.93 25.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.47 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -68.77 -50.85 47.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -48.53 -50.56 31.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 123' ' ' ALA . 3.4 mttm -65.13 -39.36 92.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.626 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -43.16 -42.82 4.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.2 tptt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.928 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 13.13 14.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.888 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -108.83 16.95 22.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.07 116.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.16 140.18 15.6 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.3 m -119.89 120.51 36.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.1 132.94 6.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -136.02 131.43 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -1.141 . . . . 0.0 109.282 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.03 -174.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.23 -169.17 38.71 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -140.31 100.51 6.97 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' CYS . 69.0 Cg_exo -47.06 -60.55 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.52 2.146 . . . . 0.0 112.152 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.71 -20.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 35' ' ' PRO . 3.7 m -118.85 -32.39 4.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 81.0 25.81 54.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.78 132.39 35.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -1.115 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -107.36 115.39 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.7 ttt -113.94 102.15 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -84.92 155.04 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.51 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.89 110.83 2.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -115.26 123.56 49.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.405 HG13 ' H ' ' A' ' 45' ' ' ILE . 0.6 OUTLIER -103.95 153.23 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -126.0 134.38 51.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.75 148.1 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.199 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.58 -94.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.039 -1.038 . . . . 0.0 109.612 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -156.43 20.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.46 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -1.2 3.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.915 . . . . 0.0 109.46 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.11 15.06 31.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mm -105.32 122.35 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -1.147 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.0 mt -67.82 111.93 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.253 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' O ' ' CD ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -88.19 -8.07 55.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.817 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 56' ' ' ALA . 7.0 t70 -171.96 165.86 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 55' ' ' ASP . . . -149.55 139.79 22.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 165.46 24.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD1' HG21 ' A' ' 74' ' ' THR . 8.3 p90 -170.61 -174.49 1.63 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.809 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -172.03 111.08 0.28 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.038 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.1 p -84.32 149.45 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.816 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.7 116.09 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.37 -0.832 . . . . 0.0 109.316 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.49 -87.23 0.14 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 140.32 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -1.11 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.11 55.37 3.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.55 -32.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -83.6 1.23 43.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 67' ' ' ILE . 5.8 mm -59.07 4.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -94.09 -38.66 11.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -70.62 -52.82 18.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -53.11 -33.67 53.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.514 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' ' OG1' ' A' ' 74' ' ' THR . 6.2 m -71.51 -35.77 70.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.97 -65.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.802 ' O ' HG22 ' A' ' 77' ' ' VAL . 1.2 tt -46.12 -39.56 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.781 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 70' ' ' SER . 16.6 p -62.89 -40.01 96.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 1.39 51.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.902 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -17.37 14.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.823 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 73' ' ' ILE . 17.8 m -114.03 53.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.039 . . . . 0.0 109.648 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -126.26 104.34 8.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.375 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -24.02 33.99 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -65.38 -179.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.405 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.6 159.17 15.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.124 -0.985 . . . . 0.0 109.65 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mt -56.43 -22.29 30.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.888 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.08 -46.47 70.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.138 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.81 -45.58 93.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.132 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.46 72.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.153 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 49.0 4.15 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.98 -32.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -1.075 . . . . 0.0 109.182 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.544 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -34.16 -44.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.45 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 88' ' ' ILE . 49.3 mttt 57.79 145.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.835 . . . . 0.0 109.559 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.35 -28.82 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 0.0 109.37 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.3 p -54.53 -39.86 68.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -53.9 12.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.425 ' H ' HG13 ' A' ' 93' ' ' ILE . 23.3 mt -51.49 -40.61 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.45 -58.82 5.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.392 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.63 -53.01 34.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.214 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -47.24 -50.51 21.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.342 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.5 mp -70.19 -40.34 74.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.357 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 1.8 tp10 81.71 32.6 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.19 146.14 50.6 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 102' ' ' VAL . 20.5 Cg_endo -64.77 152.59 81.5 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.558 2.172 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.11 20.11 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.875 2.383 . . . . 0.0 112.131 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 100' ' ' PRO . 33.0 m -87.93 -21.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.63 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -137.18 47.74 2.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.793 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.45 -9.5 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 108.998 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.764 ' O ' HD13 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -56.28 -27.15 54.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 45.2 t -69.87 -64.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -49.59 -65.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.363 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 107' ' ' SER . 80.0 mt -40.98 -44.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 105' ' ' HIS . 2.0 mp -57.46 -44.23 84.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -57.69 -48.1 80.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.271 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -59.61 -59.68 5.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 -25.89 3.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.885 . . . . 0.0 109.441 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -72.1 -38.9 69.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 111' ' ' GLU . 2.1 tp -70.23 -35.76 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.476 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 13.7 mttt -77.92 -30.4 50.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.531 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.86 -43.85 87.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.358 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.14 77.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.273 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.16 -45.72 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.429 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.83 75.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 29' ' ' THR . 4.8 m-20 -66.92 -8.64 30.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -87.22 -52.36 5.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -61.89 -41.78 98.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.633 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.51 -0.59 5.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.429 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.296 0.57 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -92.11 12.31 22.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.333 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -114.89 19.96 15.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.0 t -139.29 99.42 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.52 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.04 120.87 5.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -82.96 136.69 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 109.52 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.12 85.59 0.32 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mtt -94.69 107.27 19.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -1.103 . . . . 0.0 109.559 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.1 170.78 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.526 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.94 -173.21 34.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.1 87.09 55.97 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.184 . . . . 0.0 109.481 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.94 -12.8 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.736 2.291 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.8 m -120.18 -38.68 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.5 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.12 36.88 0.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.41 115.8 28.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.127 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.72 131.23 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.091 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -134.55 131.5 38.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.801 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 5.4 tt0 -125.41 131.88 52.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.274 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -142.96 111.87 6.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.506 ' NE2' ' OE1' ' A' ' 42' ' ' GLN . 9.2 mt-30 -103.22 143.92 32.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.454 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.3 OUTLIER -106.77 147.5 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.574 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 117.94 29.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.8 134.0 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.675 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.6 m-20 -170.39 -31.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.575 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 14.0 m-20 -62.7 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.092 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-80 74.49 48.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.488 -0.758 . . . . 0.0 109.067 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.65 -8.54 58.97 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 53' ' ' ILE . 45.2 mm -87.71 162.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.524 ' N ' HG22 ' A' ' 52' ' ' ILE . 62.3 mt -79.37 120.33 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.75 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.38 -31.9 21.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.64 157.11 1.99 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.221 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.87 139.09 50.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -103.22 117.66 35.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 74' ' ' THR . 15.1 p90 -103.88 166.42 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.5 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -167.05 93.49 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.357 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.78 135.66 50.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.505 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -150.59 139.61 21.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.71 -45.21 0.76 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.6 OUTLIER -119.58 123.71 44.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -1.107 . . . . 0.0 109.389 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 67.19 0.17 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.6 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -174.8 -48.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -1.15 . . . . 0.0 109.633 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.03 -2.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.6 ' H ' ' C ' ' A' ' 65' ' ' SER . 6.2 mm -82.4 -12.05 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.317 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.16 -48.45 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 109.683 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.545 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -63.72 -40.68 97.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.687 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 74' ' ' THR . 1.0 OUTLIER -55.25 -47.16 75.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.72 -42.99 99.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.862 . . . . 0.0 109.813 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.412 HD21 ' OE1' ' A' ' 96' ' ' GLU . 1.9 tp -61.93 -68.25 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.61 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.635 HG23 ' N ' ' A' ' 74' ' ' THR . 17.7 tt -47.99 -49.61 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.754 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.635 ' N ' HG23 ' A' ' 73' ' ' ILE . 6.5 p -50.49 -46.79 57.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.84 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.52 -5.42 54.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -5.98 26.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.52 -5.85 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.22 114.09 19.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.627 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.21 -6.72 63.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -91.24 165.48 13.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -1.21 . . . . 0.0 109.635 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.486 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 18.1 m -100.42 166.98 10.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.543 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -23.44 67.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.51 -44.82 93.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.83 -59.03 2.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.92 . . . . 0.0 109.387 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.42 -26.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.269 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.17 44.21 1.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.554 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -161.99 -37.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.096 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.554 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.0 pt -41.54 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -136.84 154.49 50.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.54 ' O ' ' C ' ' A' ' 91' ' ' SER . 18.5 p-10 -73.77 -50.71 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.54 ' C ' ' O ' ' A' ' 90' ' ' ASN . 4.0 t -35.01 -46.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.536 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.94 -49.9 72.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.2 mt -55.68 -35.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.221 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.95 -24.3 60.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -81.6 -47.47 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.412 ' OE1' HD21 ' A' ' 72' ' ' LEU . 11.2 tt0 -62.28 -29.36 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 99' ' ' LEU . 1.3 mp -98.05 -28.81 13.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.534 ' O ' ' C ' ' A' ' 99' ' ' LEU . 1.6 tt0 64.8 -2.94 0.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.259 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.534 ' C ' ' O ' ' A' ' 98' ' ' GLU . 1.7 pp -34.58 150.23 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.477 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -40.33 108.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.858 2.372 . . . . 0.0 112.097 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.23 8.54 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.536 2.157 . . . . 0.0 112.445 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 102' ' ' VAL . 2.5 m -56.84 -14.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -153.11 -38.8 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' CYS . 5.9 t 64.85 5.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.471 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 7.6 p-80 -45.6 -20.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' VAL . 1.8 m -75.41 -75.67 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 4.4 m -43.24 -38.78 2.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.8 mt -57.86 -52.65 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.5 mp -59.25 -23.08 62.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -66.74 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.534 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 6.9 tp10 -60.08 -40.06 88.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -27.69 69.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.177 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -73.44 -65.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.47 HG22 ' OE1' ' A' ' 111' ' ' GLU . 2.4 tp -43.08 -33.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -67.6 -73.25 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.352 -0.843 . . . . 0.0 109.414 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.544 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -35.48 -36.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' LYS . . . -60.96 -63.93 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.9 mt -47.49 -25.34 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.412 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -67.1 -59.22 3.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -61.58 -40.28 94.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.313 -0.867 . . . . 0.0 109.093 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -52.43 -57.77 8.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 109.188 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' LYS . 1.7 ttmm -54.44 -47.94 72.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.478 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -44.43 -21.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.51 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 122' ' ' LYS . 42.6 mmtt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.387 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.278 0.561 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.521 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 3.3 m -103.97 -0.41 28.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.71 11.98 36.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.336 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.37 110.06 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.86 145.68 17.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 m -139.96 137.28 34.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.6 150.73 22.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.9 mtt -144.11 105.0 4.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -1.112 . . . . 0.0 109.209 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.25 -176.15 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.84 157.11 17.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.63 138.4 20.61 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.178 -1.189 . . . . 0.0 109.466 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.99 3.72 4.28 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.609 2.206 . . . . 0.0 112.216 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.17 -79.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -109.37 20.74 17.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.354 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 53.51 16.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.644 ' OD2' ' SG ' ' A' ' 63' ' ' CYS . 1.5 m-20 -86.56 116.93 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -1.105 . . . . 0.0 109.698 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -95.09 121.17 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 109.211 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.34 112.89 20.62 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.168 -0.957 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -99.76 140.15 34.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 109.084 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.428 HD21 HD12 ' A' ' 114' ' ' ILE . 3.3 tt -151.11 121.31 7.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.727 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -126.49 176.79 6.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.98 157.44 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -131.88 134.93 46.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.582 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 30.0 t -124.9 122.65 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.686 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.3 m-20 -157.78 -32.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.546 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 11.1 t70 -62.22 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER 78.89 52.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -0.833 . . . . 0.0 109.535 179.784 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.86 9.45 66.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 53' ' ' ILE . 43.6 mm -105.03 155.52 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -1.18 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.42 ' N ' HG22 ' A' ' 52' ' ' ILE . 74.4 mt -75.27 114.46 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -85.37 -35.35 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.73 164.2 31.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.72 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.14 120.36 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.303 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -99.21 122.48 42.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.868 ' CD2' HG21 ' A' ' 74' ' ' THR . 11.6 p90 -139.7 160.49 39.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -140.02 120.02 13.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.305 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.6 HG21 ' OG ' ' A' ' 70' ' ' SER . 7.1 p -121.44 137.48 54.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.733 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -162.12 100.73 1.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.8 -50.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.975 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.644 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 11.5 m -122.01 179.1 4.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -1.232 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.752 ' O ' HG22 ' A' ' 67' ' ' ILE . . . -102.87 -21.08 10.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . 9.6 t -83.91 -66.68 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -1.164 . . . . 0.0 109.412 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -45.66 -21.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.323 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 64' ' ' GLY . 0.6 OUTLIER -64.79 -5.04 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.396 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.19 -55.33 2.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.5 m -52.47 -45.55 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.6 ' OG ' HG21 ' A' ' 60' ' ' THR . 0.5 OUTLIER -50.24 -51.41 44.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.64 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.98 -43.52 81.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.754 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.19 -68.5 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.9 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.633 HG23 ' N ' ' A' ' 74' ' ' THR . 9.1 tt -50.86 -53.05 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.868 HG21 ' CD2' ' A' ' 58' ' ' PHE . 33.4 p -48.01 -28.37 2.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.814 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -101.29 -4.62 26.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -89.84 -18.16 26.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.68 26.18 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -102.75 103.83 14.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.43 0.15 27.9 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -100.38 -176.51 3.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -1.14 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -108.23 173.85 6.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.594 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.8 mt -65.58 -18.04 65.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.594 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.42 -30.57 67.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -86.43 -53.17 5.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.57 -18.89 64.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.351 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.93 40.1 2.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -158.02 -35.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -1.089 . . . . 0.0 109.24 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -44.65 169.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -133.01 -170.4 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.185 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -99.02 -30.33 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.59 -40.83 93.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 95' ' ' GLU . 12.7 mm100 -58.5 -70.92 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.644 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 93' ' ' ILE . 40.9 mt -44.46 -34.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.99 73.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 92' ' ' GLN . 2.2 tt0 -80.65 -15.49 56.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.193 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -81.24 -51.98 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -78.79 -22.98 45.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 2.4 tt0 73.2 36.15 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.449 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -74.37 146.0 83.45 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.4 155.74 50.64 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.658 2.239 . . . . 0.0 112.261 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.6 Cg_endo -75.31 -2.24 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.852 2.368 . . . . 0.0 112.374 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.87 -2.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.657 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 101' ' ' PRO . 29.4 tttt -166.07 61.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 106' ' ' CYS . 20.4 t -60.63 -25.79 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.422 ' ND1' ' CD1' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -49.15 -17.9 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.159 -0.963 . . . . 0.0 109.287 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -74.01 -62.86 1.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.9 t -57.19 -36.55 70.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.319 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 109' ' ' LEU . 4.6 mt -61.43 -64.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.268 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.543 ' N ' HG22 ' A' ' 108' ' ' ILE . 2.7 mp -42.61 -41.12 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -54.92 -63.4 1.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 109.677 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 112' ' ' ASP . 2.1 tm-20 -52.89 -67.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 111' ' ' GLU . 11.4 t70 -37.47 -37.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -60.88 -67.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.81 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.9 tp -41.14 -39.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.9 tmtt? -58.82 -55.3 36.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.98 -56.66 9.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.689 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.96 5.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.587 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 66.7 mt -75.55 -59.63 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -37.02 -51.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 122' ' ' LYS . 27.2 t0 -68.69 -58.09 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 109.701 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.534 ' C ' ' O ' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -33.17 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 109.7 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.676 ' HB2' ' HZ2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -96.93 -34.24 11.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.585 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -78.96 -17.78 54.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 123' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.592 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 1.5 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 170.89 76.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.683 ' CD2' ' O ' ' A' ' 3' ' ' TYR . 46.4 t80 -72.27 13.39 0.33 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.4 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 2' ' ' ALA . 11.0 p -120.26 166.89 12.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.435 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -90.96 23.72 3.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.41 121.76 40.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.598 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.529 ' O ' ' C ' ' A' ' 8' ' ' ILE . 28.2 t -104.02 -11.5 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.867 . . . . 0.0 109.34 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.529 ' C ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -35.87 147.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.404 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 74.0 m-20 -83.45 -30.39 27.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.643 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER 178.34 160.7 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 109.463 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -69.68 -38.34 77.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.534 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -133.97 -87.29 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -147.07 149.76 36.38 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 109.549 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.88 7.62 1.95 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.814 2.343 . . . . 0.0 112.257 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -97.87 27.96 4.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' VAL . 3.7 m-20 56.2 77.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.563 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 18' ' ' GLY . 53.6 t 55.76 162.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.544 ' N ' HG12 ' A' ' 17' ' ' VAL . . . 167.36 -88.02 0.1 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.85 145.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -1.16 . . . . 0.0 109.528 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.85 HD11 ' NZ ' ' A' ' 57' ' ' LYS . 2.5 tp 59.64 107.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.545 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -178.58 6.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 1.1 mptt 57.46 -0.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.524 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 21' ' ' ASP . 5.6 mtmm -135.01 63.07 1.63 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.204 -0.935 . . . . 0.0 109.504 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -147.08 161.07 41.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -82.21 -12.94 57.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.347 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -92.88 10.77 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.387 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 t -136.55 117.58 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.84 130.34 10.24 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 m -110.44 147.73 33.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.453 -1.028 . . . . 0.0 109.322 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.79 117.6 0.82 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.15 108.41 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.279 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.27 -172.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.33 -171.52 38.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -131.84 74.88 76.76 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.16 . . . . 0.0 109.653 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.27 -2.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.786 2.324 . . . . 0.0 112.148 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -79.48 -7.89 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 3.2 m -149.93 -56.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.927 . . . . 0.0 109.477 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.472 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . 144.03 54.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -124.9 136.64 53.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -1.186 . . . . 0.0 109.347 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.78 135.97 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.66 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.9 ttt -133.68 136.96 45.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.504 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -129.63 126.97 39.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 tt -132.47 132.82 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -131.08 133.5 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.153 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -116.16 149.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 14.5 tttm -111.59 136.3 50.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.714 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 82' ' ' LEU . 24.7 t -129.28 116.57 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.168 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.691 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.8 m-20 -159.96 -34.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 109.893 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 51.8 t0 -62.29 50.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.305 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.1 m120 81.61 54.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.505 -0.747 . . . . 0.0 109.266 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.64 0.98 9.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 53' ' ' ILE . 3.8 mm -93.01 164.25 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.292 -1.122 . . . . 0.0 109.468 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.581 ' N ' HG22 ' A' ' 52' ' ' ILE . 3.3 mt -97.32 114.38 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -97.38 -38.86 9.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -124.39 151.33 44.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 109.783 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.61 99.56 3.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.85 ' NZ ' HD11 ' A' ' 20' ' ' LEU . 1.1 mttt -94.4 175.21 6.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.641 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' A' ' 74' ' ' THR . 45.4 p90 -165.02 176.91 8.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.474 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -166.31 110.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 41' ' ' MET . 10.7 p -129.13 96.65 4.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.954 . . . . 0.0 109.487 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -115.14 104.21 11.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.48 -41.3 0.28 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' SER . 1.4 t -106.76 105.62 15.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -1.086 . . . . 0.0 109.219 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -67.0 74.44 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 67' ' ' ILE . 1.2 p 162.74 -42.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -1.172 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.45 1.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.582 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.5 mp -73.32 -54.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.52 -71.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 73' ' ' ILE . 7.4 t -45.78 -43.03 12.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 109.613 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.0 -36.33 38.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.644 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -31.25 57.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -54.98 7.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 74' ' ' THR . 10.9 tt -58.18 -47.91 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.598 ' N ' HG23 ' A' ' 73' ' ' ILE . 11.9 p -61.19 -34.19 74.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.08 -7.82 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.13 -0.981 . . . . 0.0 109.623 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -87.13 -36.82 17.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.419 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' GLY . 35.5 m -88.31 -28.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -47.98 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 77' ' ' VAL . . . 120.38 -26.97 6.81 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.639 ' NZ ' ' OE1' ' A' ' 84' ' ' GLU . 7.1 mtpt -74.13 -165.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.92 163.5 24.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.97 . . . . 0.0 109.596 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 47' ' ' VAL . 17.6 mt -55.81 -37.58 68.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.34 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -56.12 -32.56 64.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.3 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE1' ' NZ ' ' A' ' 80' ' ' LYS . 38.7 mt-10 -84.2 -42.96 15.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -60.45 -30.83 69.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.15 43.86 3.07 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.04 -35.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.129 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 88' ' ' ILE . 2.4 pt -52.52 157.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.455 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -129.23 164.99 22.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -30.08 69.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -60.65 -29.09 69.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -58.99 -56.22 25.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 mp -70.41 -38.97 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.96 55.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.623 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.42 -43.03 15.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.591 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' O ' ' CD ' ' A' ' 96' ' ' GLU . 12.6 tm-20 -63.93 -23.18 67.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.67 -37.9 9.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 67.57 73.44 0.32 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.51 149.17 60.9 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.86 157.71 41.84 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.759 2.306 . . . . 0.0 112.069 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.56 15.01 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.818 2.345 . . . . 0.0 112.315 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.0 m -104.87 16.75 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -151.73 18.24 0.7 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 104' ' ' VAL . 10.6 t -57.69 -14.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -51.19 -27.13 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 2.1 m -77.63 -75.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.524 ' C ' ' O ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -36.28 -33.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 106' ' ' CYS . 8.5 mt -68.26 -54.97 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 6.3 mp -59.77 -19.64 51.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.57 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -72.46 -64.88 0.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 114' ' ' ILE . 3.1 tm-20 -64.36 -45.74 86.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -54.64 -35.87 63.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.214 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 109' ' ' LEU . . . -63.22 -57.83 9.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 111' ' ' GLU . 0.4 OUTLIER -50.01 -36.29 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.413 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.401 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.8 tttt -63.24 -37.86 88.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.02 76.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.54 93.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.93 . . . . 0.0 109.501 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.61 -40.86 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.66 88.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.483 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.31 -16.38 60.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.413 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' A' ' 25' ' ' SER . 93.1 t80 -79.39 -31.61 42.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -94.27 -22.63 18.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -76.53 -18.48 58.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 19.03 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.505 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -161.83 40.65 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.483 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -106.54 -102.83 2.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 mp -81.58 -17.01 49.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -1.161 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 54.32 -133.94 1.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.577 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 129' ' ' HIS . 4.3 p80 -127.79 -176.15 3.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.872 . . . . 0.0 109.406 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.99 -27.1 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.308 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -134.91 140.9 46.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 109.285 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.492 ' O ' ' C ' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -167.52 64.77 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.682 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.492 ' C ' ' O ' ' A' ' 132' ' ' HIS . 8.5 p80 -39.25 135.03 1.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 109.3 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.572 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.72 -65.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.404 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.457 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 14.3 p90 -120.25 125.56 48.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.349 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.35 150.87 5.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.524 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -150.63 -60.35 0.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.333 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -67.16 135.11 53.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.411 -0.805 . . . . 0.0 109.429 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.417 HG22 ' N ' ' A' ' 8' ' ' ILE . 7.4 p -71.16 155.07 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 8' ' ' ILE . 3.1 tt -76.54 108.32 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.287 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -112.66 -176.42 2.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 0.0 109.647 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.41 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 1.4 t-80 176.96 70.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.205 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.41 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 11.3 m-85 -150.89 134.84 16.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.971 -1.08 . . . . 0.0 110.067 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.29 153.98 39.4 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.14 152.36 15.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.033 -1.042 . . . . 0.0 109.934 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.54 66.04 5.6 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.866 2.377 . . . . 0.0 112.11 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.01 -42.71 8.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -129.99 109.28 10.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.75 -20.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.89 -105.77 0.27 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -93.33 -154.72 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -1.162 . . . . 0.0 109.515 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.558 ' HB3' HG21 ' A' ' 27' ' ' VAL . 1.7 tp -118.67 152.34 36.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.404 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -46.71 143.82 2.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.435 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -67.53 -5.15 13.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -77.19 29.95 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.93 . . . . 0.0 109.4 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -114.92 151.49 33.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.67 6.14 36.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -120.21 -15.94 8.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.697 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.558 HG21 ' HB3' ' A' ' 20' ' ' LEU . 40.8 t -103.12 128.95 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.353 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -127.05 149.75 17.8 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 120' ' ' ASP . 52.2 m -127.71 149.16 50.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -1.081 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.87 125.37 2.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 ttt -119.74 92.9 3.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -1.205 . . . . 0.0 109.367 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 m -103.56 163.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 109.286 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.27 -176.08 29.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -138.26 96.07 10.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.337 -1.096 . . . . 0.0 109.386 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.501 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.9 Cg_exo -56.66 -26.37 64.76 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.652 2.235 . . . . 0.0 112.28 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.93 -59.99 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.34 -48.31 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.62 52.78 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -116.34 117.22 29.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.151 . . . . 0.0 109.416 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 m -105.92 141.47 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.495 ' SD ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -135.9 128.82 31.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.28 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -112.68 125.0 53.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.616 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tp -124.01 136.4 54.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.411 HE21 ' HB2' ' A' ' 44' ' ' GLN . 2.3 mt-30 -118.85 145.78 45.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 109.654 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.667 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.1 pp -126.31 126.09 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -103.21 109.33 20.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.466 HG23 HD12 ' A' ' 45' ' ' ILE . 24.5 t -94.57 110.83 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 47' ' ' VAL . 1.1 t70 -40.16 -77.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.437 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 7.2 t0 -179.71 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 0.0 108.862 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -84.06 -17.09 41.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.458 -0.776 . . . . 0.0 109.352 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.2 12.01 5.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.4 mm -104.87 134.39 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.413 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.4 88.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.408 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.51 -52.38 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.261 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -143.24 -179.16 6.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 109.141 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.79 144.48 7.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.957 . . . . 0.0 109.743 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -135.32 162.59 32.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.342 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.64 ' CD1' HG21 ' A' ' 74' ' ' THR . 5.9 p90 -145.81 167.92 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.368 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -165.83 114.29 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.495 HG22 ' SD ' ' A' ' 41' ' ' MET . 80.7 p -108.95 141.93 40.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.43 99.65 2.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.9 -54.14 0.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 49.4 t -124.98 173.52 8.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -1.21 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.476 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -121.53 19.06 8.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.7 p -113.83 -8.63 13.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -1.127 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.42 -2.81 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.506 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 68' ' ' ALA . 8.5 mm -61.65 -53.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.402 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -41.4 -53.51 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.457 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 70' ' ' SER . 25.1 p -58.09 -54.26 48.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -43.94 -38.01 3.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.7 m -71.02 -44.96 64.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.24 -55.62 26.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.866 HG23 ' H ' ' A' ' 74' ' ' THR . 2.2 tt -62.33 -61.75 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.866 ' H ' HG23 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -35.31 -32.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.78 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -85.57 -30.87 22.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 0.0 109.825 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.606 ' N ' ' O ' ' A' ' 73' ' ' ILE . 10.7 m0 -82.69 0.82 41.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.719 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 73' ' ' ILE . 6.4 m -123.51 65.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.51 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -148.3 94.35 2.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.31 61.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -72.17 -168.2 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.421 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -115.69 141.1 48.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mt -48.77 -11.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' SER . 35.1 tt0 -71.08 -55.59 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.235 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -66.36 -30.67 71.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.256 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -24.09 52.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 109.22 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.77 50.24 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.78 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -1.123 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.51 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -36.46 -23.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.744 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 87' ' ' ALA . 10.0 mttm 61.32 173.85 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.304 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.484 HD22 HG12 ' A' ' 108' ' ' ILE . 8.0 p-10 -95.73 -42.55 8.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.444 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 88.9 p -52.76 -50.02 64.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' SER . 4.5 tt0 -44.06 -65.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.194 -0.942 . . . . 0.0 109.779 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.5 mt -59.65 -32.01 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.713 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.58 -32.61 69.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.876 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.84 -33.92 24.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.689 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -55.94 -42.84 76.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.3 mt -83.0 -28.39 29.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 65.64 74.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 148.83 59.88 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.158 -0.963 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.61 148.64 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.58 2.187 . . . . 0.0 112.125 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.54 6.09 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.738 2.292 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.68 -35.88 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -135.52 42.43 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.402 ' C ' ' N ' ' A' ' 106' ' ' CYS . 9.8 p -58.4 -18.79 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -45.32 -24.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.338 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -64.87 -47.35 78.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.167 -0.958 . . . . 0.0 109.2 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -50.1 67.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.484 HG12 HD22 ' A' ' 90' ' ' ASN . 4.4 mm -56.0 -33.45 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.883 . . . . 0.0 109.369 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 34' ' ' ALA . 1.4 mp -63.92 -61.65 2.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -40.36 -53.68 2.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -61.15 -58.25 9.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.3 -34.07 2.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -64.92 -69.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.658 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.1 tp -37.78 -35.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -65.53 -68.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -43.33 -46.22 6.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.307 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.667 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -55.43 -40.72 71.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.22 -46.89 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.417 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.49 -58.11 7.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.53 ' CG ' ' O ' ' A' ' 29' ' ' THR . 5.2 m-20 -49.0 -59.6 3.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.715 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -51.08 -21.59 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.685 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -96.93 -8.6 30.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.18 -8.4 17.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -15.77 60.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.42 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -48.5 -75.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.474 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 168.61 43.8 0.03 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.446 ' HA ' HD13 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -113.59 -6.31 13.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.49 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 127' ' ' LEU . 10.5 mm-40 -42.82 -60.56 1.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -76.12 150.05 37.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.644 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -117.76 -161.64 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.384 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -169.56 33.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.628 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 1.1 p80 -114.62 45.89 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.542 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -158.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.348 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.444 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.553 ' O ' ' O ' ' A' ' 2' ' ' ALA . 5.6 ttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.553 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 55.5 118.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.347 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -79.18 -24.27 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.937 . . . . 0.0 109.45 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -60.54 -160.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.457 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.58 ' N ' ' OG ' ' A' ' 4' ' ' SER . 0.5 OUTLIER -117.84 177.93 4.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 109.519 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 5' ' ' GLU . 20.7 mmtt -47.89 -177.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.309 -0.869 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.3 t -91.79 127.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.426 ' N ' HD13 ' A' ' 8' ' ' ILE . 2.7 mm -78.34 -37.07 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.533 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -77.86 54.82 1.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -113.74 -157.87 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 0.0 109.383 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -133.68 103.52 5.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.501 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.528 ' O ' ' C ' ' A' ' 13' ' ' ASN . 1.6 tt0 -168.83 20.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.474 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.683 ' O ' ' N ' ' A' ' 15' ' ' ARG . 18.5 m-80 36.45 83.09 0.21 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -55.87 35.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.774 2.316 . . . . 0.0 112.133 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.683 ' N ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -150.43 177.33 10.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.454 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 15' ' ' ARG . 5.6 t-20 77.42 -59.43 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.438 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -121.04 158.22 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.424 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.52 -26.13 25.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -174.98 -179.32 1.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.153 . . . . 0.0 109.527 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.507 ' CB ' ' O ' ' A' ' 19' ' ' SER . 11.9 tp 77.27 57.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.386 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -162.17 19.8 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.81 . . . . 0.0 109.482 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt 49.67 11.2 0.05 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 21' ' ' ASP . 9.6 mttt -143.7 62.44 1.36 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.271 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -132.2 137.4 47.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.151 -0.968 . . . . 0.0 109.364 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.44 1.68 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -117.04 5.59 12.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.5 98.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.59 124.62 8.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -102.7 131.91 49.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -1.155 . . . . 0.0 109.329 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.93 96.44 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.0 ttt -99.52 133.44 43.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.144 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 41' ' ' MET . 30.4 m -125.23 156.11 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.035 -1.041 . . . . 0.0 109.808 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' A' ' 40' ' ' VAL . . . -138.06 121.61 2.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 39' ' ' ASP . . . -118.13 87.09 28.0 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.263 -1.139 . . . . 0.0 109.428 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.99 36.25 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.893 2.395 . . . . 0.0 112.303 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.67 -39.64 1.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.8 t -177.02 -29.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.394 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.73 71.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 0.8 OUTLIER 62.7 -174.21 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -1.154 . . . . 0.0 109.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.472 HG12 ' HA2' ' A' ' 33' ' ' GLY . 8.5 m -95.46 149.45 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.384 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 32' ' ' VAL . 8.5 ttt -142.34 133.29 25.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.46 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -107.33 127.83 53.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.45 135.56 44.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.557 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.19 137.54 37.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 45' ' ' ILE . 1.5 pp -120.64 143.36 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 109.427 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -102.31 152.14 21.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.96 116.72 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 48' ' ' ASP . 33.5 t0 -57.7 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.56 19.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -148.76 24.84 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.502 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.81 30.28 56.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.5 mm -109.41 134.63 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -1.21 . . . . 0.0 109.414 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.6 mt -80.56 81.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.22 -40.49 74.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -137.64 163.51 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.77 102.59 4.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.53 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -97.81 155.49 17.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.502 ' CD1' HG21 ' A' ' 74' ' ' THR . 27.0 p90 -166.46 171.29 12.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -163.96 126.04 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.81 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.15 121.8 45.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.028 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 101.53 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.6 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 156.74 -57.25 0.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.8 148.6 26.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -1.117 . . . . 0.0 109.598 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.94 16.97 30.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.38 -35.49 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 0.0 109.459 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.11 -3.09 3.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.9 mm -58.95 -35.32 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.339 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.12 -62.54 1.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' LEU . 3.9 m -58.38 -54.59 45.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.467 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.508 ' C ' ' O ' ' A' ' 69' ' ' SER . 50.6 m -36.98 -66.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.62 -30.52 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' SER . 12.2 tp -68.93 -73.89 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.723 HG23 ' H ' ' A' ' 74' ' ' THR . 0.9 OUTLIER -39.7 -59.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.723 ' H ' HG23 ' A' ' 73' ' ' ILE . 42.4 p -44.21 -44.95 8.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.317 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -73.46 -14.98 61.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.307 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.553 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.07 -11.71 35.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 77' ' ' VAL . 33.5 m -123.91 61.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.4 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.09 103.1 7.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.481 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 4.01 89.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -78.55 -161.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -1.155 . . . . 0.0 109.39 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 83' ' ' GLU . 3.7 t -126.69 144.51 50.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -47.78 -15.07 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 0.0 109.24 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -80.71 -23.83 39.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.412 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -95.29 -18.78 20.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.0 -29.95 11.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.96 42.97 2.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -152.14 -37.0 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -1.137 . . . . 0.0 108.602 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -47.22 -175.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -141.38 -177.88 5.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 109.399 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.57 ' CG ' ' N ' ' A' ' 91' ' ' SER . 1.1 p-10 -87.69 -50.93 6.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -54.53 -22.31 12.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.25 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -68.0 -59.18 3.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 109.206 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.69 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 109.272 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.13 -36.49 73.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.245 -0.909 . . . . 0.0 109.196 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.19 -41.97 99.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.271 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.87 -32.9 73.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 0.0 109.047 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.5 mt -93.39 -28.36 16.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.301 -0.875 . . . . 0.0 109.112 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.4 tm-20 51.93 67.09 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.714 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.003 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.4 pt? -117.81 148.46 43.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.272 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.596 ' HB2' HG22 ' A' ' 102' ' ' VAL . 71.4 Cg_exo -40.51 155.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.792 2.328 . . . . 0.0 112.268 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.08 -0.15 8.12 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.834 2.356 . . . . 0.0 112.177 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 100' ' ' PRO . 34.3 m -88.32 -5.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' C ' ' N ' ' A' ' 105' ' ' HIS . 0.6 OUTLIER -125.72 -9.42 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 107' ' ' SER . 8.0 p -45.78 -24.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.489 ' C ' ' O ' ' A' ' 104' ' ' VAL . 15.2 m80 -38.9 -50.0 1.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.63 -36.47 64.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.114 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.628 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.1 p -66.31 -67.23 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.096 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.628 ' N ' ' OG ' ' A' ' 107' ' ' SER . 42.8 mt -45.91 -25.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.088 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 mp -75.98 -44.88 37.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.428 -0.795 . . . . 0.0 109.385 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.36 83.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.723 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.485 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 5.1 tp10 -65.93 -68.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -22.95 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.93 . . . . 0.0 109.641 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.19 -52.87 9.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -55.95 -40.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.59 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.495 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 5.7 tptt -66.14 -51.52 57.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.74 -41.99 64.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.415 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.34 -45.16 95.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 121' ' ' TYR . 61.7 mt -64.49 -61.12 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -40.69 -37.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.185 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -37.71 80.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.052 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 118' ' ' ILE . 7.5 t80 -72.35 -16.99 61.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -88.49 -44.94 10.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.209 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.1 95.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.317 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -72.49 -0.77 13.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -62.26 -20.78 64.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.635 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -142.46 20.47 2.41 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 126' ' ' GLY . 2.0 mp 35.81 48.07 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.235 -1.156 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -108.36 149.69 28.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.545 ' O ' ' CG ' ' A' ' 129' ' ' HIS . 20.7 p-80 -55.36 97.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 109.536 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.478 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -110.87 151.75 27.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 109.421 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER 40.03 83.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 171.94 9.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.922 . . . . 0.0 109.424 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -75.37 -86.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.4 p80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.43 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 3' ' ' TYR . . . -62.5 -79.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.421 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.8 m-85 -137.93 146.72 43.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 t -74.91 115.64 14.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.252 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.42 -72.9 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.694 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HG3' ' H ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.69 -52.86 2.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.809 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.416 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 10.7 p -146.21 155.92 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.827 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 pt -90.3 92.15 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.322 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.17 57.41 1.01 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -97.62 -126.93 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.113 -0.992 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -151.81 -172.02 4.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.536 ' H ' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tt0 -154.14 -73.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.644 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.8 t30 -79.71 -43.86 1.56 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 15.7 Cg_exo -65.02 98.52 0.31 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.913 2.408 . . . . 0.0 112.014 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -122.7 -67.75 0.93 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.628 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -112.45 118.6 35.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.21 -3.39 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.306 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.37 57.22 0.47 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -171.3 167.35 6.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -1.14 . . . . 0.0 109.274 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.438 ' CB ' ' O ' ' A' ' 19' ' ' SER . 0.3 OUTLIER 70.14 -17.9 0.25 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.201 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 19' ' ' SER . 46.6 m-20 -68.89 147.34 51.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.39 -0.818 . . . . 0.0 109.471 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 10.0 tttt -73.58 16.68 0.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -133.23 27.04 4.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.786 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.5 156.01 20.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.349 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.2 m -85.71 -4.3 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -0.87 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.88 129.69 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.8 147.48 18.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.1 m -130.28 130.32 44.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -1.093 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.45 137.8 10.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.03 120.46 17.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -1.112 . . . . 0.0 109.351 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.75 146.6 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.89 -166.35 10.66 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -122.12 80.92 43.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.262 -1.14 . . . . 0.0 109.512 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.88 2.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.707 2.271 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.6 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -91.53 -3.73 56.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.41 -58.48 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.38 46.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.01 126.77 54.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 109.507 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 40' ' ' VAL . 3.1 p -107.86 113.45 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -119.47 119.08 32.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 43' ' ' LEU . 7.9 tt0 -103.23 154.93 18.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.198 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.46 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -155.87 119.47 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.487 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -122.23 151.24 41.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.296 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.79 138.01 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 109.565 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -107.57 127.95 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.04 150.66 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.7 t0 -94.21 -103.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -139.45 4.25 2.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.43 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -128.97 17.28 6.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.21 10.2 85.73 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 mm -93.08 132.71 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -1.105 . . . . 0.0 109.529 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 53' ' ' ILE . 17.6 mt -81.54 93.38 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.413 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -53.54 56.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.446 ' HA ' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -132.04 139.35 48.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.72 133.31 55.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.67 161.38 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.526 ' CD1' HG21 ' A' ' 74' ' ' THR . 10.7 p90 -169.05 174.32 6.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 109.821 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -165.07 121.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.476 -0.765 . . . . 0.0 109.105 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.3 142.57 51.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -158.55 -177.55 6.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.47 -56.82 2.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 66.4 m -120.94 158.64 27.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -1.141 . . . . 0.0 109.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.27 11.49 58.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.98 -39.84 4.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.14 -22.13 66.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.73 -44.96 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -46.73 -62.56 1.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -43.22 -48.05 6.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 109.717 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.519 ' O ' ' C ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -49.55 -68.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 109.397 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -37.27 -39.22 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.617 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 73' ' ' ILE . 11.3 tp -66.89 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.615 ' O ' HG22 ' A' ' 77' ' ' VAL . 4.4 tt -33.74 -48.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 110.054 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.526 HG21 ' CD1' ' A' ' 58' ' ' PHE . 3.2 p -49.8 -46.81 51.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.3 tp10 -86.15 -11.96 51.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.902 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -2.57 57.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.368 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 73' ' ' ILE . 28.8 m -123.48 -27.11 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 0.0 109.61 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' NZ ' ' HA ' ' A' ' 55' ' ' ASP . 9.8 ttmm -62.1 113.14 2.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.05 58.18 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.44 -164.88 1.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 m -121.02 175.0 6.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.861 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.55 -17.98 64.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.778 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -77.46 -40.6 42.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.73 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -69.16 -44.65 71.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 109.839 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.77 -33.84 52.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.54 52.27 4.68 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -171.9 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.4 pt -36.47 132.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' SER . 50.2 mttt -117.97 142.78 46.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -41.35 -25.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -66.44 -39.41 88.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.568 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -67.73 -55.88 11.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.466 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 93' ' ' ILE . 1.6 mp -58.74 -30.08 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.592 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.09 -60.29 2.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.742 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -55.27 -20.52 11.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -64.53 1.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.5 OUTLIER -69.12 -14.46 63.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.651 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 52.81 43.62 31.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.894 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.698 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.5 pt? -85.8 151.21 54.84 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -41.52 105.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.559 2.173 . . . . 0.0 111.913 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.87 20.36 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.343 2.028 . . . . 0.0 112.338 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.435 HG23 ' N ' ' A' ' 103' ' ' LYS . 17.6 m -70.47 -40.63 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 104' ' ' VAL . 21.2 mttt -109.94 -23.44 11.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 103' ' ' LYS . 2.5 t 41.43 30.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.5 ' NE2' ' HB1' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -81.16 -35.64 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 60.7 m -59.73 -64.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.563 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 108' ' ' ILE . 2.6 m -51.45 -58.27 6.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.0 mt -42.12 -41.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -63.8 -46.42 85.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -54.63 -66.7 0.36 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.78 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.2 tm-20 -46.06 -69.64 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.536 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -38.75 -26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -73.87 -63.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.69 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 2.3 tp -46.13 -37.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.579 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 58.6 tttt -66.53 -43.49 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.59 77.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.493 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.25 -54.67 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mt -49.95 -34.85 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 109.256 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -56.86 10.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -11.52 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.415 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -85.0 -43.7 13.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -94.73 3.71 54.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.8 -33.06 10.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.329 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 126' ' ' GLY . 7.4 tttt -75.33 -10.53 59.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 124' ' ' LYS . 8.2 tt0 -45.11 -17.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . 145.81 -39.37 1.15 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 129' ' ' HIS . 5.9 mt -61.71 -37.37 83.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -1.131 . . . . 0.0 109.597 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.26 4.52 0.47 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.89 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.445 ' H ' ' C ' ' A' ' 127' ' ' LEU . 4.1 m80 -131.15 176.45 8.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.459 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.456 ' ND1' ' N ' ' A' ' 131' ' ' HIS . 20.6 p80 -112.27 -158.45 0.65 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.456 ' N ' ' ND1' ' A' ' 130' ' ' HIS . 11.1 p-80 -163.57 -154.04 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -144.16 54.29 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.479 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 48.1 m170 46.51 -133.48 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.586 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.535 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -49.53 -55.73 12.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -94.29 42.87 1.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.49 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -19.73 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' LYS . 3.6 pm0 -78.64 -177.29 5.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.663 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 62.6 mttt 54.16 106.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 8' ' ' ILE . 2.3 p -109.35 150.62 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.599 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -91.52 -155.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.273 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.81 -162.43 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 109.296 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.76 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -124.47 126.45 45.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.257 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.51 ' C ' ' O ' ' A' ' 10' ' ' HIS . 95.9 m-85 38.53 75.37 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 108.945 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.35 96.87 3.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -0.838 . . . . 0.0 109.84 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.737 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -86.33 -37.02 0.53 Allowed Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.275 -0.891 . . . . 0.0 109.283 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 27.3 Cg_exo -59.77 -21.58 64.12 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.795 2.33 . . . . 0.0 111.917 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 68.16 135.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -0.858 . . . . 0.0 109.426 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -57.75 117.47 4.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.515 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.45 22.53 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.385 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 64.79 -154.0 49.46 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 18' ' ' GLY . 2.8 p -54.01 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -1.169 . . . . 0.0 109.55 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 20' ' ' LEU . 11.1 tp -112.89 -135.32 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 109.538 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.1 p30 -93.64 10.13 34.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.881 . . . . 0.0 109.56 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.543 ' C ' ' H ' ' A' ' 24' ' ' ASP . 26.3 tttt 64.94 -39.98 0.27 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 21' ' ' ASP . 11.3 mptt -70.64 21.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.977 . . . . 0.0 109.372 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 22' ' ' LYS . 6.8 t0 -98.65 166.24 11.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 14.5 m -101.55 5.36 41.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -117.59 37.39 3.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.625 ' O ' HG12 ' A' ' 27' ' ' VAL . 2.7 t -143.41 98.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.359 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.08 132.55 11.29 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 m -108.85 134.11 51.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -1.111 . . . . 0.0 109.362 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.3 90.77 0.23 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ttm -108.94 128.8 55.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -1.164 . . . . 0.0 109.686 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.533 HG21 ' HG ' ' A' ' 109' ' ' LEU . 2.0 m -130.51 165.1 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.392 -0.818 . . . . 0.0 109.173 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.86 121.81 2.1 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HB3' ' N ' ' A' ' 39' ' ' ASP . . . -112.45 93.33 22.48 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.339 -1.095 . . . . 0.0 109.364 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.39 40.7 0.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.665 2.243 . . . . 0.0 112.271 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -144.55 -40.1 0.27 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.7 m -168.11 -32.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' C ' ' HB3' ' A' ' 34' ' ' ALA . . . -66.29 -19.01 68.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.513 ' N ' ' HB3' ' A' ' 34' ' ' ALA . 1.6 m-20 61.06 -168.93 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 109.456 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -86.84 140.77 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -142.5 125.77 16.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.318 -0.864 . . . . 0.0 109.599 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.94 113.5 20.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.04 107.17 11.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 109.894 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.474 ' NE2' ' HB3' ' A' ' 19' ' ' SER . 8.4 tt0 -109.67 129.18 55.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.07 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.56 144.81 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 109.699 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -108.96 138.94 44.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.99 151.5 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 23.5 t0 -81.93 -48.84 11.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.634 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 162.15 -22.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 9.5 p-10 -102.47 25.52 8.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.466 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.37 -4.7 58.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.16 146.46 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.348 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.24 108.61 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -44.03 32.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.78 164.41 28.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.273 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.09 118.83 16.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -96.05 133.83 39.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.476 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 10.3 p90 -136.08 168.88 18.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -171.89 104.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.803 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 p -96.42 147.95 23.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.085 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -162.0 111.58 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.701 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.44 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 130.58 -41.11 1.57 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.9 t -103.7 121.26 42.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.636 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 46.72 1.98 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -158.32 -12.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.157 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.88 37.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.29 -33.1 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.88 -41.73 74.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 71' ' ' SER . 17.9 p -67.11 -64.15 0.91 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.511 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.8 OUTLIER -38.76 -26.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.33 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 69' ' ' SER . 7.5 t -78.4 -44.7 24.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 69' ' ' SER . 21.4 tp -60.97 -52.14 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.948 . . . . 0.0 109.471 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.894 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.3 tt -58.9 -41.46 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -66.79 -19.35 65.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.663 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 31.4 mm-40 -92.02 -16.35 26.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.49 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.04 -17.0 18.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 73' ' ' ILE . 27.8 m -109.07 40.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.661 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -118.8 96.44 5.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.97 -27.05 17.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -59.69 -160.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -1.124 . . . . 0.0 109.498 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.09 165.85 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.89 -41.27 82.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -24.72 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.593 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -90.7 -48.48 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.536 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.556 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -61.88 -17.36 56.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.84 11.65 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -148.47 -35.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -41.74 172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.538 -0.726 . . . . 0.0 109.654 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.33 168.44 19.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.55 -32.81 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.749 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.543 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -50.89 -33.22 23.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -73.83 -59.97 2.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.557 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.6 mt -46.02 -42.46 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 -46.71 74.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.355 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.4 -37.92 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -67.58 -45.01 76.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.5 -15.08 61.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.152 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.94 33.87 7.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.9 pp -75.16 135.94 72.95 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.532 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.659 ' O ' HD12 ' A' ' 99' ' ' LEU . 75.4 Cg_exo -42.22 155.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.512 2.141 . . . . 0.0 112.245 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.24 -11.16 28.41 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.729 2.286 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.8 39.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HG2' ' SG ' ' A' ' 106' ' ' CYS . 2.5 ttmt -176.83 32.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.87 . . . . 0.0 109.189 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 t -74.68 -9.21 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.671 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.33 67.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.42 ' SG ' ' HG2' ' A' ' 103' ' ' LYS . 18.6 m -73.4 -59.26 2.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.651 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.1 p -48.57 -56.17 9.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 108.974 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.46 ' N ' ' OG ' ' A' ' 107' ' ' SER . 82.3 mt -52.32 -35.58 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.533 ' HG ' HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -66.17 -29.3 69.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -51.36 60.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.201 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.402 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 9.6 tp10 -71.73 -32.55 67.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.18 -33.98 75.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.223 -0.923 . . . . 0.0 109.314 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -72.09 -61.55 1.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.556 HG12 ' HB1' ' A' ' 85' ' ' ALA . 0.7 OUTLIER -46.29 -35.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.129 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 11.4 tttt -74.86 -31.38 61.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.853 . . . . 0.0 109.141 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.93 -43.43 83.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.188 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.31 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.2 mt -45.53 -50.76 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.69 -51.68 66.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.88 -21.54 64.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -71.69 -54.88 8.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.364 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -65.55 -34.67 78.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.91 55.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -90.44 46.74 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -121.15 -35.9 3.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.482 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -141.86 6.99 2.4 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tp 38.51 57.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.12 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.07 168.54 10.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.923 . . . . 0.0 109.437 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -45.39 149.94 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 109.524 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.513 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -133.79 125.04 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.256 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.513 ' C ' ' O ' ' A' ' 130' ' ' HIS . 57.6 m170 38.68 -119.1 0.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.293 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.433 ' C ' ' CG ' ' A' ' 133' ' ' HIS . 0.7 OUTLIER -125.79 27.59 6.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 109.242 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.596 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -148.34 -151.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.855 . . . . 0.0 109.392 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.601 ' O ' ' ND1' ' A' ' 134' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.488 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mtt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.89 -121.25 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.06 82.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.452 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.39 88.08 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -138.73 174.48 10.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.553 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.19 67.1 0.87 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.262 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 7' ' ' VAL . 1.6 m -87.45 0.21 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.107 -0.996 . . . . 0.0 109.644 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.0 pt -75.91 9.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.522 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -113.62 -71.56 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.411 ' HB3' ' H ' ' A' ' 11' ' ' TYR . 23.2 m-70 47.03 -155.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 109.475 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.411 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 1.9 m-85 -98.25 9.36 43.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.749 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -128.27 128.36 44.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -0.947 . . . . 0.0 109.659 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 12' ' ' GLU . 3.1 m-20 -163.81 89.01 1.16 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.848 . . . . 0.0 109.427 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -51.04 -41.9 54.97 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.909 2.406 . . . . 0.0 112.46 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.73 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -46.58 117.85 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.485 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -80.36 90.86 5.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.45 ' H ' HG22 ' A' ' 17' ' ' VAL . 3.2 m -57.21 127.94 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.614 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.99 164.09 12.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.5 p -69.82 146.73 51.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -1.13 . . . . 0.0 109.435 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -162.6 -15.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.494 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.642 ' OD1' ' N ' ' A' ' 22' ' ' LYS . 38.3 t0 -110.16 175.32 5.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.642 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 18.4 ttpp -57.33 0.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.423 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -71.98 10.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -137.13 133.71 35.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.29 8.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.398 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.657 ' ND2' ' O ' ' A' ' 47' ' ' VAL . 1.2 m120 -115.17 3.26 14.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.9 t -122.1 92.45 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.84 155.0 47.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.4 m -131.41 118.56 20.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -1.224 . . . . 0.0 109.817 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.61 93.3 0.56 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -92.5 131.85 37.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.973 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.574 ' O ' ' O ' ' A' ' 41' ' ' MET . 18.5 m -144.53 177.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 108.997 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.62 178.97 41.12 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -118.69 82.31 19.98 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.336 -1.096 . . . . 0.0 109.352 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 37' ' ' CYS . 72.8 Cg_exo -43.97 -10.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.593 2.195 . . . . 0.0 111.99 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.623 ' O ' ' CB ' ' A' ' 37' ' ' CYS . . . -76.07 20.34 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 1.6 t 85.64 -18.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -43.3 -50.3 6.58 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.643 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 153.89 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -1.074 . . . . 0.0 109.424 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 46.9 t -113.56 150.56 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.574 ' O ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -145.73 140.88 27.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.106 -0.996 . . . . 0.0 109.78 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' A' ' 41' ' ' MET . 39.2 tt0 -129.49 145.14 51.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.85 138.74 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.591 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -130.84 136.28 48.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.526 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -119.7 132.34 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -115.72 120.01 37.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.276 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.657 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 54.3 t -97.72 126.88 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -56.67 -60.02 4.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.3 OUTLIER 163.85 -22.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 0.0 109.197 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.45 -7.52 47.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.451 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.14 17.59 7.18 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -113.36 150.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -1.144 . . . . 0.0 109.504 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.532 ' O ' ' C ' ' A' ' 54' ' ' GLU . 36.1 mt -85.67 77.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 53' ' ' ILE . 2.5 tt0 -34.63 -48.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -153.04 167.68 28.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.94 122.97 13.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -103.99 142.08 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.328 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.587 ' CD1' HG21 ' A' ' 74' ' ' THR . 21.8 p90 -137.3 176.06 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.59 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -165.58 132.94 2.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.1 143.66 33.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -159.99 121.16 3.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.77 -61.02 0.29 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.5 t -121.39 140.74 51.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.124 . . . . 0.0 109.677 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.65 -6.98 87.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.6 p -95.13 0.43 54.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -1.15 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.46 2.76 45.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -83.16 -13.86 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.32 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.31 -64.41 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.435 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.814 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -62.97 -30.21 71.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.93 . . . . 0.0 109.453 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 74' ' ' THR . 2.3 t -61.74 -46.14 90.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -64.68 -36.36 84.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.512 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -71.96 -74.54 0.16 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.824 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.7 tt -34.36 -46.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.873 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.587 HG21 ' CD1' ' A' ' 58' ' ' PHE . 34.0 p -60.16 -47.24 86.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.0 mt-10 -72.64 -5.92 40.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 109.652 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 73' ' ' ILE . 16.3 m -112.63 58.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -138.1 105.22 5.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.431 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.4 87.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -83.77 -168.5 2.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -1.124 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 t -107.12 146.21 31.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.26 -27.68 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.319 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -61.03 -38.18 85.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.364 -0.835 . . . . 0.0 109.587 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 88' ' ' ILE . 16.4 mt-10 -79.77 -28.91 40.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.648 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.31 -32.7 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.972 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.53 30.2 5.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.89 19.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.351 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.2 pt -91.7 -24.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 88' ' ' ILE . 11.3 mttp 56.72 152.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.581 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -79.55 -22.15 44.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.4 m -60.56 -39.99 89.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.52 -47.65 83.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.08 -36.42 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.19 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.25 -44.15 80.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.266 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.41 -31.83 72.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.79 -41.52 83.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -96.79 -35.36 10.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.646 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 94' ' ' ALA . 9.1 tt0 78.1 32.69 0.36 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.464 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 pp -48.1 147.13 3.84 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -67.56 147.17 76.09 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.61 2.207 . . . . 0.0 112.066 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.9 15.6 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.679 2.252 . . . . 0.0 112.323 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 m -98.43 6.71 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.295 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -160.03 24.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.346 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' LYS . 26.9 t -38.4 -26.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.854 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.669 ' O ' HD13 ' A' ' 109' ' ' LEU . 1.8 m-70 -42.95 -28.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 1.9 m -66.36 -37.17 84.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.779 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -68.26 -61.48 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.3 mt -52.29 -33.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.539 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.669 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.1 mp -64.7 -42.99 94.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.63 -55.31 36.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.499 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -61.52 -56.58 18.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -48.87 -31.13 6.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.26 -65.03 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.86 -30.26 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.309 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.54 -43.3 63.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.439 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.25 69.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.426 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.526 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -71.0 -58.62 3.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.94 . . . . 0.0 109.302 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.2 mt -48.8 -43.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.1 4.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.89 -35.54 15.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.69 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -69.63 -65.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.652 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -24.71 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.652 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.22 -4.74 3.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -110.97 -29.19 8.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.636 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -78.52 -11.75 59.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.34 -16.69 49.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.6 tp -80.97 -18.55 46.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -1.144 . . . . 0.0 109.499 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.77 -57.16 2.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -90.04 -161.71 0.82 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -150.82 14.77 0.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.286 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.8 m80 64.39 -132.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.813 . . . . 0.0 109.642 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 56.63 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 109.1 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -130.06 -32.25 1.84 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.672 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.647 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 23.8 p-80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 mtp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 3' ' ' TYR . . . -61.87 108.07 0.96 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.47 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 2' ' ' ALA . 39.7 m-85 40.68 57.02 2.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.54 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.5 m -158.92 110.87 2.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 109.73 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -111.13 82.3 1.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 109.268 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -73.78 -117.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.708 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.85 -161.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.693 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.8 mt -140.27 -86.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.3 160.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.672 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.502 ' C ' ' H ' ' A' ' 12' ' ' GLU . 40.1 m80 -137.23 -32.09 0.79 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 109.231 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -74.21 26.28 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.314 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.524 ' O ' ' O ' ' A' ' 13' ' ' ASN . 3.4 mp0 -47.65 133.15 13.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 109.697 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.524 ' O ' ' O ' ' A' ' 12' ' ' GLU . 2.7 m120 -35.58 156.17 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 0.0 109.545 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 15' ' ' ARG . 17.8 Cg_endo -63.12 49.6 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.899 2.399 . . . . 0.0 112.264 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 13' ' ' ASN . 2.9 ttp180 60.3 149.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.663 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 18' ' ' GLY . 10.3 t-20 -162.6 -137.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.514 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 17' ' ' VAL . 3.0 p -42.18 95.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.616 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -139.53 80.42 0.27 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -61.09 179.5 0.19 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -1.185 . . . . 0.0 109.454 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 22' ' ' LYS . 3.6 tp 75.67 14.9 2.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 109.543 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -60.11 5.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.354 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.586 ' H ' ' C ' ' A' ' 20' ' ' LEU . 14.7 mttt 57.12 6.84 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 21' ' ' ASP . 15.9 mttp -135.58 32.31 3.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.326 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -108.2 169.37 8.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.437 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 9.4 t -94.8 -0.62 54.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.55 12.04 22.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.01 107.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.24 150.29 18.64 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -135.75 148.88 48.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.23 103.22 0.29 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 ttp -92.93 129.27 38.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 0.0 109.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' MET . 2.9 m -150.63 -171.75 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.63 -174.52 32.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.94 93.74 26.21 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -1.136 . . . . 0.0 109.485 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.525 ' O ' ' C ' ' A' ' 36' ' ' ALA . 50.6 Cg_exo -50.43 -46.07 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.684 2.256 . . . . 0.0 112.254 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.65 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -37.36 -42.86 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.2 m 159.25 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -35.11 -57.3 0.84 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 153.09 169.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.393 -1.063 . . . . 0.0 109.523 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.563 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 7.6 p -96.12 146.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 108.909 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' VAL . 9.8 ttt -142.3 126.34 17.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 110.002 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -115.6 140.69 48.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.835 . . . . 0.0 108.922 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.24 121.33 13.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.805 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HG2' ' N ' ' A' ' 45' ' ' ILE . 47.4 tt0 -122.57 152.88 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.21 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.662 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -123.17 152.9 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.524 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HB3' ' H ' ' A' ' 55' ' ' ASP . 15.4 tttp -124.84 131.03 53.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.7 137.53 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.682 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -175.31 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.8 m-20 -63.2 51.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 0.0 109.108 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.682 ' N ' ' O ' ' A' ' 48' ' ' ASP . 6.1 m120 72.17 55.15 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.634 -0.666 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.53 77.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 53' ' ' ILE . 4.1 mm -97.61 157.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 109.524 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.459 ' N ' HG22 ' A' ' 52' ' ' ILE . 54.0 mt -74.97 99.26 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -59.81 -51.51 69.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 46' ' ' LYS . 1.6 t70 -148.98 -174.75 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.797 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.72 122.74 4.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.127 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -95.25 146.92 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 109.9 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.663 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -134.61 165.28 25.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.064 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -162.9 114.18 1.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.049 -1.032 . . . . 0.0 109.999 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 129.0 27.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.197 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.583 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -151.51 118.58 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -0.971 . . . . 0.0 109.759 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.89 -53.37 0.46 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.624 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -107.39 137.23 45.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -1.151 . . . . 0.0 109.392 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.53 26.26 4.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -121.73 -42.42 2.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -1.186 . . . . 0.0 109.493 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.585 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -65.29 -29.01 69.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 67' ' ' ILE . 5.1 mm -50.87 -4.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.441 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.585 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -97.67 -56.26 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.547 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.826 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -50.0 -20.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 71' ' ' SER . 8.7 p -70.6 -63.09 1.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.546 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -51.33 -35.23 37.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.802 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 73' ' ' ILE . 6.7 tp -68.74 -79.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.949 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 69' ' ' SER . 3.3 tt -42.33 -48.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 109.915 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.61 ' N ' HG23 ' A' ' 73' ' ' ILE . 56.7 p -54.06 -36.81 63.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.685 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 72' ' ' LEU . 9.1 tt0 -79.38 -12.91 59.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.624 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -100.41 -4.22 29.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.7 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 73' ' ' ILE . 28.0 m -126.27 32.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 105.94 14.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.043 -1.035 . . . . 0.0 109.105 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.59 10.62 61.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -90.63 -170.81 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -1.14 . . . . 0.0 109.451 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.37 148.46 35.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.1 -21.97 2.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -83.79 -15.35 48.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.907 . . . . 0.0 109.284 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.46 -28.13 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 0.0 109.253 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.58 -22.38 16.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.63 53.73 4.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.95 -34.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -1.131 . . . . 0.0 109.001 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 2.8 pt -45.45 162.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.42 -0.8 . . . . 0.0 109.364 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.37 -167.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.422 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -103.84 -24.39 13.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.345 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.8 t -68.98 -36.2 77.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' GLU . 9.1 mt-30 -62.02 -73.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLN . 2.2 mt -43.86 -41.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.68 -37.17 62.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.429 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' GLN . 31.9 tt0 -76.35 -38.34 56.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.401 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -39.42 76.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.81 -22.59 24.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 50.0 70.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.479 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.059 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.3 pt? -117.85 147.67 41.66 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.43 103.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.006 2.47 . . . . 0.0 112.354 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.0 Cg_exo -49.62 -14.86 0.78 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.818 2.345 . . . . 0.0 112.387 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 102' ' ' VAL . 6.9 m -62.73 11.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 109.312 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 101' ' ' PRO . 14.7 ttpp -165.89 64.05 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.055 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.728 ' O ' HG12 ' A' ' 104' ' ' VAL . 57.6 t -86.54 39.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.808 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.819 ' O ' HD13 ' A' ' 109' ' ' LEU . 4.2 m-70 -84.68 -24.32 29.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.164 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 m -71.85 -52.83 15.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.96 -52.24 66.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.37 -36.68 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.2 mp -65.03 -39.49 93.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.913 . . . . 0.0 109.393 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.02 -43.88 94.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 88' ' ' ILE . 15.7 tp10 -66.98 -61.41 1.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -49.27 -22.3 1.03 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.11 -50.66 18.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.75 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.9 tp -56.54 -41.82 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 109.57 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.1 mtpp -62.81 -50.35 71.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 0.0 109.361 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -35.92 32.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -62.39 -62.06 2.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.379 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.0 mt -52.36 -38.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.404 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.78 -67.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.64 -48.4 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.281 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.563 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 2.9 t80 -49.54 -45.19 47.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.483 ' HG2' HD22 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -65.92 -54.97 19.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.596 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.05 -46.41 22.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.693 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -78.1 43.82 0.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 109.737 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -130.07 -21.03 3.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 109.593 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 124.64 18.83 2.63 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.483 HD22 ' HG2' ' A' ' 122' ' ' LYS . 2.7 tp -58.36 -24.94 61.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -1.061 . . . . 0.0 109.493 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -123.01 -164.28 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.579 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 0.5 OUTLIER -148.57 160.14 43.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 109.503 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -121.24 -131.85 0.29 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.256 -0.902 . . . . 0.0 109.373 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -159.24 99.02 1.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.426 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -124.62 141.27 52.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.485 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 132' ' ' HIS . 43.8 p-80 -52.17 -175.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.438 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.597 ' C ' ' H ' ' A' ' 3' ' ' TYR . 12.8 mmt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 3' ' ' TYR . . . 51.64 2.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.56 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.597 ' H ' ' C ' ' A' ' 1' ' ' MET . 25.7 m-85 52.17 178.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.485 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.5 m 54.35 68.93 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.492 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -135.27 137.93 43.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.975 . . . . 0.0 109.406 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -75.19 167.95 20.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.552 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 t -119.53 66.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.297 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.66 ' O ' ' N ' ' A' ' 10' ' ' HIS . 33.9 mt -105.46 -79.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.581 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.527 ' C ' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -34.77 -27.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 109.901 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.66 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -87.51 125.0 34.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 109.669 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' HIS . 1.2 m-85 -44.17 158.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.481 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -125.17 28.39 6.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.51 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.66 151.85 40.34 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.317 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.2 -75.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.75 2.3 . . . . 0.0 112.004 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.747 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -73.69 -152.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.222 -0.924 . . . . 0.0 109.448 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -169.07 -43.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.384 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -89.66 160.03 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 0.0 109.336 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.42 37.82 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.28 97.28 3.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -1.15 . . . . 0.0 109.517 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tp -178.02 -18.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.328 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.607 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -94.99 140.84 29.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -65.77 18.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 109.61 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.607 ' H ' ' C ' ' A' ' 21' ' ' ASP . 5.4 mttp -117.9 -13.39 10.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.314 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -65.78 165.91 11.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 0.0 109.477 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 124' ' ' LYS . 3.0 t -101.75 5.57 41.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.369 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.26 -4.18 15.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.5 t -116.41 117.58 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.21 136.72 13.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -115.72 111.88 21.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -1.161 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.86 91.21 0.73 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.37 119.41 27.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.65 171.23 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.43 162.73 36.36 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -123.93 75.99 57.83 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.32 -8.54 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.69 2.26 . . . . 0.0 112.019 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -83.99 -30.22 26.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.88 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 9.9 p -112.66 -17.7 12.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.16 -0.963 . . . . 0.0 109.678 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.53 42.14 6.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.46 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 7.0 t70 -122.38 125.12 45.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.33 146.8 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -148.07 141.99 25.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.687 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -132.87 111.32 10.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.07 145.91 26.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -142.4 114.53 8.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.7 134.83 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -108.16 146.74 32.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.732 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.68 146.32 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.281 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -179.41 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.893 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.2 m-20 -62.77 44.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.321 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.685 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.2 m120 76.98 51.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.13 -0.88 86.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 80' ' ' LYS . 34.3 mm -95.12 146.83 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -1.174 . . . . 0.0 109.368 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.641 ' O ' HG22 ' A' ' 53' ' ' ILE . 34.4 mt -75.06 84.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.867 . . . . 0.0 109.259 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -46.85 66.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -142.75 177.59 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.07 123.54 4.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -103.47 154.16 19.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' HG21 ' A' ' 74' ' ' THR . 32.1 p90 -142.12 175.81 9.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.505 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.37 99.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.253 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.96 130.34 55.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.408 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -144.45 129.33 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 109.581 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.24 -57.65 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.73 150.85 40.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.231 . . . . 0.0 109.543 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.88 56.57 0.51 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -144.06 -11.81 0.65 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.493 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.42 -12.02 17.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.557 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 67' ' ' ILE . 1.6 mp -40.87 -54.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.404 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -49.9 -65.95 0.48 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 68' ' ' ALA . 10.9 m -38.94 -54.94 1.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.927 . . . . 0.0 109.533 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' OG1' ' A' ' 74' ' ' THR . 19.4 p -50.57 -46.23 57.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.01 71.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' GLU . 58.8 tp -68.29 -76.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 77' ' ' VAL . 1.4 tt -40.63 -45.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 ' CD1' ' A' ' 58' ' ' PHE . 6.8 p -55.81 -35.25 66.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.288 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 72' ' ' LEU . 7.4 mt-10 -93.78 4.16 54.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -106.27 -34.59 7.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.0 109.619 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 73' ' ' ILE . 35.2 m -103.88 35.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -111.62 119.28 38.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.382 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.94 -2.92 85.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 52' ' ' ILE . 52.7 mmtt -85.53 -167.9 2.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.38 149.61 37.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.417 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.32 -20.79 46.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.98 -26.97 67.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -91.78 -38.06 12.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -68.79 -26.26 65.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.535 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.44 38.73 3.18 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -153.86 -34.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -1.104 . . . . 0.0 109.398 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.579 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.6 pt -40.52 169.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -140.92 161.6 37.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.369 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.617 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 14.7 p-10 -80.97 -28.79 35.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.59 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -57.5 7.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -55.65 -54.92 38.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.0 mt -55.64 -32.57 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.622 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.94 88.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 109.713 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -69.87 -22.69 63.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -74.7 -38.04 62.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -98.27 -15.31 19.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 109.599 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 47.76 68.81 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.334 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -97.28 149.35 35.62 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.703 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 102' ' ' VAL . 71.6 Cg_exo -41.32 101.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.989 2.459 . . . . 0.0 112.352 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.23 -8.63 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.618 2.212 . . . . 0.0 111.937 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 100' ' ' PRO . 18.3 m -77.59 -7.17 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HE3' ' SG ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -147.6 48.27 1.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.313 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.16 -1.97 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.595 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -13.74 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.958 . . . . 0.0 109.232 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.442 ' SG ' ' HE3' ' A' ' 103' ' ' LYS . 24.0 m -80.01 -55.18 5.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.9 t -50.37 -47.05 56.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.137 -0.977 . . . . 0.0 108.995 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.29 -46.94 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 mp -53.86 -30.87 47.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.144 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.71 -61.49 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -0.824 . . . . 0.0 109.273 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.617 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 58.5 tt0 -51.02 -54.06 27.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.249 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.79 -41.82 71.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.417 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -49.05 -50.12 38.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.449 HG12 ' HB1' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -59.68 -39.77 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 5.8 tttt -64.46 -46.29 83.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.73 -61.87 2.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.659 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -47.63 -35.64 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.84 -38.53 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 109.553 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.63 -42.32 67.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 109.962 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.33 -39.87 92.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.992 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -68.67 -38.07 80.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.868 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -77.96 -27.45 49.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -66.01 -44.19 85.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.559 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.6 OUTLIER -77.64 25.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.547 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 123' ' ' ALA . 15.1 tt0 -170.35 54.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.996 . . . . 0.0 109.71 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -143.35 6.02 1.92 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mt -107.39 11.25 29.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -1.204 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.62 -157.44 0.25 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.314 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.33 56.25 1.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.581 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -91.87 30.87 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.47 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.436 ' C ' ' CG ' ' A' ' 132' ' ' HIS . 17.0 m-70 -69.39 -140.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.448 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.436 ' CG ' ' C ' ' A' ' 131' ' ' HIS . 30.2 m-70 -151.1 -148.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.467 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 1.6 t-160 -163.05 -55.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.558 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.467 ' CE1' ' HB3' ' A' ' 133' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.476 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.302 0.572 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -51.03 120.62 5.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.54 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.45 ' CD2' ' N ' ' A' ' 4' ' ' SER . 32.5 p90 -100.38 -173.71 2.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.45 ' N ' ' CD2' ' A' ' 3' ' ' TYR . 0.8 OUTLIER -157.53 70.32 0.59 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 109.52 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' O ' ' A' ' 6' ' ' LYS . 35.7 mm-40 -111.66 -4.37 14.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.391 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' O ' ' O ' ' A' ' 5' ' ' GLU . 1.0 OUTLIER 58.01 144.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.554 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.9 134.44 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.81 135.25 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.344 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -96.51 -148.4 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.533 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.65 -67.16 0.87 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.337 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -45.87 105.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.415 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -139.34 138.0 36.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' PRO . 1.9 t-20 -176.11 77.44 0.28 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 109.25 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 13' ' ' ASN . 50.4 Cg_exo -48.92 -130.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.848 2.366 . . . . 0.0 112.306 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.71 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -122.45 176.18 6.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.543 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -54.49 109.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.405 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 19' ' ' SER . 16.7 t -64.36 -68.5 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 109.561 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -62.46 57.21 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.6 OUTLIER 169.77 160.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -1.117 . . . . 0.0 109.447 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 19' ' ' SER . 1.8 mm? 39.0 69.8 0.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.461 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.656 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.2 m-20 -157.62 10.98 0.19 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.19 15.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.348 -0.845 . . . . 0.0 109.414 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.656 ' N ' ' O ' ' A' ' 21' ' ' ASP . 15.8 mmtt -139.63 30.96 2.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.746 ' OD2' HG23 ' A' ' 27' ' ' VAL . 7.2 p-10 -122.14 141.46 51.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -0.964 . . . . 0.0 109.457 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 m -75.91 8.43 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.398 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.03 12.07 29.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.608 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.746 HG23 ' OD2' ' A' ' 24' ' ' ASP . 27.4 t -132.45 101.69 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 109.303 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.29 9.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.97 141.0 51.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -1.092 . . . . 0.0 109.239 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.36 142.97 8.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 ptm -141.31 147.6 38.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -1.201 . . . . 0.0 109.743 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 m -136.0 -179.75 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.025 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.66 163.16 31.12 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.049 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 91.93 42.76 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.368 -1.078 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.25 -27.01 12.17 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.712 2.275 . . . . 0.0 112.44 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.03 -33.95 40.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.1 m -130.13 7.56 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' OD1' ' A' ' 39' ' ' ASP . . . 57.46 71.54 0.73 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.553 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 30.2 m-20 -141.18 131.19 24.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.02 126.65 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.775 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.43 ' HG2' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -110.53 149.17 30.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.43 ' N ' ' HG2' ' A' ' 41' ' ' MET . 0.6 OUTLIER -124.88 122.99 38.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.63 134.75 54.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -135.83 116.89 14.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.302 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.18 159.07 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -127.03 140.65 52.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.56 150.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.146 -0.971 . . . . 0.0 109.648 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 9.8 p-10 -75.99 -94.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.601 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -156.26 15.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.67 -7.37 3.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.7 9.88 17.97 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.8 mm -98.41 143.84 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -1.155 . . . . 0.0 109.454 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.2 115.39 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.45 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.92 -37.36 15.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.67 168.09 20.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.23 105.74 3.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -99.88 141.4 32.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.766 ' CD1' HG21 ' A' ' 74' ' ' THR . 13.7 p90 -139.99 179.08 6.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.382 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -164.76 123.75 1.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -137.55 141.51 41.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -158.36 134.26 9.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.42 -69.32 0.54 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.02 128.41 38.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -1.163 . . . . 0.0 109.656 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.45 70.57 0.86 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.99 -17.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -1.112 . . . . 0.0 109.295 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . . . -105.74 6.33 31.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.431 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 68' ' ' ALA . 41.8 mt -79.05 -53.13 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -44.25 -45.3 8.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -70.85 -38.54 73.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.416 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.604 ' O ' HG23 ' A' ' 74' ' ' THR . 41.8 t -56.21 -39.96 73.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -73.72 -32.77 64.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.323 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.422 ' CD2' ' OE1' ' A' ' 96' ' ' GLU . 10.8 tp -68.96 -59.24 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 74' ' ' THR . 11.2 tt -52.34 -41.59 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.766 HG21 ' CD1' ' A' ' 58' ' ' PHE . 31.8 p -63.34 -32.33 73.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.331 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.47 -4.77 59.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.288 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.8 -26.44 14.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.57 22.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.298 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -95.49 120.38 35.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.412 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.01 5.48 89.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -87.04 -168.68 2.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -1.17 . . . . 0.0 109.534 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.13 152.47 39.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.369 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -57.82 -28.85 64.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.1 -36.35 79.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 85' ' ' ALA . 63.5 mm-40 -76.84 -56.1 4.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.46 -32.65 1.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.18 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.78 39.3 3.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -159.98 -40.57 0.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 108.781 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.54 ' O ' ' O ' ' A' ' 87' ' ' ALA . 12.4 pt -45.67 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 109.161 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -150.86 -178.63 6.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.154 -0.966 . . . . 0.0 109.572 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -90.88 -16.7 27.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.402 -0.811 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.27 -45.3 65.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.485 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -62.48 -69.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 92' ' ' GLN . 7.9 mt -41.71 -39.96 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HA ' HD21 ' A' ' 99' ' ' LEU . . . -67.17 -42.12 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.503 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -68.0 -11.41 58.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.443 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' OE1' ' CD2' ' A' ' 72' ' ' LEU . 13.2 tt0 -88.37 -54.77 4.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.413 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mt -81.94 -7.34 59.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 99' ' ' LEU . 6.0 tp10 48.5 23.56 0.62 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -43.97 149.21 0.69 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.67 164.2 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.67 2.246 . . . . 0.0 112.217 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 74.5 Cg_endo -79.91 18.4 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.985 2.456 . . . . 0.0 112.638 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.0 t -110.62 0.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 109.727 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.658 ' O ' ' N ' ' A' ' 105' ' ' HIS . 13.0 mtmt -140.33 10.7 2.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.445 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 101' ' ' PRO . 5.0 t -45.11 -10.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.442 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.658 ' N ' ' O ' ' A' ' 103' ' ' LYS . 3.2 m-70 -59.72 -37.92 80.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 86.3 m -60.66 -50.68 72.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -60.85 -52.82 63.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.372 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.5 mt -46.73 -36.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.262 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.59 -28.17 58.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.627 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.21 -50.95 71.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.999 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 112' ' ' ASP . 70.9 tt0 -66.55 -63.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.873 . . . . 0.0 109.133 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' GLU . 4.8 t70 -44.1 -35.06 1.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 115' ' ' LYS . . . -58.04 -64.53 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.006 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.8 tp -46.43 -22.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 108.513 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 116' ' ' ALA . 14.5 tttt -74.1 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -40.55 -51.53 2.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.602 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.78 -51.75 67.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.465 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mt -49.73 -43.07 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -55.96 -65.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.537 ' O ' ' C ' ' A' ' 121' ' ' TYR . 27.0 t70 -44.66 -68.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.595 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.537 ' C ' ' O ' ' A' ' 120' ' ' ASP . 54.2 t80 -35.33 -42.99 0.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -68.8 -51.64 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -65.29 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -53.3 -7.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 123' ' ' ALA . 6.8 tt0 -136.32 50.78 2.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -152.95 -44.22 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.27 -32.77 57.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -1.175 . . . . 0.0 109.446 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -68.68 -179.01 1.28 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.898 . . . . 0.0 109.478 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.81 175.72 8.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.414 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.572 ' ND1' ' O ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -97.03 -144.45 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.612 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.572 ' O ' ' ND1' ' A' ' 130' ' ' HIS . 0.2 OUTLIER -75.24 158.62 32.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.513 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -101.04 137.57 39.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.331 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 134' ' ' HIS . 20.6 p80 -145.4 -135.2 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 109.521 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.433 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 9.4 p80 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.506 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.26 0.552 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' A' ' 4' ' ' SER . . . -98.8 -10.63 22.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -63.61 60.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.511 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.62 ' N ' ' O ' ' A' ' 2' ' ' ALA . 0.7 OUTLIER -75.17 -12.22 60.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.37 -0.831 . . . . 0.0 109.465 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.9 -48.17 5.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 tptm 51.23 75.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.644 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.42 141.96 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.328 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.8 tt -143.43 159.95 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 109.565 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 10' ' ' HIS . 1.0 OUTLIER -60.47 144.44 51.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.5 ' C ' ' O ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -38.64 153.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.112 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.87 117.86 8.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 109.74 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -108.54 -166.73 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.13 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 15' ' ' ARG . 7.4 t-20 -165.58 86.25 0.99 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.064 -1.023 . . . . 0.0 109.781 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.53 66.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.846 2.364 . . . . 0.0 111.973 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.716 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -97.44 92.2 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.816 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 m120 56.91 14.3 1.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.882 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.689 HG22 ' H ' ' A' ' 18' ' ' GLY . 8.6 p -113.34 175.22 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.53 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.689 ' H ' HG22 ' A' ' 17' ' ' VAL . . . 87.25 10.42 71.28 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.542 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.6 p -143.67 -164.03 1.79 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mp 58.72 0.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.878 . . . . 0.0 109.327 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.542 ' OD1' ' O ' ' A' ' 19' ' ' SER . 1.3 m-20 -103.89 148.21 26.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.52 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.552 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -64.96 -25.16 67.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -63.82 7.98 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.406 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.552 ' H ' ' C ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -111.54 119.39 38.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 109.358 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.39 9.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.585 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 24' ' ' ASP . 4.6 m-20 -125.06 30.01 5.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 27' ' ' VAL . 34.9 t -127.1 91.36 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.313 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.42 142.2 16.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -129.17 112.57 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.46 134.93 12.2 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.41 114.41 16.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -1.118 . . . . 0.0 109.524 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.67 174.14 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.19 -178.9 21.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -122.12 89.19 48.58 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 109.367 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -54.46 29.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.95 2.433 . . . . 0.0 112.386 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -105.89 -42.83 5.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.7 -22.0 3.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.601 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.13 51.27 0.52 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.2 m-20 -106.76 140.22 39.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -1.145 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.74 114.54 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.167 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.5 ttt -112.54 140.99 46.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -126.5 128.97 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -0.878 . . . . 0.0 108.986 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -120.64 138.44 53.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.819 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -126.47 132.24 51.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 109.189 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.57 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -128.63 143.24 50.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.61 145.47 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -92.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -161.07 18.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.36 -21.2 3.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.72 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.55 6.06 6.27 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -103.64 130.08 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.641 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.44 97.66 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.299 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.67 -38.39 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.578 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.26 169.44 17.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.136 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -166.78 118.64 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.131 -0.981 . . . . 0.0 109.593 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -95.97 -177.94 4.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.176 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD1' HG21 ' A' ' 74' ' ' THR . 17.6 p90 -168.06 -179.72 4.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.184 -0.947 . . . . 0.0 109.418 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -171.61 113.98 0.36 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.5 p -119.62 131.89 55.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.206 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -140.89 111.27 6.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . 84.88 49.66 4.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.535 ' O ' ' O ' ' A' ' 64' ' ' GLY . 14.5 p -121.5 142.79 49.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.458 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 63' ' ' CYS . . . -38.99 -94.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.3 m -125.68 30.76 5.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.16 -31.51 72.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.497 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.8 mp -38.41 -32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.431 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -86.03 -64.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 109.312 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 m -54.21 -29.48 46.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.52 ' O ' ' OG1' ' A' ' 74' ' ' THR . 78.8 p -62.95 -34.52 77.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.115 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -74.42 -33.24 62.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.83 . . . . 0.0 109.225 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tp -64.34 -60.26 3.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.661 HG23 ' N ' ' A' ' 74' ' ' THR . 12.6 tt -51.95 -51.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.582 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.661 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -53.62 -31.15 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.374 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.09 -14.98 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.396 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -89.89 -23.96 21.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' ILE . 17.0 m -97.11 13.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 82.0 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.975 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.7 -9.45 8.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -98.75 -159.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -128.07 164.49 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 109.709 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt -50.53 -28.68 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.86 -53.01 61.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.351 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.79 -36.3 71.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.829 . . . . 0.0 109.328 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.649 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -67.97 -40.32 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.255 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 44.4 3.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -161.4 -35.31 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.137 . . . . 0.0 109.404 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.2 pt -40.39 -21.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 mttp 55.51 169.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.973 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.32 -45.32 5.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.553 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 37.1 t -56.19 -22.35 28.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.403 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -67.72 -64.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.369 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -51.35 -30.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.16 90.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.77 -18.32 61.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.372 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -71.14 -51.58 24.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.92 -11.92 56.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.21 19.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.673 ' N ' HD23 ' A' ' 99' ' ' LEU . 1.7 pt? -59.18 149.2 68.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 109.149 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -37.51 145.39 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.823 2.349 . . . . 0.0 112.23 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.63 8.83 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.671 2.247 . . . . 0.0 112.265 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.77 -30.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -94.09 16.89 13.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.907 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.06 -19.79 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.542 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -54.58 -33.49 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.59 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 90.6 m -58.02 -58.19 9.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.915 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -48.87 -55.77 10.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.478 ' N ' HD22 ' A' ' 90' ' ' ASN . 28.2 mt -47.77 -65.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.313 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 34' ' ' ALA . 6.5 mp -43.79 -27.32 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -69.57 -71.31 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -50.93 -30.78 15.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.911 . . . . 0.0 109.249 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -73.01 -25.08 60.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -75.02 -35.09 61.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.618 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.649 HG12 ' HB1' ' A' ' 85' ' ' ALA . 2.2 tp -75.03 -42.34 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 109.42 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 22.1 tttt -59.94 -40.3 88.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.982 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -62.61 -54.12 44.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -50.07 -63.48 1.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.227 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 117' ' ' ALA . 67.5 mt -37.77 -44.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.21 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -55.12 -57.34 12.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -58.75 -45.35 89.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.34 -20.57 44.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -91.36 -29.91 16.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.385 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.97 -7.34 59.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.07 21.84 1.29 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -160.91 55.45 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -129.74 -69.86 0.12 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 129' ' ' HIS . 10.0 mp -55.43 -37.3 67.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -1.139 . . . . 0.0 109.446 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -73.04 36.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 131' ' ' HIS . 66.7 m80 -147.95 130.42 15.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -67.1 44.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 0.0 109.369 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.527 ' N ' ' O ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -73.05 86.52 1.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 109.422 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.24 7.73 1.37 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.346 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.608 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 2.8 p-80 -120.45 50.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.408 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.409 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.69 98.8 6.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 4' ' ' SER . 54.5 t80 -118.62 76.25 1.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.3 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 3' ' ' TYR . 6.9 t -53.95 -161.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -130.86 85.77 2.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.907 . . . . 0.0 109.54 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -139.05 159.21 42.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.364 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 m -119.71 52.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.218 -0.926 . . . . 0.0 109.954 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.6 mt -95.81 57.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.131 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.2 -163.71 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.728 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -107.27 -167.78 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -143.71 28.75 1.42 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.16 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.73 120.67 15.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 109.661 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.635 ' O ' ' N ' ' A' ' 15' ' ' ARG . 63.1 m-20 -59.38 155.14 38.76 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.28 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -40.64 -11.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.768 2.312 . . . . 0.0 112.231 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.716 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -73.18 137.89 45.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 -11.24 15.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.385 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.704 HG12 ' N ' ' A' ' 18' ' ' GLY . 57.9 t -92.12 173.6 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.607 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.704 ' N ' HG12 ' A' ' 17' ' ' VAL . . . 150.82 -14.55 0.9 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 1.5 t 153.7 162.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.545 -0.973 . . . . 0.0 109.166 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.796 HD12 ' NZ ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -111.75 88.55 2.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.696 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.624 ' C ' ' H ' ' A' ' 23' ' ' LYS . 6.1 m-20 58.46 109.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 109.524 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -58.1 4.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.388 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 21' ' ' ASP . 8.8 tttm -50.95 -28.59 10.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 109.692 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 23' ' ' LYS . 5.8 t0 80.16 -146.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.522 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.8 OUTLIER 74.41 11.17 4.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' A' ' 25' ' ' SER . 1.7 p-10 174.78 -28.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.96 . . . . 0.0 109.681 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -91.74 114.98 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.09 119.27 5.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.487 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 27.3 m -93.71 136.38 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -1.15 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.67 110.05 0.67 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 ttt -125.63 122.14 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -1.137 . . . . 0.0 109.651 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 41' ' ' MET . 2.1 m -124.55 -169.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.377 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.15 146.83 5.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.11 133.52 20.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.3 Cg_endo -75.44 -26.38 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.493 2.129 . . . . 0.0 112.256 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.53 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.89 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -98.88 5.32 47.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.04 48.79 10.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -89.66 127.07 35.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.401 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.0 131.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.405 ' HB3' HG23 ' A' ' 32' ' ' VAL . 4.7 ttt -128.06 130.53 48.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 109.293 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -125.38 142.07 51.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.801 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.56 156.84 43.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.182 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.78 150.56 38.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.78 139.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.316 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.796 ' NZ ' HD12 ' A' ' 20' ' ' LEU . 35.5 ttmt -113.38 146.51 39.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.71 147.63 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 2.2 t0 -88.9 -60.17 2.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 167.27 -23.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.145 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -100.12 22.66 11.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.541 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 15.26 80.14 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -104.93 136.66 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.483 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.34 97.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.7 -44.32 57.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.76 157.1 8.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.33 179.31 6.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.351 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -151.29 170.75 18.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 74' ' ' THR . 21.3 p90 -137.35 167.88 20.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 109.384 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -169.71 85.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.17 133.51 55.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -147.18 105.85 3.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.06 -50.66 0.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.1 p -128.9 120.55 26.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.52 66.57 1.02 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.55 -50.93 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.92 -26.4 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.354 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' ALA . 77.8 mt -44.67 -53.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.0 109.217 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.09 60.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 108.921 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.2 -40.37 64.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.34 -0.85 . . . . 0.0 109.024 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 74' ' ' THR . 2.3 t -65.69 -24.55 67.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 109.168 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.7 t -76.12 -46.21 29.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.308 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.05 -59.25 4.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 74' ' ' THR . 17.3 tt -49.21 -43.95 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.585 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -54.88 -42.27 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.591 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.19 -18.45 60.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.942 . . . . 0.0 109.729 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -89.35 -21.9 22.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.517 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 77' ' ' VAL . 4.8 m -107.49 52.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.14 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -142.11 82.43 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.646 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.74 40.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -102.25 -167.44 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -1.189 . . . . 0.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -102.94 139.24 38.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.77 -23.73 60.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.401 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -75.98 -13.97 60.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.35 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.55 -35.05 11.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.49 2.84 42.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.19 25.8 11.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.96 18.66 0.16 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -1.153 . . . . 0.0 109.409 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.05 2.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.847 . . . . 0.0 109.327 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.4 mttt 56.83 167.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.04 -13.16 48.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.339 -0.851 . . . . 0.0 109.541 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.3 p -75.76 -21.52 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.564 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -74.79 -56.01 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.423 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.0 mt -59.67 -41.98 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.88 82.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.184 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.35 -46.49 80.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 109.399 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -49.69 -62.45 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.17 -16.65 61.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 52.84 23.52 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.0 OUTLIER -55.26 146.84 39.36 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.582 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.423 ' O ' HD12 ' A' ' 99' ' ' LEU . 73.1 Cg_exo -42.04 146.78 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.74 2.293 . . . . 0.0 112.239 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.664 ' O ' HG23 ' A' ' 104' ' ' VAL . 57.2 Cg_endo -73.94 -27.59 12.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.762 2.308 . . . . 0.0 112.386 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 102' ' ' VAL . 4.9 t -70.5 26.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.739 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 101' ' ' PRO . 9.6 tttm -165.17 37.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 101' ' ' PRO . 3.5 t -71.39 1.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.392 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.583 ' O ' HD13 ' A' ' 109' ' ' LEU . 34.4 m80 -58.79 -29.26 66.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -67.59 -41.64 83.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.59 85.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.885 . . . . 0.0 109.177 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -62.56 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.295 -0.878 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 105' ' ' HIS . 7.8 mp -63.23 -25.21 68.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.428 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -74.15 -71.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 114' ' ' ILE . 12.9 tp10 -50.75 -31.48 16.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.42 -38.77 85.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.138 -0.976 . . . . 0.0 109.158 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -69.9 -58.91 3.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.661 ' O ' HD13 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -44.22 -38.09 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 116' ' ' ALA . 4.0 tptt -75.17 -66.13 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -36.61 -39.58 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -64.38 -57.95 7.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -38.01 -49.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.413 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -56.18 -61.15 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.507 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 119' ' ' ALA . 4.3 m-20 -38.83 -62.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -46.42 -57.43 4.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 125' ' ' GLN . 1.0 OUTLIER -47.31 -29.16 2.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -41.25 -47.81 3.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.587 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.462 ' HZ2' ' HB3' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -90.82 23.81 2.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 122' ' ' LYS . 14.1 tp60 -165.98 39.93 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.15 -0.969 . . . . 0.0 109.467 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.43 -100.26 0.47 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.664 ' O ' ' N ' ' A' ' 129' ' ' HIS . 0.5 OUTLIER -117.52 -32.73 4.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.714 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 128' ' ' GLU . 17.0 mp0 -46.64 -6.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.621 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.664 ' N ' ' O ' ' A' ' 127' ' ' LEU . 28.9 t-80 -112.68 -95.91 0.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.933 . . . . 0.0 109.585 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.636 ' C ' ' ND1' ' A' ' 131' ' ' HIS . 0.8 OUTLIER 177.47 -164.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.275 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.636 ' ND1' ' C ' ' A' ' 130' ' ' HIS . 2.0 p-80 -179.86 115.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.14 -0.975 . . . . 0.0 109.624 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 134' ' ' HIS . 2.0 t60 178.12 -81.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.766 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -70.87 23.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.897 . . . . 0.0 109.849 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.521 ' H ' ' C ' ' A' ' 132' ' ' HIS . 1.6 p-80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.362 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.276 0.56 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -49.64 126.27 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.566 ' O ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -81.41 157.3 25.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.627 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER 55.43 119.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.9 . . . . 0.0 109.501 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -72.02 172.33 10.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.292 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -149.82 61.17 1.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 109.54 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t 60.74 86.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.677 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 9' ' ' ASP . 1.9 pt -144.36 160.61 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.3 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 8' ' ' ILE . 45.3 t0 40.74 85.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.402 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 9' ' ' ASP . 4.8 m-70 -43.97 131.02 5.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.31 109.51 19.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.66 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 63.83 123.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.342 -0.849 . . . . 0.0 109.567 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.417 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 1.2 t-20 -147.8 57.25 3.18 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.191 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 33.2 Cg_endo -67.89 4.29 1.53 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.884 2.389 . . . . 0.0 112.327 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 58.86 -92.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.167 -0.958 . . . . 0.0 109.515 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -173.07 -4.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.1 t -56.56 127.71 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.372 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.27 80.35 0.67 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 20' ' ' LEU . 8.9 p -174.23 113.15 0.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -1.119 . . . . 0.0 109.393 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.606 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 5.7 tp 72.61 -3.27 2.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.383 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.584 ' C ' ' H ' ' A' ' 23' ' ' LYS . 2.3 m-20 -69.7 16.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 20' ' ' LEU . 3.5 mtpp 63.5 -9.36 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.584 ' H ' ' C ' ' A' ' 21' ' ' ASP . 2.6 ttmm -132.17 62.29 1.64 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.538 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.606 ' OD2' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -123.93 156.34 36.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.85 -2.65 43.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -97.13 3.95 51.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.6 96.82 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 155.53 28.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -138.6 117.27 12.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -1.199 . . . . 0.0 109.62 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.06 114.4 4.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.53 108.59 14.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -1.196 . . . . 0.0 109.565 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.67 175.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.11 168.35 41.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -120.74 80.81 32.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -47.08 -14.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.848 2.366 . . . . 0.0 112.311 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -60.47 2.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -91.55 -8.75 46.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 43.27 9.38 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.2 148.48 25.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.111 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.1 139.89 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ttt -147.0 130.0 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -133.52 118.87 18.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.65 127.46 50.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -106.34 168.82 8.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.728 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.515 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -150.11 127.87 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.224 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -98.74 105.15 17.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.58 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.09 144.78 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 109.252 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.617 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 6.6 t70 -78.94 -101.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -148.35 13.6 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.617 ' ND2' ' OD2' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -139.27 2.25 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.68 33.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.432 HD13 ' OG ' ' A' ' 81' ' ' SER . 4.5 mm -83.32 144.06 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -1.187 . . . . 0.0 109.418 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 55' ' ' ASP . 72.1 mt -90.19 91.41 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.85 -54.03 16.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 15.9 t0 -136.59 -177.08 4.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.357 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.91 116.29 1.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.593 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -96.46 141.72 29.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.69 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -117.01 162.63 17.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.403 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -157.16 97.24 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.435 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.52 124.98 50.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -150.78 97.11 2.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.35 -39.7 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 34.3 t -130.12 121.79 27.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.93 47.41 1.89 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.09 2.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -1.16 . . . . 0.0 109.562 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.01 -4.25 20.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.452 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.542 ' O ' ' C ' ' A' ' 68' ' ' ALA . 3.1 mp -62.29 -65.85 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.542 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.5 -71.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -41.5 -60.32 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.496 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 84.1 p -46.29 -47.76 18.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.342 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.406 ' C ' ' OG1' ' A' ' 74' ' ' THR . 1.7 m -57.71 -23.95 54.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 74' ' ' THR . 1.4 tp -78.82 -71.54 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.287 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.577 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -40.52 -24.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -75.56 -56.17 4.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.252 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.16 -15.52 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -88.63 -32.55 18.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 77' ' ' VAL . 17.2 m -104.6 55.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.648 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 84.29 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.11 -15.1 23.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -78.25 -174.42 3.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.418 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.432 ' OG ' HD13 ' A' ' 52' ' ' ILE . 73.4 m -109.45 174.39 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.23 -26.03 68.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.633 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -64.61 -17.44 64.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -100.09 -38.87 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.08 -25.29 58.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.73 54.25 0.68 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.17 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -1.169 . . . . 0.0 109.404 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.54 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -35.89 -43.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 91' ' ' SER . 0.3 OUTLIER 63.6 119.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.582 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 91' ' ' SER . 43.0 p30 -40.93 -25.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.025 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.535 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.5 m -50.44 -36.9 35.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 93' ' ' ILE . 12.6 tt0 -83.46 -60.31 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.477 ' C ' ' O ' ' A' ' 92' ' ' GLN . 69.6 mt -40.13 -48.1 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 95' ' ' GLU . . . -72.44 -55.2 7.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 94' ' ' ALA . 3.7 tt0 -36.07 -34.06 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 94' ' ' ALA . 1.2 tp10 -81.79 -62.19 1.71 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.619 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.8 OUTLIER -63.29 -16.91 61.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 97' ' ' LEU . 1.1 tp10 37.94 47.43 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -71.28 150.47 94.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.169 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -36.15 109.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.87 2.38 . . . . 0.0 112.045 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.9 16.41 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.559 2.173 . . . . 0.0 112.477 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 102' ' ' VAL . 10.9 m -82.3 13.64 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' VAL . 4.9 tptt -168.21 -38.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.43 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 103' ' ' LYS . 12.4 t 44.22 57.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.27 -57.85 2.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' A' ' 107' ' ' SER . 48.0 t -44.46 -60.42 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.807 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.486 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -43.38 -63.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 107' ' ' SER . 27.4 mt -38.1 -62.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 34' ' ' ALA . 8.6 mp -48.65 -37.25 17.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.587 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.12 -73.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.637 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.551 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 3.8 tp10 -46.69 -58.54 3.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.9 OUTLIER -43.74 -38.34 3.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.768 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -51.96 65.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.6 tp -61.61 -41.1 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.677 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.479 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -62.08 -41.14 97.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 109.511 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.42 67.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -55.02 -33.91 63.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.314 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 68.9 mt -69.38 -66.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.851 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -38.69 -46.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.395 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -63.28 -43.85 96.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.394 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 118' ' ' ILE . 59.5 t80 -56.45 -42.25 77.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 126' ' ' GLY . 23.6 mttp -72.04 -43.98 64.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.05 -11.91 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.417 ' N ' ' C ' ' A' ' 122' ' ' LYS . 6.3 mttt -108.47 -65.87 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.488 ' O ' ' CG ' ' A' ' 125' ' ' GLN . 2.8 tt0 -85.05 14.67 4.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -49.16 -88.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 mt -125.71 -8.92 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -1.146 . . . . 0.0 109.366 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -170.4 -152.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.646 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 0.3 OUTLIER -94.44 55.24 1.94 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.66 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.468 ' CG ' ' H ' ' A' ' 131' ' ' HIS . 7.6 t-80 -62.39 -158.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.957 . . . . 0.0 109.237 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.468 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 7.0 p80 -163.27 150.89 13.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.674 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 134' ' ' HIS . 76.7 t60 -54.24 108.52 0.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.89 . . . . 0.0 109.381 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -53.65 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 132' ' ' HIS . 4.6 t60 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.562 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' O ' ' C ' ' A' ' 2' ' ' ALA . 5.2 tpt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 43.98 75.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.422 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 4' ' ' SER . 2.4 t80 -165.83 -21.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.58 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.57 ' O ' ' OG ' ' A' ' 4' ' ' SER . 1.0 OUTLIER 45.15 62.6 2.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.953 . . . . 0.0 109.532 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.53 -79.88 0.47 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.21 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HG2' ' H ' ' A' ' 7' ' ' VAL . 8.2 tttp -101.15 162.18 13.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 7' ' ' VAL . 2.5 m -56.6 154.7 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.488 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 8' ' ' ILE . 9.0 mt -149.28 151.39 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 p30 176.86 34.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.618 ' O ' ' CG ' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -117.66 36.15 4.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.44 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER 53.8 72.08 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -83.15 -20.18 35.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 0.0 109.374 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -123.94 97.25 41.32 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 109.346 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -48.73 149.59 7.26 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.585 2.19 . . . . 0.0 112.185 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.731 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -105.23 -62.11 1.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.9 . . . . 0.0 109.575 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.89 91.78 8.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.927 . . . . 0.0 109.515 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -129.66 137.14 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.91 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 19' ' ' SER . . . 76.09 97.44 0.15 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.59 ' HG ' ' HG1' ' A' ' 29' ' ' THR . 4.6 t 40.32 -141.07 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -1.14 . . . . 0.0 109.474 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.02 133.89 55.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.0 106.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.392 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.8 -2.15 4.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.579 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -50.22 -28.89 8.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.942 . . . . 0.0 109.431 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.9 OUTLIER 45.75 -165.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.31 -1.94 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 24' ' ' ASP . 1.9 p-10 -167.84 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.59 92.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.8 144.57 18.25 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.59 ' HG1' ' HG ' ' A' ' 19' ' ' SER . 4.8 m -135.43 130.55 34.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.46 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.15 140.52 16.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.21 125.08 21.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 109.575 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.62 170.42 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.08 141.84 7.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -110.67 129.2 24.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.183 . . . . 0.0 109.186 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 36' ' ' ALA . 63.8 Cg_endo -77.14 -45.02 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.515 2.143 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.31 -55.28 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -113.55 29.04 8.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 109.69 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.4 51.67 0.74 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 37' ' ' CYS . 78.8 m-20 -102.24 111.77 24.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -99.3 130.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.759 ' HG3' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -137.05 150.74 48.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.492 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -136.76 116.36 12.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.376 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 tt -105.6 143.25 34.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 45' ' ' ILE . 4.8 tt0 -135.51 162.33 32.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.325 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.533 ' N ' ' CG ' ' A' ' 44' ' ' GLN . 1.3 pt -147.41 162.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.426 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 10.6 mmtm -129.52 138.48 51.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.21 155.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.562 ' OD2' ' OD1' ' A' ' 49' ' ' ASP . 38.5 t70 -88.65 -49.7 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.631 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER 160.78 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.234 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -101.39 -11.72 19.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 8.71 7.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.36 149.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.9 mt -90.92 95.55 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' CG ' ' N ' ' A' ' 55' ' ' ASP . 19.9 pt-20 -58.03 -46.24 85.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 54' ' ' GLU . 1.7 t0 -137.53 168.17 20.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.579 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.05 100.51 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.07 159.5 14.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.509 ' CD1' HG21 ' A' ' 74' ' ' THR . 34.6 p90 -140.35 -175.0 4.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.58 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -171.35 83.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.759 HG22 ' HG3' ' A' ' 41' ' ' MET . 59.6 p -92.9 149.04 21.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -155.06 141.56 18.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.85 -80.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 65' ' ' SER . 0.1 OUTLIER -82.11 136.94 35.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -1.157 . . . . 0.0 109.444 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.83 45.76 3.07 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -154.6 -47.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.392 -1.063 . . . . 0.0 109.336 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.68 -14.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' SER . 7.2 mt -65.88 -22.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.43 -67.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 73' ' ' ILE . 20.9 p -46.39 -53.41 11.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.166 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 74' ' ' THR . 83.9 p -49.88 -33.57 17.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.524 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.3 OUTLIER -71.17 -37.71 72.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.292 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.22 -67.84 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.848 . . . . 0.0 109.441 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' VAL . 5.3 tt -44.42 -40.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.948 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 71' ' ' SER . 1.5 p -57.48 -48.31 79.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.894 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.14 -21.57 50.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -11.54 59.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 73' ' ' ILE . 16.4 m -124.67 20.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.253 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -90.54 99.78 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.402 -0.812 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.04 56.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -81.88 171.14 14.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.15 150.68 21.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.532 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.7 mt -54.79 -15.81 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.99 -33.4 74.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.36 -47.48 8.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.871 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.8 -5.58 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.298 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.83 31.54 6.98 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.22 -36.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -1.16 . . . . 0.0 109.184 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.4 pt -44.81 120.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.839 . . . . 0.0 109.545 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -94.3 179.39 5.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -13.9 60.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.462 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -82.75 -43.89 16.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -58.28 -36.59 73.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.005 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.15 -33.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.02 -21.08 66.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.899 . . . . 0.0 108.971 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -94.18 -35.32 12.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.179 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -58.74 -36.18 73.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.352 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 mt -106.03 -3.87 21.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 47.12 50.88 13.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 99' ' ' LEU . 3.5 pp -85.88 146.8 44.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.427 ' O ' HG12 ' A' ' 102' ' ' VAL . 37.0 Cg_endo -69.08 151.99 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.744 2.296 . . . . 0.0 112.053 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.621 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.5 Cg_endo -69.5 19.13 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.887 2.391 . . . . 0.0 112.369 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.532 ' C ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -35.53 -28.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.31 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.649 ' C ' HG23 ' A' ' 104' ' ' VAL . 5.9 tptt -173.35 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.374 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 ' C ' ' A' ' 103' ' ' LYS . 1.6 t 69.87 2.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 37.4 p-80 -65.15 -36.76 85.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 3.9 t -58.7 -56.39 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.06 -44.31 74.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.8 mt -56.53 -41.58 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.39 -32.28 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -63.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.887 . . . . 0.0 109.62 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.1 -49.77 76.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -53.52 -28.03 29.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.973 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -79.3 -64.42 1.19 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.6 tp -44.94 -41.16 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 109.833 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.497 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -73.45 -37.15 65.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.442 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.09 80.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -68.59 -60.34 2.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ALA . 44.4 mt -38.57 -49.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.48 80.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.567 ' OD2' ' O ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -52.67 -66.64 0.35 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.253 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -46.92 -39.02 11.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 109.177 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -59.54 -51.17 70.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.814 . . . . 0.0 109.366 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.72 -6.48 2.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -97.21 40.21 1.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -117.85 -74.77 0.59 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 128' ' ' GLU . . . -176.38 -49.97 0.06 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 127' ' ' LEU . 6.8 tp -45.64 -11.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -1.124 . . . . 0.0 109.447 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 126' ' ' GLY . 2.5 tm-20 -56.78 -55.06 39.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.347 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.419 ' C ' ' ND1' ' A' ' 129' ' ' HIS . 0.5 OUTLIER 57.45 86.23 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.76 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 154.64 40.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.06 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -175.79 80.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.084 -1.01 . . . . 0.0 109.681 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.522 ' CG ' ' H ' ' A' ' 133' ' ' HIS . 4.8 t60 -57.97 -177.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 109.087 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.522 ' H ' ' CG ' ' A' ' 132' ' ' HIS . 4.3 m80 -129.09 159.36 36.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.105 -0.997 . . . . 0.0 109.566 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.449 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 4' ' ' SER . . . -70.28 170.6 11.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.55 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -47.45 82.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.548 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 2' ' ' ALA . 14.0 t -166.69 10.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.657 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.522 ' CD ' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -112.34 113.2 25.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.162 -0.962 . . . . 0.0 109.46 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -59.36 163.94 3.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -18.61 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.717 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.3 mt -95.31 83.83 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -145.62 66.28 1.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 10' ' ' HIS . 1.4 m170 -77.41 115.81 17.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.448 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.62 26.55 6.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.452 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.04 70.32 0.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -134.28 60.33 43.14 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.476 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -65.33 -152.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.758 2.305 . . . . 0.0 112.349 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.14 -170.14 0.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.215 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -154.74 -105.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.669 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.91 87.62 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.131 -0.981 . . . . 0.0 109.594 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' SER . . . -50.57 176.12 0.05 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' GLY . 1.8 t -42.57 148.43 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -1.217 . . . . 0.0 109.377 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.567 ' O ' ' O ' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -92.25 51.57 1.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.442 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 23' ' ' LYS . 9.4 m-20 53.73 159.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 15.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.124 -0.985 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.583 ' H ' ' C ' ' A' ' 21' ' ' ASP . 11.5 mmtm -95.99 23.62 6.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.838 . . . . 0.0 109.335 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' HG23 ' A' ' 27' ' ' VAL . 4.2 t0 -96.11 167.42 11.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.538 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.529 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 3.7 m -101.61 7.24 42.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.529 ' OD1' ' O ' ' A' ' 25' ' ' SER . 56.9 m-20 -144.2 14.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.435 HG23 ' OD2' ' A' ' 24' ' ' ASP . 32.9 t -118.46 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.192 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.53 153.13 34.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.542 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 7.8 m -127.15 120.7 29.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -1.043 . . . . 0.0 109.108 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.24 106.5 1.81 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.0 ttt -112.33 112.4 23.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -1.216 . . . . 0.0 109.462 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.48 154.44 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.39 -170.1 11.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.31 92.24 4.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 53.7 Cg_exo -48.55 -48.03 18.65 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.689 2.259 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.09 -34.2 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.469 ' O ' ' C ' ' A' ' 38' ' ' GLY . 21.2 m -120.01 12.05 11.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.83 56.89 3.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -124.5 117.6 24.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.29 130.06 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -128.86 137.04 51.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.325 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -121.54 164.01 17.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.689 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tp -158.51 126.19 5.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -117.77 140.55 49.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.426 HD11 ' HB1' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -129.54 124.34 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.57 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -101.39 143.6 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 48' ' ' ASP . 92.5 t -131.3 156.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.291 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.0 t70 -85.16 -106.12 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.448 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 2.1 p30 -140.02 8.65 2.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.75 -29.52 3.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.461 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.66 -5.6 4.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.38 137.04 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -1.151 . . . . 0.0 109.487 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 53' ' ' ILE . 8.1 mt -91.17 107.01 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -70.93 -16.45 62.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.725 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 15.7 t0 -172.91 151.75 2.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.053 -1.029 . . . . 0.0 109.791 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.556 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -133.12 107.76 8.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.22 154.77 17.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 109.561 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 74' ' ' THR . 2.4 p90 -136.99 -176.5 4.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.58 106.94 0.56 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.349 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.43 ' CG2' ' OG ' ' A' ' 70' ' ' SER . 81.9 p -112.77 145.15 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -154.45 108.79 3.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 109.423 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.84 -58.19 0.3 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.6 t -106.68 136.02 47.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -1.153 . . . . 0.0 109.371 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.63 38.25 2.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.5 20.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -1.185 . . . . 0.0 109.525 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -93.43 -29.49 15.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.805 ' H ' ' CD1' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -42.93 -27.16 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -46.72 -57.59 4.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.852 . . . . 0.0 109.705 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -49.89 29.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.707 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.43 ' OG ' ' CG2' ' A' ' 60' ' ' THR . 0.3 OUTLIER -48.63 -41.62 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.873 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.57 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.15 -45.17 74.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 73' ' ' ILE . 46.3 tp -57.06 -71.22 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.74 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.641 ' O ' HG22 ' A' ' 77' ' ' VAL . 9.5 tt -40.78 -44.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 109.941 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.824 HG21 ' CD1' ' A' ' 58' ' ' PHE . 1.1 p -59.22 -36.92 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.764 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' LEU . 21.6 tt0 -71.69 -55.65 7.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -31.88 27.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.664 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.867 ' O ' HG23 ' A' ' 77' ' ' VAL . 4.2 m -105.37 63.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.7 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -144.58 95.5 2.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.56 -15.47 35.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -76.08 -160.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -1.109 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 t -117.96 159.08 23.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 82' ' ' LEU . 14.0 mt -57.11 -19.18 18.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.327 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -67.83 -30.8 70.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.376 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.7 tp10 -86.39 -45.86 10.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.608 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.46 60.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.62 46.73 1.13 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -168.33 -33.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.093 . . . . 0.0 108.93 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 84' ' ' GLU . 16.2 pt -50.3 179.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.49 -0.756 . . . . 0.0 109.579 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -143.58 179.98 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.282 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -96.15 -13.22 23.73 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 t -70.84 -41.93 70.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.813 . . . . 0.0 109.268 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -65.86 -52.15 52.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.212 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 mt -57.97 -27.01 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.221 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.67 -42.06 78.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.318 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.51 -22.02 62.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.19 -54.92 5.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.532 ' O ' ' C ' ' A' ' 98' ' ' GLU . 4.4 tp -80.75 -3.47 51.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 97' ' ' LEU . 7.6 tm-20 36.0 70.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.326 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.04 149.76 36.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.373 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -71.03 151.66 62.03 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.714 2.276 . . . . 0.0 112.112 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.02 19.39 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.797 2.331 . . . . 0.0 112.211 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.31 16.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.493 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 105' ' ' HIS . 8.8 tttp -176.49 46.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.567 ' O ' HG12 ' A' ' 104' ' ' VAL . 18.7 t -65.86 20.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.64 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.611 ' H ' ' C ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -86.24 -30.51 22.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 p -65.85 -44.37 85.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.25 -45.92 89.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.7 mt -68.2 -30.04 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 mp -73.27 -40.93 64.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.641 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -60.15 -53.77 53.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.831 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.31 -56.85 8.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.709 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -51.55 -17.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.38 -55.06 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 tp -51.13 -33.07 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.0 109.653 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.503 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -75.39 -61.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -37.47 -35.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 119' ' ' ALA . . . -77.75 -66.34 0.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 117' ' ' ALA . 48.0 mt -37.47 -28.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 117' ' ' ALA . . . -77.9 -52.9 8.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD2' ' O ' ' A' ' 29' ' ' THR . 37.3 m-20 -49.75 -44.19 48.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.71 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.59 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -76.12 -59.17 2.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 109.547 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' TYR . 22.6 tptt -43.11 -33.26 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.8 -20.87 16.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -111.23 24.12 13.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -154.5 44.15 0.52 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.656 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.08 -36.43 0.13 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -96.05 -14.2 23.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -1.194 . . . . 0.0 109.697 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -152.9 164.94 36.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.583 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -167.13 49.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.487 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 4.5 p80 -134.08 132.27 39.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.565 ' N ' ' ND1' ' A' ' 131' ' ' HIS . 1.0 OUTLIER -178.84 87.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.379 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' HIS . 31.2 m80 -40.18 -80.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -124.27 -143.47 0.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.552 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.454 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.09 172.17 13.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 109.432 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.74 131.89 52.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 t -124.48 137.84 54.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.4 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -90.61 -74.36 0.5 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.339 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -151.8 -57.54 0.15 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.427 -0.795 . . . . 0.0 109.121 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.548 ' O ' ' C ' ' A' ' 8' ' ' ILE . 15.9 m -87.47 160.96 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.358 -0.838 . . . . 0.0 109.139 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.548 ' C ' ' O ' ' A' ' 7' ' ' VAL . 26.1 mm -36.13 143.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.31 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -100.35 161.97 13.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.09 -1.006 . . . . 0.0 109.734 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -107.39 141.68 38.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.399 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -87.42 -15.84 36.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 63.07 -122.43 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.657 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.49 146.47 86.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.608 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.679 ' O ' ' N ' ' A' ' 16' ' ' ASN . 57.4 Cg_endo -74.44 8.24 2.29 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.836 2.357 . . . . 0.0 112.408 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 14' ' ' PRO . 14.4 ptm180 -42.81 -13.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 109.57 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' PRO . 4.0 m-80 -64.14 86.85 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.534 ' C ' ' O ' ' A' ' 16' ' ' ASN . 3.0 m -36.18 118.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -162.72 -177.1 35.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 0.9 OUTLIER 77.11 177.58 0.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.144 -1.209 . . . . 0.0 109.428 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.91 -49.13 4.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 47.22 32.23 2.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.836 . . . . 0.0 109.524 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 21' ' ' ASP . 21.5 tptp -45.3 -43.91 11.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.321 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.582 ' O ' ' O ' ' A' ' 24' ' ' ASP . 3.1 tttt -155.11 13.91 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.588 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 48.95 172.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.538 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 58.91 -4.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.337 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 24' ' ' ASP . 8.9 p-10 -146.65 13.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.383 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.06 101.58 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.744 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.19 128.86 9.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.74 152.9 21.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -1.212 . . . . 0.0 109.661 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 43' ' ' LEU . . . -131.51 118.18 2.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.96 95.3 4.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -1.146 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.92 145.56 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.86 177.75 20.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.57 77.15 73.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.171 -1.194 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.03 -6.36 1.8 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.854 2.369 . . . . 0.0 112.107 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.62 -11.08 59.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.588 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.4 -39.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.98 69.63 0.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.1 145.89 44.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -1.157 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.22 117.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.85 . . . . 0.0 109.212 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ttt -120.11 120.24 35.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.893 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -113.34 142.72 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 108.97 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 tt -150.62 149.39 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 109.886 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 12.9 pt20 -150.99 123.27 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.787 . . . . 0.0 109.214 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.3 151.12 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -112.68 150.0 32.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.568 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.84 144.52 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.203 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.605 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 36.7 p-10 -85.13 -108.76 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.963 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.605 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 34.0 t0 -131.95 -23.39 2.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.545 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.37 -1.68 57.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 28.83 12.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 53' ' ' ILE . 45.9 mm -108.89 161.43 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 109.373 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.463 ' N ' HG22 ' A' ' 52' ' ' ILE . 8.4 mt -100.49 105.47 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.222 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.3 -36.29 20.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.803 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.79 160.31 38.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.707 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.29 112.88 4.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 109.417 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -107.77 146.63 31.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -140.35 -175.44 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.542 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -170.75 107.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.433 HG21 ' CB ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -121.39 105.87 10.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.474 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.1 122.54 24.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.09 -39.44 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.0 139.06 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -1.099 . . . . 0.0 109.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.52 60.45 1.52 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.565 ' C ' ' H ' ' A' ' 67' ' ' ILE . 2.3 p -175.73 -59.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 106' ' ' CYS . . . -54.02 -1.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.532 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.565 ' H ' ' C ' ' A' ' 65' ' ' SER . 4.2 mt -65.76 -8.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.25 -49.75 9.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.09 -52.82 59.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.327 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -43.37 -56.51 3.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -53.21 -30.43 37.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 109.352 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 69' ' ' SER . 11.4 tp -70.53 -67.45 0.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 109.554 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.651 ' O ' HG22 ' A' ' 77' ' ' VAL . 3.9 tt -48.72 -40.35 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.458 ' N ' HG23 ' A' ' 73' ' ' ILE . 21.0 p -58.66 -47.19 85.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.74 -10.17 58.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.87 -31.37 17.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 73' ' ' ILE . 4.2 m -102.42 64.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -133.93 100.5 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.67 -9.39 77.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -81.45 -171.22 3.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -1.204 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.11 -178.27 3.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.24 -10.32 49.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -71.06 -34.48 71.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.156 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.0 -37.13 13.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.402 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 -29.53 63.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.67 48.29 1.51 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.97 -42.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -1.12 . . . . 0.0 109.027 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.465 ' C ' ' O ' ' A' ' 87' ' ' ALA . 2.3 pt -40.98 151.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.398 -0.814 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -129.53 173.42 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 109.669 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.495 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 4.1 p-10 -86.75 -7.86 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.357 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 -47.38 39.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -60.08 4.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 109.409 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.31 -38.25 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 90' ' ' ASN . . . -62.75 -33.87 76.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.55 -22.31 30.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.486 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.02 -24.85 58.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.4 mt -111.21 -19.26 12.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.242 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.47 62.79 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.684 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -97.56 153.23 38.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.335 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.0 152.13 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.547 2.164 . . . . 0.0 112.028 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.41 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 57.6 Cg_endo -74.67 -11.05 22.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.752 2.301 . . . . 0.0 112.229 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -92.01 11.11 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 105' ' ' HIS . 34.7 mttt -139.83 6.56 2.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.454 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 104' ' ' VAL . 3.8 t -47.09 -17.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -51.4 -14.69 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.514 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.628 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 42.2 t -76.05 -71.12 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.668 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.0 p -48.62 -44.06 36.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.7 mt -57.93 -51.83 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp -52.52 -27.91 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.82 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 16.4 tt0 -64.5 -44.92 89.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -35.23 79.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.36 65.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp -58.53 -41.37 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.975 . . . . 0.0 109.567 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.485 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 40.4 tttm -61.27 -28.56 69.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 109.155 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.37 -47.53 19.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.6 -32.41 41.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.92 -41.34 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.42 84.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.11 -52.64 22.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.87 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -49.36 -42.13 41.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.224 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -28.55 63.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 127' ' ' LEU . . . -92.96 4.64 53.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -79.05 -58.45 3.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.37 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -99.22 54.93 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.547 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -161.82 -50.4 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.953 HD13 ' HB1' ' A' ' 123' ' ' ALA . 1.2 mp -35.28 -51.3 0.58 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -1.124 . . . . 0.0 109.423 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -155.5 -141.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.572 ' C ' ' ND1' ' A' ' 129' ' ' HIS . 0.2 OUTLIER -146.31 -83.86 0.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.482 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -155.34 -63.32 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.406 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -86.55 134.08 33.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.908 . . . . 0.0 109.347 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -140.52 -58.1 0.53 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.647 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -110.27 146.27 35.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.631 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.48 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.607 ' O ' ' NZ ' ' A' ' 6' ' ' LYS . 3.7 ttm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.555 ' O ' ' CB ' ' A' ' 3' ' ' TYR . . . -97.34 105.81 18.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER 78.44 98.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.16 -80.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -126.29 29.1 5.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.607 ' NZ ' ' O ' ' A' ' 1' ' ' MET . 6.8 mttt -76.22 -75.35 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.882 . . . . 0.0 109.426 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -61.46 -178.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.183 -0.948 . . . . 0.0 109.367 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 8' ' ' ILE . 5.6 mt 46.56 78.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.09 -99.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.303 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.467 ' O ' ' C ' ' A' ' 11' ' ' TYR . 2.0 t60 -90.07 -64.88 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.181 -0.949 . . . . 0.0 109.304 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 10' ' ' HIS . 3.8 m-85 -42.09 134.24 2.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 109.254 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.7 62.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.581 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.675 ' O ' ' N ' ' A' ' 15' ' ' ARG . 4.0 m-20 177.31 72.09 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -55.91 31.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.761 2.307 . . . . 0.0 112.036 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.675 ' N ' ' O ' ' A' ' 13' ' ' ASN . 9.5 mtt180 52.2 67.93 0.9 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.296 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.51 ' CG ' ' O ' ' A' ' 16' ' ' ASN . 5.8 p30 -161.96 116.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.54 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -54.22 -67.97 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.557 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 136.43 112.24 1.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER 52.11 165.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -1.116 . . . . 0.0 109.574 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.52 ' HB2' HG21 ' A' ' 27' ' ' VAL . 87.8 mt -82.13 88.51 6.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 3.1 t0 73.71 -40.53 0.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 109.525 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 5.5 tttt 74.41 -9.07 1.36 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -0.833 . . . . 0.0 109.731 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -131.0 48.7 2.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -114.92 161.23 18.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.424 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -82.99 9.31 10.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.684 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -118.92 -13.68 9.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.363 -0.836 . . . . 0.0 109.364 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 20' ' ' LEU . 21.1 t -121.12 94.08 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.369 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.73 142.5 20.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -120.94 158.88 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -1.089 . . . . 0.0 109.177 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.15 145.4 12.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 ttt -145.62 119.3 9.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -126.17 170.34 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.75 178.29 28.27 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.29 75.34 70.72 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -1.091 . . . . 0.0 109.187 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 75.3 Cg_exo -44.48 -25.74 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 112.434 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.1 -51.2 8.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.8 p -114.79 -24.54 8.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.45 46.11 1.09 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 36.9 t0 -108.09 135.61 49.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 109.488 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 4.0 m -108.43 137.72 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.9 ttt -137.86 128.56 26.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -117.26 142.91 46.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 109.409 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 tp -149.53 121.09 7.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -117.67 155.41 29.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.849 . . . . 0.0 109.371 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.79 125.48 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.66 ' NZ ' ' OE1' ' A' ' 54' ' ' GLU . 11.2 tttp -100.0 114.71 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -122.39 127.55 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.941 . . . . 0.0 109.495 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 50' ' ' ASN . 6.3 m-20 -158.02 -32.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -62.57 50.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER 78.54 54.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' C ' HG12 ' A' ' 47' ' ' VAL . . . 68.61 18.17 71.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.2 mm -105.73 134.9 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.389 -1.065 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.703 ' O ' HG22 ' A' ' 53' ' ' ILE . 32.4 mt -63.06 80.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.216 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.66 ' OE1' ' NZ ' ' A' ' 46' ' ' LYS . 35.5 tt0 -49.61 -22.73 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.18 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -169.11 159.57 9.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.034 -1.041 . . . . 0.0 109.808 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.05 134.0 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -116.68 144.59 44.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -143.66 170.64 15.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -171.7 96.54 0.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 0.0 108.975 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.32 148.64 42.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -152.79 147.93 26.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.152 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.73 -74.03 0.45 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 1.6 p -116.24 122.18 44.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.134 . . . . 0.0 109.348 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.25 -9.68 2.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 63' ' ' CYS . 0.5 OUTLIER -93.27 10.3 32.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.711 ' HB2' ' SG ' ' A' ' 63' ' ' CYS . . . -100.88 -3.49 29.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.86 -24.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.8 65.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.622 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -76.91 -50.78 12.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.1 t -49.34 -38.41 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.359 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.1 t -72.21 -39.28 68.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 HG23 ' A' ' 93' ' ' ILE . 49.9 tp -61.0 -59.87 4.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.344 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.727 HG23 ' H ' ' A' ' 74' ' ' THR . 1.0 OUTLIER -53.13 -59.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.727 ' H ' HG23 ' A' ' 73' ' ' ILE . 2.4 p -42.86 -32.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.824 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -91.01 -11.31 39.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.782 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -93.87 -17.31 23.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.975 . . . . 0.0 109.533 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.36 40.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -95.89 116.93 29.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.43 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.69 5.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -73.74 -173.78 1.6 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.4 m -101.49 158.4 16.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.865 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -70.21 -16.56 63.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.86 -26.22 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.208 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -93.43 -43.4 8.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.376 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.21 67.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.47 33.11 4.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.1 26.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -1.109 . . . . 0.0 109.253 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.57 -25.02 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.832 . . . . 0.0 109.621 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 71.16 156.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.448 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.684 ' ND2' ' OE1' ' A' ' 111' ' ' GLU . 2.6 p30 -93.48 -41.96 9.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.616 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -35.96 79.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -58.54 -67.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.408 HG23 HD23 ' A' ' 72' ' ' LEU . 4.3 mt -49.8 -33.47 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.751 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 107' ' ' SER . . . -69.3 -31.08 69.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 109.741 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.4 -36.14 60.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.23 -43.3 82.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.25 -17.15 62.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.404 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 54.24 39.08 30.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.3 pp -82.27 149.0 60.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.304 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.404 ' O ' HD12 ' A' ' 99' ' ' LEU . 29.3 Cg_endo -66.16 149.31 85.63 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.645 2.23 . . . . 0.0 112.147 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -73.2 20.06 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.926 2.417 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.0 m -85.47 -13.52 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.885 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 105' ' ' HIS . 1.0 OUTLIER -150.12 55.8 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.849 ' O ' HG12 ' A' ' 104' ' ' VAL . 74.5 t -73.3 40.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.467 ' H ' ' C ' ' A' ' 103' ' ' LYS . 62.4 m80 -97.42 -26.46 14.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.868 . . . . 0.0 109.718 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.642 ' SG ' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -74.94 -45.11 44.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.626 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.642 ' N ' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -53.84 -46.92 71.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 56.2 mt -68.05 -43.65 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.4 mp -58.27 -37.35 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -63.33 -59.07 5.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.422 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.684 ' OE1' ' ND2' ' A' ' 90' ' ' ASN . 87.1 tt0 -56.09 -60.51 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.362 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 111' ' ' GLU . 1.6 t0 -43.9 -32.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.354 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -68.89 -61.2 1.9 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.46 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 tp -49.61 -20.68 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -85.26 -57.9 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.353 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.56 5.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.225 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.94 -58.03 3.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.126 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.5 mt -46.72 -31.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.365 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.89 38.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.05 -0.79 12.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.147 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -102.81 -32.05 10.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -95.74 -31.4 13.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.26 -18.18 63.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.484 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.49 5.61 30.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -100.99 -21.66 14.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 109.287 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -87.21 -18.75 56.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 128' ' ' GLU . 3.5 tp -69.66 -15.13 63.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.425 -1.044 . . . . 0.0 109.223 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' A' ' 130' ' ' HIS . 1.6 tt0 41.92 87.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.328 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.45 ' C ' ' O ' ' A' ' 128' ' ' GLU . 1.9 m-70 -41.24 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 109.643 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.652 ' N ' ' O ' ' A' ' 128' ' ' GLU . 0.9 OUTLIER -102.89 -139.44 0.35 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.207 -0.933 . . . . 0.0 109.141 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.525 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 48.9 t-80 -45.11 156.23 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.31 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.51 ' N ' ' HD1' ' A' ' 131' ' ' HIS . 40.1 m80 -123.15 167.99 12.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.501 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.13 146.62 32.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.69 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 1.9 t60 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.522 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.59 139.29 30.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.425 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -89.14 79.94 7.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -123.56 38.69 4.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.319 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.85 73.68 3.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HG2' ' H ' ' A' ' 6' ' ' LYS . 7.0 pttp -83.93 19.36 1.76 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.301 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 7' ' ' VAL . 25.7 m -89.22 62.47 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.469 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 mt -83.69 21.26 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.267 -0.895 . . . . 0.0 109.474 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -119.51 -72.19 0.7 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.61 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.512 ' C ' ' O ' ' A' ' 9' ' ' ASP . 37.7 t60 36.69 63.75 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -106.58 58.47 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 109.59 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -127.85 -51.23 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.624 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 12' ' ' GLU . 2.4 m120 -42.33 157.88 0.22 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.51 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 15' ' ' ARG . 53.6 Cg_endo -73.93 -0.08 9.01 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.883 2.389 . . . . 0.0 112.314 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.545 ' O ' ' O ' ' A' ' 14' ' ' PRO . 16.2 mmm180 57.94 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.313 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -100.17 59.56 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.963 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 18' ' ' GLY . 9.4 p -57.55 165.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' N ' HG22 ' A' ' 17' ' ' VAL . . . 142.66 -65.38 0.48 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 160.54 22.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.3 mt -124.88 142.01 51.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.509 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER 53.2 90.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.35 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 1.47 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 21' ' ' ASP . 11.7 ttmt -60.36 -22.65 63.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.951 . . . . 0.0 109.015 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 57.23 25.26 10.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -71.27 2.4 4.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.277 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 25' ' ' SER . 2.4 p30 165.75 33.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.41 96.76 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.454 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.0 100.95 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 m -86.17 133.16 33.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -1.152 . . . . 0.0 109.657 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.33 145.78 17.57 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.21 110.8 5.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -1.213 . . . . 0.0 109.774 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.77 144.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.34 178.17 21.09 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.93 92.57 49.07 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.139 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.8 Cg_exo -50.15 -40.15 51.28 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.852 2.368 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.43 -44.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 109.671 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.32 -13.03 9.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.599 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.22 57.9 2.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -113.35 110.84 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.5 130.54 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.99 118.96 15.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -111.14 136.23 50.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.707 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' CB ' ' HB1' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -126.35 141.89 51.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -140.84 135.84 31.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -118.09 136.01 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' CD ' ' OD2' ' A' ' 55' ' ' ASP . 36.8 tttt -105.87 118.92 37.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.25 146.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.7 m-20 -173.92 -33.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -62.47 42.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.672 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.1 m120 80.99 43.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 109.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.13 0.54 82.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.525 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.0 mm -98.23 151.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.494 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -84.39 116.03 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -44.57 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD2' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -130.11 131.2 45.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.561 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.96 121.51 45.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.425 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 115.13 29.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.402 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.744 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -101.78 167.91 9.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 83.74 1.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.92 127.47 41.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.47 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -151.57 141.56 22.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.596 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.98 -53.06 0.59 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 42.6 t -91.11 172.57 8.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -1.188 . . . . 0.0 109.442 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.495 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -129.92 -10.85 2.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.8 13.65 30.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -1.112 . . . . 0.0 109.368 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.93 -31.37 9.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.845 . . . . 0.0 109.486 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.6 mp -36.7 -35.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.933 . . . . 0.0 109.172 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -75.44 -55.86 5.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.7 m -51.11 -39.87 57.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -70.05 -66.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.67 -19.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.328 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -79.75 -78.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.937 . . . . 0.0 109.573 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 74' ' ' THR . 11.3 tt -45.95 -36.77 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.57 HG21 ' CG ' ' A' ' 58' ' ' PHE . 43.7 p -68.76 -39.07 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.82 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -79.78 -12.22 59.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -98.6 -26.36 14.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.539 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.3 -34.76 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -50.73 116.31 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.41 57.49 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -89.22 -177.89 5.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.391 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.525 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 50.6 m -107.17 -178.95 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.9 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.2 mt -77.68 -23.07 49.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 -14.22 60.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.378 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -101.23 -41.95 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.14 1.71 56.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.6 47.07 1.08 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -176.85 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -1.127 . . . . 0.0 109.394 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.498 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -38.16 155.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -116.43 158.6 23.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.539 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.534 ' OD1' ' OE1' ' A' ' 111' ' ' GLU . 1.4 p-10 -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -47.55 -37.06 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.19 -66.97 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 109.555 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -44.95 -44.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.46 -39.76 77.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.105 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -75.86 -10.01 59.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.234 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -79.47 -62.87 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 97' ' ' LEU . 6.2 mt -72.52 -2.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.09 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 46.9 77.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 110.086 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.608 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.4 OUTLIER -126.69 148.52 65.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 108.875 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -37.78 148.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.887 2.391 . . . . 0.0 112.358 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.71 -79.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.676 2.251 . . . . 0.0 112.348 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 103' ' ' LYS . 3.3 t 47.16 -138.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.195 -0.941 . . . . 0.0 109.298 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.69 ' H ' HG12 ' A' ' 102' ' ' VAL . 14.6 tttt -78.42 -6.45 55.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 104' ' ' VAL . 12.0 p 31.97 41.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.485 -0.759 . . . . 0.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.666 ' HA ' HD12 ' A' ' 108' ' ' ILE . 16.0 p80 -68.65 -24.4 64.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.8 t -59.48 -71.18 0.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 69.6 m -46.35 -42.19 14.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.299 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 105' ' ' HIS . 87.5 mt -54.77 -70.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 108' ' ' ILE . 6.4 mp -36.64 -34.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 109.452 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -61.4 -72.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' OD1' ' A' ' 90' ' ' ASN . 16.9 tt0 -54.49 -38.33 66.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -27.99 68.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.892 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 43' ' ' LEU . . . -79.09 -58.26 3.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.529 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.5 tp -44.7 -39.5 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 109.548 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -67.79 -55.9 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.553 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -45.54 -50.17 13.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.87 -59.98 4.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.506 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.9 mt -52.02 -22.18 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -73.25 -49.93 25.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.47 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -68.77 -50.85 47.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -48.53 -50.56 31.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 123' ' ' ALA . 3.4 mttm -65.13 -39.36 92.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.626 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -43.16 -42.82 4.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -53.61 -43.96 69.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.928 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -51.22 -21.78 2.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 109.666 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.94 28.96 11.04 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.6 mt 54.28 14.98 0.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -1.197 . . . . 0.0 109.54 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.575 ' C ' ' CG ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER 61.63 -173.97 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.433 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.575 ' CG ' ' C ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER 179.1 81.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.586 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 2.1 t60 -138.06 13.34 2.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.319 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -50.7 161.89 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.559 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.661 ' N ' ' ND1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -173.76 69.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.376 -0.827 . . . . 0.0 109.497 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.528 ' O ' ' C ' ' A' ' 134' ' ' HIS . 9.8 m-70 -101.74 -117.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.528 ' C ' ' O ' ' A' ' 133' ' ' HIS . 35.5 m170 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.455 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.258 0.552 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.91 -159.24 0.29 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.945 . . . . 0.0 109.524 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -100.31 -5.7 27.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.409 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -132.49 163.1 29.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 4' ' ' SER . 3.3 tp10 75.05 55.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 109.517 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.35 -56.15 4.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 7' ' ' VAL . 5.1 t -58.19 151.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.346 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 mt -66.9 -57.92 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -148.68 153.27 38.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.384 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -94.61 60.66 2.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 0.0 109.496 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -164.06 147.67 9.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.537 ' C ' ' OD1' ' A' ' 13' ' ' ASN . 72.7 mt-10 -145.14 -120.6 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.2 -0.937 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.537 ' OD1' ' C ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -148.9 162.23 30.05 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.37 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.18 -28.45 28.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.757 2.304 . . . . 0.0 112.013 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.728 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -73.19 124.75 26.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.81 6.59 2.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.109 -0.994 . . . . 0.0 109.627 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.89 29.07 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.516 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.53 158.9 23.22 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 20' ' ' LEU . 26.7 p -144.06 -129.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.165 . . . . 0.0 109.438 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.541 ' N ' ' OG ' ' A' ' 19' ' ' SER . 3.0 tp 77.15 -28.26 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.553 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -46.43 -15.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.501 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 22.3 tttt 78.13 -21.64 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 21' ' ' ASP . 3.2 pttt -117.04 36.03 4.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.878 . . . . 0.0 109.391 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -102.89 158.55 16.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.439 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 13.13 14.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.888 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -108.83 16.95 22.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.07 116.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.16 140.18 15.6 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.3 m -119.89 120.51 36.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.1 132.94 6.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -136.02 131.43 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -1.141 . . . . 0.0 109.282 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.03 -174.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.23 -169.17 38.71 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -140.31 100.51 6.97 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' CYS . 69.0 Cg_exo -47.06 -60.55 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.52 2.146 . . . . 0.0 112.152 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.71 -20.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 35' ' ' PRO . 3.7 m -118.85 -32.39 4.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 81.0 25.81 54.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.78 132.39 35.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -1.115 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -107.36 115.39 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.7 ttt -113.94 102.15 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -84.92 155.04 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.51 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.89 110.83 2.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -115.26 123.56 49.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.405 HG13 ' H ' ' A' ' 45' ' ' ILE . 0.6 OUTLIER -103.95 153.23 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -126.0 134.38 51.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.75 148.1 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.199 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.58 -94.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.039 -1.038 . . . . 0.0 109.612 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -156.43 20.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.46 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -1.2 3.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.915 . . . . 0.0 109.46 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.11 15.06 31.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mm -105.32 122.35 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -1.147 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.0 mt -67.82 111.93 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.253 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' O ' ' CD ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -88.19 -8.07 55.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.817 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 56' ' ' ALA . 7.0 t70 -171.96 165.86 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 55' ' ' ASP . . . -149.55 139.79 22.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 165.46 24.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD1' HG21 ' A' ' 74' ' ' THR . 8.3 p90 -170.61 -174.49 1.63 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.809 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -172.03 111.08 0.28 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.038 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.1 p -84.32 149.45 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.816 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.7 116.09 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.37 -0.832 . . . . 0.0 109.316 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.49 -87.23 0.14 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 140.32 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -1.11 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.11 55.37 3.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.55 -32.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -83.6 1.23 43.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 67' ' ' ILE . 5.8 mm -59.07 4.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -94.09 -38.66 11.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -70.62 -52.82 18.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -53.11 -33.67 53.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.514 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' ' OG1' ' A' ' 74' ' ' THR . 6.2 m -71.51 -35.77 70.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.97 -65.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.802 ' O ' HG22 ' A' ' 77' ' ' VAL . 1.2 tt -46.12 -39.56 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.781 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 70' ' ' SER . 16.6 p -62.89 -40.01 96.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 1.39 51.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.902 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -17.37 14.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.823 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 73' ' ' ILE . 17.8 m -114.03 53.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.039 . . . . 0.0 109.648 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -126.26 104.34 8.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.375 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -24.02 33.99 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -65.38 -179.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.405 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.6 159.17 15.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.124 -0.985 . . . . 0.0 109.65 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mt -56.43 -22.29 30.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.888 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.08 -46.47 70.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.138 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.81 -45.58 93.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.132 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.46 72.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.153 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 49.0 4.15 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.98 -32.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -1.075 . . . . 0.0 109.182 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.544 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -34.16 -44.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.45 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 88' ' ' ILE . 49.3 mttt 57.79 145.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.835 . . . . 0.0 109.559 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.35 -28.82 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 0.0 109.37 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.3 p -54.53 -39.86 68.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -53.9 12.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.425 ' H ' HG13 ' A' ' 93' ' ' ILE . 23.3 mt -51.49 -40.61 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.45 -58.82 5.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.392 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.63 -53.01 34.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.214 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -47.24 -50.51 21.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.342 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.5 mp -70.19 -40.34 74.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.357 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 1.8 tp10 81.71 32.6 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.19 146.14 50.6 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 102' ' ' VAL . 20.5 Cg_endo -64.77 152.59 81.5 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.558 2.172 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.11 20.11 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.875 2.383 . . . . 0.0 112.131 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 100' ' ' PRO . 33.0 m -87.93 -21.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.63 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -137.18 47.74 2.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.793 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.45 -9.5 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 108.998 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.764 ' O ' HD13 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -56.28 -27.15 54.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 45.2 t -69.87 -64.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -49.59 -65.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.363 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 107' ' ' SER . 80.0 mt -40.98 -44.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 105' ' ' HIS . 2.0 mp -57.46 -44.23 84.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -57.69 -48.1 80.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.271 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -59.61 -59.68 5.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 -25.89 3.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.885 . . . . 0.0 109.441 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -72.1 -38.9 69.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 111' ' ' GLU . 2.1 tp -70.23 -35.76 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.476 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 13.7 mttt -77.92 -30.4 50.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.531 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.86 -43.85 87.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.358 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.14 77.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.273 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.16 -45.72 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.429 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.83 75.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 29' ' ' THR . 4.8 m-20 -66.92 -8.64 30.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -87.22 -52.36 5.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -61.89 -41.78 98.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.633 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.51 -0.59 5.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.7 18.1 22.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.429 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -90.16 -69.58 0.72 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -89.41 -10.88 65.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.56 ' N ' ' OE2' ' A' ' 128' ' ' GLU . 11.4 mt 61.44 41.27 12.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -1.16 . . . . 0.0 109.384 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.635 ' CD ' ' H ' ' A' ' 128' ' ' GLU . 2.4 pm0 -89.16 166.99 13.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.279 -0.888 . . . . 0.0 109.45 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 128' ' ' GLU . 51.3 m80 -155.68 -137.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.862 . . . . 0.0 109.383 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -135.92 -29.4 1.02 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -0.98 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -162.48 97.7 0.99 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 109.698 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.708 ' N ' ' ND1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -134.21 109.92 9.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.932 . . . . 0.0 109.307 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -111.17 11.14 21.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.973 . . . . 0.0 109.491 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.438 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.403 ' O ' ' CE2' ' A' ' 3' ' ' TYR . 3.5 ttm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.313 0.578 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.5 150.33 24.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.512 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 1' ' ' MET . 39.5 m-85 -134.28 -18.54 1.99 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.466 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -48.52 73.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.97 -129.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.723 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.85 87.99 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.563 ' C ' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -106.86 -56.86 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.524 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.789 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.7 mp 53.97 109.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.433 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 3.7 p30 -143.35 -13.62 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 0.0 109.638 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.661 ' ND1' ' N ' ' A' ' 11' ' ' TYR . 3.3 p80 -70.99 -106.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.661 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 50.8 t80 44.6 53.38 7.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.677 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 3.5 pm0 -65.91 142.67 57.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.466 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.64 155.93 68.25 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.614 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.92 140.25 37.9 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.881 2.387 . . . . 0.0 112.442 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -100.14 -177.24 3.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.57 ' OD1' HG22 ' A' ' 17' ' ' VAL . 17.1 p-10 -166.85 -50.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 109.684 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.57 HG22 ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -92.0 120.87 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.623 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' SER . . . -111.91 -109.95 3.08 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER 44.36 77.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -1.153 . . . . 0.0 109.633 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 21' ' ' ASP . 12.3 mt -64.94 160.84 19.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.445 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 20' ' ' LEU . 2.8 m-20 -49.72 174.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.355 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -81.01 16.16 1.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.142 -0.974 . . . . 0.0 109.403 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 23' ' ' LYS . 19.8 ttpt -83.37 -11.93 57.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.516 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.95 156.59 16.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.527 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -92.11 12.31 22.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.333 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -114.89 19.96 15.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.0 t -139.29 99.42 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.52 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.04 120.87 5.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -82.96 136.69 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 109.52 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.12 85.59 0.32 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mtt -94.69 107.27 19.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -1.103 . . . . 0.0 109.559 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.1 170.78 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.526 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.94 -173.21 34.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.1 87.09 55.97 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.184 . . . . 0.0 109.481 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.94 -12.8 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.736 2.291 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.8 m -120.18 -38.68 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.5 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.12 36.88 0.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.41 115.8 28.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.127 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.72 131.23 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.091 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -134.55 131.5 38.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.801 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 5.4 tt0 -125.41 131.88 52.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.274 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -142.96 111.87 6.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.506 ' NE2' ' OE1' ' A' ' 42' ' ' GLN . 9.2 mt-30 -103.22 143.92 32.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.454 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.3 OUTLIER -106.77 147.5 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.574 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 117.94 29.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.8 134.0 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.675 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.6 m-20 -170.39 -31.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.575 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 14.0 m-20 -62.7 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.092 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-80 74.49 48.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.488 -0.758 . . . . 0.0 109.067 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.65 -8.54 58.97 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 53' ' ' ILE . 45.2 mm -87.71 162.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.524 ' N ' HG22 ' A' ' 52' ' ' ILE . 62.3 mt -79.37 120.33 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.75 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.38 -31.9 21.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.64 157.11 1.99 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.221 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.87 139.09 50.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -103.22 117.66 35.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 74' ' ' THR . 15.1 p90 -103.88 166.42 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.5 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -167.05 93.49 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.357 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.78 135.66 50.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.505 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -150.59 139.61 21.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.71 -45.21 0.76 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.6 OUTLIER -119.58 123.71 44.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -1.107 . . . . 0.0 109.389 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 67.19 0.17 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.6 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -174.8 -48.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -1.15 . . . . 0.0 109.633 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.03 -2.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.6 ' H ' ' C ' ' A' ' 65' ' ' SER . 6.2 mm -82.4 -12.05 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.317 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.16 -48.45 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 109.683 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.545 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -63.72 -40.68 97.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.687 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 74' ' ' THR . 1.0 OUTLIER -55.25 -47.16 75.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.72 -42.99 99.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.862 . . . . 0.0 109.813 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.412 HD21 ' OE1' ' A' ' 96' ' ' GLU . 1.9 tp -61.93 -68.25 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.61 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.635 HG23 ' N ' ' A' ' 74' ' ' THR . 17.7 tt -47.99 -49.61 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.754 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.635 ' N ' HG23 ' A' ' 73' ' ' ILE . 6.5 p -50.49 -46.79 57.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.84 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.52 -5.42 54.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -5.98 26.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.52 -5.85 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.22 114.09 19.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.627 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.21 -6.72 63.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -91.24 165.48 13.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -1.21 . . . . 0.0 109.635 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.486 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 18.1 m -100.42 166.98 10.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.543 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -23.44 67.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.51 -44.82 93.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.83 -59.03 2.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.92 . . . . 0.0 109.387 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.42 -26.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.269 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.17 44.21 1.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.554 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -161.99 -37.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.096 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.554 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.0 pt -41.54 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -136.84 154.49 50.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.54 ' O ' ' C ' ' A' ' 91' ' ' SER . 18.5 p-10 -73.77 -50.71 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.54 ' C ' ' O ' ' A' ' 90' ' ' ASN . 4.0 t -35.01 -46.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.536 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.94 -49.9 72.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.2 mt -55.68 -35.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.221 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.95 -24.3 60.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -81.6 -47.47 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.412 ' OE1' HD21 ' A' ' 72' ' ' LEU . 11.2 tt0 -62.28 -29.36 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 99' ' ' LEU . 1.3 mp -98.05 -28.81 13.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.534 ' O ' ' C ' ' A' ' 99' ' ' LEU . 1.6 tt0 64.8 -2.94 0.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.259 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.534 ' C ' ' O ' ' A' ' 98' ' ' GLU . 1.7 pp -34.58 150.23 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.477 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -40.33 108.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.858 2.372 . . . . 0.0 112.097 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.23 8.54 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.536 2.157 . . . . 0.0 112.445 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 102' ' ' VAL . 2.5 m -56.84 -14.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -153.11 -38.8 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' CYS . 5.9 t 64.85 5.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.471 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 7.6 p-80 -45.6 -20.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' VAL . 1.8 m -75.41 -75.67 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 4.4 m -43.24 -38.78 2.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.8 mt -57.86 -52.65 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.5 mp -59.25 -23.08 62.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -66.74 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.534 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 6.9 tp10 -60.08 -40.06 88.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -27.69 69.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.177 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -73.44 -65.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.47 HG22 ' OE1' ' A' ' 111' ' ' GLU . 2.4 tp -43.08 -33.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -67.6 -73.25 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.352 -0.843 . . . . 0.0 109.414 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.544 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -35.48 -36.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' LYS . . . -60.96 -63.93 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.9 mt -47.49 -25.34 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.412 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -67.1 -59.22 3.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -61.58 -40.28 94.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.313 -0.867 . . . . 0.0 109.093 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -52.43 -57.77 8.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 109.188 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' LYS . 1.7 ttmm -54.44 -47.94 72.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.478 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -44.43 -21.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.51 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 122' ' ' LYS . 42.6 mmtt -98.4 -49.64 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.387 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -119.27 68.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.602 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -95.29 -93.28 1.72 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mt -114.51 -17.51 11.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -1.145 . . . . 0.0 109.175 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 58.15 175.54 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.847 . . . . 0.0 109.609 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.75 25.1 11.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 109.298 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -153.1 106.4 3.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' A' ' 132' ' ' HIS . 6.8 t-80 -129.42 118.0 21.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.68 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.59 ' O ' ' CE1' ' A' ' 131' ' ' HIS . 23.9 t60 -84.65 149.52 25.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.421 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 132' ' ' HIS . 2.2 m-70 -42.75 -48.9 5.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.411 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 2' ' ' ALA . 16.2 mtp . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -42.57 -72.89 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.78 124.99 22.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.193 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -120.33 -9.39 9.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 109.679 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.5 ' C ' ' CD ' ' A' ' 5' ' ' GLU . 3.0 tm-20 -74.85 101.44 4.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -153.24 53.0 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.539 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 8' ' ' ILE . 14.7 p -106.4 157.41 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.426 ' N ' HG22 ' A' ' 7' ' ' VAL . 11.5 mt -99.79 146.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.55 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.635 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -120.53 -87.36 0.64 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.39 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -60.49 -175.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.432 ' C ' ' CD ' ' A' ' 12' ' ' GLU . 60.6 m-85 -109.98 -116.87 0.29 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 109.368 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.432 ' CD ' ' C ' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -131.34 -176.15 3.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.922 . . . . 0.0 109.385 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.433 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 13.8 p-10 -144.34 80.06 12.32 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.955 . . . . 0.0 109.423 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 15' ' ' ARG . 50.1 Cg_exo -48.8 -179.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.762 2.308 . . . . 0.0 112.188 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.563 ' O ' ' O ' ' A' ' 14' ' ' PRO . 11.1 mtp180 36.1 95.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.7 127.65 56.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.344 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 t -120.34 126.96 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.403 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.83 145.7 10.93 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.655 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -70.48 -169.37 0.31 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -1.124 . . . . 0.0 109.464 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 mt 61.58 -33.94 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 109.68 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.655 ' N ' ' O ' ' A' ' 19' ' ' SER . 9.5 t0 -82.42 168.42 17.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.587 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -85.39 23.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.445 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -115.39 22.45 13.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.96 165.06 18.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.521 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 3.3 m -103.97 -0.41 28.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.71 11.98 36.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.336 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.37 110.06 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.86 145.68 17.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 m -139.96 137.28 34.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.6 150.73 22.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.9 mtt -144.11 105.0 4.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -1.112 . . . . 0.0 109.209 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.25 -176.15 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.84 157.11 17.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.63 138.4 20.61 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.178 -1.189 . . . . 0.0 109.466 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.99 3.72 4.28 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.609 2.206 . . . . 0.0 112.216 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.17 -79.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -109.37 20.74 17.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.354 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 53.51 16.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.644 ' OD2' ' SG ' ' A' ' 63' ' ' CYS . 1.5 m-20 -86.56 116.93 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -1.105 . . . . 0.0 109.698 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -95.09 121.17 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 109.211 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.34 112.89 20.62 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.168 -0.957 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -99.76 140.15 34.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 109.084 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.428 HD21 HD12 ' A' ' 114' ' ' ILE . 3.3 tt -151.11 121.31 7.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.727 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -126.49 176.79 6.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.98 157.44 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -131.88 134.93 46.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.582 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 30.0 t -124.9 122.65 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.686 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.3 m-20 -157.78 -32.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.546 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 11.1 t70 -62.22 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER 78.89 52.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -0.833 . . . . 0.0 109.535 179.784 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.86 9.45 66.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 53' ' ' ILE . 43.6 mm -105.03 155.52 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -1.18 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.42 ' N ' HG22 ' A' ' 52' ' ' ILE . 74.4 mt -75.27 114.46 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -85.37 -35.35 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.73 164.2 31.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.72 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.14 120.36 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.303 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -99.21 122.48 42.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.868 ' CD2' HG21 ' A' ' 74' ' ' THR . 11.6 p90 -139.7 160.49 39.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -140.02 120.02 13.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.305 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.6 HG21 ' OG ' ' A' ' 70' ' ' SER . 7.1 p -121.44 137.48 54.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.733 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -162.12 100.73 1.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.8 -50.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.975 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.644 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 11.5 m -122.01 179.1 4.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -1.232 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.752 ' O ' HG22 ' A' ' 67' ' ' ILE . . . -102.87 -21.08 10.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . 9.6 t -83.91 -66.68 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -1.164 . . . . 0.0 109.412 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -45.66 -21.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.323 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 64' ' ' GLY . 0.6 OUTLIER -64.79 -5.04 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.396 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.19 -55.33 2.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.5 m -52.47 -45.55 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.6 ' OG ' HG21 ' A' ' 60' ' ' THR . 0.5 OUTLIER -50.24 -51.41 44.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.64 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.98 -43.52 81.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.754 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.19 -68.5 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.9 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.633 HG23 ' N ' ' A' ' 74' ' ' THR . 9.1 tt -50.86 -53.05 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.868 HG21 ' CD2' ' A' ' 58' ' ' PHE . 33.4 p -48.01 -28.37 2.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.814 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -101.29 -4.62 26.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -89.84 -18.16 26.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.68 26.18 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -102.75 103.83 14.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.43 0.15 27.9 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -100.38 -176.51 3.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -1.14 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -108.23 173.85 6.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.594 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.8 mt -65.58 -18.04 65.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.594 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.42 -30.57 67.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -86.43 -53.17 5.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.57 -18.89 64.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.351 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.93 40.1 2.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -158.02 -35.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -1.089 . . . . 0.0 109.24 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -44.65 169.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -133.01 -170.4 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.185 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -99.02 -30.33 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.59 -40.83 93.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 95' ' ' GLU . 12.7 mm100 -58.5 -70.92 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.644 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 93' ' ' ILE . 40.9 mt -44.46 -34.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.99 73.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 92' ' ' GLN . 2.2 tt0 -80.65 -15.49 56.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.193 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -81.24 -51.98 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -78.79 -22.98 45.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 2.4 tt0 73.2 36.15 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.449 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -74.37 146.0 83.45 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.4 155.74 50.64 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.658 2.239 . . . . 0.0 112.261 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.6 Cg_endo -75.31 -2.24 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.852 2.368 . . . . 0.0 112.374 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.87 -2.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.657 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 101' ' ' PRO . 29.4 tttt -166.07 61.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 106' ' ' CYS . 20.4 t -60.63 -25.79 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.422 ' ND1' ' CD1' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -49.15 -17.9 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.159 -0.963 . . . . 0.0 109.287 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -74.01 -62.86 1.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.9 t -57.19 -36.55 70.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.319 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 109' ' ' LEU . 4.6 mt -61.43 -64.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.268 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.543 ' N ' HG22 ' A' ' 108' ' ' ILE . 2.7 mp -42.61 -41.12 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -54.92 -63.4 1.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 109.677 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 112' ' ' ASP . 2.1 tm-20 -52.89 -67.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 111' ' ' GLU . 11.4 t70 -37.47 -37.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -60.88 -67.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.81 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.9 tp -41.14 -39.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.9 tmtt? -58.82 -55.3 36.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.98 -56.66 9.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.689 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.96 5.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.587 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 66.7 mt -75.55 -59.63 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -37.02 -51.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 122' ' ' LYS . 27.2 t0 -68.69 -58.09 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 109.701 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.534 ' C ' ' O ' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -33.17 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 109.7 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.676 ' HB2' ' HZ2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -96.93 -34.24 11.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.585 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -78.96 -17.78 54.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 123' ' ' ALA . 0.2 OUTLIER -41.99 -41.64 2.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -84.15 -32.45 24.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.563 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.43 3.35 55.41 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 128' ' ' GLU . 2.9 mm? -61.54 -42.05 98.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -1.104 . . . . 0.0 109.553 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 127' ' ' LEU . 5.7 mt-10 39.06 86.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 109.367 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -144.57 119.38 9.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 109.604 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -154.15 -54.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.638 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 1.7 t60 -151.11 -129.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.365 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.638 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 95.4 m-70 -141.42 -56.41 0.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -46.93 -72.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.458 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.63 ' OXT' ' CG ' ' A' ' 134' ' ' HIS . 4.1 p80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.586 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.313 0.578 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -82.21 -12.94 57.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.347 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -92.88 10.77 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.387 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 t -136.55 117.58 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.84 130.34 10.24 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 m -110.44 147.73 33.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.453 -1.028 . . . . 0.0 109.322 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.79 117.6 0.82 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.15 108.41 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.279 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.27 -172.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.33 -171.52 38.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -131.84 74.88 76.76 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.16 . . . . 0.0 109.653 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.27 -2.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.786 2.324 . . . . 0.0 112.148 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -79.48 -7.89 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 3.2 m -149.93 -56.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.927 . . . . 0.0 109.477 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.472 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . 144.03 54.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -124.9 136.64 53.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -1.186 . . . . 0.0 109.347 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.78 135.97 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.66 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.9 ttt -133.68 136.96 45.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.504 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -129.63 126.97 39.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 tt -132.47 132.82 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -131.08 133.5 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.153 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -116.16 149.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 14.5 tttm -111.59 136.3 50.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.714 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 82' ' ' LEU . 24.7 t -129.28 116.57 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.168 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.691 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.8 m-20 -159.96 -34.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 109.893 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 51.8 t0 -62.29 50.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.305 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.9 m-20 81.61 54.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.505 -0.747 . . . . 0.0 109.266 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.64 0.98 9.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 53' ' ' ILE . 3.8 mm -93.01 164.25 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.292 -1.122 . . . . 0.0 109.468 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.581 ' N ' HG22 ' A' ' 52' ' ' ILE . 3.3 mt -97.32 114.38 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -97.38 -38.86 9.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -124.39 151.33 44.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 109.783 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.61 99.56 3.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -94.4 175.21 6.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.641 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' A' ' 74' ' ' THR . 45.4 p90 -165.02 176.91 8.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.474 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -166.31 110.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 41' ' ' MET . 10.7 p -129.13 96.65 4.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.954 . . . . 0.0 109.487 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -115.14 104.21 11.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.48 -41.3 0.28 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' SER . 1.4 t -106.76 105.62 15.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -1.086 . . . . 0.0 109.219 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -67.0 74.44 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 67' ' ' ILE . 1.2 p 162.74 -42.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -1.172 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.45 1.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.582 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.5 mp -73.32 -54.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.52 -71.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 73' ' ' ILE . 7.4 t -45.78 -43.03 12.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 109.613 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.0 -36.33 38.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.644 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -31.25 57.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -54.98 7.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 74' ' ' THR . 10.9 tt -58.18 -47.91 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.598 ' N ' HG23 ' A' ' 73' ' ' ILE . 11.9 p -61.19 -34.19 74.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.08 -7.82 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.13 -0.981 . . . . 0.0 109.623 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -87.13 -36.82 17.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.419 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' GLY . 35.5 m -88.31 -28.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -47.98 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 77' ' ' VAL . . . 120.38 -26.97 6.81 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.639 ' NZ ' ' OE1' ' A' ' 84' ' ' GLU . 7.1 mtpt -74.13 -165.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.92 163.5 24.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.97 . . . . 0.0 109.596 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 47' ' ' VAL . 17.6 mt -55.81 -37.58 68.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.34 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -56.12 -32.56 64.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.3 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE1' ' NZ ' ' A' ' 80' ' ' LYS . 38.7 mt-10 -84.2 -42.96 15.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -60.45 -30.83 69.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.15 43.86 3.07 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.04 -35.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.129 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 88' ' ' ILE . 2.4 pt -52.52 157.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.455 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -129.23 164.99 22.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -30.08 69.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -60.65 -29.09 69.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -58.99 -56.22 25.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 mp -70.41 -38.97 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.96 55.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.623 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.42 -43.03 15.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.591 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' O ' ' CD ' ' A' ' 96' ' ' GLU . 12.6 tm-20 -63.93 -23.18 67.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.67 -37.9 9.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 67.57 73.44 0.32 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.51 149.17 60.9 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.86 157.71 41.84 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.759 2.306 . . . . 0.0 112.069 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.56 15.01 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.818 2.345 . . . . 0.0 112.315 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.0 m -104.87 16.75 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -151.73 18.24 0.7 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 104' ' ' VAL . 10.6 t -57.69 -14.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -51.19 -27.13 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 2.1 m -77.63 -75.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.524 ' C ' ' O ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -36.28 -33.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 106' ' ' CYS . 8.5 mt -68.26 -54.97 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 6.3 mp -59.77 -19.64 51.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.57 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -72.46 -64.88 0.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 114' ' ' ILE . 3.1 tm-20 -64.36 -45.74 86.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -54.64 -35.87 63.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.214 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 109' ' ' LEU . . . -63.22 -57.83 9.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 111' ' ' GLU . 0.4 OUTLIER -50.01 -36.29 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.413 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.401 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.8 tttt -63.24 -37.86 88.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.02 76.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.54 93.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.93 . . . . 0.0 109.501 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.61 -40.86 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.66 88.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.483 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.31 -16.38 60.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.413 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' A' ' 25' ' ' SER . 93.1 t80 -79.39 -31.61 42.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -94.27 -22.63 18.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.53 -18.48 58.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.468 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.505 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.67 6.14 36.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -120.21 -15.94 8.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.697 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.8 t -103.12 128.95 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.353 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -127.05 149.75 17.8 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 120' ' ' ASP . 52.2 m -127.71 149.16 50.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -1.081 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.87 125.37 2.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 ttt -119.74 92.9 3.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -1.205 . . . . 0.0 109.367 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 m -103.56 163.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 109.286 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.27 -176.08 29.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -138.26 96.07 10.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.337 -1.096 . . . . 0.0 109.386 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.501 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.9 Cg_exo -56.66 -26.37 64.76 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.652 2.235 . . . . 0.0 112.28 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.93 -59.99 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.34 -48.31 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.62 52.78 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -116.34 117.22 29.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.151 . . . . 0.0 109.416 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 m -105.92 141.47 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.495 ' SD ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -135.9 128.82 31.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.28 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.808 HE21 ' NE2' ' A' ' 44' ' ' GLN . 25.4 tt0 -112.68 125.0 53.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.616 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tp -124.01 136.4 54.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.808 ' NE2' HE21 ' A' ' 42' ' ' GLN . 12.8 mt-30 -118.85 145.78 45.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 109.654 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.667 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.1 pp -126.31 126.09 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -103.21 109.33 20.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.466 HG23 HD12 ' A' ' 45' ' ' ILE . 24.5 t -94.57 110.83 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 47' ' ' VAL . 1.1 t70 -40.16 -77.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.437 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 7.2 t0 -179.71 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 0.0 108.862 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -84.06 -17.09 41.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.458 -0.776 . . . . 0.0 109.352 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.2 12.01 5.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.4 mm -104.87 134.39 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.413 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.4 88.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.408 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.51 -52.38 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.261 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -143.24 -179.16 6.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 109.141 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.79 144.48 7.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.957 . . . . 0.0 109.743 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -135.32 162.59 32.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.342 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.64 ' CD1' HG21 ' A' ' 74' ' ' THR . 5.9 p90 -145.81 167.92 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.368 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -165.83 114.29 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.495 HG22 ' SD ' ' A' ' 41' ' ' MET . 80.7 p -108.95 141.93 40.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.43 99.65 2.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.9 -54.14 0.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 49.4 t -124.98 173.52 8.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -1.21 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.476 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -121.53 19.06 8.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.7 p -113.83 -8.63 13.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -1.127 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.42 -2.81 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.506 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 68' ' ' ALA . 8.5 mm -61.65 -53.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.402 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -41.4 -53.51 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.457 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 70' ' ' SER . 25.1 p -58.09 -54.26 48.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -43.94 -38.01 3.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.7 m -71.02 -44.96 64.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.24 -55.62 26.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.866 HG23 ' H ' ' A' ' 74' ' ' THR . 2.2 tt -62.33 -61.75 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.866 ' H ' HG23 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -35.31 -32.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.78 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -85.57 -30.87 22.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 0.0 109.825 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.606 ' N ' ' O ' ' A' ' 73' ' ' ILE . 10.7 m0 -82.69 0.82 41.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.719 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 73' ' ' ILE . 6.4 m -123.51 65.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.51 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -148.3 94.35 2.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.31 61.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -72.17 -168.2 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.421 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -115.69 141.1 48.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mt -48.77 -11.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' SER . 35.1 tt0 -71.08 -55.59 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.235 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -66.36 -30.67 71.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.256 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -24.09 52.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 109.22 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.77 50.24 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.78 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -1.123 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.51 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -36.46 -23.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.744 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 87' ' ' ALA . 10.0 mttm 61.32 173.85 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.304 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.484 HD22 HG12 ' A' ' 108' ' ' ILE . 8.0 p-10 -95.73 -42.55 8.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.444 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 88.9 p -52.76 -50.02 64.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' SER . 4.5 tt0 -44.06 -65.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.194 -0.942 . . . . 0.0 109.779 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.5 mt -59.65 -32.01 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.713 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.58 -32.61 69.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.876 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.84 -33.92 24.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.689 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -55.94 -42.84 76.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.3 mt -83.0 -28.39 29.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 65.64 74.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 148.83 59.88 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.158 -0.963 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.61 148.64 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.58 2.187 . . . . 0.0 112.125 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.54 6.09 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.738 2.292 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.68 -35.88 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -135.52 42.43 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.402 ' C ' ' N ' ' A' ' 106' ' ' CYS . 9.8 p -58.4 -18.79 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.432 ' CD2' ' C ' ' A' ' 105' ' ' HIS . 8.1 p-80 -45.32 -24.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.338 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -64.87 -47.35 78.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.167 -0.958 . . . . 0.0 109.2 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -50.1 67.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.484 HG12 HD22 ' A' ' 90' ' ' ASN . 4.4 mm -56.0 -33.45 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.883 . . . . 0.0 109.369 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 34' ' ' ALA . 1.4 mp -63.92 -61.65 2.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -40.36 -53.68 2.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -61.15 -58.25 9.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.3 -34.07 2.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -64.92 -69.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.658 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.1 tp -37.78 -35.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -65.53 -68.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -43.33 -46.22 6.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.307 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.667 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -55.43 -40.72 71.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.22 -46.89 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.417 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.49 -58.11 7.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.53 ' CG ' ' O ' ' A' ' 29' ' ' THR . 5.2 m-20 -49.0 -59.6 3.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.715 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -51.08 -21.59 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.685 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -96.93 -8.6 30.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.18 -8.4 17.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.42 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.44 1.68 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -117.04 5.59 12.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.5 98.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.59 124.62 8.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -102.7 131.91 49.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -1.155 . . . . 0.0 109.329 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.93 96.44 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.0 ttt -99.52 133.44 43.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.144 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 41' ' ' MET . 30.4 m -125.23 156.11 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.035 -1.041 . . . . 0.0 109.808 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' A' ' 40' ' ' VAL . . . -138.06 121.61 2.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 39' ' ' ASP . . . -118.13 87.09 28.0 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.263 -1.139 . . . . 0.0 109.428 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.99 36.25 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.893 2.395 . . . . 0.0 112.303 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.67 -39.64 1.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.8 t -177.02 -29.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.394 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.73 71.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 0.8 OUTLIER 62.7 -174.21 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -1.154 . . . . 0.0 109.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.472 HG12 ' HA2' ' A' ' 33' ' ' GLY . 8.5 m -95.46 149.45 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.384 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 32' ' ' VAL . 8.5 ttt -142.34 133.29 25.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.46 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.468 ' HG2' HE21 ' A' ' 44' ' ' GLN . 7.4 tt0 -107.33 127.83 53.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.45 135.56 44.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.557 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.468 HE21 ' HG2' ' A' ' 42' ' ' GLN . 6.5 mp0 -138.19 137.54 37.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 45' ' ' ILE . 1.5 pp -120.64 143.36 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 109.427 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -102.31 152.14 21.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.96 116.72 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 48' ' ' ASP . 33.5 t0 -57.7 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.56 19.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -148.76 24.84 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.502 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.81 30.28 56.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.5 mm -109.41 134.63 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -1.21 . . . . 0.0 109.414 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.6 mt -80.56 81.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.22 -40.49 74.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -137.64 163.51 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.77 102.59 4.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.53 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -97.81 155.49 17.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.502 ' CD1' HG21 ' A' ' 74' ' ' THR . 27.0 p90 -166.46 171.29 12.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -163.96 126.04 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.81 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.15 121.8 45.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.028 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 101.53 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.6 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 156.74 -57.25 0.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.8 148.6 26.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -1.117 . . . . 0.0 109.598 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.94 16.97 30.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.38 -35.49 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 0.0 109.459 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.11 -3.09 3.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.9 mm -58.95 -35.32 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.339 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.12 -62.54 1.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' LEU . 3.9 m -58.38 -54.59 45.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.467 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.508 ' C ' ' O ' ' A' ' 69' ' ' SER . 50.6 m -36.98 -66.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.62 -30.52 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' SER . 12.2 tp -68.93 -73.89 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.723 HG23 ' H ' ' A' ' 74' ' ' THR . 0.9 OUTLIER -39.7 -59.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.723 ' H ' HG23 ' A' ' 73' ' ' ILE . 42.4 p -44.21 -44.95 8.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.317 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -73.46 -14.98 61.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.307 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.553 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.07 -11.71 35.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 77' ' ' VAL . 33.5 m -123.91 61.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.4 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.09 103.1 7.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.481 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 4.01 89.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -78.55 -161.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -1.155 . . . . 0.0 109.39 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 83' ' ' GLU . 3.7 t -126.69 144.51 50.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -47.78 -15.07 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 0.0 109.24 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -80.71 -23.83 39.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.412 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -95.29 -18.78 20.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.0 -29.95 11.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.96 42.97 2.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -152.14 -37.0 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -1.137 . . . . 0.0 108.602 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -47.22 -175.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -141.38 -177.88 5.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 109.399 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.57 ' CG ' ' N ' ' A' ' 91' ' ' SER . 1.1 p-10 -87.69 -50.93 6.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -54.53 -22.31 12.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.25 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -68.0 -59.18 3.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 109.206 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.69 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 109.272 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.13 -36.49 73.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.245 -0.909 . . . . 0.0 109.196 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.19 -41.97 99.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.271 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.87 -32.9 73.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 0.0 109.047 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.5 mt -93.39 -28.36 16.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.301 -0.875 . . . . 0.0 109.112 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.4 tm-20 51.93 67.09 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.714 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.003 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.4 pt? -117.81 148.46 43.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.272 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.596 ' HB2' HG22 ' A' ' 102' ' ' VAL . 71.4 Cg_exo -40.51 155.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.792 2.328 . . . . 0.0 112.268 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.08 -0.15 8.12 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.834 2.356 . . . . 0.0 112.177 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 100' ' ' PRO . 34.3 m -88.32 -5.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.404 ' C ' ' N ' ' A' ' 105' ' ' HIS . 0.6 OUTLIER -125.72 -9.42 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 107' ' ' SER . 8.0 p -45.78 -24.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.489 ' C ' ' O ' ' A' ' 104' ' ' VAL . 15.2 m80 -38.9 -50.0 1.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.63 -36.47 64.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.114 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.628 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.1 p -66.31 -67.23 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.096 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.628 ' N ' ' OG ' ' A' ' 107' ' ' SER . 42.8 mt -45.91 -25.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.088 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 mp -75.98 -44.88 37.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.428 -0.795 . . . . 0.0 109.385 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.36 83.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.723 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.485 ' O ' ' OE2' ' A' ' 111' ' ' GLU . 5.1 tp10 -65.93 -68.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -22.95 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.93 . . . . 0.0 109.641 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.19 -52.87 9.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -55.95 -40.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.59 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.495 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 5.7 tptt -66.14 -51.52 57.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.74 -41.99 64.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.415 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.34 -45.16 95.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 121' ' ' TYR . 61.7 mt -64.49 -61.12 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -40.69 -37.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.185 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -37.71 80.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.052 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 118' ' ' ILE . 7.5 t80 -72.35 -16.99 61.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -88.49 -44.94 10.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.209 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.1 95.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.317 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 179.899 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.2 m -85.71 -4.3 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -0.87 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.88 129.69 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.8 147.48 18.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.1 m -130.28 130.32 44.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -1.093 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.45 137.8 10.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.03 120.46 17.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -1.112 . . . . 0.0 109.351 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.75 146.6 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.89 -166.35 10.66 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -122.12 80.92 43.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.262 -1.14 . . . . 0.0 109.512 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.88 2.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.707 2.271 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.6 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -91.53 -3.73 56.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.41 -58.48 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.38 46.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.01 126.77 54.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 109.507 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 40' ' ' VAL . 3.1 p -107.86 113.45 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -119.47 119.08 32.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 43' ' ' LEU . 7.1 tt0 -103.23 154.93 18.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.198 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.46 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -155.87 119.47 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.487 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -122.23 151.24 41.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.296 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.79 138.01 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 109.565 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -107.57 127.95 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.04 150.66 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.7 t0 -94.21 -103.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -139.45 4.25 2.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.43 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -128.97 17.28 6.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.21 10.2 85.73 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 mm -93.08 132.71 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -1.105 . . . . 0.0 109.529 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 53' ' ' ILE . 17.6 mt -81.54 93.38 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.413 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -53.54 56.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.446 ' HA ' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -132.04 139.35 48.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.72 133.31 55.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.67 161.38 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.526 ' CD1' HG21 ' A' ' 74' ' ' THR . 10.7 p90 -169.05 174.32 6.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 109.821 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -165.07 121.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.476 -0.765 . . . . 0.0 109.105 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.3 142.57 51.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -158.55 -177.55 6.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.47 -56.82 2.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 66.4 m -120.94 158.64 27.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -1.141 . . . . 0.0 109.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.27 11.49 58.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.98 -39.84 4.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.14 -22.13 66.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.73 -44.96 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -46.73 -62.56 1.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -43.22 -48.05 6.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 109.717 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.519 ' O ' ' C ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -49.55 -68.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 109.397 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -37.27 -39.22 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.617 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 73' ' ' ILE . 11.3 tp -66.89 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.615 ' O ' HG22 ' A' ' 77' ' ' VAL . 4.4 tt -33.74 -48.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 110.054 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.526 HG21 ' CD1' ' A' ' 58' ' ' PHE . 3.2 p -49.8 -46.81 51.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.3 tp10 -86.15 -11.96 51.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.902 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -2.57 57.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.368 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 73' ' ' ILE . 28.8 m -123.48 -27.11 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 0.0 109.61 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' NZ ' ' HA ' ' A' ' 55' ' ' ASP . 9.8 ttmm -62.1 113.14 2.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.05 58.18 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.44 -164.88 1.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 m -121.02 175.0 6.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.861 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.55 -17.98 64.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.778 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -77.46 -40.6 42.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.73 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -69.16 -44.65 71.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 109.839 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.77 -33.84 52.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.54 52.27 4.68 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -171.9 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.4 pt -36.47 132.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' SER . 50.2 mttt -117.97 142.78 46.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -41.35 -25.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -66.44 -39.41 88.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.568 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -67.73 -55.88 11.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.466 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 93' ' ' ILE . 1.6 mp -58.74 -30.08 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.592 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.09 -60.29 2.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.742 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -55.27 -20.52 11.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -64.53 1.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.5 OUTLIER -69.12 -14.46 63.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.651 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 52.81 43.62 31.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.894 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.698 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.5 pt? -85.8 151.21 54.84 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -41.52 105.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.559 2.173 . . . . 0.0 111.913 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.87 20.36 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.343 2.028 . . . . 0.0 112.338 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.435 HG23 ' N ' ' A' ' 103' ' ' LYS . 17.6 m -70.47 -40.63 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 104' ' ' VAL . 21.2 mttt -109.94 -23.44 11.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 103' ' ' LYS . 2.5 t 41.43 30.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.5 ' NE2' ' HB1' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -81.16 -35.64 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 60.7 m -59.73 -64.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.563 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 108' ' ' ILE . 2.6 m -51.45 -58.27 6.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.0 mt -42.12 -41.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -63.8 -46.42 85.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -54.63 -66.7 0.36 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.78 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.2 tm-20 -46.06 -69.64 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.536 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -38.75 -26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -73.87 -63.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.69 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 2.3 tp -46.13 -37.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.579 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 58.6 tttt -66.53 -43.49 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.59 77.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.493 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.25 -54.67 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mt -49.95 -34.85 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 109.256 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -56.86 10.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -11.52 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.415 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -85.0 -43.7 13.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -94.73 3.71 54.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.8 -33.06 10.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.329 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 tttt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 25' ' ' SER . 6.8 t0 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 14.5 m -101.55 5.36 41.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -117.59 37.39 3.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.625 ' O ' HG12 ' A' ' 27' ' ' VAL . 2.7 t -143.41 98.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.359 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.08 132.55 11.29 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 m -108.85 134.11 51.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -1.111 . . . . 0.0 109.362 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.3 90.77 0.23 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ttm -108.94 128.8 55.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -1.164 . . . . 0.0 109.686 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.533 HG21 ' HG ' ' A' ' 109' ' ' LEU . 2.0 m -130.51 165.1 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.392 -0.818 . . . . 0.0 109.173 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.86 121.81 2.1 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HB3' ' N ' ' A' ' 39' ' ' ASP . . . -112.45 93.33 22.48 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.339 -1.095 . . . . 0.0 109.364 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.39 40.7 0.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.665 2.243 . . . . 0.0 112.271 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.543 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -144.55 -40.1 0.27 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.7 m -168.11 -32.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' C ' ' HB3' ' A' ' 34' ' ' ALA . . . -66.29 -19.01 68.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.513 ' N ' ' HB3' ' A' ' 34' ' ' ALA . 1.6 m-20 61.06 -168.93 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 109.456 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -86.84 140.77 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -142.5 125.77 16.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.318 -0.864 . . . . 0.0 109.599 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.94 113.5 20.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.04 107.17 11.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 109.894 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.476 ' NE2' ' CG1' ' A' ' 27' ' ' VAL . 7.7 tt0 -109.67 129.18 55.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.07 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.56 144.81 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 109.699 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -108.96 138.94 44.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.99 151.5 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 23.5 t0 -81.93 -48.84 11.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.634 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 162.15 -22.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 9.5 p-10 -102.47 25.52 8.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.466 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.37 -4.7 58.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.16 146.46 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.348 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.24 108.61 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -44.03 32.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.78 164.41 28.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.273 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.09 118.83 16.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -96.05 133.83 39.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.476 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 10.3 p90 -136.08 168.88 18.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -171.89 104.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.803 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 p -96.42 147.95 23.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.085 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -162.0 111.58 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.701 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.44 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 130.58 -41.11 1.57 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.9 t -103.7 121.26 42.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.636 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 46.72 1.98 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -158.32 -12.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.157 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.88 37.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.29 -33.1 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.88 -41.73 74.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 71' ' ' SER . 17.9 p -67.11 -64.15 0.91 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.511 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.8 OUTLIER -38.76 -26.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.33 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 69' ' ' SER . 7.5 t -78.4 -44.7 24.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 69' ' ' SER . 21.4 tp -60.97 -52.14 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.948 . . . . 0.0 109.471 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.894 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.3 tt -58.9 -41.46 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -66.79 -19.35 65.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -92.02 -16.35 26.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.49 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.04 -17.0 18.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 73' ' ' ILE . 27.8 m -109.07 40.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.661 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -118.8 96.44 5.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.97 -27.05 17.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -59.69 -160.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -1.124 . . . . 0.0 109.498 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.09 165.85 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.89 -41.27 82.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -24.72 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.593 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -90.7 -48.48 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.536 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.556 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -61.88 -17.36 56.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.84 11.65 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -148.47 -35.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -41.74 172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.538 -0.726 . . . . 0.0 109.654 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.33 168.44 19.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.55 -32.81 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.749 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.543 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -50.89 -33.22 23.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -73.83 -59.97 2.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.557 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.6 mt -46.02 -42.46 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 -46.71 74.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.355 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.4 -37.92 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -67.58 -45.01 76.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.5 -15.08 61.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.152 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.94 33.87 7.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.9 pp -75.16 135.94 72.95 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.532 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.659 ' O ' HD12 ' A' ' 99' ' ' LEU . 75.4 Cg_exo -42.22 155.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.512 2.141 . . . . 0.0 112.245 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.24 -11.16 28.41 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.729 2.286 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.8 39.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HG2' ' SG ' ' A' ' 106' ' ' CYS . 2.5 ttmt -176.83 32.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.87 . . . . 0.0 109.189 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 t -74.68 -9.21 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.671 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.33 67.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.42 ' SG ' ' HG2' ' A' ' 103' ' ' LYS . 18.6 m -73.4 -59.26 2.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.651 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.1 p -48.57 -56.17 9.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 108.974 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.46 ' N ' ' OG ' ' A' ' 107' ' ' SER . 82.3 mt -52.32 -35.58 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.533 ' HG ' HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -66.17 -29.3 69.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -51.36 60.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.201 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.402 ' O ' ' OE2' ' A' ' 111' ' ' GLU . 9.6 tp10 -71.73 -32.55 67.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.18 -33.98 75.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.223 -0.923 . . . . 0.0 109.314 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -72.09 -61.55 1.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.556 HG12 ' HB1' ' A' ' 85' ' ' ALA . 0.7 OUTLIER -46.29 -35.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.129 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 11.4 tttt -74.86 -31.38 61.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.853 . . . . 0.0 109.141 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.93 -43.43 83.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.188 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.31 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.2 mt -45.53 -50.76 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.69 -51.68 66.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.88 -21.54 64.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -71.69 -54.88 8.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.364 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -65.55 -34.67 78.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.91 55.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.4 tttt . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.425 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.29 8.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.398 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.545 ' OD1' ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -115.17 3.26 14.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.9 t -122.1 92.45 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.84 155.0 47.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.4 m -131.41 118.56 20.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -1.224 . . . . 0.0 109.817 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.61 93.3 0.56 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -92.5 131.85 37.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.973 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.574 ' O ' ' O ' ' A' ' 41' ' ' MET . 18.5 m -144.53 177.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 108.997 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.62 178.97 41.12 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -118.69 82.31 19.98 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.336 -1.096 . . . . 0.0 109.352 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 37' ' ' CYS . 72.8 Cg_exo -43.97 -10.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.593 2.195 . . . . 0.0 111.99 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.623 ' O ' ' CB ' ' A' ' 37' ' ' CYS . . . -76.07 20.34 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 1.6 t 85.64 -18.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -43.3 -50.3 6.58 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.643 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 153.89 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -1.074 . . . . 0.0 109.424 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 46.9 t -113.56 150.56 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.574 ' O ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -145.73 140.88 27.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.106 -0.996 . . . . 0.0 109.78 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' A' ' 41' ' ' MET . 6.0 tt0 -129.49 145.14 51.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.85 138.74 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.591 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -130.84 136.28 48.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.526 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -119.7 132.34 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -115.72 120.01 37.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.276 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.545 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 54.3 t -97.72 126.88 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -56.67 -60.02 4.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.3 OUTLIER 163.85 -22.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 0.0 109.197 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.45 -7.52 47.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.451 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.14 17.59 7.18 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -113.36 150.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -1.144 . . . . 0.0 109.504 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.532 ' O ' ' C ' ' A' ' 54' ' ' GLU . 36.1 mt -85.67 77.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 53' ' ' ILE . 2.5 tt0 -34.63 -48.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -153.04 167.68 28.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.94 122.97 13.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -103.99 142.08 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.328 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.587 ' CD1' HG21 ' A' ' 74' ' ' THR . 21.8 p90 -137.3 176.06 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.59 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -165.58 132.94 2.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.1 143.66 33.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -159.99 121.16 3.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.77 -61.02 0.29 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.5 t -121.39 140.74 51.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.124 . . . . 0.0 109.677 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.65 -6.98 87.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.6 p -95.13 0.43 54.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -1.15 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.46 2.76 45.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -83.16 -13.86 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.32 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.31 -64.41 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.435 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.814 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -62.97 -30.21 71.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.93 . . . . 0.0 109.453 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 74' ' ' THR . 2.3 t -61.74 -46.14 90.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -64.68 -36.36 84.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.512 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -71.96 -74.54 0.16 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.824 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.7 tt -34.36 -46.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.873 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.587 HG21 ' CD1' ' A' ' 58' ' ' PHE . 34.0 p -60.16 -47.24 86.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.0 mt-10 -72.64 -5.92 40.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 109.652 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 73' ' ' ILE . 16.3 m -112.63 58.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -138.1 105.22 5.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.431 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.4 87.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -83.77 -168.5 2.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -1.124 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 t -107.12 146.21 31.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.26 -27.68 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.319 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -61.03 -38.18 85.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.364 -0.835 . . . . 0.0 109.587 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 88' ' ' ILE . 16.4 mt-10 -79.77 -28.91 40.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.648 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.31 -32.7 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.972 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.53 30.2 5.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.89 19.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.351 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.2 pt -91.7 -24.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 88' ' ' ILE . 11.3 mttp 56.72 152.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.581 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -79.55 -22.15 44.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.4 m -60.56 -39.99 89.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.52 -47.65 83.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.08 -36.42 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.19 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.25 -44.15 80.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.266 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.41 -31.83 72.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.79 -41.52 83.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -96.79 -35.36 10.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.646 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 94' ' ' ALA . 9.1 tt0 78.1 32.69 0.36 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.464 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 pp -48.1 147.13 3.84 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -67.56 147.17 76.09 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.61 2.207 . . . . 0.0 112.066 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.9 15.6 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.679 2.252 . . . . 0.0 112.323 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 m -98.43 6.71 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.295 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -160.03 24.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.346 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' LYS . 26.9 t -38.4 -26.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.854 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.669 ' O ' HD13 ' A' ' 109' ' ' LEU . 1.8 m-70 -42.95 -28.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 1.9 m -66.36 -37.17 84.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.779 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -68.26 -61.48 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.3 mt -52.29 -33.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.539 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.669 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.1 mp -64.7 -42.99 94.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.63 -55.31 36.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.499 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -61.52 -56.58 18.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -48.87 -31.13 6.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.26 -65.03 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.86 -30.26 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.309 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.54 -43.3 63.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.439 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.25 69.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.426 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.526 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -71.0 -58.62 3.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.94 . . . . 0.0 109.302 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.2 mt -48.8 -43.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.1 4.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.89 -35.54 15.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.69 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -69.63 -65.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.652 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -24.71 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.652 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.22 -4.74 3.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.5 mttm . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.636 -179.875 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.437 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 9.4 t -94.8 -0.62 54.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.55 12.04 22.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.01 107.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.24 150.29 18.64 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -135.75 148.88 48.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.23 103.22 0.29 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 ttp -92.93 129.27 38.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 0.0 109.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' MET . 2.9 m -150.63 -171.75 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.63 -174.52 32.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.94 93.74 26.21 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -1.136 . . . . 0.0 109.485 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.525 ' O ' ' C ' ' A' ' 36' ' ' ALA . 50.6 Cg_exo -50.43 -46.07 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.684 2.256 . . . . 0.0 112.254 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.65 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -37.36 -42.86 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.2 m 159.25 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -35.11 -57.3 0.84 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 153.09 169.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.393 -1.063 . . . . 0.0 109.523 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.563 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 7.6 p -96.12 146.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 108.909 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' VAL . 9.8 ttt -142.3 126.34 17.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 110.002 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -115.6 140.69 48.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.835 . . . . 0.0 108.922 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.24 121.33 13.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.805 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HG2' ' N ' ' A' ' 45' ' ' ILE . 47.4 tt0 -122.57 152.88 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.21 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.662 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -123.17 152.9 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.524 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HB3' ' H ' ' A' ' 55' ' ' ASP . 15.4 tttp -124.84 131.03 53.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.7 137.53 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.682 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -175.31 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.8 m-20 -63.2 51.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 0.0 109.108 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.682 ' N ' ' O ' ' A' ' 48' ' ' ASP . 6.3 m-80 72.17 55.15 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.634 -0.666 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.53 77.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 53' ' ' ILE . 4.1 mm -97.61 157.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 109.524 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.459 ' N ' HG22 ' A' ' 52' ' ' ILE . 54.0 mt -74.97 99.26 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -59.81 -51.51 69.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 46' ' ' LYS . 1.6 t70 -148.98 -174.75 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.797 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.72 122.74 4.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.127 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -95.25 146.92 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 109.9 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.663 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -134.61 165.28 25.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.064 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -162.9 114.18 1.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.049 -1.032 . . . . 0.0 109.999 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 129.0 27.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.197 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.583 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -151.51 118.58 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -0.971 . . . . 0.0 109.759 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.89 -53.37 0.46 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.624 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -107.39 137.23 45.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -1.151 . . . . 0.0 109.392 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.53 26.26 4.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -121.73 -42.42 2.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -1.186 . . . . 0.0 109.493 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.585 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -65.29 -29.01 69.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 67' ' ' ILE . 5.1 mm -50.87 -4.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.441 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.585 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -97.67 -56.26 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.547 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.826 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -50.0 -20.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 71' ' ' SER . 8.7 p -70.6 -63.09 1.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.546 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -51.33 -35.23 37.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.802 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 73' ' ' ILE . 6.7 tp -68.74 -79.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.949 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 69' ' ' SER . 3.3 tt -42.33 -48.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 109.915 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.61 ' N ' HG23 ' A' ' 73' ' ' ILE . 56.7 p -54.06 -36.81 63.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.685 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 72' ' ' LEU . 9.1 tt0 -79.38 -12.91 59.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.624 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -100.41 -4.22 29.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.7 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 73' ' ' ILE . 28.0 m -126.27 32.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 105.94 14.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.043 -1.035 . . . . 0.0 109.105 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.59 10.62 61.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -90.63 -170.81 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -1.14 . . . . 0.0 109.451 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.37 148.46 35.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.1 -21.97 2.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -83.79 -15.35 48.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.907 . . . . 0.0 109.284 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.46 -28.13 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 0.0 109.253 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.58 -22.38 16.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.63 53.73 4.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.95 -34.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -1.131 . . . . 0.0 109.001 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 2.8 pt -45.45 162.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.42 -0.8 . . . . 0.0 109.364 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.37 -167.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.422 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.84 -24.39 13.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.345 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.8 t -68.98 -36.2 77.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' GLU . 9.1 mt-30 -62.02 -73.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLN . 2.2 mt -43.86 -41.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.68 -37.17 62.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.429 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' GLN . 31.9 tt0 -76.35 -38.34 56.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.401 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -39.42 76.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.81 -22.59 24.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 50.0 70.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.479 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.059 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.3 pt? -117.85 147.67 41.66 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.43 103.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.006 2.47 . . . . 0.0 112.354 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.0 Cg_exo -49.62 -14.86 0.78 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.818 2.345 . . . . 0.0 112.387 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 102' ' ' VAL . 6.9 m -62.73 11.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 109.312 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 101' ' ' PRO . 14.7 ttpp -165.89 64.05 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.055 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 104' ' ' VAL . 57.6 t -86.54 39.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.808 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.819 ' O ' HD13 ' A' ' 109' ' ' LEU . 4.2 m-70 -84.68 -24.32 29.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.164 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 m -71.85 -52.83 15.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.96 -52.24 66.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.37 -36.68 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.2 mp -65.03 -39.49 93.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.913 . . . . 0.0 109.393 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.02 -43.88 94.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 88' ' ' ILE . 15.7 tp10 -66.98 -61.41 1.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -49.27 -22.3 1.03 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.11 -50.66 18.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.75 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.9 tp -56.54 -41.82 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 109.57 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.1 mtpp -62.81 -50.35 71.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 0.0 109.361 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -35.92 32.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -62.39 -62.06 2.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.379 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.0 mt -52.36 -38.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.404 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.78 -67.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.64 -48.4 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.281 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.563 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 2.9 t80 -49.54 -45.19 47.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -54.97 19.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.596 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.05 -46.41 22.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.693 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.1 mttt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 109.737 -179.74 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 124' ' ' LYS . 3.0 t -101.75 5.57 41.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.369 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.26 -4.18 15.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.5 t -116.41 117.58 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.21 136.72 13.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -115.72 111.88 21.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -1.161 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.86 91.21 0.73 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.37 119.41 27.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.65 171.23 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.43 162.73 36.36 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -123.93 75.99 57.83 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.32 -8.54 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.69 2.26 . . . . 0.0 112.019 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -83.99 -30.22 26.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.88 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 9.9 p -112.66 -17.7 12.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.16 -0.963 . . . . 0.0 109.678 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.53 42.14 6.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.46 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 7.0 t70 -122.38 125.12 45.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.33 146.8 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -148.07 141.99 25.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.687 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -132.87 111.32 10.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.07 145.91 26.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -142.4 114.53 8.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.7 134.83 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -108.16 146.74 32.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.732 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.68 146.32 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.281 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -179.41 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.893 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.2 m-20 -62.77 44.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.321 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.685 ' N ' ' O ' ' A' ' 48' ' ' ASP . 3.2 m-80 76.98 51.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.13 -0.88 86.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 80' ' ' LYS . 34.3 mm -95.12 146.83 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -1.174 . . . . 0.0 109.368 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 53' ' ' ILE . 34.4 mt -75.06 84.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.867 . . . . 0.0 109.259 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -46.85 66.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -142.75 177.59 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.07 123.54 4.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -103.47 154.16 19.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' HG21 ' A' ' 74' ' ' THR . 32.1 p90 -142.12 175.81 9.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.505 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.37 99.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.253 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.96 130.34 55.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.408 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -144.45 129.33 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 109.581 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.24 -57.65 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.73 150.85 40.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.231 . . . . 0.0 109.543 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.88 56.57 0.51 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -144.06 -11.81 0.65 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.493 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.42 -12.02 17.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.557 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.465 HD12 ' H ' ' A' ' 67' ' ' ILE . 1.6 mp -40.87 -54.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.404 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -49.9 -65.95 0.48 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 68' ' ' ALA . 10.9 m -38.94 -54.94 1.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.927 . . . . 0.0 109.533 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' OG1' ' A' ' 74' ' ' THR . 19.4 p -50.57 -46.23 57.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.01 71.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' GLU . 58.8 tp -68.29 -76.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 77' ' ' VAL . 1.4 tt -40.63 -45.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 ' CD1' ' A' ' 58' ' ' PHE . 6.8 p -55.81 -35.25 66.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.288 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 72' ' ' LEU . 7.4 mt-10 -93.78 4.16 54.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -106.27 -34.59 7.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.0 109.619 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 73' ' ' ILE . 35.2 m -103.88 35.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -111.62 119.28 38.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.382 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.94 -2.92 85.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 52' ' ' ILE . 52.7 mmtt -85.53 -167.9 2.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.38 149.61 37.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.417 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.32 -20.79 46.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.98 -26.97 67.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -91.78 -38.06 12.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.449 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -68.79 -26.26 65.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.535 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.44 38.73 3.18 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -153.86 -34.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -1.104 . . . . 0.0 109.398 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.579 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.6 pt -40.52 169.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -140.92 161.6 37.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.369 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.617 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 14.7 p-10 -80.97 -28.79 35.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.59 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -57.5 7.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -55.65 -54.92 38.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.0 mt -55.64 -32.57 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.622 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.94 88.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 109.713 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -69.87 -22.69 63.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -74.7 -38.04 62.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -98.27 -15.31 19.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 109.599 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 47.76 68.81 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.334 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -97.28 149.35 35.62 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.703 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 102' ' ' VAL . 71.6 Cg_exo -41.32 101.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.989 2.459 . . . . 0.0 112.352 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.23 -8.63 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.618 2.212 . . . . 0.0 111.937 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 100' ' ' PRO . 18.3 m -77.59 -7.17 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HE3' ' SG ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -147.6 48.27 1.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.313 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.16 -1.97 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.595 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -13.74 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.958 . . . . 0.0 109.232 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.442 ' SG ' ' HE3' ' A' ' 103' ' ' LYS . 24.0 m -80.01 -55.18 5.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.9 t -50.37 -47.05 56.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.137 -0.977 . . . . 0.0 108.995 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.29 -46.94 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 mp -53.86 -30.87 47.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.144 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.71 -61.49 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -0.824 . . . . 0.0 109.273 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.617 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 58.5 tt0 -51.02 -54.06 27.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.249 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.79 -41.82 71.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.417 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -49.05 -50.12 38.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.449 HG12 ' HB1' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -59.68 -39.77 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 5.8 tttt -64.46 -46.29 83.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.73 -61.87 2.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.659 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -47.63 -35.64 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.84 -38.53 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 109.553 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.63 -42.32 67.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 109.962 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.33 -39.87 92.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.992 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -68.67 -38.07 80.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.868 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -77.96 -27.45 49.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.19 85.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.559 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.547 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.746 ' OD2' HG23 ' A' ' 27' ' ' VAL . 7.2 p-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 m -75.91 8.43 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.398 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.03 12.07 29.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.608 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.746 HG23 ' OD2' ' A' ' 24' ' ' ASP . 27.4 t -132.45 101.69 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 109.303 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.29 9.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.97 141.0 51.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -1.092 . . . . 0.0 109.239 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.36 142.97 8.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 ptm -141.31 147.6 38.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -1.201 . . . . 0.0 109.743 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 m -136.0 -179.75 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.025 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.66 163.16 31.12 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.049 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 91.93 42.76 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.368 -1.078 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.25 -27.01 12.17 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.712 2.275 . . . . 0.0 112.44 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.03 -33.95 40.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.1 m -130.13 7.56 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' OD1' ' A' ' 39' ' ' ASP . . . 57.46 71.54 0.73 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.553 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 30.2 m-20 -141.18 131.19 24.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.02 126.65 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.775 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.43 ' HG2' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -110.53 149.17 30.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.43 ' N ' ' HG2' ' A' ' 41' ' ' MET . 4.0 tt0 -124.88 122.99 38.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.63 134.75 54.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -135.83 116.89 14.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.302 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.18 159.07 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -127.03 140.65 52.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.56 150.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.146 -0.971 . . . . 0.0 109.648 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 9.8 p-10 -75.99 -94.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.601 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -156.26 15.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.67 -7.37 3.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.7 9.88 17.97 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.8 mm -98.41 143.84 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -1.155 . . . . 0.0 109.454 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.2 115.39 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.45 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.92 -37.36 15.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.67 168.09 20.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.23 105.74 3.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -99.88 141.4 32.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.766 ' CD1' HG21 ' A' ' 74' ' ' THR . 13.7 p90 -139.99 179.08 6.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.382 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -164.76 123.75 1.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -137.55 141.51 41.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -158.36 134.26 9.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.42 -69.32 0.54 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.02 128.41 38.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -1.163 . . . . 0.0 109.656 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.45 70.57 0.86 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.99 -17.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -1.112 . . . . 0.0 109.295 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . . . -105.74 6.33 31.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.431 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 68' ' ' ALA . 41.8 mt -79.05 -53.13 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -44.25 -45.3 8.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -70.85 -38.54 73.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.416 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.604 ' O ' HG23 ' A' ' 74' ' ' THR . 41.8 t -56.21 -39.96 73.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -73.72 -32.77 64.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.323 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.422 ' CD2' ' OE1' ' A' ' 96' ' ' GLU . 10.8 tp -68.96 -59.24 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 74' ' ' THR . 11.2 tt -52.34 -41.59 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.766 HG21 ' CD1' ' A' ' 58' ' ' PHE . 31.8 p -63.34 -32.33 73.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.331 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.47 -4.77 59.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.288 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.8 -26.44 14.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.57 22.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.298 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -95.49 120.38 35.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.412 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.01 5.48 89.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -87.04 -168.68 2.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -1.17 . . . . 0.0 109.534 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.13 152.47 39.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.369 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -57.82 -28.85 64.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.1 -36.35 79.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 85' ' ' ALA . 63.5 mm-40 -76.84 -56.1 4.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.46 -32.65 1.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.18 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.78 39.3 3.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -159.98 -40.57 0.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 108.781 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.54 ' O ' ' O ' ' A' ' 87' ' ' ALA . 12.4 pt -45.67 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 109.161 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -150.86 -178.63 6.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.154 -0.966 . . . . 0.0 109.572 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -90.88 -16.7 27.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.402 -0.811 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.27 -45.3 65.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.485 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -62.48 -69.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 92' ' ' GLN . 7.9 mt -41.71 -39.96 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HA ' HD21 ' A' ' 99' ' ' LEU . . . -67.17 -42.12 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.503 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -68.0 -11.41 58.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.443 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' OE1' ' CD2' ' A' ' 72' ' ' LEU . 13.2 tt0 -88.37 -54.77 4.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.413 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mt -81.94 -7.34 59.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 99' ' ' LEU . 6.0 tp10 48.5 23.56 0.62 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -43.97 149.21 0.69 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.67 164.2 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.67 2.246 . . . . 0.0 112.217 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 74.5 Cg_endo -79.91 18.4 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.985 2.456 . . . . 0.0 112.638 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.0 t -110.62 0.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 109.727 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.658 ' O ' ' N ' ' A' ' 105' ' ' HIS . 13.0 mtmt -140.33 10.7 2.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.445 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 101' ' ' PRO . 5.0 t -45.11 -10.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.442 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.658 ' N ' ' O ' ' A' ' 103' ' ' LYS . 3.2 m-70 -59.72 -37.92 80.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 86.3 m -60.66 -50.68 72.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -60.85 -52.82 63.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.372 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.5 mt -46.73 -36.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.262 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.59 -28.17 58.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.627 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.21 -50.95 71.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.999 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 112' ' ' ASP . 70.9 tt0 -66.55 -63.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.873 . . . . 0.0 109.133 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' GLU . 4.8 t70 -44.1 -35.06 1.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 115' ' ' LYS . . . -58.04 -64.53 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.006 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.8 tp -46.43 -22.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 108.513 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 116' ' ' ALA . 14.5 tttt -74.1 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -40.55 -51.53 2.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.602 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.78 -51.75 67.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.465 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mt -49.73 -43.07 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -55.96 -65.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.537 ' O ' ' C ' ' A' ' 121' ' ' TYR . 27.0 t70 -44.66 -68.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.595 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.537 ' C ' ' O ' ' A' ' 120' ' ' ASP . 54.2 t80 -35.33 -42.99 0.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -68.8 -51.64 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 mttt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.824 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.691 ' C ' HD22 ' A' ' 26' ' ' ASN . 1.0 OUTLIER -72.39 9.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.585 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.691 HD22 ' C ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -125.06 30.01 5.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 27' ' ' VAL . 34.9 t -127.1 91.36 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.313 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.42 142.2 16.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -129.17 112.57 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.46 134.93 12.2 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.41 114.41 16.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -1.118 . . . . 0.0 109.524 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.67 174.14 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.19 -178.9 21.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -122.12 89.19 48.58 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 109.367 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -54.46 29.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.95 2.433 . . . . 0.0 112.386 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -105.89 -42.83 5.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.7 -22.0 3.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.601 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.13 51.27 0.52 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.2 m-20 -106.76 140.22 39.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -1.145 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.74 114.54 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.167 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.5 ttt -112.54 140.99 46.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -126.5 128.97 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -0.878 . . . . 0.0 108.986 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -120.64 138.44 53.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.819 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -126.47 132.24 51.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 109.189 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.57 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -128.63 143.24 50.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.61 145.47 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -92.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -161.07 18.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.432 HD22 HG12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -128.36 -21.2 3.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.72 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.55 6.06 6.27 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.432 HG12 HD22 ' A' ' 50' ' ' ASN . 43.1 mm -103.64 130.08 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.641 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.44 97.66 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.299 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.67 -38.39 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.578 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.26 169.44 17.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.136 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -166.78 118.64 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.131 -0.981 . . . . 0.0 109.593 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -95.97 -177.94 4.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.176 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD1' HG21 ' A' ' 74' ' ' THR . 17.6 p90 -168.06 -179.72 4.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.184 -0.947 . . . . 0.0 109.418 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -171.61 113.98 0.36 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.5 p -119.62 131.89 55.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.206 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -140.89 111.27 6.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . 84.88 49.66 4.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.535 ' O ' ' O ' ' A' ' 64' ' ' GLY . 14.5 p -121.5 142.79 49.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.458 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 63' ' ' CYS . . . -38.99 -94.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.3 m -125.68 30.76 5.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.16 -31.51 72.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.497 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.8 mp -38.41 -32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.431 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -86.03 -64.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 109.312 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 m -54.21 -29.48 46.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.52 ' O ' ' OG1' ' A' ' 74' ' ' THR . 78.8 p -62.95 -34.52 77.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.115 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -74.42 -33.24 62.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.83 . . . . 0.0 109.225 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tp -64.34 -60.26 3.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.661 HG23 ' N ' ' A' ' 74' ' ' THR . 12.6 tt -51.95 -51.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.582 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.661 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -53.62 -31.15 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.374 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.09 -14.98 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.396 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -89.89 -23.96 21.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' ILE . 17.0 m -97.11 13.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 82.0 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.975 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.7 -9.45 8.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -98.75 -159.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -128.07 164.49 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 109.709 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt -50.53 -28.68 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.86 -53.01 61.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.351 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.79 -36.3 71.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.829 . . . . 0.0 109.328 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.649 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -67.97 -40.32 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.255 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 44.4 3.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -161.4 -35.31 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.137 . . . . 0.0 109.404 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.2 pt -40.39 -21.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 mttp 55.51 169.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.973 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.32 -45.32 5.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.553 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 37.1 t -56.19 -22.35 28.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.403 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -67.72 -64.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.369 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -51.35 -30.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.16 90.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.77 -18.32 61.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.372 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -71.14 -51.58 24.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.92 -11.92 56.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.21 19.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 99' ' ' LEU . 1.7 pt? -59.18 149.2 68.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 109.149 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -37.51 145.39 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.823 2.349 . . . . 0.0 112.23 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.63 8.83 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.671 2.247 . . . . 0.0 112.265 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.77 -30.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -94.09 16.89 13.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.907 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.06 -19.79 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.542 ' ND1' ' N ' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -54.58 -33.49 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.59 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 90.6 m -58.02 -58.19 9.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.915 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -48.87 -55.77 10.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.478 ' N ' HD22 ' A' ' 90' ' ' ASN . 28.2 mt -47.77 -65.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.313 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 34' ' ' ALA . 6.5 mp -43.79 -27.32 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -69.57 -71.31 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -50.93 -30.78 15.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.911 . . . . 0.0 109.249 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -73.01 -25.08 60.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -75.02 -35.09 61.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.618 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.649 HG12 ' HB1' ' A' ' 85' ' ' ALA . 2.2 tp -75.03 -42.34 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 109.42 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 22.1 tttt -59.94 -40.3 88.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.982 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -62.61 -54.12 44.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -50.07 -63.48 1.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.227 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 117' ' ' ALA . 67.5 mt -37.77 -44.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.21 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -55.12 -57.34 12.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -58.75 -45.35 89.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.34 -20.57 44.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -91.36 -29.91 16.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.385 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.97 -7.34 59.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 25' ' ' SER . 5.8 t0 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.522 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.8 OUTLIER 74.41 11.17 4.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' A' ' 25' ' ' SER . 1.7 p-10 174.78 -28.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.96 . . . . 0.0 109.681 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -91.74 114.98 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.09 119.27 5.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.487 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 27.3 m -93.71 136.38 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -1.15 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.67 110.05 0.67 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 ttt -125.63 122.14 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -1.137 . . . . 0.0 109.651 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 41' ' ' MET . 2.1 m -124.55 -169.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.377 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.15 146.83 5.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.11 133.52 20.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.519 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.3 Cg_endo -75.44 -26.38 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.493 2.129 . . . . 0.0 112.256 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.53 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.89 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -98.88 5.32 47.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.04 48.79 10.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -89.66 127.07 35.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.401 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.0 131.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.405 ' HB3' HG23 ' A' ' 32' ' ' VAL . 4.7 ttt -128.06 130.53 48.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 109.293 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -125.38 142.07 51.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.801 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.56 156.84 43.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.182 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.78 150.56 38.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.78 139.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.316 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -113.38 146.51 39.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.71 147.63 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.485 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 2.2 t0 -88.9 -60.17 2.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' OD1' ' C ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 167.27 -23.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.145 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.485 ' ND2' ' OD2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -100.12 22.66 11.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.541 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 15.26 80.14 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -104.93 136.66 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.483 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.34 97.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.7 -44.32 57.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.76 157.1 8.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.33 179.31 6.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.351 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -151.29 170.75 18.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 74' ' ' THR . 21.3 p90 -137.35 167.88 20.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 109.384 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -169.71 85.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.17 133.51 55.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -147.18 105.85 3.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.06 -50.66 0.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.1 p -128.9 120.55 26.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.52 66.57 1.02 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.55 -50.93 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.92 -26.4 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.354 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' ALA . 77.8 mt -44.67 -53.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.0 109.217 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.09 60.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 108.921 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.2 -40.37 64.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.34 -0.85 . . . . 0.0 109.024 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 74' ' ' THR . 2.3 t -65.69 -24.55 67.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 109.168 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.7 t -76.12 -46.21 29.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.308 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.05 -59.25 4.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 74' ' ' THR . 17.3 tt -49.21 -43.95 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.585 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -54.88 -42.27 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.591 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.19 -18.45 60.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.942 . . . . 0.0 109.729 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -89.35 -21.9 22.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.517 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 77' ' ' VAL . 4.8 m -107.49 52.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.14 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -142.11 82.43 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.646 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.74 40.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -102.25 -167.44 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -1.189 . . . . 0.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -102.94 139.24 38.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.77 -23.73 60.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.401 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -75.98 -13.97 60.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.35 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.55 -35.05 11.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.49 2.84 42.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.19 25.8 11.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.96 18.66 0.16 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -1.153 . . . . 0.0 109.409 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.05 2.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.847 . . . . 0.0 109.327 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.4 mttt 56.83 167.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.548 ' ND2' ' C ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -86.04 -13.16 48.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.339 -0.851 . . . . 0.0 109.541 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.3 p -75.76 -21.52 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.564 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.469 ' HA ' HE21 ' A' ' 92' ' ' GLN . 0.1 OUTLIER -74.79 -56.01 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.423 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.0 mt -59.67 -41.98 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.88 82.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.184 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.35 -46.49 80.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 109.399 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -49.69 -62.45 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.17 -16.65 61.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 52.84 23.52 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.0 OUTLIER -55.26 146.84 39.36 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.582 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.423 ' O ' HD12 ' A' ' 99' ' ' LEU . 73.1 Cg_exo -42.04 146.78 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.74 2.293 . . . . 0.0 112.239 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.664 ' O ' HG23 ' A' ' 104' ' ' VAL . 57.2 Cg_endo -73.94 -27.59 12.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.762 2.308 . . . . 0.0 112.386 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 102' ' ' VAL . 4.9 t -70.5 26.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.739 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 101' ' ' PRO . 9.6 tttm -165.17 37.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 101' ' ' PRO . 3.5 t -71.39 1.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.392 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.583 ' O ' HD13 ' A' ' 109' ' ' LEU . 34.4 m80 -58.79 -29.26 66.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -67.59 -41.64 83.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.59 85.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.885 . . . . 0.0 109.177 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -62.56 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.295 -0.878 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 105' ' ' HIS . 7.8 mp -63.23 -25.21 68.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.428 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -74.15 -71.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 114' ' ' ILE . 12.9 tp10 -50.75 -31.48 16.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.42 -38.77 85.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.138 -0.976 . . . . 0.0 109.158 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -69.9 -58.91 3.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -44.22 -38.09 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 116' ' ' ALA . 4.0 tptt -75.17 -66.13 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -36.61 -39.58 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -64.38 -57.95 7.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -38.01 -49.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.413 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -56.18 -61.15 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.507 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 119' ' ' ALA . 4.3 m-20 -38.83 -62.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -46.42 -57.43 4.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 123' ' ' ALA . 1.0 OUTLIER -47.31 -29.16 2.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -41.25 -47.81 3.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.587 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.446 ' HZ2' ' HB3' ' A' ' 24' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.574 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.85 -2.65 43.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -97.13 3.95 51.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.6 96.82 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 155.53 28.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -138.6 117.27 12.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -1.199 . . . . 0.0 109.62 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.06 114.4 4.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.53 108.59 14.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -1.196 . . . . 0.0 109.565 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.67 175.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.11 168.35 41.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -120.74 80.81 32.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -47.08 -14.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.848 2.366 . . . . 0.0 112.311 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -60.47 2.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -91.55 -8.75 46.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 43.27 9.38 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.2 148.48 25.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.111 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.1 139.89 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ttt -147.0 130.0 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -133.52 118.87 18.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.65 127.46 50.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -106.34 168.82 8.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.728 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.515 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -150.11 127.87 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.224 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -98.74 105.15 17.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.58 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.09 144.78 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 109.252 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.617 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 6.6 t70 -78.94 -101.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -148.35 13.6 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.617 ' ND2' ' OD2' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -139.27 2.25 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.68 33.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.432 HD13 ' OG ' ' A' ' 81' ' ' SER . 4.5 mm -83.32 144.06 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -1.187 . . . . 0.0 109.418 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 55' ' ' ASP . 72.1 mt -90.19 91.41 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.85 -54.03 16.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 15.9 t0 -136.59 -177.08 4.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.357 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.91 116.29 1.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.593 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -96.46 141.72 29.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -117.01 162.63 17.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.403 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -157.16 97.24 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.435 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.52 124.98 50.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -150.78 97.11 2.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.35 -39.7 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 34.3 t -130.12 121.79 27.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.93 47.41 1.89 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.09 2.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -1.16 . . . . 0.0 109.562 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.01 -4.25 20.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.452 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.542 ' O ' ' C ' ' A' ' 68' ' ' ALA . 3.1 mp -62.29 -65.85 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.542 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.5 -71.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -41.5 -60.32 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.496 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 84.1 p -46.29 -47.76 18.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.342 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.406 ' C ' ' OG1' ' A' ' 74' ' ' THR . 1.7 m -57.71 -23.95 54.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 74' ' ' THR . 1.4 tp -78.82 -71.54 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.287 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.577 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -40.52 -24.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -75.56 -56.17 4.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.252 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.16 -15.52 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -88.63 -32.55 18.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 77' ' ' VAL . 17.2 m -104.6 55.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.648 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 84.29 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.11 -15.1 23.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -78.25 -174.42 3.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.418 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.432 ' OG ' HD13 ' A' ' 52' ' ' ILE . 73.4 m -109.45 174.39 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.23 -26.03 68.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.633 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -64.61 -17.44 64.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -100.09 -38.87 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.08 -25.29 58.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.73 54.25 0.68 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.17 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -1.169 . . . . 0.0 109.404 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.54 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -35.89 -43.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 91' ' ' SER . 0.3 OUTLIER 63.6 119.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.582 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 91' ' ' SER . 43.0 p30 -40.93 -25.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.025 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.535 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.5 m -50.44 -36.9 35.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 93' ' ' ILE . 12.6 tt0 -83.46 -60.31 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.477 ' C ' ' O ' ' A' ' 92' ' ' GLN . 69.6 mt -40.13 -48.1 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 95' ' ' GLU . . . -72.44 -55.2 7.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 94' ' ' ALA . 3.7 tt0 -36.07 -34.06 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 94' ' ' ALA . 1.2 tp10 -81.79 -62.19 1.71 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.619 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.8 OUTLIER -63.29 -16.91 61.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 97' ' ' LEU . 1.1 tp10 37.94 47.43 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -71.28 150.47 94.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.169 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -36.15 109.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.87 2.38 . . . . 0.0 112.045 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.9 16.41 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.559 2.173 . . . . 0.0 112.477 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 102' ' ' VAL . 10.9 m -82.3 13.64 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' VAL . 4.9 tptt -168.21 -38.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.43 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 103' ' ' LYS . 12.4 t 44.22 57.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.27 -57.85 2.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' A' ' 107' ' ' SER . 48.0 t -44.46 -60.42 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.807 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.486 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -43.38 -63.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 107' ' ' SER . 27.4 mt -38.1 -62.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 34' ' ' ALA . 8.6 mp -48.65 -37.25 17.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.587 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.12 -73.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.637 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.551 ' O ' ' OE2' ' A' ' 111' ' ' GLU . 3.8 tp10 -46.69 -58.54 3.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.9 OUTLIER -43.74 -38.34 3.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.768 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -51.96 65.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.6 tp -61.61 -41.1 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.677 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.479 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -62.08 -41.14 97.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 109.511 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.42 67.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -55.02 -33.91 63.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.314 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 68.9 mt -69.38 -66.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.851 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -38.69 -46.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.395 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -63.28 -43.85 96.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.394 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 118' ' ' ILE . 59.5 t80 -56.45 -42.25 77.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.449 ' NZ ' ' CG2' ' A' ' 118' ' ' ILE . 23.6 mttp -72.04 -43.98 64.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.05 -11.91 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.417 ' N ' ' C ' ' A' ' 122' ' ' LYS . 6.3 mttt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.31 -1.94 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 24' ' ' ASP . 1.9 p-10 -167.84 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.59 92.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.8 144.57 18.25 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.567 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 4.8 m -135.43 130.55 34.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.46 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.15 140.52 16.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.21 125.08 21.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 109.575 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.62 170.42 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.08 141.84 7.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -110.67 129.2 24.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.183 . . . . 0.0 109.186 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 36' ' ' ALA . 63.8 Cg_endo -77.14 -45.02 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.515 2.143 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.31 -55.28 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -113.55 29.04 8.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 109.69 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.4 51.67 0.74 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 37' ' ' CYS . 78.8 m-20 -102.24 111.77 24.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -99.3 130.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.759 ' HG3' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -137.05 150.74 48.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.492 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -136.76 116.36 12.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.376 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 tt -105.6 143.25 34.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 45' ' ' ILE . 4.8 tt0 -135.51 162.33 32.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.325 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.533 ' N ' ' CG ' ' A' ' 44' ' ' GLN . 1.3 pt -147.41 162.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.426 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 10.6 mmtm -129.52 138.48 51.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.21 155.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.562 ' OD2' ' OD1' ' A' ' 49' ' ' ASP . 38.5 t70 -88.65 -49.7 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.631 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER 160.78 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.234 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -101.39 -11.72 19.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 8.71 7.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.36 149.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.9 mt -90.92 95.55 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' CG ' ' N ' ' A' ' 55' ' ' ASP . 19.9 pt-20 -58.03 -46.24 85.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 54' ' ' GLU . 1.7 t0 -137.53 168.17 20.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.579 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.05 100.51 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.07 159.5 14.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.509 ' CD1' HG21 ' A' ' 74' ' ' THR . 34.6 p90 -140.35 -175.0 4.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.58 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -171.35 83.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.759 HG22 ' HG3' ' A' ' 41' ' ' MET . 59.6 p -92.9 149.04 21.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -155.06 141.56 18.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.85 -80.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 65' ' ' SER . 0.1 OUTLIER -82.11 136.94 35.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -1.157 . . . . 0.0 109.444 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.83 45.76 3.07 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -154.6 -47.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.392 -1.063 . . . . 0.0 109.336 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.68 -14.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' SER . 7.2 mt -65.88 -22.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.43 -67.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 73' ' ' ILE . 20.9 p -46.39 -53.41 11.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.166 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 74' ' ' THR . 83.9 p -49.88 -33.57 17.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.524 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.3 OUTLIER -71.17 -37.71 72.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.292 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.22 -67.84 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.848 . . . . 0.0 109.441 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' VAL . 5.3 tt -44.42 -40.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.948 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 71' ' ' SER . 1.5 p -57.48 -48.31 79.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.894 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.14 -21.57 50.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -11.54 59.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 73' ' ' ILE . 16.4 m -124.67 20.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.253 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -90.54 99.78 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.402 -0.812 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.04 56.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -81.88 171.14 14.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.15 150.68 21.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.532 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.7 mt -54.79 -15.81 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.99 -33.4 74.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.36 -47.48 8.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.871 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.8 -5.58 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.298 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.83 31.54 6.98 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.22 -36.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -1.16 . . . . 0.0 109.184 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.4 pt -44.81 120.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.839 . . . . 0.0 109.545 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.437 ' H ' ' NE2' ' A' ' 92' ' ' GLN . 18.8 mttm -94.3 179.39 5.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -13.9 60.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.462 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -82.75 -43.89 16.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.437 ' NE2' ' H ' ' A' ' 89' ' ' LYS . 58.3 mt-30 -58.28 -36.59 73.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.005 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.15 -33.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.02 -21.08 66.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.899 . . . . 0.0 108.971 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -94.18 -35.32 12.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.179 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -58.74 -36.18 73.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.352 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 mt -106.03 -3.87 21.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 47.12 50.88 13.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.431 HD12 ' C ' ' A' ' 99' ' ' LEU . 3.5 pp -85.88 146.8 44.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.427 ' O ' HG12 ' A' ' 102' ' ' VAL . 37.0 Cg_endo -69.08 151.99 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.744 2.296 . . . . 0.0 112.053 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.621 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.5 Cg_endo -69.5 19.13 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.887 2.391 . . . . 0.0 112.369 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.532 ' C ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -35.53 -28.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.31 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.649 ' C ' HG23 ' A' ' 104' ' ' VAL . 5.9 tptt -173.35 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.374 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 ' C ' ' A' ' 103' ' ' LYS . 1.6 t 69.87 2.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 37.4 p-80 -65.15 -36.76 85.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 3.9 t -58.7 -56.39 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.06 -44.31 74.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.8 mt -56.53 -41.58 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.39 -32.28 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -63.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.887 . . . . 0.0 109.62 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.1 -49.77 76.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -53.52 -28.03 29.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.973 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -79.3 -64.42 1.19 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.6 tp -44.94 -41.16 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 109.833 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.497 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -73.45 -37.15 65.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.442 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.09 80.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -68.59 -60.34 2.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ALA . 44.4 mt -38.57 -49.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.48 80.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.567 ' OD2' ' O ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -52.67 -66.64 0.35 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.253 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -46.92 -39.02 11.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 109.177 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -59.54 -51.17 70.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.814 . . . . 0.0 109.366 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.72 -6.48 2.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.522 -179.95 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' HG23 ' A' ' 27' ' ' VAL . 4.2 t0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.359 0.6 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.529 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 3.7 m -101.61 7.24 42.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.529 ' OD1' ' O ' ' A' ' 25' ' ' SER . 56.9 m-20 -144.2 14.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.435 HG23 ' OD2' ' A' ' 24' ' ' ASP . 32.9 t -118.46 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.192 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.53 153.13 34.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.542 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 7.8 m -127.15 120.7 29.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -1.043 . . . . 0.0 109.108 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.24 106.5 1.81 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.0 ttt -112.33 112.4 23.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -1.216 . . . . 0.0 109.462 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.48 154.44 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.39 -170.1 11.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.31 92.24 4.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 53.7 Cg_exo -48.55 -48.03 18.65 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.689 2.259 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.09 -34.2 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.469 ' O ' ' C ' ' A' ' 38' ' ' GLY . 21.2 m -120.01 12.05 11.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.83 56.89 3.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -124.5 117.6 24.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.29 130.06 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -128.86 137.04 51.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.325 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -121.54 164.01 17.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.689 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tp -158.51 126.19 5.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -117.77 140.55 49.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.426 HD11 ' HB1' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -129.54 124.34 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.57 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -101.39 143.6 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 48' ' ' ASP . 92.5 t -131.3 156.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.291 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.0 t70 -85.16 -106.12 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.448 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 2.1 p30 -140.02 8.65 2.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.637 HD22 ' H ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -124.75 -29.52 3.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.461 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.437 ' N ' HD22 ' A' ' 50' ' ' ASN . . . 135.66 -5.6 4.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.637 ' H ' HD22 ' A' ' 50' ' ' ASN . 50.0 mm -79.38 137.04 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -1.151 . . . . 0.0 109.487 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 53' ' ' ILE . 8.1 mt -91.17 107.01 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -70.93 -16.45 62.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.725 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 15.7 t0 -172.91 151.75 2.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.053 -1.029 . . . . 0.0 109.791 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.556 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -133.12 107.76 8.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.22 154.77 17.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 109.561 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 74' ' ' THR . 2.4 p90 -136.99 -176.5 4.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.58 106.94 0.56 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.349 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.43 ' CG2' ' OG ' ' A' ' 70' ' ' SER . 81.9 p -112.77 145.15 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -154.45 108.79 3.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 109.423 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.84 -58.19 0.3 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.6 t -106.68 136.02 47.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -1.153 . . . . 0.0 109.371 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.63 38.25 2.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.5 20.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -1.185 . . . . 0.0 109.525 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -93.43 -29.49 15.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.805 ' CD1' ' H ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -42.93 -27.16 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -46.72 -57.59 4.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.852 . . . . 0.0 109.705 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -49.89 29.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.707 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.43 ' OG ' ' CG2' ' A' ' 60' ' ' THR . 0.3 OUTLIER -48.63 -41.62 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.873 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.57 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.15 -45.17 74.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 73' ' ' ILE . 46.3 tp -57.06 -71.22 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.74 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.641 HD12 ' HB1' ' A' ' 110' ' ' ALA . 9.5 tt -40.78 -44.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 109.941 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.824 HG21 ' CD1' ' A' ' 58' ' ' PHE . 1.1 p -59.22 -36.92 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.764 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' LEU . 21.6 tt0 -71.69 -55.65 7.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -31.88 27.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.664 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 77' ' ' VAL . 4.2 m -105.37 63.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.7 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -144.58 95.5 2.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.56 -15.47 35.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -76.08 -160.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -1.109 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 t -117.96 159.08 23.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 82' ' ' LEU . 14.0 mt -57.11 -19.18 18.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.327 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -67.83 -30.8 70.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.376 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.7 tp10 -86.39 -45.86 10.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.608 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.46 60.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.62 46.73 1.13 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -168.33 -33.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.093 . . . . 0.0 108.93 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 84' ' ' GLU . 16.2 pt -50.3 179.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.49 -0.756 . . . . 0.0 109.579 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -143.58 179.98 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.282 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -96.15 -13.22 23.73 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 t -70.84 -41.93 70.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.813 . . . . 0.0 109.268 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -65.86 -52.15 52.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.212 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 mt -57.97 -27.01 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.221 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.67 -42.06 78.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.318 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.51 -22.02 62.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.19 -54.92 5.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.532 ' O ' ' C ' ' A' ' 98' ' ' GLU . 4.4 tp -80.75 -3.47 51.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 97' ' ' LEU . 7.6 tm-20 36.0 70.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.326 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.04 149.76 36.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.373 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -71.03 151.66 62.03 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.714 2.276 . . . . 0.0 112.112 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.02 19.39 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.797 2.331 . . . . 0.0 112.211 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.31 16.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.493 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 105' ' ' HIS . 8.8 tttp -176.49 46.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 104' ' ' VAL . 18.7 t -65.86 20.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.64 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.611 ' H ' ' C ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -86.24 -30.51 22.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 p -65.85 -44.37 85.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.25 -45.92 89.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.7 mt -68.2 -30.04 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 mp -73.27 -40.93 64.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.641 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -60.15 -53.77 53.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.831 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.31 -56.85 8.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.709 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -51.55 -17.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.38 -55.06 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 tp -51.13 -33.07 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.0 109.653 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.503 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -75.39 -61.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -37.47 -35.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 119' ' ' ALA . . . -77.75 -66.34 0.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 117' ' ' ALA . 48.0 mt -37.47 -28.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 117' ' ' ALA . . . -77.9 -52.9 8.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD2' ' O ' ' A' ' 29' ' ' THR . 37.3 m-20 -49.75 -44.19 48.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.71 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.59 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -76.12 -59.17 2.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 109.547 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' TYR . 22.6 tptt -43.11 -33.26 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.8 -20.87 16.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 mttt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.944 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.286 0.565 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 58.91 -4.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.337 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 24' ' ' ASP . 8.9 p-10 -146.65 13.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.383 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.06 101.58 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.744 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.19 128.86 9.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.74 152.9 21.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -1.212 . . . . 0.0 109.661 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 43' ' ' LEU . . . -131.51 118.18 2.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.96 95.3 4.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -1.146 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.92 145.56 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.86 177.75 20.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.57 77.15 73.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.171 -1.194 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.03 -6.36 1.8 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.854 2.369 . . . . 0.0 112.107 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.62 -11.08 59.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.588 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.4 -39.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.98 69.63 0.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.1 145.89 44.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -1.157 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.22 117.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.85 . . . . 0.0 109.212 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ttt -120.11 120.24 35.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.893 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.34 142.72 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 108.97 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 tt -150.62 149.39 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 109.886 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 12.9 pt20 -150.99 123.27 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.787 . . . . 0.0 109.214 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.3 151.12 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -112.68 150.0 32.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.568 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.84 144.52 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.203 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.605 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 36.7 p-10 -85.13 -108.76 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.963 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.605 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 34.0 t0 -131.95 -23.39 2.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.545 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.37 -1.68 57.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 28.83 12.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 53' ' ' ILE . 45.9 mm -108.89 161.43 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 109.373 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.463 ' N ' HG22 ' A' ' 52' ' ' ILE . 8.4 mt -100.49 105.47 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.222 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.3 -36.29 20.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.803 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.79 160.31 38.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.707 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.29 112.88 4.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 109.417 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -107.77 146.63 31.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -140.35 -175.44 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.542 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -170.75 107.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.433 HG21 ' CB ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -121.39 105.87 10.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.474 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.1 122.54 24.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.09 -39.44 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.0 139.06 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -1.099 . . . . 0.0 109.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.52 60.45 1.52 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.565 ' C ' ' H ' ' A' ' 67' ' ' ILE . 2.3 p -175.73 -59.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 106' ' ' CYS . . . -54.02 -1.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.532 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.565 ' H ' ' C ' ' A' ' 65' ' ' SER . 4.2 mt -65.76 -8.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.25 -49.75 9.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.09 -52.82 59.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.327 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -43.37 -56.51 3.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -53.21 -30.43 37.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 109.352 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 69' ' ' SER . 11.4 tp -70.53 -67.45 0.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 109.554 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.651 ' O ' HG22 ' A' ' 77' ' ' VAL . 3.9 tt -48.72 -40.35 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.458 ' N ' HG23 ' A' ' 73' ' ' ILE . 21.0 p -58.66 -47.19 85.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.74 -10.17 58.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.87 -31.37 17.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 73' ' ' ILE . 4.2 m -102.42 64.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -133.93 100.5 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.67 -9.39 77.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -81.45 -171.22 3.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -1.204 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.11 -178.27 3.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.24 -10.32 49.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -71.06 -34.48 71.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.156 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.0 -37.13 13.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.402 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 -29.53 63.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.67 48.29 1.51 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.97 -42.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -1.12 . . . . 0.0 109.027 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.465 ' C ' ' O ' ' A' ' 87' ' ' ALA . 2.3 pt -40.98 151.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.398 -0.814 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -129.53 173.42 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 109.669 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.495 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 4.1 p-10 -86.75 -7.86 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.357 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 -47.38 39.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -60.08 4.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 109.409 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.31 -38.25 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 90' ' ' ASN . . . -62.75 -33.87 76.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.55 -22.31 30.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.486 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.02 -24.85 58.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.4 mt -111.21 -19.26 12.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.242 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.47 62.79 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.684 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -97.56 153.23 38.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.335 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.0 152.13 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.547 2.164 . . . . 0.0 112.028 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.41 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 57.6 Cg_endo -74.67 -11.05 22.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.752 2.301 . . . . 0.0 112.229 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -92.01 11.11 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 105' ' ' HIS . 34.7 mttt -139.83 6.56 2.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.454 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 104' ' ' VAL . 3.8 t -47.09 -17.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -51.4 -14.69 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.514 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.628 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 42.2 t -76.05 -71.12 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.668 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.0 p -48.62 -44.06 36.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.7 mt -57.93 -51.83 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp -52.52 -27.91 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.82 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 16.4 tt0 -64.5 -44.92 89.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -35.23 79.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.36 65.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp -58.53 -41.37 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.975 . . . . 0.0 109.567 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.485 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 40.4 tttm -61.27 -28.56 69.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 109.155 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.37 -47.53 19.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.6 -32.41 41.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.92 -41.34 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.42 84.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.11 -52.64 22.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.87 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -49.36 -42.13 41.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.224 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -28.55 63.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.96 4.64 53.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.5 tptt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.37 179.941 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -82.99 9.31 10.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.684 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -118.92 -13.68 9.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.363 -0.836 . . . . 0.0 109.364 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.12 94.08 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.369 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.73 142.5 20.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -120.94 158.88 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -1.089 . . . . 0.0 109.177 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.15 145.4 12.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 ttt -145.62 119.3 9.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -126.17 170.34 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.75 178.29 28.27 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.29 75.34 70.72 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -1.091 . . . . 0.0 109.187 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 75.3 Cg_exo -44.48 -25.74 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 112.434 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.1 -51.2 8.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.8 p -114.79 -24.54 8.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.45 46.11 1.09 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 36.9 t0 -108.09 135.61 49.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 109.488 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.527 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 4.0 m -108.43 137.72 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.9 ttt -137.86 128.56 26.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -117.26 142.91 46.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 109.409 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 tp -149.53 121.09 7.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.67 155.41 29.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.849 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.79 125.48 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.66 ' NZ ' ' OE1' ' A' ' 54' ' ' GLU . 11.2 tttp -100.0 114.71 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -122.39 127.55 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.941 . . . . 0.0 109.495 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 50' ' ' ASN . 6.3 m-20 -158.02 -32.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.616 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -62.57 50.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.3 m-80 78.54 54.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' C ' HG12 ' A' ' 47' ' ' VAL . . . 68.61 18.17 71.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.2 mm -105.73 134.9 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.389 -1.065 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.703 HG22 ' O ' ' A' ' 53' ' ' ILE . 32.4 mt -63.06 80.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.216 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.66 ' OE1' ' NZ ' ' A' ' 46' ' ' LYS . 35.5 tt0 -49.61 -22.73 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.18 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -169.11 159.57 9.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.034 -1.041 . . . . 0.0 109.808 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.05 134.0 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -116.68 144.59 44.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -143.66 170.64 15.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -171.7 96.54 0.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 0.0 108.975 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.32 148.64 42.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -152.79 147.93 26.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.152 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.73 -74.03 0.45 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 1.6 p -116.24 122.18 44.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.134 . . . . 0.0 109.348 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.25 -9.68 2.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 63' ' ' CYS . 0.5 OUTLIER -93.27 10.3 32.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.711 ' HB2' ' SG ' ' A' ' 63' ' ' CYS . . . -100.88 -3.49 29.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.86 -24.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.8 65.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.622 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -76.91 -50.78 12.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.1 t -49.34 -38.41 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.359 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.1 t -72.21 -39.28 68.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 HG23 ' A' ' 93' ' ' ILE . 49.9 tp -61.0 -59.87 4.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.344 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.727 HG23 ' H ' ' A' ' 74' ' ' THR . 1.0 OUTLIER -53.13 -59.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.727 ' H ' HG23 ' A' ' 73' ' ' ILE . 2.4 p -42.86 -32.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.824 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -91.01 -11.31 39.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.782 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -93.87 -17.31 23.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.975 . . . . 0.0 109.533 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.36 40.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -95.89 116.93 29.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.43 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.69 5.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -73.74 -173.78 1.6 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.4 m -101.49 158.4 16.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.865 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -70.21 -16.56 63.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.86 -26.22 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.208 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -93.43 -43.4 8.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.376 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.21 67.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.47 33.11 4.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.1 26.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -1.109 . . . . 0.0 109.253 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.57 -25.02 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.832 . . . . 0.0 109.621 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 71.16 156.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.448 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.55 ' OD1' ' OE1' ' A' ' 111' ' ' GLU . 6.6 p-10 -93.48 -41.96 9.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.616 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -35.96 79.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -58.54 -67.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.408 HG23 HD23 ' A' ' 72' ' ' LEU . 4.3 mt -49.8 -33.47 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.751 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 107' ' ' SER . . . -69.3 -31.08 69.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 109.741 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.4 -36.14 60.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.23 -43.3 82.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.25 -17.15 62.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.404 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 54.24 39.08 30.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.3 pp -82.27 149.0 60.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.304 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.404 ' O ' HD12 ' A' ' 99' ' ' LEU . 29.3 Cg_endo -66.16 149.31 85.63 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.645 2.23 . . . . 0.0 112.147 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -73.2 20.06 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.926 2.417 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.0 m -85.47 -13.52 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.885 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 105' ' ' HIS . 1.0 OUTLIER -150.12 55.8 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.849 HG12 ' O ' ' A' ' 104' ' ' VAL . 74.5 t -73.3 40.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.467 ' H ' ' C ' ' A' ' 103' ' ' LYS . 62.4 m80 -97.42 -26.46 14.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.868 . . . . 0.0 109.718 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.642 ' SG ' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -74.94 -45.11 44.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.626 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.642 ' N ' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -53.84 -46.92 71.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 56.2 mt -68.05 -43.65 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.4 mp -58.27 -37.35 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -63.33 -59.07 5.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.422 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.55 ' OE1' ' OD1' ' A' ' 90' ' ' ASN . 87.1 tt0 -56.09 -60.51 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.362 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 111' ' ' GLU . 1.6 t0 -43.9 -32.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.354 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -68.89 -61.2 1.9 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.46 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 tp -49.61 -20.68 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -85.26 -57.9 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.353 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.56 5.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.225 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.94 -58.03 3.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.126 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.5 mt -46.72 -31.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.365 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.89 38.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.05 -0.79 12.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.147 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -102.81 -32.05 10.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -95.74 -31.4 13.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.26 -18.18 63.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.484 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.192 0.52 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -71.27 2.4 4.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.277 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 25' ' ' SER . 2.4 p30 165.75 33.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.41 96.76 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.454 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.0 100.95 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 m -86.17 133.16 33.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -1.152 . . . . 0.0 109.657 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.33 145.78 17.57 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.21 110.8 5.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -1.213 . . . . 0.0 109.774 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.77 144.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.34 178.17 21.09 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.93 92.57 49.07 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.139 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.8 Cg_exo -50.15 -40.15 51.28 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.852 2.368 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.43 -44.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 109.671 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.32 -13.03 9.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.599 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.22 57.9 2.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -113.35 110.84 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.5 130.54 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.99 118.96 15.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -111.14 136.23 50.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.707 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' CB ' ' HB1' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -126.35 141.89 51.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -140.84 135.84 31.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -118.09 136.01 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' CD ' ' OD2' ' A' ' 55' ' ' ASP . 36.8 tttt -105.87 118.92 37.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.25 146.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.7 m-20 -173.92 -33.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.614 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -62.47 42.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.672 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.8 m-80 80.99 43.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 109.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.13 0.54 82.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.525 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.0 mm -98.23 151.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.494 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -84.39 116.03 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -44.57 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD2' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -130.11 131.2 45.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.561 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.96 121.51 45.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.425 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 115.13 29.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.402 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.744 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -101.78 167.91 9.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 83.74 1.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.92 127.47 41.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.47 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -151.57 141.56 22.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.596 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.98 -53.06 0.59 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 42.6 t -91.11 172.57 8.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -1.188 . . . . 0.0 109.442 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.495 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -129.92 -10.85 2.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.8 13.65 30.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -1.112 . . . . 0.0 109.368 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.93 -31.37 9.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.845 . . . . 0.0 109.486 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.6 mp -36.7 -35.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.933 . . . . 0.0 109.172 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -75.44 -55.86 5.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.7 m -51.11 -39.87 57.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -70.05 -66.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.67 -19.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.328 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -79.75 -78.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.937 . . . . 0.0 109.573 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 74' ' ' THR . 11.3 tt -45.95 -36.77 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.57 HG21 ' CG ' ' A' ' 58' ' ' PHE . 43.7 p -68.76 -39.07 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.82 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -79.78 -12.22 59.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -98.6 -26.36 14.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.539 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.3 -34.76 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -50.73 116.31 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.41 57.49 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -89.22 -177.89 5.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.391 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.525 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 50.6 m -107.17 -178.95 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.9 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.2 mt -77.68 -23.07 49.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 -14.22 60.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.378 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -101.23 -41.95 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.14 1.71 56.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.6 47.07 1.08 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -176.85 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -1.127 . . . . 0.0 109.394 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.498 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -38.16 155.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -116.43 158.6 23.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.539 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.534 ' OD1' ' OE1' ' A' ' 111' ' ' GLU . 1.4 p-10 -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -47.55 -37.06 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.19 -66.97 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 109.555 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -44.95 -44.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.46 -39.76 77.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.105 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -75.86 -10.01 59.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.234 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -79.47 -62.87 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 97' ' ' LEU . 6.2 mt -72.52 -2.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.09 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 46.9 77.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 110.086 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -126.69 148.52 65.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 108.875 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -37.78 148.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.887 2.391 . . . . 0.0 112.358 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.71 -79.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.676 2.251 . . . . 0.0 112.348 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 103' ' ' LYS . 3.3 t 47.16 -138.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.195 -0.941 . . . . 0.0 109.298 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.69 ' H ' HG12 ' A' ' 102' ' ' VAL . 14.6 tttt -78.42 -6.45 55.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 104' ' ' VAL . 12.0 p 31.97 41.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.485 -0.759 . . . . 0.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.666 ' HA ' HD12 ' A' ' 108' ' ' ILE . 16.0 p80 -68.65 -24.4 64.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.8 t -59.48 -71.18 0.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 69.6 m -46.35 -42.19 14.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.299 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 105' ' ' HIS . 87.5 mt -54.77 -70.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 108' ' ' ILE . 6.4 mp -36.64 -34.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 109.452 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -61.4 -72.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' OD1' ' A' ' 90' ' ' ASN . 16.9 tt0 -54.49 -38.33 66.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -27.99 68.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.892 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 43' ' ' LEU . . . -79.09 -58.26 3.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.529 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.5 tp -44.7 -39.5 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 109.548 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -67.79 -55.9 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.553 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -45.54 -50.17 13.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.87 -59.98 4.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.506 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.9 mt -52.02 -22.18 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -73.25 -49.93 25.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.47 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -68.77 -50.85 47.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -48.53 -50.56 31.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 123' ' ' ALA . 3.4 mttm -65.13 -39.36 92.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.626 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -43.16 -42.82 4.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.2 tptt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.928 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 13.13 14.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.888 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -108.83 16.95 22.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.07 116.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.16 140.18 15.6 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.3 m -119.89 120.51 36.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.1 132.94 6.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -136.02 131.43 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -1.141 . . . . 0.0 109.282 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.03 -174.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.23 -169.17 38.71 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -140.31 100.51 6.97 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' CYS . 69.0 Cg_exo -47.06 -60.55 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.52 2.146 . . . . 0.0 112.152 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.71 -20.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 35' ' ' PRO . 3.7 m -118.85 -32.39 4.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 81.0 25.81 54.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.78 132.39 35.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -1.115 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -107.36 115.39 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.7 ttt -113.94 102.15 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -84.92 155.04 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.51 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.89 110.83 2.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -115.26 123.56 49.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.405 HG13 ' H ' ' A' ' 45' ' ' ILE . 0.6 OUTLIER -103.95 153.23 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -126.0 134.38 51.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.75 148.1 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.199 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.58 -94.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.039 -1.038 . . . . 0.0 109.612 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -156.43 20.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.46 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -1.2 3.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.915 . . . . 0.0 109.46 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.11 15.06 31.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mm -105.32 122.35 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -1.147 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.0 mt -67.82 111.93 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.253 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' CD ' ' O ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -88.19 -8.07 55.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.817 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 56' ' ' ALA . 7.0 t70 -171.96 165.86 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 55' ' ' ASP . . . -149.55 139.79 22.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 165.46 24.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD1' HG21 ' A' ' 74' ' ' THR . 8.3 p90 -170.61 -174.49 1.63 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.809 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -172.03 111.08 0.28 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.038 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.1 p -84.32 149.45 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.816 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.7 116.09 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.37 -0.832 . . . . 0.0 109.316 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.49 -87.23 0.14 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 140.32 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -1.11 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.11 55.37 3.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.55 -32.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -83.6 1.23 43.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 67' ' ' ILE . 5.8 mm -59.07 4.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -94.09 -38.66 11.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -70.62 -52.82 18.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -53.11 -33.67 53.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.514 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' ' OG1' ' A' ' 74' ' ' THR . 6.2 m -71.51 -35.77 70.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.97 -65.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.802 ' O ' HG22 ' A' ' 77' ' ' VAL . 1.2 tt -46.12 -39.56 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.781 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 70' ' ' SER . 16.6 p -62.89 -40.01 96.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 1.39 51.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.902 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -17.37 14.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.823 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 73' ' ' ILE . 17.8 m -114.03 53.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.039 . . . . 0.0 109.648 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -126.26 104.34 8.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.375 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -24.02 33.99 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -65.38 -179.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.405 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.6 159.17 15.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.124 -0.985 . . . . 0.0 109.65 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mt -56.43 -22.29 30.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.888 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.08 -46.47 70.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.138 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.81 -45.58 93.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.132 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.46 72.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.153 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 49.0 4.15 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.98 -32.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -1.075 . . . . 0.0 109.182 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.544 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -34.16 -44.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.45 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 88' ' ' ILE . 49.3 mttt 57.79 145.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.835 . . . . 0.0 109.559 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.35 -28.82 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 0.0 109.37 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.3 p -54.53 -39.86 68.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -53.9 12.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.425 ' H ' HG13 ' A' ' 93' ' ' ILE . 23.3 mt -51.49 -40.61 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.45 -58.82 5.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.392 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.63 -53.01 34.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.214 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -47.24 -50.51 21.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.342 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.5 mp -70.19 -40.34 74.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.357 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 1.8 tp10 81.71 32.6 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.19 146.14 50.6 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 102' ' ' VAL . 20.5 Cg_endo -64.77 152.59 81.5 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.558 2.172 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.11 20.11 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.875 2.383 . . . . 0.0 112.131 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 100' ' ' PRO . 33.0 m -87.93 -21.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.63 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -137.18 47.74 2.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.793 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.45 -9.5 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 108.998 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.764 ' O ' HD13 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -56.28 -27.15 54.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 45.2 t -69.87 -64.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -49.59 -65.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.363 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 107' ' ' SER . 80.0 mt -40.98 -44.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 105' ' ' HIS . 2.0 mp -57.46 -44.23 84.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -57.69 -48.1 80.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.271 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -59.61 -59.68 5.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 -25.89 3.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.885 . . . . 0.0 109.441 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -72.1 -38.9 69.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 111' ' ' GLU . 2.1 tp -70.23 -35.76 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.476 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 13.7 mttt -77.92 -30.4 50.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.531 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.86 -43.85 87.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.358 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.14 77.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.273 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.16 -45.72 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.429 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.83 75.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 29' ' ' THR . 4.8 m-20 -66.92 -8.64 30.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -87.22 -52.36 5.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -61.89 -41.78 98.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.633 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.51 -0.59 5.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.429 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.296 0.57 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -92.11 12.31 22.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.333 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.418 HD22 HG23 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -114.89 19.96 15.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.418 HG23 HD22 ' A' ' 26' ' ' ASN . 38.0 t -139.29 99.42 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.52 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.04 120.87 5.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -82.96 136.69 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 109.52 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.12 85.59 0.32 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mtt -94.69 107.27 19.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -1.103 . . . . 0.0 109.559 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.1 170.78 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.526 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.94 -173.21 34.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.1 87.09 55.97 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.184 . . . . 0.0 109.481 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.94 -12.8 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.736 2.291 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.8 m -120.18 -38.68 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.5 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.12 36.88 0.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.41 115.8 28.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.127 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.72 131.23 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.091 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -134.55 131.5 38.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.801 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 5.4 tt0 -125.41 131.88 52.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.274 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -142.96 111.87 6.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.506 ' NE2' ' OE1' ' A' ' 42' ' ' GLN . 9.2 mt-30 -103.22 143.92 32.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.454 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.3 OUTLIER -106.77 147.5 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.574 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 117.94 29.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.8 134.0 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.675 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.6 m-20 -170.39 -31.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.575 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 14.0 m-20 -62.7 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.092 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-80 74.49 48.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.488 -0.758 . . . . 0.0 109.067 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.65 -8.54 58.97 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 53' ' ' ILE . 45.2 mm -87.71 162.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.524 ' N ' HG22 ' A' ' 52' ' ' ILE . 62.3 mt -79.37 120.33 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.75 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.38 -31.9 21.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.64 157.11 1.99 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.221 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.87 139.09 50.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -103.22 117.66 35.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 74' ' ' THR . 15.1 p90 -103.88 166.42 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.5 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -167.05 93.49 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.357 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.78 135.66 50.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.505 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -150.59 139.61 21.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.71 -45.21 0.76 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.6 OUTLIER -119.58 123.71 44.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -1.107 . . . . 0.0 109.389 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 67.19 0.17 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.6 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -174.8 -48.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -1.15 . . . . 0.0 109.633 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.03 -2.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.6 ' H ' ' C ' ' A' ' 65' ' ' SER . 6.2 mm -82.4 -12.05 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.317 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.16 -48.45 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 109.683 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.545 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -63.72 -40.68 97.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.687 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 74' ' ' THR . 1.0 OUTLIER -55.25 -47.16 75.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.72 -42.99 99.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.862 . . . . 0.0 109.813 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.412 HD21 ' OE1' ' A' ' 96' ' ' GLU . 1.9 tp -61.93 -68.25 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.61 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.635 HG23 ' N ' ' A' ' 74' ' ' THR . 17.7 tt -47.99 -49.61 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.754 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.635 ' N ' HG23 ' A' ' 73' ' ' ILE . 6.5 p -50.49 -46.79 57.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.84 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.52 -5.42 54.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -5.98 26.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.52 -5.85 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.22 114.09 19.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.627 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.21 -6.72 63.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -91.24 165.48 13.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -1.21 . . . . 0.0 109.635 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.486 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 18.1 m -100.42 166.98 10.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.543 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -23.44 67.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.51 -44.82 93.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.83 -59.03 2.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.92 . . . . 0.0 109.387 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.42 -26.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.269 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.17 44.21 1.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.554 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -161.99 -37.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.096 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.554 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.0 pt -41.54 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -136.84 154.49 50.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.54 ' O ' ' C ' ' A' ' 91' ' ' SER . 18.5 p-10 -73.77 -50.71 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.54 ' C ' ' O ' ' A' ' 90' ' ' ASN . 4.0 t -35.01 -46.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.536 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.94 -49.9 72.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.2 mt -55.68 -35.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.221 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.95 -24.3 60.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -81.6 -47.47 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.412 ' OE1' HD21 ' A' ' 72' ' ' LEU . 11.2 tt0 -62.28 -29.36 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 99' ' ' LEU . 1.3 mp -98.05 -28.81 13.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.534 ' O ' ' C ' ' A' ' 99' ' ' LEU . 1.6 tt0 64.8 -2.94 0.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.259 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.534 ' C ' ' O ' ' A' ' 98' ' ' GLU . 1.7 pp -34.58 150.23 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.477 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -40.33 108.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.858 2.372 . . . . 0.0 112.097 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.23 8.54 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.536 2.157 . . . . 0.0 112.445 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 102' ' ' VAL . 2.5 m -56.84 -14.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -153.11 -38.8 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' CYS . 5.9 t 64.85 5.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.471 ' ND1' ' N ' ' A' ' 105' ' ' HIS . 7.6 p-80 -45.6 -20.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' VAL . 1.8 m -75.41 -75.67 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 4.4 m -43.24 -38.78 2.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.8 mt -57.86 -52.65 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.5 mp -59.25 -23.08 62.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -66.74 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.534 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 6.9 tp10 -60.08 -40.06 88.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -27.69 69.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.177 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -73.44 -65.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.47 HG22 ' OE1' ' A' ' 111' ' ' GLU . 2.4 tp -43.08 -33.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -67.6 -73.25 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.352 -0.843 . . . . 0.0 109.414 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.544 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -35.48 -36.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' LYS . . . -60.96 -63.93 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.9 mt -47.49 -25.34 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.412 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -67.1 -59.22 3.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -61.58 -40.28 94.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.313 -0.867 . . . . 0.0 109.093 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -52.43 -57.77 8.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 109.188 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' LYS . 1.7 ttmm -54.44 -47.94 72.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.478 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -44.43 -21.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.51 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 122' ' ' LYS . 42.6 mmtt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.387 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.278 0.561 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.521 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 3.3 m -103.97 -0.41 28.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.659 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.71 11.98 36.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.336 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.37 110.06 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.86 145.68 17.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 m -139.96 137.28 34.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.6 150.73 22.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.9 mtt -144.11 105.0 4.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -1.112 . . . . 0.0 109.209 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.25 -176.15 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.84 157.11 17.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.63 138.4 20.61 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.178 -1.189 . . . . 0.0 109.466 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.99 3.72 4.28 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.609 2.206 . . . . 0.0 112.216 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.17 -79.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -109.37 20.74 17.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.354 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 53.51 16.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.644 ' OD2' ' SG ' ' A' ' 63' ' ' CYS . 1.5 m-20 -86.56 116.93 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -1.105 . . . . 0.0 109.698 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -95.09 121.17 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 109.211 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.34 112.89 20.62 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.168 -0.957 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -99.76 140.15 34.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 109.084 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.428 HD21 HD12 ' A' ' 114' ' ' ILE . 3.3 tt -151.11 121.31 7.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.727 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -126.49 176.79 6.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.98 157.44 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -131.88 134.93 46.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.582 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 30.0 t -124.9 122.65 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.686 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.3 m-20 -157.78 -32.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.546 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 11.1 t70 -62.22 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.5 m-20 78.89 52.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -0.833 . . . . 0.0 109.535 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.86 9.45 66.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 53' ' ' ILE . 43.6 mm -105.03 155.52 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -1.18 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.42 ' N ' HG22 ' A' ' 52' ' ' ILE . 74.4 mt -75.27 114.46 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -85.37 -35.35 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.73 164.2 31.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.72 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.14 120.36 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.303 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -99.21 122.48 42.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.868 ' CD2' HG21 ' A' ' 74' ' ' THR . 11.6 p90 -139.7 160.49 39.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -140.02 120.02 13.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.305 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.6 HG21 ' OG ' ' A' ' 70' ' ' SER . 7.1 p -121.44 137.48 54.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.733 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -162.12 100.73 1.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.8 -50.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.975 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.644 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 11.5 m -122.01 179.1 4.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -1.232 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.752 ' O ' HG22 ' A' ' 67' ' ' ILE . . . -102.87 -21.08 10.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . 9.6 t -83.91 -66.68 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -1.164 . . . . 0.0 109.412 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -45.66 -21.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.323 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 64' ' ' GLY . 0.6 OUTLIER -64.79 -5.04 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.396 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.19 -55.33 2.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.5 m -52.47 -45.55 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.6 ' OG ' HG21 ' A' ' 60' ' ' THR . 0.5 OUTLIER -50.24 -51.41 44.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.64 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.98 -43.52 81.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.754 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.19 -68.5 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.9 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.633 HG23 ' N ' ' A' ' 74' ' ' THR . 9.1 tt -50.86 -53.05 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.868 HG21 ' CD2' ' A' ' 58' ' ' PHE . 33.4 p -48.01 -28.37 2.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.814 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -101.29 -4.62 26.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -89.84 -18.16 26.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.68 26.18 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -102.75 103.83 14.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.43 0.15 27.9 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -100.38 -176.51 3.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -1.14 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -108.23 173.85 6.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.594 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.8 mt -65.58 -18.04 65.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.594 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.42 -30.57 67.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -86.43 -53.17 5.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.57 -18.89 64.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.351 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.93 40.1 2.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -158.02 -35.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -1.089 . . . . 0.0 109.24 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -44.65 169.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -133.01 -170.4 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.185 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -99.02 -30.33 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.59 -40.83 93.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 95' ' ' GLU . 4.0 mm-40 -58.5 -70.92 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.644 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 93' ' ' ILE . 40.9 mt -44.46 -34.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.99 73.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 92' ' ' GLN . 2.2 tt0 -80.65 -15.49 56.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.193 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -81.24 -51.98 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -78.79 -22.98 45.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 2.4 tt0 73.2 36.15 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.449 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -74.37 146.0 83.45 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.4 155.74 50.64 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.658 2.239 . . . . 0.0 112.261 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.6 Cg_endo -75.31 -2.24 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.852 2.368 . . . . 0.0 112.374 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.87 -2.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.657 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 101' ' ' PRO . 29.4 tttt -166.07 61.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 106' ' ' CYS . 20.4 t -60.63 -25.79 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.422 ' ND1' ' CD1' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -49.15 -17.9 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.159 -0.963 . . . . 0.0 109.287 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -74.01 -62.86 1.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.9 t -57.19 -36.55 70.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.319 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 109' ' ' LEU . 4.6 mt -61.43 -64.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.268 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.543 ' N ' HG22 ' A' ' 108' ' ' ILE . 2.7 mp -42.61 -41.12 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -54.92 -63.4 1.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 109.677 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 112' ' ' ASP . 2.1 tm-20 -52.89 -67.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 111' ' ' GLU . 11.4 t70 -37.47 -37.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -60.88 -67.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.81 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.9 tp -41.14 -39.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.9 tmtt? -58.82 -55.3 36.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.98 -56.66 9.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.689 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.96 5.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.587 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 66.7 mt -75.55 -59.63 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -37.02 -51.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 122' ' ' LYS . 27.2 t0 -68.69 -58.09 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 109.701 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.534 ' C ' ' O ' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -33.17 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 109.7 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.676 ' HB2' ' HZ2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -96.93 -34.24 11.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.585 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -78.96 -17.78 54.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 123' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.592 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 1.5 ptt? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 170.89 76.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.683 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 46.4 t80 -72.27 13.39 0.33 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.4 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 2' ' ' ALA . 11.0 p -120.26 166.89 12.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.435 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -90.96 23.72 3.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.41 121.76 40.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.598 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.529 ' O ' ' C ' ' A' ' 8' ' ' ILE . 28.2 t -104.02 -11.5 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.867 . . . . 0.0 109.34 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.529 ' C ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -35.87 147.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.404 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 74.0 m-20 -83.45 -30.39 27.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.643 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER 178.34 160.7 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 109.463 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -69.68 -38.34 77.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.534 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -133.97 -87.29 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -147.07 149.76 36.38 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 109.549 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.88 7.62 1.95 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.814 2.343 . . . . 0.0 112.257 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -97.87 27.96 4.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.487 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER 56.2 77.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.563 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 18' ' ' GLY . 53.6 t 55.76 162.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.544 ' N ' HG12 ' A' ' 17' ' ' VAL . . . 167.36 -88.02 0.1 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.85 145.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -1.16 . . . . 0.0 109.528 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.85 HD11 ' NZ ' ' A' ' 57' ' ' LYS . 2.5 tp 59.64 107.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 109.545 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -178.58 6.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 1.1 mptt 57.46 -0.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.524 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 21' ' ' ASP . 5.6 mtmm -135.01 63.07 1.63 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.204 -0.935 . . . . 0.0 109.504 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -147.08 161.07 41.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -82.21 -12.94 57.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.347 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -92.88 10.77 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.387 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 t -136.55 117.58 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.84 130.34 10.24 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 m -110.44 147.73 33.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.453 -1.028 . . . . 0.0 109.322 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.79 117.6 0.82 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.15 108.41 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.279 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.27 -172.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.33 -171.52 38.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -131.84 74.88 76.76 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.16 . . . . 0.0 109.653 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.27 -2.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.786 2.324 . . . . 0.0 112.148 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -79.48 -7.89 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 36' ' ' ALA . 3.2 m -149.93 -56.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.927 . . . . 0.0 109.477 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.472 ' C ' ' OD1' ' A' ' 39' ' ' ASP . . . 144.03 54.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -124.9 136.64 53.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -1.186 . . . . 0.0 109.347 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.78 135.97 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.66 ' HA ' HG22 ' A' ' 60' ' ' THR . 3.9 ttt -133.68 136.96 45.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.504 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -129.63 126.97 39.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 tt -132.47 132.82 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -131.08 133.5 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.153 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -116.16 149.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 14.5 tttm -111.59 136.3 50.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 0.0 109.714 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 82' ' ' LEU . 24.7 t -129.28 116.57 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.168 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.691 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.8 m-20 -159.96 -34.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 109.893 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 51.8 t0 -62.29 50.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.305 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.9 m-20 81.61 54.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.505 -0.747 . . . . 0.0 109.266 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.64 0.98 9.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 53' ' ' ILE . 3.8 mm -93.01 164.25 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.292 -1.122 . . . . 0.0 109.468 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.581 ' N ' HG22 ' A' ' 52' ' ' ILE . 3.3 mt -97.32 114.38 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -97.38 -38.86 9.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -124.39 151.33 44.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 109.783 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.61 99.56 3.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.85 ' NZ ' HD11 ' A' ' 20' ' ' LEU . 1.1 mttt -94.4 175.21 6.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.641 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.53 ' CD1' HG21 ' A' ' 74' ' ' THR . 45.4 p90 -165.02 176.91 8.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.474 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -166.31 110.27 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 41' ' ' MET . 10.7 p -129.13 96.65 4.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.954 . . . . 0.0 109.487 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -115.14 104.21 11.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.48 -41.3 0.28 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' SER . 1.4 t -106.76 105.62 15.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -1.086 . . . . 0.0 109.219 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -67.0 74.44 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 67' ' ' ILE . 1.2 p 162.74 -42.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -1.172 . . . . 0.0 109.632 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.45 1.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.582 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.5 mp -73.32 -54.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.328 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.52 -71.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.633 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 73' ' ' ILE . 7.4 t -45.78 -43.03 12.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.882 . . . . 0.0 109.613 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.0 -36.33 38.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.644 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -31.25 57.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -54.98 7.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 74' ' ' THR . 10.9 tt -58.18 -47.91 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.598 ' N ' HG23 ' A' ' 73' ' ' ILE . 11.9 p -61.19 -34.19 74.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.08 -7.82 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.13 -0.981 . . . . 0.0 109.623 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -87.13 -36.82 17.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.419 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 79' ' ' GLY . 35.5 m -88.31 -28.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.307 -0.871 . . . . 0.0 109.47 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -47.98 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 77' ' ' VAL . . . 120.38 -26.97 6.81 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.639 ' NZ ' ' OE1' ' A' ' 84' ' ' GLU . 7.1 mtpt -74.13 -165.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.92 163.5 24.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -0.97 . . . . 0.0 109.596 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 47' ' ' VAL . 17.6 mt -55.81 -37.58 68.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.34 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -56.12 -32.56 64.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.3 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.639 ' OE1' ' NZ ' ' A' ' 80' ' ' LYS . 38.7 mt-10 -84.2 -42.96 15.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.491 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -60.45 -30.83 69.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.15 43.86 3.07 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.04 -35.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.129 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 88' ' ' ILE . 2.4 pt -52.52 157.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.455 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -129.23 164.99 22.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -30.08 69.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.474 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.0 p -60.65 -29.09 69.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -58.99 -56.22 25.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 mp -70.41 -38.97 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.521 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.96 55.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.623 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -84.42 -43.03 15.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.169 -0.957 . . . . 0.0 109.591 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' O ' ' CD ' ' A' ' 96' ' ' GLU . 12.6 tm-20 -63.93 -23.18 67.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.67 -37.9 9.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 67.57 73.44 0.32 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.51 149.17 60.9 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.465 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.86 157.71 41.84 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.759 2.306 . . . . 0.0 112.069 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.56 15.01 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.818 2.345 . . . . 0.0 112.315 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.0 m -104.87 16.75 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -151.73 18.24 0.7 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 104' ' ' VAL . 10.6 t -57.69 -14.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -51.19 -27.13 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 2.1 m -77.63 -75.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.524 ' C ' ' O ' ' A' ' 106' ' ' CYS . 0.4 OUTLIER -36.28 -33.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 106' ' ' CYS . 8.5 mt -68.26 -54.97 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 6.3 mp -59.77 -19.64 51.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.57 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -72.46 -64.88 0.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 114' ' ' ILE . 3.1 tm-20 -64.36 -45.74 86.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -54.64 -35.87 63.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.214 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 109' ' ' LEU . . . -63.22 -57.83 9.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.862 . . . . 0.0 109.436 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 111' ' ' GLU . 0.4 OUTLIER -50.01 -36.29 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.413 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.401 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.8 tttt -63.24 -37.86 88.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.02 76.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.54 93.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.93 . . . . 0.0 109.501 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.61 -40.86 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.82 -46.66 88.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.483 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.31 -16.38 60.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.413 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' A' ' 25' ' ' SER . 93.1 t80 -79.39 -31.61 42.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -94.27 -22.63 18.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.51 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -76.53 -18.48 58.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 19.03 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.505 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -161.83 40.65 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.178 -0.951 . . . . 0.0 109.483 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -106.54 -102.83 2.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 mp -81.58 -17.01 49.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -1.161 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 54.32 -133.94 1.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.577 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 129' ' ' HIS . 4.3 p80 -127.79 -176.15 3.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.872 . . . . 0.0 109.406 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.99 -27.1 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.308 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -134.91 140.9 46.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.879 . . . . 0.0 109.285 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.492 ' O ' ' C ' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -167.52 64.77 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.682 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.492 ' C ' ' O ' ' A' ' 132' ' ' HIS . 8.5 p80 -39.25 135.03 1.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.959 . . . . 0.0 109.3 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.572 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.72 -65.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.404 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.457 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 14.3 p90 -120.25 125.56 48.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.349 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.35 150.87 5.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.524 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -150.63 -60.35 0.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.333 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -67.16 135.11 53.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.411 -0.805 . . . . 0.0 109.429 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.417 HG22 ' N ' ' A' ' 8' ' ' ILE . 7.4 p -71.16 155.07 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 0.0 109.594 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 8' ' ' ILE . 3.1 tt -76.54 108.32 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.287 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -112.66 -176.42 2.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 0.0 109.647 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.41 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 1.4 t-80 176.96 70.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.205 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.41 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 11.3 m-85 -150.89 134.84 16.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.971 -1.08 . . . . 0.0 110.067 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.548 ' C ' HD22 ' A' ' 13' ' ' ASN . 0.3 OUTLIER -148.29 153.98 39.4 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.548 HD22 ' C ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -161.14 152.36 15.73 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.033 -1.042 . . . . 0.0 109.934 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.54 66.04 5.6 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.866 2.377 . . . . 0.0 112.11 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.01 -42.71 8.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -129.99 109.28 10.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.75 -20.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.89 -105.77 0.27 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -93.33 -154.72 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -1.162 . . . . 0.0 109.515 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.558 ' HB3' HG21 ' A' ' 27' ' ' VAL . 1.7 tp -118.67 152.34 36.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.404 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -46.71 143.82 2.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.435 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -67.53 -5.15 13.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -77.19 29.95 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.93 . . . . 0.0 109.4 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -114.92 151.49 33.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.67 6.14 36.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -120.21 -15.94 8.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.697 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.558 HG21 ' HB3' ' A' ' 20' ' ' LEU . 40.8 t -103.12 128.95 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.353 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -127.05 149.75 17.8 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 120' ' ' ASP . 52.2 m -127.71 149.16 50.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -1.081 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.87 125.37 2.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 ttt -119.74 92.9 3.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -1.205 . . . . 0.0 109.367 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 m -103.56 163.52 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 109.286 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.27 -176.08 29.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -138.26 96.07 10.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.337 -1.096 . . . . 0.0 109.386 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.501 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.9 Cg_exo -56.66 -26.37 64.76 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.652 2.235 . . . . 0.0 112.28 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.93 -59.99 0.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.34 -48.31 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.62 52.78 0.06 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -116.34 117.22 29.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.151 . . . . 0.0 109.416 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 m -105.92 141.47 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.495 ' SD ' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -135.9 128.82 31.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.28 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.808 HE21 ' NE2' ' A' ' 44' ' ' GLN . 25.4 tt0 -112.68 125.0 53.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.147 -0.97 . . . . 0.0 109.616 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tp -124.01 136.4 54.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.226 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.808 ' NE2' HE21 ' A' ' 42' ' ' GLN . 12.8 mt-30 -118.85 145.78 45.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.202 -0.936 . . . . 0.0 109.654 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.667 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.1 pp -126.31 126.09 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -103.21 109.33 20.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.466 HG23 HD12 ' A' ' 45' ' ' ILE . 24.5 t -94.57 110.83 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.572 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' C ' ' O ' ' A' ' 47' ' ' VAL . 1.1 t70 -40.16 -77.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.437 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 7.2 t0 -179.71 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.407 -0.808 . . . . 0.0 108.862 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -84.06 -17.09 41.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.458 -0.776 . . . . 0.0 109.352 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.2 12.01 5.46 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.4 mm -104.87 134.39 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.413 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.4 88.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 109.408 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.51 -52.38 22.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.261 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -143.24 -179.16 6.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 109.141 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.79 144.48 7.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.957 . . . . 0.0 109.743 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -135.32 162.59 32.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.342 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.64 ' CD1' HG21 ' A' ' 74' ' ' THR . 5.9 p90 -145.81 167.92 22.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.368 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -165.83 114.29 0.96 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.495 HG22 ' SD ' ' A' ' 41' ' ' MET . 80.7 p -108.95 141.93 40.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.43 99.65 2.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.9 -54.14 0.27 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 49.4 t -124.98 173.52 8.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -1.21 . . . . 0.0 109.532 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.476 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -121.53 19.06 8.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.7 p -113.83 -8.63 13.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -1.127 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.42 -2.81 44.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.506 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 68' ' ' ALA . 8.5 mm -61.65 -53.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 0.0 109.402 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -41.4 -53.51 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.457 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 70' ' ' SER . 25.1 p -58.09 -54.26 48.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -43.94 -38.01 3.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 109.377 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.7 m -71.02 -44.96 64.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.24 -55.62 26.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.866 HG23 ' H ' ' A' ' 74' ' ' THR . 2.2 tt -62.33 -61.75 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.918 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.866 ' H ' HG23 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -35.31 -32.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.78 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -85.57 -30.87 22.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 0.0 109.825 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.606 ' N ' ' O ' ' A' ' 73' ' ' ILE . 10.7 m0 -82.69 0.82 41.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.719 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 73' ' ' ILE . 6.4 m -123.51 65.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.51 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -148.3 94.35 2.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.01 -15.31 61.77 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -72.17 -168.2 0.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -1.201 . . . . 0.0 109.421 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -115.69 141.1 48.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mt -48.77 -11.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' SER . 35.1 tt0 -71.08 -55.59 7.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.235 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -66.36 -30.67 71.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.256 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -24.09 52.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 109.22 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.77 50.24 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.78 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -1.123 . . . . 0.0 109.396 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.51 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -36.46 -23.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.744 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 87' ' ' ALA . 10.0 mttm 61.32 173.85 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.304 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.484 HD22 HG12 ' A' ' 108' ' ' ILE . 8.0 p-10 -95.73 -42.55 8.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.444 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 88.9 p -52.76 -50.02 64.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' SER . 4.5 tt0 -44.06 -65.74 0.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.194 -0.942 . . . . 0.0 109.779 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.5 mt -59.65 -32.01 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.713 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.58 -32.61 69.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.876 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.84 -33.92 24.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.689 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -55.94 -42.84 76.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.257 -0.902 . . . . 0.0 109.686 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.3 mt -83.0 -28.39 29.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 65.64 74.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.52 148.83 59.88 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.158 -0.963 . . . . 0.0 109.158 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.61 148.64 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.58 2.187 . . . . 0.0 112.125 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.54 6.09 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.738 2.292 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 p -64.68 -35.88 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -135.52 42.43 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 109.611 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.402 ' C ' ' N ' ' A' ' 106' ' ' CYS . 9.8 p -58.4 -18.79 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.432 ' CD2' ' C ' ' A' ' 105' ' ' HIS . 8.1 p-80 -45.32 -24.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.338 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -64.87 -47.35 78.19 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.167 -0.958 . . . . 0.0 109.2 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -50.1 67.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.484 HG12 HD22 ' A' ' 90' ' ' ASN . 4.4 mm -56.0 -33.45 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.883 . . . . 0.0 109.369 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 34' ' ' ALA . 1.4 mp -63.92 -61.65 2.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -40.36 -53.68 2.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -61.15 -58.25 9.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.3 -34.07 2.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.507 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -64.92 -69.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.265 -0.897 . . . . 0.0 109.658 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.1 tp -37.78 -35.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -65.53 -68.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -43.33 -46.22 6.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.307 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.667 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -55.43 -40.72 71.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.22 -46.89 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.417 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.49 -58.11 7.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.264 -0.898 . . . . 0.0 109.495 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.53 ' CG ' ' O ' ' A' ' 29' ' ' THR . 5.2 m-20 -49.0 -59.6 3.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.715 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -51.08 -21.59 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.685 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -96.93 -8.6 30.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.714 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.18 -8.4 17.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -15.77 60.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.42 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -48.5 -75.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.474 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 168.61 43.8 0.03 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 127' ' ' LEU . 0.8 OUTLIER -113.59 -6.31 13.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 109.49 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 127' ' ' LEU . 10.5 mm-40 -42.82 -60.56 1.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -76.12 150.05 37.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.644 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -117.76 -161.64 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.384 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -169.56 33.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.628 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 1.1 p80 -114.62 45.89 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.542 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -158.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 109.348 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.444 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.553 ' O ' ' O ' ' A' ' 2' ' ' ALA . 5.6 ttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.553 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 55.5 118.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.347 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -79.18 -24.27 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.937 . . . . 0.0 109.45 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.58 ' OG ' ' N ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -60.54 -160.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.457 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.58 ' N ' ' OG ' ' A' ' 4' ' ' SER . 0.5 OUTLIER -117.84 177.93 4.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 109.519 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 5' ' ' GLU . 20.7 mmtt -47.89 -177.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.309 -0.869 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.3 t -91.79 127.95 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.426 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.7 mm -78.34 -37.07 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.533 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -77.86 54.82 1.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -113.74 -157.87 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 0.0 109.383 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -133.68 103.52 5.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.882 . . . . 0.0 109.501 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.528 ' O ' ' C ' ' A' ' 13' ' ' ASN . 1.6 tt0 -168.83 20.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.474 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.683 ' O ' ' N ' ' A' ' 15' ' ' ARG . 18.5 m-80 36.45 83.09 0.21 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -55.87 35.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.774 2.316 . . . . 0.0 112.133 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.683 ' N ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -150.43 177.33 10.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.454 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 15' ' ' ARG . 5.6 t-20 77.42 -59.43 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.438 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -121.04 158.22 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.424 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.52 -26.13 25.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -174.98 -179.32 1.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.153 . . . . 0.0 109.527 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.507 ' CB ' ' O ' ' A' ' 19' ' ' SER . 11.9 tp 77.27 57.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.386 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -162.17 19.8 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.81 . . . . 0.0 109.482 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt 49.67 11.2 0.05 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 21' ' ' ASP . 9.6 mttt -143.7 62.44 1.36 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.89 . . . . 0.0 109.271 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -132.2 137.4 47.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.151 -0.968 . . . . 0.0 109.364 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.44 1.68 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -117.04 5.59 12.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.5 98.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.59 124.62 8.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -102.7 131.91 49.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -1.155 . . . . 0.0 109.329 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.93 96.44 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.0 ttt -99.52 133.44 43.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -1.128 . . . . 0.0 109.144 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 41' ' ' MET . 30.4 m -125.23 156.11 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.035 -1.041 . . . . 0.0 109.808 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.472 ' HA2' HG12 ' A' ' 40' ' ' VAL . . . -138.06 121.61 2.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 39' ' ' ASP . . . -118.13 87.09 28.0 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.263 -1.139 . . . . 0.0 109.428 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.99 36.25 0.61 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.893 2.395 . . . . 0.0 112.303 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.67 -39.64 1.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.8 t -177.02 -29.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.394 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.3 -8.73 71.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 0.8 OUTLIER 62.7 -174.21 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -1.154 . . . . 0.0 109.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.472 HG12 ' HA2' ' A' ' 33' ' ' GLY . 8.5 m -95.46 149.45 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 109.384 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.488 ' O ' HG22 ' A' ' 32' ' ' VAL . 8.5 ttt -142.34 133.29 25.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 109.46 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' HG2' HE21 ' A' ' 44' ' ' GLN . 7.4 tt0 -107.33 127.83 53.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 109.392 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.45 135.56 44.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.557 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.468 HE21 ' HG2' ' A' ' 42' ' ' GLN . 6.5 mp0 -138.19 137.54 37.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' H ' HG13 ' A' ' 45' ' ' ILE . 1.5 pp -120.64 143.36 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 109.427 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -102.31 152.14 21.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.96 116.72 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 48' ' ' ASP . 33.5 t0 -57.7 -94.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.56 19.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -148.76 24.84 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.502 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.81 30.28 56.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.5 mm -109.41 134.63 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -1.21 . . . . 0.0 109.414 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.6 mt -80.56 81.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.47 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.22 -40.49 74.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -137.64 163.51 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.77 102.59 4.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.53 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -97.81 155.49 17.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.502 ' CD1' HG21 ' A' ' 74' ' ' THR . 27.0 p90 -166.46 171.29 12.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -163.96 126.04 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.81 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.15 121.8 45.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.028 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 101.53 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.6 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 156.74 -57.25 0.38 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.8 148.6 26.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -1.117 . . . . 0.0 109.598 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.94 16.97 30.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.38 -35.49 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 0.0 109.459 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.11 -3.09 3.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.485 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.9 mm -58.95 -35.32 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.339 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.12 -62.54 1.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' LEU . 3.9 m -58.38 -54.59 45.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.467 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.508 ' C ' ' O ' ' A' ' 69' ' ' SER . 50.6 m -36.98 -66.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.62 -30.52 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 69' ' ' SER . 12.2 tp -68.93 -73.89 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.421 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.723 HG23 ' H ' ' A' ' 74' ' ' THR . 0.9 OUTLIER -39.7 -59.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.723 ' H ' HG23 ' A' ' 73' ' ' ILE . 42.4 p -44.21 -44.95 8.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.317 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -73.46 -14.98 61.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.307 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.553 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.07 -11.71 35.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 77' ' ' VAL . 33.5 m -123.91 61.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.4 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.09 103.1 7.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.481 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 4.01 89.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -78.55 -161.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -1.155 . . . . 0.0 109.39 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 83' ' ' GLU . 3.7 t -126.69 144.51 50.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -47.78 -15.07 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 0.0 109.24 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -80.71 -23.83 39.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.412 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -95.29 -18.78 20.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.0 -29.95 11.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.482 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.96 42.97 2.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -152.14 -37.0 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -1.137 . . . . 0.0 108.602 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -47.22 -175.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -141.38 -177.88 5.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 109.399 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.57 ' CG ' ' N ' ' A' ' 91' ' ' SER . 1.1 p-10 -87.69 -50.93 6.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -54.53 -22.31 12.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.25 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -68.0 -59.18 3.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 109.206 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.69 -45.92 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.852 . . . . 0.0 109.272 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.13 -36.49 73.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.245 -0.909 . . . . 0.0 109.196 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.19 -41.97 99.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.271 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.87 -32.9 73.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.262 -0.899 . . . . 0.0 109.047 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.5 mt -93.39 -28.36 16.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.301 -0.875 . . . . 0.0 109.112 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.4 tm-20 51.93 67.09 1.02 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.714 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.003 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.4 pt? -117.81 148.46 43.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.272 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.596 ' HB2' HG22 ' A' ' 102' ' ' VAL . 71.4 Cg_exo -40.51 155.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.792 2.328 . . . . 0.0 112.268 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.08 -0.15 8.12 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.834 2.356 . . . . 0.0 112.177 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 100' ' ' PRO . 34.3 m -88.32 -5.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' C ' ' N ' ' A' ' 105' ' ' HIS . 0.6 OUTLIER -125.72 -9.42 6.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 107' ' ' SER . 8.0 p -45.78 -24.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.489 ' C ' ' O ' ' A' ' 104' ' ' VAL . 15.2 m80 -38.9 -50.0 1.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.243 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.63 -36.47 64.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.114 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.628 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.1 p -66.31 -67.23 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.096 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.628 ' N ' ' OG ' ' A' ' 107' ' ' SER . 42.8 mt -45.91 -25.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.088 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 mp -75.98 -44.88 37.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.428 -0.795 . . . . 0.0 109.385 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.36 83.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.723 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.485 ' O ' ' OE2' ' A' ' 111' ' ' GLU . 5.1 tp10 -65.93 -68.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.775 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -22.95 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.93 . . . . 0.0 109.641 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.19 -52.87 9.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -55.95 -40.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.59 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.495 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 5.7 tptt -66.14 -51.52 57.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.74 -41.99 64.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.415 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.34 -45.16 95.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 0.0 109.324 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 121' ' ' TYR . 61.7 mt -64.49 -61.12 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.288 -0.882 . . . . 0.0 109.381 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -40.69 -37.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 0.0 109.185 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -37.71 80.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.052 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 118' ' ' ILE . 7.5 t80 -72.35 -16.99 61.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.249 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -88.49 -44.94 10.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.209 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.1 95.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.317 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -72.49 -0.77 13.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -62.26 -20.78 64.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.635 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -142.46 20.47 2.41 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 126' ' ' GLY . 2.0 mp 35.81 48.07 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.235 -1.156 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -108.36 149.69 28.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 129' ' ' HIS . 20.7 p-80 -55.36 97.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 109.536 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.478 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -110.87 151.75 27.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 109.421 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.478 ' C ' ' O ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER 40.03 83.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.879 ' CD2' ' H ' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -89.25 171.94 9.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.922 . . . . 0.0 109.424 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -75.37 -86.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.4 p80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.43 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.518 ' O ' ' CD1' ' A' ' 3' ' ' TYR . . . -62.5 -79.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.421 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.8 m-85 -137.93 146.72 43.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 t -74.91 115.64 14.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.252 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.42 -72.9 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.694 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HG3' ' H ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -116.69 -52.86 2.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.809 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.416 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 10.7 p -146.21 155.92 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.827 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 pt -90.3 92.15 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.322 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.17 57.41 1.01 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -97.62 -126.93 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.113 -0.992 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -151.81 -172.02 4.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.536 ' H ' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tt0 -154.14 -73.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.644 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 2.8 t30 -79.71 -43.86 1.56 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 15.7 Cg_exo -65.02 98.52 0.31 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.913 2.408 . . . . 0.0 112.014 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -122.7 -67.75 0.93 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.628 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 16' ' ' ASN . 1.7 t-20 -112.45 118.6 35.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 109.452 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.21 -3.39 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.931 . . . . 0.0 109.306 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.37 57.22 0.47 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -171.3 167.35 6.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -1.14 . . . . 0.0 109.274 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.438 ' CB ' ' O ' ' A' ' 19' ' ' SER . 0.3 OUTLIER 70.14 -17.9 0.25 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.201 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 19' ' ' SER . 46.6 m-20 -68.89 147.34 51.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.39 -0.818 . . . . 0.0 109.471 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 10.0 tttt -73.58 16.68 0.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -133.23 27.04 4.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.786 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.5 156.01 20.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.349 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.2 m -85.71 -4.3 59.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -0.87 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.88 129.69 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.8 147.48 18.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.1 m -130.28 130.32 44.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -1.093 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -126.45 137.8 10.29 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.03 120.46 17.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -1.112 . . . . 0.0 109.351 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.75 146.6 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.89 -166.35 10.66 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -122.12 80.92 43.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.262 -1.14 . . . . 0.0 109.512 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.88 2.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.707 2.271 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.6 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -91.53 -3.73 56.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.41 -58.48 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.38 46.5 0.06 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.01 126.77 54.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 109.507 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 40' ' ' VAL . 3.1 p -107.86 113.45 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -119.47 119.08 32.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.5 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 43' ' ' LEU . 7.1 tt0 -103.23 154.93 18.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.198 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.46 ' N ' ' HG3' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -155.87 119.47 4.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.487 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -122.23 151.24 41.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.296 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.79 138.01 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.965 . . . . 0.0 109.565 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -107.57 127.95 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.04 150.66 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.7 t0 -94.21 -103.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -139.45 4.25 2.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.43 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -128.97 17.28 6.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.21 10.2 85.73 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 mm -93.08 132.71 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -1.105 . . . . 0.0 109.529 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 53' ' ' ILE . 17.6 mt -81.54 93.38 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.413 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.44 -53.54 56.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.446 ' HA ' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -132.04 139.35 48.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.318 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.72 133.31 55.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.67 161.38 15.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.526 ' CD1' HG21 ' A' ' 74' ' ' THR . 10.7 p90 -169.05 174.32 6.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 109.821 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -165.07 121.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.476 -0.765 . . . . 0.0 109.105 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.3 142.57 51.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -158.55 -177.55 6.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.47 -56.82 2.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 66.4 m -120.94 158.64 27.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -1.141 . . . . 0.0 109.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.27 11.49 58.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.98 -39.84 4.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -1.12 . . . . 0.0 109.404 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.14 -22.13 66.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.73 -44.96 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -46.73 -62.56 1.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -43.22 -48.05 6.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 109.717 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.519 ' O ' ' C ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -49.55 -68.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 109.397 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -37.27 -39.22 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.617 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 73' ' ' ILE . 11.3 tp -66.89 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.615 ' O ' HG22 ' A' ' 77' ' ' VAL . 4.4 tt -33.74 -48.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.267 -0.895 . . . . 0.0 110.054 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.526 HG21 ' CD1' ' A' ' 58' ' ' PHE . 3.2 p -49.8 -46.81 51.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.3 tp10 -86.15 -11.96 51.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.902 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.99 -2.57 57.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.368 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 73' ' ' ILE . 28.8 m -123.48 -27.11 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.328 -0.857 . . . . 0.0 109.61 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' NZ ' ' HA ' ' A' ' 55' ' ' ASP . 9.8 ttmm -62.1 113.14 2.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.05 58.18 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.44 -164.88 1.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.427 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 m -121.02 175.0 6.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.861 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.55 -17.98 64.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.778 . . . . 0.0 109.777 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -77.46 -40.6 42.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.73 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -69.16 -44.65 71.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.301 -0.874 . . . . 0.0 109.839 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.77 -33.84 52.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.54 52.27 4.68 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -171.9 -36.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -1.119 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.4 pt -36.47 132.07 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' SER . 50.2 mttt -117.97 142.78 46.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -41.35 -25.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.6 OUTLIER -66.44 -39.41 88.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.568 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -67.73 -55.88 11.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.466 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 93' ' ' ILE . 1.6 mp -58.74 -30.08 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.592 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.09 -60.29 2.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.742 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -55.27 -20.52 11.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -64.53 1.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.5 OUTLIER -69.12 -14.46 63.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.651 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 52.81 43.62 31.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.894 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.698 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.5 pt? -85.8 151.21 54.84 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -41.52 105.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.559 2.173 . . . . 0.0 111.913 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.87 20.36 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.343 2.028 . . . . 0.0 112.338 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.435 HG23 ' N ' ' A' ' 103' ' ' LYS . 17.6 m -70.47 -40.63 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 104' ' ' VAL . 21.2 mttt -109.94 -23.44 11.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.902 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 103' ' ' LYS . 2.5 t 41.43 30.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.5 ' NE2' ' HB1' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -81.16 -35.64 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 60.7 m -59.73 -64.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.563 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 108' ' ' ILE . 2.6 m -51.45 -58.27 6.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.0 mt -42.12 -41.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 mp -63.8 -46.42 85.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -54.63 -66.7 0.36 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.78 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.2 tm-20 -46.06 -69.64 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.536 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -38.75 -26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -73.87 -63.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.69 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 2.3 tp -46.13 -37.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.579 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 58.6 tttt -66.53 -43.49 85.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.59 77.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.493 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.25 -54.67 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.429 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 23.1 mt -49.95 -34.85 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 109.256 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.17 -56.86 10.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -11.52 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.415 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -85.0 -43.7 13.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -94.73 3.71 54.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.8 -33.06 10.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.329 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 126' ' ' GLY . 7.4 tttt -75.33 -10.53 59.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 124' ' ' LYS . 8.2 tt0 -45.11 -17.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . 145.81 -39.37 1.15 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 129' ' ' HIS . 5.9 mt -61.71 -37.37 83.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -1.131 . . . . 0.0 109.597 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.26 4.52 0.47 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.89 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.445 ' H ' ' C ' ' A' ' 127' ' ' LEU . 4.1 m80 -131.15 176.45 8.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.459 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.456 ' ND1' ' N ' ' A' ' 131' ' ' HIS . 20.6 p80 -112.27 -158.45 0.65 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.456 ' N ' ' ND1' ' A' ' 130' ' ' HIS . 11.1 p-80 -163.57 -154.04 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -144.16 54.29 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.479 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 48.1 m170 46.51 -133.48 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.586 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.638 ' H ' ' CD2' ' A' ' 134' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.535 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -49.53 -55.73 12.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -94.29 42.87 1.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.49 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -19.73 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 6' ' ' LYS . 3.6 pm0 -78.64 -177.29 5.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.663 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 62.6 mttt 54.16 106.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 8' ' ' ILE . 2.3 p -109.35 150.62 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.599 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.456 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -91.52 -155.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.273 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.81 -162.43 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 109.296 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.76 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -124.47 126.45 45.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.257 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.51 ' C ' ' O ' ' A' ' 10' ' ' HIS . 95.9 m-85 38.53 75.37 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.113 -0.992 . . . . 0.0 108.945 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.35 96.87 3.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -0.838 . . . . 0.0 109.84 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.737 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -86.33 -37.02 0.53 Allowed Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.275 -0.891 . . . . 0.0 109.283 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 27.3 Cg_exo -59.77 -21.58 64.12 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.795 2.33 . . . . 0.0 111.917 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 68.16 135.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -0.858 . . . . 0.0 109.426 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -57.75 117.47 4.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.515 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.45 22.53 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.217 -0.927 . . . . 0.0 109.385 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 64.79 -154.0 49.46 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 18' ' ' GLY . 2.8 p -54.01 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -1.169 . . . . 0.0 109.55 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 20' ' ' LEU . 11.1 tp -112.89 -135.32 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 109.538 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.1 p30 -93.64 10.13 34.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -0.881 . . . . 0.0 109.56 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.543 ' C ' ' H ' ' A' ' 24' ' ' ASP . 26.3 tttt 64.94 -39.98 0.27 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 21' ' ' ASP . 11.3 mptt -70.64 21.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.977 . . . . 0.0 109.372 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 22' ' ' LYS . 6.8 t0 -98.65 166.24 11.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.492 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 14.5 m -101.55 5.36 41.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.527 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -117.59 37.39 3.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.625 ' O ' HG12 ' A' ' 27' ' ' VAL . 2.7 t -143.41 98.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 109.359 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.08 132.55 11.29 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 m -108.85 134.11 51.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -1.111 . . . . 0.0 109.362 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.3 90.77 0.23 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.3 ttm -108.94 128.8 55.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -1.164 . . . . 0.0 109.686 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.533 HG21 ' HG ' ' A' ' 109' ' ' LEU . 2.0 m -130.51 165.1 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.392 -0.818 . . . . 0.0 109.173 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.86 121.81 2.1 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HB3' ' N ' ' A' ' 39' ' ' ASP . . . -112.45 93.33 22.48 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.339 -1.095 . . . . 0.0 109.364 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.39 40.7 0.93 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.665 2.243 . . . . 0.0 112.271 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -144.55 -40.1 0.27 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.7 m -168.11 -32.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' C ' ' HB3' ' A' ' 34' ' ' ALA . . . -66.29 -19.01 68.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.513 ' N ' ' HB3' ' A' ' 34' ' ' ALA . 1.6 m-20 61.06 -168.93 0.17 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 109.456 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -86.84 140.77 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -142.5 125.77 16.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.318 -0.864 . . . . 0.0 109.599 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.94 113.5 20.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.04 107.17 11.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 109.894 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.476 ' NE2' ' CG1' ' A' ' 27' ' ' VAL . 7.7 tt0 -109.67 129.18 55.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.07 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.56 144.81 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.123 -0.986 . . . . 0.0 109.699 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -108.96 138.94 44.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.99 151.5 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 23.5 t0 -81.93 -48.84 11.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.634 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER 162.15 -22.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.211 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 9.5 p-10 -102.47 25.52 8.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.466 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.37 -4.7 58.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.8 mm -81.16 146.46 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.348 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.24 108.61 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -44.03 32.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.78 164.41 28.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.273 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.09 118.83 16.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -96.05 133.83 39.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.476 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 10.3 p90 -136.08 168.88 18.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -171.89 104.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.803 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 p -96.42 147.95 23.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.085 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -162.0 111.58 1.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.701 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.44 ' C ' ' OD2' ' A' ' 39' ' ' ASP . . . 130.58 -41.11 1.57 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.9 t -103.7 121.26 42.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.636 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 46.72 1.98 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -158.32 -12.71 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.232 -1.157 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.88 37.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.519 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mp -48.29 -33.1 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.88 -41.73 74.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 71' ' ' SER . 17.9 p -67.11 -64.15 0.91 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.511 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.8 OUTLIER -38.76 -26.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.33 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 69' ' ' SER . 7.5 t -78.4 -44.7 24.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 69' ' ' SER . 21.4 tp -60.97 -52.14 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.948 . . . . 0.0 109.471 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.894 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.3 tt -58.9 -41.46 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -66.79 -19.35 65.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.663 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 31.4 mm-40 -92.02 -16.35 26.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.49 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.04 -17.0 18.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 73' ' ' ILE . 27.8 m -109.07 40.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.661 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -118.8 96.44 5.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.97 -27.05 17.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -59.69 -160.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -1.124 . . . . 0.0 109.498 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.09 165.85 21.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.89 -41.27 82.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -24.72 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.593 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -90.7 -48.48 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.912 . . . . 0.0 109.536 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.556 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -61.88 -17.36 56.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -102.05 29.84 11.65 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.575 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -148.47 -35.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.38 -1.071 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -41.74 172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.538 -0.726 . . . . 0.0 109.654 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.33 168.44 19.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.55 -32.81 10.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.749 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.543 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -50.89 -33.22 23.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.96 . . . . 0.0 109.558 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -73.83 -59.97 2.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.557 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.6 mt -46.02 -42.46 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.85 -46.71 74.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.355 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.4 -37.92 65.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.388 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -67.58 -45.01 76.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.5 -15.08 61.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.152 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.94 33.87 7.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.9 pp -75.16 135.94 72.95 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.532 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.659 ' O ' HD12 ' A' ' 99' ' ' LEU . 75.4 Cg_exo -42.22 155.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.512 2.141 . . . . 0.0 112.245 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.24 -11.16 28.41 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.729 2.286 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.8 39.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HG2' ' SG ' ' A' ' 106' ' ' CYS . 2.5 ttmt -176.83 32.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.87 . . . . 0.0 109.189 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 t -74.68 -9.21 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 0.0 109.671 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.33 67.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.42 ' SG ' ' HG2' ' A' ' 103' ' ' LYS . 18.6 m -73.4 -59.26 2.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.651 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.1 p -48.57 -56.17 9.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 108.974 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.46 ' N ' ' OG ' ' A' ' 107' ' ' SER . 82.3 mt -52.32 -35.58 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.533 ' HG ' HG21 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -66.17 -29.3 69.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -51.36 60.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.419 -0.801 . . . . 0.0 109.201 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.402 ' O ' ' OE2' ' A' ' 111' ' ' GLU . 9.6 tp10 -71.73 -32.55 67.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.18 -33.98 75.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.223 -0.923 . . . . 0.0 109.314 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -72.09 -61.55 1.75 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.556 HG12 ' HB1' ' A' ' 85' ' ' ALA . 0.7 OUTLIER -46.29 -35.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.129 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 11.4 tttt -74.86 -31.38 61.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.853 . . . . 0.0 109.141 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.93 -43.43 83.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.188 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -53.31 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.2 mt -45.53 -50.76 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -0.943 . . . . 0.0 109.516 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.69 -51.68 66.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.88 -21.54 64.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.612 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -71.69 -54.88 8.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.364 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -65.55 -34.67 78.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.91 55.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -90.44 46.74 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -121.15 -35.9 3.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.308 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.482 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -141.86 6.99 2.4 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tp 38.51 57.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.12 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.07 168.54 10.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.923 . . . . 0.0 109.437 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.505 ' CE1' ' O ' ' A' ' 131' ' ' HIS . 14.2 t-160 -45.39 149.94 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 109.524 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.513 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -133.79 125.04 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.256 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.513 ' C ' ' O ' ' A' ' 130' ' ' HIS . 57.6 m170 38.68 -119.1 0.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.293 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.433 ' C ' ' CG ' ' A' ' 133' ' ' HIS . 0.7 OUTLIER -125.79 27.59 6.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 109.242 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.596 ' ND1' ' N ' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -148.34 -151.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.855 . . . . 0.0 109.392 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.601 ' O ' ' ND1' ' A' ' 134' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.488 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mtt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.89 -121.25 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.859 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.06 82.3 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.452 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.39 88.08 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -138.73 174.48 10.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.553 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.19 67.1 0.87 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.262 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 7' ' ' VAL . 1.6 m -87.45 0.21 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.107 -0.996 . . . . 0.0 109.644 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.0 pt -75.91 9.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.522 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -113.62 -71.56 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.411 ' HB3' ' H ' ' A' ' 11' ' ' TYR . 23.2 m-70 47.03 -155.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 109.475 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.411 ' H ' ' HB3' ' A' ' 10' ' ' HIS . 1.9 m-85 -98.25 9.36 43.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.749 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -128.27 128.36 44.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -0.947 . . . . 0.0 109.659 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 12' ' ' GLU . 3.1 m-20 -163.81 89.01 1.16 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.848 . . . . 0.0 109.427 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -51.04 -41.9 54.97 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.909 2.406 . . . . 0.0 112.46 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.73 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -46.58 117.85 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.485 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -80.36 90.86 5.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.45 ' H ' HG22 ' A' ' 17' ' ' VAL . 3.2 m -57.21 127.94 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.614 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.99 164.09 12.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.5 p -69.82 146.73 51.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -1.13 . . . . 0.0 109.435 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -162.6 -15.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.494 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.642 ' OD1' ' N ' ' A' ' 22' ' ' LYS . 38.3 t0 -110.16 175.32 5.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.642 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 18.4 ttpp -57.33 0.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.423 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -71.98 10.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -137.13 133.71 35.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.29 8.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 109.398 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.545 ' OD1' ' O ' ' A' ' 47' ' ' VAL . 0.8 OUTLIER -115.17 3.26 14.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.9 t -122.1 92.45 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.84 155.0 47.57 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.4 m -131.41 118.56 20.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -1.224 . . . . 0.0 109.817 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.61 93.3 0.56 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -92.5 131.85 37.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.973 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.574 ' O ' ' O ' ' A' ' 41' ' ' MET . 18.5 m -144.53 177.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 108.997 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.62 178.97 41.12 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -118.69 82.31 19.98 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.336 -1.096 . . . . 0.0 109.352 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 37' ' ' CYS . 72.8 Cg_exo -43.97 -10.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.593 2.195 . . . . 0.0 111.99 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.623 ' O ' ' CB ' ' A' ' 37' ' ' CYS . . . -76.07 20.34 0.2 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.307 -0.871 . . . . 0.0 109.295 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.623 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 1.6 t 85.64 -18.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.394 -0.816 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -43.3 -50.3 6.58 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.643 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 153.89 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -1.074 . . . . 0.0 109.424 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 46.9 t -113.56 150.56 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.574 ' O ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -145.73 140.88 27.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.106 -0.996 . . . . 0.0 109.78 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' A' ' 41' ' ' MET . 6.0 tt0 -129.49 145.14 51.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.85 138.74 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.591 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -130.84 136.28 48.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.372 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.526 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -119.7 132.34 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.663 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -115.72 120.01 37.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 109.276 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.545 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 54.3 t -97.72 126.88 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -56.67 -60.02 4.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -0.855 . . . . 0.0 109.094 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.3 OUTLIER 163.85 -22.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 0.0 109.197 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.45 -7.52 47.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.451 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.14 17.59 7.18 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mm -113.36 150.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -1.144 . . . . 0.0 109.504 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.532 ' O ' ' C ' ' A' ' 54' ' ' GLU . 36.1 mt -85.67 77.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 53' ' ' ILE . 2.5 tt0 -34.63 -48.06 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.555 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -153.04 167.68 28.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.383 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.94 122.97 13.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -103.99 142.08 35.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.328 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.587 ' CD1' HG21 ' A' ' 74' ' ' THR . 21.8 p90 -137.3 176.06 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.59 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -165.58 132.94 2.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.1 143.66 33.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.935 . . . . 0.0 109.518 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -159.99 121.16 3.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.521 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.77 -61.02 0.29 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.5 t -121.39 140.74 51.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.124 . . . . 0.0 109.677 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.65 -6.98 87.25 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.6 p -95.13 0.43 54.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -1.15 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.46 2.76 45.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -83.16 -13.86 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.32 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.31 -64.41 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.435 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.814 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -62.97 -30.21 71.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.93 . . . . 0.0 109.453 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 74' ' ' THR . 2.3 t -61.74 -46.14 90.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -64.68 -36.36 84.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.512 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -71.96 -74.54 0.16 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.824 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.7 tt -34.36 -46.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.873 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.587 HG21 ' CD1' ' A' ' 58' ' ' PHE . 34.0 p -60.16 -47.24 86.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 72' ' ' LEU . 35.0 mt-10 -72.64 -5.92 40.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 109.652 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -99.7 -25.54 14.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 73' ' ' ILE . 16.3 m -112.63 58.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -138.1 105.22 5.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.431 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.4 87.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -83.77 -168.5 2.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -1.124 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 t -107.12 146.21 31.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.26 -27.68 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.319 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -61.03 -38.18 85.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.364 -0.835 . . . . 0.0 109.587 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 88' ' ' ILE . 16.4 mt-10 -79.77 -28.91 40.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.648 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.31 -32.7 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.972 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.53 30.2 5.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.89 19.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 109.351 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.2 pt -91.7 -24.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.39 -0.819 . . . . 0.0 109.247 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 88' ' ' ILE . 11.3 mttp 56.72 152.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.581 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -79.55 -22.15 44.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.4 m -60.56 -39.99 89.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.52 -47.65 83.02 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.08 -36.42 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.19 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.25 -44.15 80.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.266 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.41 -31.83 72.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.79 -41.52 83.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -96.79 -35.36 10.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.646 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 94' ' ' ALA . 9.1 tt0 78.1 32.69 0.36 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.464 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 pp -48.1 147.13 3.84 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.486 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -67.56 147.17 76.09 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.61 2.207 . . . . 0.0 112.066 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.9 15.6 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.679 2.252 . . . . 0.0 112.323 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 m -98.43 6.71 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.295 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.1 OUTLIER -160.03 24.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.346 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.481 ' C ' ' O ' ' A' ' 103' ' ' LYS . 26.9 t -38.4 -26.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.854 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.669 ' O ' HD13 ' A' ' 109' ' ' LEU . 1.8 m-70 -42.95 -28.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.726 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 1.9 m -66.36 -37.17 84.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.779 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -68.26 -61.48 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 109.637 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.3 mt -52.29 -33.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.539 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.669 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.1 mp -64.7 -42.99 94.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.63 -55.31 36.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.499 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -61.52 -56.58 18.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -48.87 -31.13 6.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.26 -65.03 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.568 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.86 -30.26 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.309 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.54 -43.3 63.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.439 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.44 -31.25 69.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.426 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.526 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -71.0 -58.62 3.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.94 . . . . 0.0 109.302 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 22.2 mt -48.8 -43.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.1 4.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.89 -35.54 15.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.69 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -69.63 -65.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.652 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -24.71 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 109.652 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.22 -4.74 3.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -110.97 -29.19 8.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.636 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -78.52 -11.75 59.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.34 -16.69 49.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.6 tp -80.97 -18.55 46.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -1.144 . . . . 0.0 109.499 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.77 -57.16 2.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -90.04 -161.71 0.82 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -150.82 14.77 0.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.286 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.8 m80 64.39 -132.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.813 . . . . 0.0 109.642 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 56.63 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 109.1 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -130.06 -32.25 1.84 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 109.672 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.647 ' CG ' ' O ' ' A' ' 134' ' ' HIS . 23.8 p-80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 mtp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 3' ' ' TYR . . . -61.87 108.07 0.96 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.47 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 2' ' ' ALA . 39.7 m-85 40.68 57.02 2.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.54 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.5 m -158.92 110.87 2.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 109.73 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -111.13 82.3 1.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 109.268 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -73.78 -117.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.708 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.85 -161.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.693 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.8 mt -140.27 -86.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.3 160.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.672 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.502 ' C ' ' H ' ' A' ' 12' ' ' GLU . 28.1 m-70 -137.23 -32.09 0.79 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.851 . . . . 0.0 109.231 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -74.21 26.28 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.314 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.524 ' O ' ' O ' ' A' ' 13' ' ' ASN . 3.4 mp0 -47.65 133.15 13.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 109.697 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.524 ' O ' ' O ' ' A' ' 12' ' ' GLU . 2.7 m120 -35.58 156.17 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 0.0 109.545 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 15' ' ' ARG . 17.8 Cg_endo -63.12 49.6 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.899 2.399 . . . . 0.0 112.264 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 13' ' ' ASN . 2.9 ttp180 60.3 149.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.306 -0.871 . . . . 0.0 109.663 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 18' ' ' GLY . 10.3 t-20 -162.6 -137.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.514 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 17' ' ' VAL . 3.0 p -42.18 95.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.616 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -139.53 80.42 0.27 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -61.09 179.5 0.19 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -1.185 . . . . 0.0 109.454 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 22' ' ' LYS . 3.6 tp 75.67 14.9 2.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 109.543 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -60.11 5.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.354 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.586 ' H ' ' C ' ' A' ' 20' ' ' LEU . 14.7 mttt 57.12 6.84 0.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 109.449 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 21' ' ' ASP . 15.9 mttp -135.58 32.31 3.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.895 . . . . 0.0 109.326 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -108.2 169.37 8.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.437 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 9.4 t -94.8 -0.62 54.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.324 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.55 12.04 22.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.01 107.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.522 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.24 150.29 18.64 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -135.75 148.88 48.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.23 103.22 0.29 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 ttp -92.93 129.27 38.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 0.0 109.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' MET . 2.9 m -150.63 -171.75 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.63 -174.52 32.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.94 93.74 26.21 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.268 -1.136 . . . . 0.0 109.485 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.525 ' O ' ' C ' ' A' ' 36' ' ' ALA . 50.6 Cg_exo -50.43 -46.07 31.1 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.684 2.256 . . . . 0.0 112.254 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.65 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . -37.36 -42.86 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.65 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 1.2 m 159.25 -21.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 39' ' ' ASP . . . -35.11 -57.3 0.84 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 153.09 169.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.393 -1.063 . . . . 0.0 109.523 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.563 ' N ' ' CG ' ' A' ' 39' ' ' ASP . 7.6 p -96.12 146.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 108.909 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' VAL . 9.8 ttt -142.3 126.34 17.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 110.002 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -115.6 140.69 48.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.835 . . . . 0.0 108.922 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.24 121.33 13.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.805 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.447 ' HG2' ' N ' ' A' ' 45' ' ' ILE . 47.4 tt0 -122.57 152.88 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.21 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.662 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -123.17 152.9 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.524 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HB3' ' H ' ' A' ' 55' ' ' ASP . 15.4 tttp -124.84 131.03 53.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.7 137.53 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.651 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.682 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -175.31 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.524 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.8 m-20 -63.2 51.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.888 . . . . 0.0 109.108 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.682 ' N ' ' O ' ' A' ' 48' ' ' ASP . 6.3 m-80 72.17 55.15 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.634 -0.666 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.42 5.53 77.87 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 53' ' ' ILE . 4.1 mm -97.61 157.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 109.524 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.459 ' N ' HG22 ' A' ' 52' ' ' ILE . 54.0 mt -74.97 99.26 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -59.81 -51.51 69.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 46' ' ' LYS . 1.6 t70 -148.98 -174.75 4.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.797 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.72 122.74 4.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.127 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -95.25 146.92 24.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -0.953 . . . . 0.0 109.9 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.663 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -134.61 165.28 25.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.064 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -162.9 114.18 1.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.049 -1.032 . . . . 0.0 109.999 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 129.0 27.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.197 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.583 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -151.51 118.58 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -0.971 . . . . 0.0 109.759 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.89 -53.37 0.46 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.624 ' SG ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -107.39 137.23 45.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -1.151 . . . . 0.0 109.392 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.53 26.26 4.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -121.73 -42.42 2.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -1.186 . . . . 0.0 109.493 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.585 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -65.29 -29.01 69.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.554 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 67' ' ' ILE . 5.1 mm -50.87 -4.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 109.441 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.585 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -97.67 -56.26 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.547 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.826 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -50.0 -20.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 71' ' ' SER . 8.7 p -70.6 -63.09 1.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.546 ' N ' ' OG ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -51.33 -35.23 37.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.802 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 73' ' ' ILE . 6.7 tp -68.74 -79.79 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.949 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 69' ' ' SER . 3.3 tt -42.33 -48.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 109.915 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.61 ' N ' HG23 ' A' ' 73' ' ' ILE . 56.7 p -54.06 -36.81 63.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.685 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 72' ' ' LEU . 9.1 tt0 -79.38 -12.91 59.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.624 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -100.41 -4.22 29.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.7 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 73' ' ' ILE . 28.0 m -126.27 32.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.029 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 105.94 14.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.043 -1.035 . . . . 0.0 109.105 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.59 10.62 61.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -90.63 -170.81 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -1.14 . . . . 0.0 109.451 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.37 148.46 35.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.1 -21.97 2.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -83.79 -15.35 48.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.907 . . . . 0.0 109.284 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.46 -28.13 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 0.0 109.253 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.58 -22.38 16.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.316 -0.865 . . . . 0.0 109.308 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.63 53.73 4.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.95 -34.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -1.131 . . . . 0.0 109.001 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.523 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 2.8 pt -45.45 162.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.42 -0.8 . . . . 0.0 109.364 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -127.37 -167.7 1.78 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.422 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.84 -24.39 13.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.345 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.8 t -68.98 -36.2 77.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 95' ' ' GLU . 9.1 mt-30 -62.02 -73.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLN . 2.2 mt -43.86 -41.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.68 -37.17 62.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.429 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' GLN . 31.9 tt0 -76.35 -38.34 56.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.401 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -39.42 76.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.4 mp -87.81 -22.59 24.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 50.0 70.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.479 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.059 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.3 pt? -117.85 147.67 41.66 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.43 103.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.006 2.47 . . . . 0.0 112.354 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.0 Cg_exo -49.62 -14.86 0.78 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.818 2.345 . . . . 0.0 112.387 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 102' ' ' VAL . 6.9 m -62.73 11.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 109.312 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 101' ' ' PRO . 14.7 ttpp -165.89 64.05 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.4 -0.813 . . . . 0.0 109.055 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 104' ' ' VAL . 57.6 t -86.54 39.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.808 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.819 ' O ' HD13 ' A' ' 109' ' ' LEU . 4.2 m-70 -84.68 -24.32 29.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.164 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 m -71.85 -52.83 15.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.96 -52.24 66.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.887 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -57.37 -36.68 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.2 mp -65.03 -39.49 93.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.913 . . . . 0.0 109.393 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.02 -43.88 94.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' O ' ' A' ' 88' ' ' ILE . 15.7 tp10 -66.98 -61.41 1.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -49.27 -22.3 1.03 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.11 -50.66 18.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.75 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.9 tp -56.54 -41.82 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.123 -0.986 . . . . 0.0 109.57 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.1 mtpp -62.81 -50.35 71.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.156 -0.965 . . . . 0.0 109.361 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -35.92 32.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -62.39 -62.06 2.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.379 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.0 mt -52.36 -38.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 0.0 109.404 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.78 -67.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.64 -48.4 19.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.281 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.563 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 2.9 t80 -49.54 -45.19 47.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.289 -0.882 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.483 ' HG2' HD22 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -65.92 -54.97 19.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.596 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.05 -46.41 22.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.693 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -78.1 43.82 0.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.983 . . . . 0.0 109.737 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -130.07 -21.03 3.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 109.593 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 124.64 18.83 2.63 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.483 HD22 ' HG2' ' A' ' 122' ' ' LYS . 2.7 tp -58.36 -24.94 61.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -1.061 . . . . 0.0 109.493 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -123.01 -164.28 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.579 ' ND1' ' N ' ' A' ' 129' ' ' HIS . 0.5 OUTLIER -148.57 160.14 43.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 109.503 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -121.24 -131.85 0.29 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.256 -0.902 . . . . 0.0 109.373 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -159.24 99.02 1.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.426 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.714 ' CD2' ' H ' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -124.62 141.27 52.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.485 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 132' ' ' HIS . 43.8 p-80 -52.17 -175.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.9 p80 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.438 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.597 ' C ' ' H ' ' A' ' 3' ' ' TYR . 12.8 mmt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 3' ' ' TYR . . . 51.64 2.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.56 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.597 ' H ' ' C ' ' A' ' 1' ' ' MET . 25.7 m-85 52.17 178.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.485 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.5 m 54.35 68.93 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.492 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -135.27 137.93 43.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.975 . . . . 0.0 109.406 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -75.19 167.95 20.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.552 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 t -119.53 66.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.297 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.66 ' O ' ' N ' ' A' ' 10' ' ' HIS . 33.9 mt -105.46 -79.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.581 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.527 ' C ' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -34.77 -27.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 109.901 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.66 ' N ' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -87.51 125.0 34.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 109.669 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.417 ' CD1' ' ND2' ' A' ' 13' ' ' ASN . 1.2 m-85 -44.17 158.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.481 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -125.17 28.39 6.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.51 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.417 ' ND2' ' CD1' ' A' ' 11' ' ' TYR . 9.7 p30 -93.66 151.85 40.34 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.317 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.2 -75.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.75 2.3 . . . . 0.0 112.004 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.747 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -73.69 -152.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.222 -0.924 . . . . 0.0 109.448 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -169.07 -43.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.384 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -89.66 160.03 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 0.0 109.336 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.42 37.82 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.28 97.28 3.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -1.15 . . . . 0.0 109.517 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tp -178.02 -18.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.328 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.607 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -94.99 140.84 29.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -65.77 18.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 109.61 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.607 ' H ' ' C ' ' A' ' 21' ' ' ASP . 5.4 mttp -117.9 -13.39 10.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.314 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -65.78 165.91 11.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 0.0 109.477 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 124' ' ' LYS . 3.0 t -101.75 5.57 41.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.369 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.26 -4.18 15.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.5 t -116.41 117.58 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.21 136.72 13.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -115.72 111.88 21.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -1.161 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.86 91.21 0.73 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.37 119.41 27.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -1.122 . . . . 0.0 109.467 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.65 171.23 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.43 162.73 36.36 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -123.93 75.99 57.83 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 109.445 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.32 -8.54 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.69 2.26 . . . . 0.0 112.019 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -83.99 -30.22 26.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.88 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 9.9 p -112.66 -17.7 12.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.16 -0.963 . . . . 0.0 109.678 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.53 42.14 6.23 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.46 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 7.0 t70 -122.38 125.12 45.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.33 146.8 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.273 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -148.07 141.99 25.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.687 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -132.87 111.32 10.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.07 145.91 26.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.533 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -142.4 114.53 8.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.638 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.7 134.83 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -108.16 146.74 32.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.732 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.68 146.32 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.281 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -179.41 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.893 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 1.2 m-20 -62.77 44.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.321 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.685 ' N ' ' O ' ' A' ' 48' ' ' ASP . 3.2 m-80 76.98 51.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.13 -0.88 86.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 80' ' ' LYS . 34.3 mm -95.12 146.83 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -1.174 . . . . 0.0 109.368 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 53' ' ' ILE . 34.4 mt -75.06 84.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.867 . . . . 0.0 109.259 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -46.85 66.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -142.75 177.59 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.549 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.07 123.54 4.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -103.47 154.16 19.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' HG21 ' A' ' 74' ' ' THR . 32.1 p90 -142.12 175.81 9.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.505 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.37 99.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.253 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.96 130.34 55.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.408 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -144.45 129.33 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.952 . . . . 0.0 109.581 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.24 -57.65 0.46 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.73 150.85 40.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.231 . . . . 0.0 109.543 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.88 56.57 0.51 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -144.06 -11.81 0.65 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.493 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.42 -12.02 17.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.557 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.465 HD12 ' H ' ' A' ' 67' ' ' ILE . 1.6 mp -40.87 -54.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.404 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -49.9 -65.95 0.48 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.497 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 68' ' ' ALA . 10.9 m -38.94 -54.94 1.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.927 . . . . 0.0 109.533 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' OG1' ' A' ' 74' ' ' THR . 19.4 p -50.57 -46.23 57.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.43 -35.01 71.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 75' ' ' GLU . 58.8 tp -68.29 -76.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 77' ' ' VAL . 1.4 tt -40.63 -45.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 ' CD1' ' A' ' 58' ' ' PHE . 6.8 p -55.81 -35.25 66.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 109.288 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 72' ' ' LEU . 7.4 mt-10 -93.78 4.16 54.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -106.27 -34.59 7.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.917 . . . . 0.0 109.619 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 73' ' ' ILE . 35.2 m -103.88 35.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -111.62 119.28 38.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.382 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.94 -2.92 85.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.55 ' O ' HG23 ' A' ' 52' ' ' ILE . 52.7 mmtt -85.53 -167.9 2.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -1.162 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.38 149.61 37.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.417 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.32 -20.79 46.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.98 -26.97 67.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -91.78 -38.06 12.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -68.79 -26.26 65.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.535 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.44 38.73 3.18 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -153.86 -34.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -1.104 . . . . 0.0 109.398 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.579 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.6 pt -40.52 169.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 109.749 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -140.92 161.6 37.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.369 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.617 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 14.7 p-10 -80.97 -28.79 35.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.59 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -57.5 7.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -55.65 -54.92 38.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.916 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 15.0 mt -55.64 -32.57 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.622 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.52 -41.94 88.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 109.713 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -69.87 -22.69 63.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.194 -0.941 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -74.7 -38.04 62.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 69' ' ' SER . 0.5 OUTLIER -98.27 -15.31 19.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.964 . . . . 0.0 109.599 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 47.76 68.81 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.334 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -97.28 149.35 35.62 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.703 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 102' ' ' VAL . 71.6 Cg_exo -41.32 101.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.989 2.459 . . . . 0.0 112.352 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.23 -8.63 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.618 2.212 . . . . 0.0 111.937 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 100' ' ' PRO . 18.3 m -77.59 -7.17 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HE3' ' SG ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -147.6 48.27 1.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.313 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.16 -1.97 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.595 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -13.74 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.958 . . . . 0.0 109.232 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.442 ' SG ' ' HE3' ' A' ' 103' ' ' LYS . 24.0 m -80.01 -55.18 5.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.9 t -50.37 -47.05 56.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.137 -0.977 . . . . 0.0 108.995 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.29 -46.94 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 mp -53.86 -30.87 47.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.144 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.71 -61.49 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -0.824 . . . . 0.0 109.273 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.617 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 58.5 tt0 -51.02 -54.06 27.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.249 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.79 -41.82 71.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 109.417 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -49.05 -50.12 38.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.449 HG12 ' HB1' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -59.68 -39.77 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 5.8 tttt -64.46 -46.29 83.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.73 -61.87 2.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.659 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -47.63 -35.64 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.84 -38.53 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.129 -0.982 . . . . 0.0 109.553 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.63 -42.32 67.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 109.962 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.33 -39.87 92.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.992 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -68.67 -38.07 80.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.868 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -77.96 -27.45 49.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -66.01 -44.19 85.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.744 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.559 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.6 OUTLIER -77.64 25.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.547 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 123' ' ' ALA . 2.5 tt0 -170.35 54.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.996 . . . . 0.0 109.71 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -143.35 6.02 1.92 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mt -107.39 11.25 29.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -1.204 . . . . 0.0 109.564 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.62 -157.44 0.25 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.314 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.33 56.25 1.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.581 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -91.87 30.87 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.47 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.441 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 17.0 m-70 -69.39 -140.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.448 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.441 ' CD2' ' O ' ' A' ' 131' ' ' HIS . 16.1 m80 -151.1 -148.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.467 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 1.6 t-160 -163.05 -55.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.558 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.467 ' CE1' ' HB3' ' A' ' 133' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.476 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.302 0.572 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -51.03 120.62 5.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.54 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.45 ' CD2' ' N ' ' A' ' 4' ' ' SER . 32.5 p90 -100.38 -173.71 2.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.45 ' N ' ' CD2' ' A' ' 3' ' ' TYR . 0.8 OUTLIER -157.53 70.32 0.59 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 109.52 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' O ' ' A' ' 6' ' ' LYS . 35.7 mm-40 -111.66 -4.37 14.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.391 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' O ' ' O ' ' A' ' 5' ' ' GLU . 1.0 OUTLIER 58.01 144.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.554 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.9 134.44 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.81 135.25 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.344 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -96.51 -148.4 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.533 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -94.65 -67.16 0.87 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.337 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -45.87 105.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.415 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -139.34 138.0 36.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' PRO . 1.9 t-20 -176.11 77.44 0.28 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 109.25 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 13' ' ' ASN . 50.4 Cg_exo -48.92 -130.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.848 2.366 . . . . 0.0 112.306 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.71 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -122.45 176.18 6.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.543 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -54.49 109.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.898 . . . . 0.0 109.405 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 19' ' ' SER . 16.7 t -64.36 -68.5 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 109.561 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -62.46 57.21 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.6 OUTLIER 169.77 160.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -1.117 . . . . 0.0 109.447 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 19' ' ' SER . 1.8 mm? 39.0 69.8 0.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.461 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.656 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.2 m-20 -157.62 10.98 0.19 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.19 15.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.348 -0.845 . . . . 0.0 109.414 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.656 ' N ' ' O ' ' A' ' 21' ' ' ASP . 15.8 mmtt -139.63 30.96 2.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.746 ' OD2' HG23 ' A' ' 27' ' ' VAL . 7.2 p-10 -122.14 141.46 51.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -0.964 . . . . 0.0 109.457 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 m -75.91 8.43 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.398 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -107.03 12.07 29.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.608 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.746 HG23 ' OD2' ' A' ' 24' ' ' ASP . 27.4 t -132.45 101.69 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 109.303 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.29 129.29 9.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.97 141.0 51.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -1.092 . . . . 0.0 109.239 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.36 142.97 8.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 ptm -141.31 147.6 38.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -1.201 . . . . 0.0 109.743 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 m -136.0 -179.75 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.025 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.66 163.16 31.12 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.049 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.29 91.93 42.76 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.368 -1.078 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -49.25 -27.01 12.17 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.712 2.275 . . . . 0.0 112.44 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.03 -33.95 40.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.1 m -130.13 7.56 5.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' OD1' ' A' ' 39' ' ' ASP . . . 57.46 71.54 0.73 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.553 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 30.2 m-20 -141.18 131.19 24.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.02 126.65 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.775 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.43 ' HG2' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -110.53 149.17 30.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.43 ' N ' ' HG2' ' A' ' 41' ' ' MET . 4.0 tt0 -124.88 122.99 38.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.63 134.75 54.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.466 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -135.83 116.89 14.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.302 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.18 159.07 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -127.03 140.65 52.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.56 150.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.146 -0.971 . . . . 0.0 109.648 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 9.8 p-10 -75.99 -94.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.601 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -156.26 15.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -132.67 -7.37 3.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.7 9.88 17.97 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.8 mm -98.41 143.84 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -1.155 . . . . 0.0 109.454 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.2 115.39 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.45 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.92 -37.36 15.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.67 168.09 20.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.23 105.74 3.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -99.88 141.4 32.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.766 ' CD1' HG21 ' A' ' 74' ' ' THR . 13.7 p90 -139.99 179.08 6.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 109.382 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -164.76 123.75 1.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -137.55 141.51 41.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -158.36 134.26 9.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.908 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.42 -69.32 0.54 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.02 128.41 38.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -1.163 . . . . 0.0 109.656 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.45 70.57 0.86 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.99 -17.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -1.112 . . . . 0.0 109.295 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . . . -105.74 6.33 31.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.431 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 68' ' ' ALA . 41.8 mt -79.05 -53.13 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -44.25 -45.3 8.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -70.85 -38.54 73.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.416 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.604 ' O ' HG23 ' A' ' 74' ' ' THR . 41.8 t -56.21 -39.96 73.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -73.72 -32.77 64.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.323 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.422 ' CD2' ' OE1' ' A' ' 96' ' ' GLU . 10.8 tp -68.96 -59.24 3.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 74' ' ' THR . 11.2 tt -52.34 -41.59 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.766 HG21 ' CD1' ' A' ' 58' ' ' PHE . 31.8 p -63.34 -32.33 73.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.0 109.331 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.47 -4.77 59.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.288 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.8 -26.44 14.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.57 22.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.298 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -95.49 120.38 35.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.412 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.01 5.48 89.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -87.04 -168.68 2.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -1.17 . . . . 0.0 109.534 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.13 152.47 39.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.369 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -57.82 -28.85 64.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.324 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.1 -36.35 79.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 85' ' ' ALA . 63.5 mm-40 -76.84 -56.1 4.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.101 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.46 -32.65 1.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.18 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.78 39.3 3.0 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -159.98 -40.57 0.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 108.781 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.54 ' O ' ' O ' ' A' ' 87' ' ' ALA . 12.4 pt -45.67 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 109.161 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -150.86 -178.63 6.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.154 -0.966 . . . . 0.0 109.572 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -90.88 -16.7 27.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.402 -0.811 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.27 -45.3 65.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.485 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -62.48 -69.77 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.531 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 92' ' ' GLN . 7.9 mt -41.71 -39.96 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HA ' HD21 ' A' ' 99' ' ' LEU . . . -67.17 -42.12 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.503 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -68.0 -11.41 58.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.443 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' OE1' ' CD2' ' A' ' 72' ' ' LEU . 13.2 tt0 -88.37 -54.77 4.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.413 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mt -81.94 -7.34 59.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 99' ' ' LEU . 6.0 tp10 48.5 23.56 0.62 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.429 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -43.97 149.21 0.69 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.67 164.2 32.17 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.67 2.246 . . . . 0.0 112.217 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 74.5 Cg_endo -79.91 18.4 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.985 2.456 . . . . 0.0 112.638 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.0 t -110.62 0.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 109.727 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.658 ' O ' ' N ' ' A' ' 105' ' ' HIS . 13.0 mtmt -140.33 10.7 2.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.445 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 101' ' ' PRO . 5.0 t -45.11 -10.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 109.442 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.658 ' N ' ' O ' ' A' ' 103' ' ' LYS . 3.2 m-70 -59.72 -37.92 80.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 86.3 m -60.66 -50.68 72.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -60.85 -52.82 63.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.372 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.5 mt -46.73 -36.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 109.262 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.59 -28.17 58.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.627 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.21 -50.95 71.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.999 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 112' ' ' ASP . 70.9 tt0 -66.55 -63.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.873 . . . . 0.0 109.133 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' GLU . 4.8 t70 -44.1 -35.06 1.99 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.201 -0.937 . . . . 0.0 109.244 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 115' ' ' LYS . . . -58.04 -64.53 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.006 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.8 tp -46.43 -22.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 108.513 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 116' ' ' ALA . 14.5 tttt -74.1 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -40.55 -51.53 2.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.602 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.78 -51.75 67.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.465 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mt -49.73 -43.07 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -55.96 -65.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.537 ' O ' ' C ' ' A' ' 121' ' ' TYR . 27.0 t70 -44.66 -68.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.595 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.537 ' C ' ' O ' ' A' ' 120' ' ' ASP . 54.2 t80 -35.33 -42.99 0.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.574 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -68.8 -51.64 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -65.29 -38.82 91.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -53.3 -7.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 123' ' ' ALA . 6.8 tt0 -136.32 50.78 2.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -152.95 -44.22 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.27 -32.77 57.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -1.175 . . . . 0.0 109.446 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -68.68 -179.01 1.28 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.898 . . . . 0.0 109.478 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.81 175.72 8.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.414 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.572 ' ND1' ' O ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -97.03 -144.45 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.612 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.706 ' CD2' ' H ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -75.24 158.62 32.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.513 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -101.04 137.57 39.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.331 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 134' ' ' HIS . 20.6 p80 -145.4 -135.2 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 109.521 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.433 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 4.0 p-80 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.506 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.26 0.552 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' A' ' 4' ' ' SER . . . -98.8 -10.63 22.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -63.61 60.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.511 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.62 ' N ' ' O ' ' A' ' 2' ' ' ALA . 0.7 OUTLIER -75.17 -12.22 60.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.37 -0.831 . . . . 0.0 109.465 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.9 -48.17 5.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 tptm 51.23 75.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.644 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.42 141.96 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.328 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.8 tt -143.43 159.95 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 109.565 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 10' ' ' HIS . 1.0 OUTLIER -60.47 144.44 51.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.5 ' C ' ' O ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -38.64 153.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.112 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.87 117.86 8.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 109.74 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -108.54 -166.73 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.13 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 15' ' ' ARG . 7.4 t-20 -165.58 86.25 0.99 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.064 -1.023 . . . . 0.0 109.781 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.53 66.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.846 2.364 . . . . 0.0 111.973 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.716 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -97.44 92.2 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.816 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.467 HD22 ' N ' ' A' ' 16' ' ' ASN . 1.3 m-80 56.91 14.3 1.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.882 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.689 HG22 ' H ' ' A' ' 18' ' ' GLY . 8.6 p -113.34 175.22 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.53 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.689 ' H ' HG22 ' A' ' 17' ' ' VAL . . . 87.25 10.42 71.28 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.542 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.6 p -143.67 -164.03 1.79 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 mp 58.72 0.28 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.878 . . . . 0.0 109.327 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.542 ' OD1' ' O ' ' A' ' 19' ' ' SER . 1.3 m-20 -103.89 148.21 26.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.52 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.552 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -64.96 -25.16 67.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.429 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -63.82 7.98 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.406 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.552 ' H ' ' C ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -111.54 119.39 38.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 109.358 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.691 ' C ' HD22 ' A' ' 26' ' ' ASN . 1.0 OUTLIER -72.39 9.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.585 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.691 HD22 ' C ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -125.06 30.01 5.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 27' ' ' VAL . 34.9 t -127.1 91.36 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.313 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.42 142.2 16.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -129.17 112.57 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 0.0 109.31 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.46 134.93 12.2 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.41 114.41 16.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.299 -1.118 . . . . 0.0 109.524 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 m -130.67 174.14 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.19 -178.9 21.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -122.12 89.19 48.58 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 109.367 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -54.46 29.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.95 2.433 . . . . 0.0 112.386 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.679 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -105.89 -42.83 5.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.7 -22.0 3.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.601 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.13 51.27 0.52 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 3.2 m-20 -106.76 140.22 39.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -1.145 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.74 114.54 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.167 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 19.5 ttt -112.54 140.99 46.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -126.5 128.97 47.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -0.878 . . . . 0.0 108.986 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -120.64 138.44 53.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.819 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -126.47 132.24 51.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.407 -0.808 . . . . 0.0 109.189 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.57 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -128.63 143.24 50.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.61 145.47 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.467 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -92.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -161.07 18.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.432 HD22 HG12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -128.36 -21.2 3.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.72 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.55 6.06 6.27 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.432 HG12 HD22 ' A' ' 50' ' ' ASN . 43.1 mm -103.64 130.08 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.641 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.44 97.66 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.397 -0.814 . . . . 0.0 109.299 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.67 -38.39 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.578 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.26 169.44 17.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.136 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -166.78 118.64 0.96 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.131 -0.981 . . . . 0.0 109.593 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp -95.97 -177.94 4.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.176 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD1' HG21 ' A' ' 74' ' ' THR . 17.6 p90 -168.06 -179.72 4.24 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.184 -0.947 . . . . 0.0 109.418 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -171.61 113.98 0.36 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.589 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.5 p -119.62 131.89 55.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.206 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -140.89 111.27 6.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . 84.88 49.66 4.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.535 ' O ' ' O ' ' A' ' 64' ' ' GLY . 14.5 p -121.5 142.79 49.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.458 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 63' ' ' CYS . . . -38.99 -94.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.3 m -125.68 30.76 5.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -1.134 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.16 -31.51 72.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.446 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.497 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.8 mp -38.41 -32.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.431 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -86.03 -64.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 109.312 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 m -54.21 -29.48 46.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.52 ' O ' ' OG1' ' A' ' 74' ' ' THR . 78.8 p -62.95 -34.52 77.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.115 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -74.42 -33.24 62.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.83 . . . . 0.0 109.225 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tp -64.34 -60.26 3.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.661 HG23 ' N ' ' A' ' 74' ' ' THR . 12.6 tt -51.95 -51.2 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.582 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.661 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -53.62 -31.15 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.374 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -84.09 -14.98 49.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.396 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -89.89 -23.96 21.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' ILE . 17.0 m -97.11 13.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 82.0 1.74 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.975 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.7 -9.45 8.11 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -98.75 -159.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.264 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -128.07 164.49 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 109.709 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt -50.53 -28.68 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.86 -53.01 61.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.351 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.79 -36.3 71.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.829 . . . . 0.0 109.328 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.649 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -67.97 -40.32 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.255 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 44.4 3.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.608 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -161.4 -35.31 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.137 . . . . 0.0 109.404 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.2 pt -40.39 -21.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 mttp 55.51 169.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.973 . . . . 0.0 109.391 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 91' ' ' SER . 0.7 OUTLIER -101.32 -45.32 5.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.553 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 37.1 t -56.19 -22.35 28.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.403 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -67.72 -64.15 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.369 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -51.35 -30.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.84 -45.16 90.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.77 -18.32 61.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.372 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -71.14 -51.58 24.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.32 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.92 -11.92 56.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.21 19.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 109.829 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.673 HD23 ' N ' ' A' ' 99' ' ' LEU . 1.7 pt? -59.18 149.2 68.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 109.149 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -37.51 145.39 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.823 2.349 . . . . 0.0 112.23 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.63 8.83 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.671 2.247 . . . . 0.0 112.265 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.77 -30.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -94.09 16.89 13.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.907 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.06 -19.79 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.542 ' ND1' ' N ' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -54.58 -33.49 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.59 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 90.6 m -58.02 -58.19 9.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.915 . . . . 0.0 109.527 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -48.87 -55.77 10.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.478 ' N ' HD22 ' A' ' 90' ' ' ASN . 28.2 mt -47.77 -65.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.313 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 34' ' ' ALA . 6.5 mp -43.79 -27.32 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -69.57 -71.31 0.24 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -50.93 -30.78 15.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.243 -0.911 . . . . 0.0 109.249 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -73.01 -25.08 60.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -75.02 -35.09 61.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.618 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.649 HG12 ' HB1' ' A' ' 85' ' ' ALA . 2.2 tp -75.03 -42.34 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.946 . . . . 0.0 109.42 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 22.1 tttt -59.94 -40.3 88.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.982 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -62.61 -54.12 44.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 109.421 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.514 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -50.07 -63.48 1.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.227 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 117' ' ' ALA . 67.5 mt -37.77 -44.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.21 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -55.12 -57.34 12.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.9 . . . . 0.0 109.426 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -58.75 -45.35 89.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.34 -20.57 44.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.393 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -91.36 -29.91 16.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.385 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.97 -7.34 59.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.385 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.07 21.84 1.29 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -160.91 55.45 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -129.74 -69.86 0.12 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 129' ' ' HIS . 10.0 mp -55.43 -37.3 67.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -1.139 . . . . 0.0 109.446 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.46 ' C ' ' CD2' ' A' ' 129' ' ' HIS . 13.8 mt-10 -73.04 36.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.527 ' O ' ' N ' ' A' ' 131' ' ' HIS . 55.4 m-70 -147.95 130.42 15.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -67.1 44.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 0.0 109.369 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.527 ' N ' ' O ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -73.05 86.52 1.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 109.422 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.24 7.73 1.37 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.346 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.608 ' ND1' ' N ' ' A' ' 133' ' ' HIS . 2.8 p-80 -120.45 50.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.408 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.409 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.69 98.8 6.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 4' ' ' SER . 54.5 t80 -118.62 76.25 1.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.3 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 3' ' ' TYR . 6.9 t -53.95 -161.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -130.86 85.77 2.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.907 . . . . 0.0 109.54 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -139.05 159.21 42.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.364 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 m -119.71 52.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.218 -0.926 . . . . 0.0 109.954 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.6 mt -95.81 57.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.131 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.2 -163.71 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.728 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -107.27 -167.78 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -143.71 28.75 1.42 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 109.16 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.73 120.67 15.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 109.661 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.635 ' O ' ' N ' ' A' ' 15' ' ' ARG . 63.1 m-20 -59.38 155.14 38.76 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.28 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -40.64 -11.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.768 2.312 . . . . 0.0 112.231 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.716 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -73.18 137.89 45.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 -11.24 15.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.385 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.704 HG12 ' N ' ' A' ' 18' ' ' GLY . 57.9 t -92.12 173.6 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.607 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.704 ' N ' HG12 ' A' ' 17' ' ' VAL . . . 150.82 -14.55 0.9 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 1.5 t 153.7 162.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.545 -0.973 . . . . 0.0 109.166 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.796 HD12 ' NZ ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -111.75 88.55 2.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.696 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.624 ' C ' ' H ' ' A' ' 23' ' ' LYS . 6.1 m-20 58.46 109.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 109.524 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -58.1 4.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.388 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 21' ' ' ASP . 8.8 tttm -50.95 -28.59 10.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 109.692 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 23' ' ' LYS . 5.8 t0 80.16 -146.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.522 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.8 OUTLIER 74.41 11.17 4.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.544 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' A' ' 25' ' ' SER . 1.7 p-10 174.78 -28.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.96 . . . . 0.0 109.681 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -91.74 114.98 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.09 119.27 5.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.487 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 27.3 m -93.71 136.38 34.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -1.15 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.67 110.05 0.67 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.6 ttt -125.63 122.14 35.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -1.137 . . . . 0.0 109.651 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 41' ' ' MET . 2.1 m -124.55 -169.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.377 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.15 146.83 5.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.11 133.52 20.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.227 -1.161 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.3 Cg_endo -75.44 -26.38 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.493 2.129 . . . . 0.0 112.256 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.53 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.89 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -98.88 5.32 47.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.04 48.79 10.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -89.66 127.07 35.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.401 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.0 131.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.405 ' HB3' HG23 ' A' ' 32' ' ' VAL . 4.7 ttt -128.06 130.53 48.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 109.293 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -125.38 142.07 51.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.801 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.56 156.84 43.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.182 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.78 150.56 38.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.656 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.78 139.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.316 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.796 ' NZ ' HD12 ' A' ' 20' ' ' LEU . 35.5 ttmt -113.38 146.51 39.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.612 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.71 147.63 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.902 . . . . 0.0 109.341 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.485 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 2.2 t0 -88.9 -60.17 2.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' OD1' ' C ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 167.27 -23.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.888 . . . . 0.0 109.145 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.485 ' ND2' ' OD2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -100.12 22.66 11.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.541 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 15.26 80.14 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -104.93 136.66 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -1.112 . . . . 0.0 109.483 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.34 97.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.7 -44.32 57.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.23 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.76 157.1 8.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.33 179.31 6.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.351 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -151.29 170.75 18.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 74' ' ' THR . 21.3 p90 -137.35 167.88 20.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.248 -0.908 . . . . 0.0 109.384 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -169.71 85.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.17 133.51 55.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.492 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -147.18 105.85 3.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.06 -50.66 0.13 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 24.1 p -128.9 120.55 26.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.52 66.57 1.02 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.55 -50.93 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -62.92 -26.4 68.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.354 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' ALA . 77.8 mt -44.67 -53.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.0 109.217 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.45 -41.09 60.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 108.921 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.2 -40.37 64.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.34 -0.85 . . . . 0.0 109.024 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 74' ' ' THR . 2.3 t -65.69 -24.55 67.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 109.168 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.7 t -76.12 -46.21 29.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.308 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.05 -59.25 4.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 74' ' ' THR . 17.3 tt -49.21 -43.95 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.585 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -54.88 -42.27 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.591 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.19 -18.45 60.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.942 . . . . 0.0 109.729 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -89.35 -21.9 22.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.517 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 77' ' ' VAL . 4.8 m -107.49 52.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.885 . . . . 0.0 109.14 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -142.11 82.43 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.646 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.68 3.74 40.04 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -102.25 -167.44 1.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -1.189 . . . . 0.0 109.524 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -102.94 139.24 38.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.77 -23.73 60.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.401 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -75.98 -13.97 60.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.35 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.55 -35.05 11.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.49 2.84 42.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -113.19 25.8 11.01 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.96 18.66 0.16 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -1.153 . . . . 0.0 109.409 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.05 2.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.847 . . . . 0.0 109.327 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.4 mttt 56.83 167.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.548 ' ND2' ' C ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -86.04 -13.16 48.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.339 -0.851 . . . . 0.0 109.541 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.3 p -75.76 -21.52 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.564 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.469 ' HA ' HE21 ' A' ' 92' ' ' GLN . 0.1 OUTLIER -74.79 -56.01 5.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.423 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.0 mt -59.67 -41.98 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.183 -0.948 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.88 82.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.184 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.35 -46.49 80.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.821 . . . . 0.0 109.399 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -49.69 -62.45 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.17 -16.65 61.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 52.84 23.52 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.0 OUTLIER -55.26 146.84 39.36 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.26 -0.9 . . . . 0.0 109.582 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.423 ' O ' HD12 ' A' ' 99' ' ' LEU . 73.1 Cg_exo -42.04 146.78 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.74 2.293 . . . . 0.0 112.239 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.664 ' O ' HG23 ' A' ' 104' ' ' VAL . 57.2 Cg_endo -73.94 -27.59 12.02 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.762 2.308 . . . . 0.0 112.386 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 102' ' ' VAL . 4.9 t -70.5 26.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.739 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 101' ' ' PRO . 9.6 tttm -165.17 37.43 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 101' ' ' PRO . 3.5 t -71.39 1.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.392 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.583 ' O ' HD13 ' A' ' 109' ' ' LEU . 34.4 m80 -58.79 -29.26 66.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -67.59 -41.64 83.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.59 85.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.885 . . . . 0.0 109.177 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -62.56 -46.36 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.295 -0.878 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 105' ' ' HIS . 7.8 mp -63.23 -25.21 68.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.428 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -74.15 -71.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 114' ' ' ILE . 12.9 tp10 -50.75 -31.48 16.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.689 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.42 -38.77 85.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.138 -0.976 . . . . 0.0 109.158 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -69.9 -58.91 3.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -44.22 -38.09 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.527 ' O ' ' C ' ' A' ' 116' ' ' ALA . 4.0 tptt -75.17 -66.13 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.483 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -36.61 -39.58 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.264 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -64.38 -57.95 7.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.7 mt -38.01 -49.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.413 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 120' ' ' ASP . . . -56.18 -61.15 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.507 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 119' ' ' ALA . 4.3 m-20 -38.83 -62.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -46.42 -57.43 4.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.722 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 125' ' ' GLN . 1.0 OUTLIER -47.31 -29.16 2.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -41.25 -47.81 3.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.587 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.462 ' HZ2' ' HB3' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -90.82 23.81 2.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 122' ' ' LYS . 14.1 tp60 -165.98 39.93 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.15 -0.969 . . . . 0.0 109.467 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.43 -100.26 0.47 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.664 ' O ' ' N ' ' A' ' 129' ' ' HIS . 0.5 OUTLIER -117.52 -32.73 4.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.714 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 128' ' ' GLU . 17.0 mp0 -46.64 -6.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.621 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.664 ' N ' ' O ' ' A' ' 127' ' ' LEU . 73.8 t60 -112.68 -95.91 0.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.933 . . . . 0.0 109.585 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.636 ' C ' ' ND1' ' A' ' 131' ' ' HIS . 0.8 OUTLIER 177.47 -164.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.275 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.636 ' ND1' ' C ' ' A' ' 130' ' ' HIS . 2.0 p-80 -179.86 115.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.14 -0.975 . . . . 0.0 109.624 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 134' ' ' HIS . 2.0 t60 178.12 -81.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.766 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -70.87 23.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.897 . . . . 0.0 109.849 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.521 ' H ' ' C ' ' A' ' 132' ' ' HIS . 1.6 p-80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.362 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.276 0.56 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -49.64 126.27 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.566 ' O ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -81.41 157.3 25.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.627 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER 55.43 119.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.9 . . . . 0.0 109.501 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -72.02 172.33 10.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.292 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -149.82 61.17 1.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 109.54 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t 60.74 86.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 109.677 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 9' ' ' ASP . 1.9 pt -144.36 160.61 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.3 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 8' ' ' ILE . 45.3 t0 40.74 85.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.402 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 9' ' ' ASP . 4.8 m-70 -43.97 131.02 5.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.31 109.51 19.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.66 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 63.83 123.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.342 -0.849 . . . . 0.0 109.567 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.417 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 1.2 t-20 -147.8 57.25 3.18 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.191 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 33.2 Cg_endo -67.89 4.29 1.53 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.884 2.389 . . . . 0.0 112.327 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 58.86 -92.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.167 -0.958 . . . . 0.0 109.515 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.725 HD22 ' N ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -173.07 -4.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.725 ' N ' HD22 ' A' ' 16' ' ' ASN . 77.1 t -56.56 127.71 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.372 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.27 80.35 0.67 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 20' ' ' LEU . 8.9 p -174.23 113.15 0.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -1.119 . . . . 0.0 109.393 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.606 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 5.7 tp 72.61 -3.27 2.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.383 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.584 ' C ' ' H ' ' A' ' 23' ' ' LYS . 2.3 m-20 -69.7 16.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 20' ' ' LEU . 3.5 mtpp 63.5 -9.36 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.425 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.584 ' H ' ' C ' ' A' ' 21' ' ' ASP . 2.6 ttmm -132.17 62.29 1.64 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.538 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.606 ' OD2' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -123.93 156.34 36.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.85 -2.65 43.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -97.13 3.95 51.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.6 96.82 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.585 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 155.53 28.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -138.6 117.27 12.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -1.199 . . . . 0.0 109.62 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.06 114.4 4.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.53 108.59 14.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -1.196 . . . . 0.0 109.565 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.67 175.01 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.11 168.35 41.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -120.74 80.81 32.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -47.08 -14.03 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.848 2.366 . . . . 0.0 112.311 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -60.47 2.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -91.55 -8.75 46.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 43.27 9.38 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.2 148.48 25.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.111 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.1 139.89 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ttt -147.0 130.0 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.557 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -133.52 118.87 18.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 0.0 109.481 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.65 127.46 50.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.286 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -106.34 168.82 8.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.728 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.515 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -150.11 127.87 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.224 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -98.74 105.15 17.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.58 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.09 144.78 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 109.252 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.617 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 6.6 t70 -78.94 -101.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -148.35 13.6 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.614 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.617 ' ND2' ' OD2' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -139.27 2.25 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.68 33.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.432 HD13 ' OG ' ' A' ' 81' ' ' SER . 4.5 mm -83.32 144.06 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -1.187 . . . . 0.0 109.418 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 55' ' ' ASP . 72.1 mt -90.19 91.41 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.85 -54.03 16.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 15.9 t0 -136.59 -177.08 4.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.357 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.91 116.29 1.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.593 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -96.46 141.72 29.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -117.01 162.63 17.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.403 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -157.16 97.24 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.435 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.52 124.98 50.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.561 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -150.78 97.11 2.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.35 -39.7 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 34.3 t -130.12 121.79 27.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.93 47.41 1.89 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.09 2.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -1.16 . . . . 0.0 109.562 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.01 -4.25 20.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.452 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.542 ' O ' ' C ' ' A' ' 68' ' ' ALA . 3.1 mp -62.29 -65.85 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.542 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.5 -71.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.581 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -41.5 -60.32 1.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.496 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 84.1 p -46.29 -47.76 18.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.342 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.406 ' C ' ' OG1' ' A' ' 74' ' ' THR . 1.7 m -57.71 -23.95 54.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 74' ' ' THR . 1.4 tp -78.82 -71.54 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.287 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.577 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -40.52 -24.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.91 . . . . 0.0 109.121 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -75.56 -56.17 4.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.252 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.16 -15.52 24.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -88.63 -32.55 18.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 77' ' ' VAL . 17.2 m -104.6 55.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.648 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.52 84.29 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.297 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.11 -15.1 23.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -78.25 -174.42 3.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.418 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.432 ' OG ' HD13 ' A' ' 52' ' ' ILE . 73.4 m -109.45 174.39 5.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.618 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mt -64.23 -26.03 68.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.633 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -64.61 -17.44 64.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -100.09 -38.87 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.557 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.08 -25.29 58.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.73 54.25 0.68 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.17 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -1.169 . . . . 0.0 109.404 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.54 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -35.89 -43.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.413 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 91' ' ' SER . 0.3 OUTLIER 63.6 119.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.9 . . . . 0.0 109.582 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 91' ' ' SER . 43.0 p30 -40.93 -25.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.025 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.535 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.5 m -50.44 -36.9 35.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.477 ' O ' ' C ' ' A' ' 93' ' ' ILE . 12.6 tt0 -83.46 -60.31 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.477 ' C ' ' O ' ' A' ' 92' ' ' GLN . 69.6 mt -40.13 -48.1 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 95' ' ' GLU . . . -72.44 -55.2 7.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 94' ' ' ALA . 3.7 tt0 -36.07 -34.06 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 94' ' ' ALA . 1.2 tp10 -81.79 -62.19 1.71 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.619 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.8 OUTLIER -63.29 -16.91 61.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 109.421 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 97' ' ' LEU . 1.1 tp10 37.94 47.43 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -71.28 150.47 94.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.169 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -36.15 109.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.87 2.38 . . . . 0.0 112.045 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.9 16.41 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.559 2.173 . . . . 0.0 112.477 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 102' ' ' VAL . 10.9 m -82.3 13.64 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 104' ' ' VAL . 4.9 tptt -168.21 -38.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.43 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 103' ' ' LYS . 12.4 t 44.22 57.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.27 -57.85 2.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' A' ' 107' ' ' SER . 48.0 t -44.46 -60.42 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.807 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.486 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -43.38 -63.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 107' ' ' SER . 27.4 mt -38.1 -62.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.85 . . . . 0.0 109.604 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 34' ' ' ALA . 8.6 mp -48.65 -37.25 17.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.587 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -61.12 -73.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.637 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.551 ' O ' ' OE2' ' A' ' 111' ' ' GLU . 3.8 tp10 -46.69 -58.54 3.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.69 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.9 OUTLIER -43.74 -38.34 3.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.768 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.8 -51.96 65.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.6 tp -61.61 -41.1 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.677 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.479 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -62.08 -41.14 97.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 109.511 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -46.42 67.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -55.02 -33.91 63.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.314 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 68.9 mt -69.38 -66.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.851 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -38.69 -46.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.395 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -63.28 -43.85 96.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 109.394 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 118' ' ' ILE . 59.5 t80 -56.45 -42.25 77.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 126' ' ' GLY . 23.6 mttp -72.04 -43.98 64.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.05 -11.91 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.417 ' N ' ' C ' ' A' ' 122' ' ' LYS . 6.3 mttt -108.47 -65.87 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.488 ' CG ' ' O ' ' A' ' 125' ' ' GLN . 5.1 tt0 -85.05 14.67 4.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -49.16 -88.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 mt -125.71 -8.92 6.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -1.146 . . . . 0.0 109.366 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -170.4 -152.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.646 ' ND1' ' N ' ' A' ' 129' ' ' HIS . 0.3 OUTLIER -94.44 55.24 1.94 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.66 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.468 ' CG ' ' H ' ' A' ' 131' ' ' HIS . 7.6 t-80 -62.39 -158.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.957 . . . . 0.0 109.237 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.468 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 7.0 p80 -163.27 150.89 13.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.674 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 134' ' ' HIS . 33.7 t-80 -54.24 108.52 0.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.89 . . . . 0.0 109.381 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -53.65 89.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 132' ' ' HIS . 4.6 t60 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.562 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' O ' ' C ' ' A' ' 2' ' ' ALA . 5.2 tpt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 43.98 75.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.422 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 4' ' ' SER . 2.4 t80 -165.83 -21.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.58 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.57 ' O ' ' OG ' ' A' ' 4' ' ' SER . 1.0 OUTLIER 45.15 62.6 2.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.953 . . . . 0.0 109.532 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.53 -79.88 0.47 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.21 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HG2' ' H ' ' A' ' 7' ' ' VAL . 8.2 tttp -101.15 162.18 13.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 7' ' ' VAL . 2.5 m -56.6 154.7 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.488 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 8' ' ' ILE . 9.0 mt -149.28 151.39 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.9 p30 176.86 34.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.618 ' CG ' ' O ' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -117.66 36.15 4.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.44 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER 53.8 72.08 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -83.15 -20.18 35.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.887 . . . . 0.0 109.374 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -123.94 97.25 41.32 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 0.0 109.346 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -48.73 149.59 7.26 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.585 2.19 . . . . 0.0 112.185 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.731 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -105.23 -62.11 1.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.9 . . . . 0.0 109.575 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.89 91.78 8.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.927 . . . . 0.0 109.515 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 p -129.66 137.14 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.91 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 19' ' ' SER . . . 76.09 97.44 0.15 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.59 ' HG ' ' HG1' ' A' ' 29' ' ' THR . 4.6 t 40.32 -141.07 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -1.14 . . . . 0.0 109.474 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.02 133.89 55.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.0 106.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.392 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.8 -2.15 4.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.579 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -50.22 -28.89 8.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.942 . . . . 0.0 109.431 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.9 OUTLIER 45.75 -165.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.31 -1.94 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 24' ' ' ASP . 1.9 p-10 -167.84 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.59 92.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.8 144.57 18.25 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.59 ' HG1' ' HG ' ' A' ' 19' ' ' SER . 4.8 m -135.43 130.55 34.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.46 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.15 140.52 16.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.21 125.08 21.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 109.575 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.62 170.42 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.3 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.08 141.84 7.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -110.67 129.2 24.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.183 . . . . 0.0 109.186 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.478 ' O ' ' C ' ' A' ' 36' ' ' ALA . 63.8 Cg_endo -77.14 -45.02 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.515 2.143 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.31 -55.28 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -113.55 29.04 8.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 109.69 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.4 51.67 0.74 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 37' ' ' CYS . 78.8 m-20 -102.24 111.77 24.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -99.3 130.86 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.759 ' HG3' HG22 ' A' ' 60' ' ' THR . 0.4 OUTLIER -137.05 150.74 48.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.492 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -136.76 116.36 12.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.376 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 tt -105.6 143.25 34.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 45' ' ' ILE . 4.8 tt0 -135.51 162.33 32.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.325 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.533 ' N ' ' CG ' ' A' ' 44' ' ' GLN . 1.3 pt -147.41 162.44 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.426 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 10.6 mmtm -129.52 138.48 51.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.21 155.8 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.562 ' OD2' ' OD1' ' A' ' 49' ' ' ASP . 38.5 t70 -88.65 -49.7 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.631 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER 160.78 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.234 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -101.39 -11.72 19.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 8.71 7.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.36 149.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.9 mt -90.92 95.55 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' CG ' ' N ' ' A' ' 55' ' ' ASP . 19.9 pt-20 -58.03 -46.24 85.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.565 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 54' ' ' GLU . 1.7 t0 -137.53 168.17 20.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.579 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.05 100.51 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.07 159.5 14.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.509 ' CD1' HG21 ' A' ' 74' ' ' THR . 34.6 p90 -140.35 -175.0 4.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.58 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -171.35 83.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.759 HG22 ' HG3' ' A' ' 41' ' ' MET . 59.6 p -92.9 149.04 21.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.663 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -155.06 141.56 18.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.85 -80.71 0.35 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 65' ' ' SER . 0.1 OUTLIER -82.11 136.94 35.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -1.157 . . . . 0.0 109.444 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.83 45.76 3.07 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -154.6 -47.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.392 -1.063 . . . . 0.0 109.336 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.68 -14.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' SER . 7.2 mt -65.88 -22.86 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.43 -67.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.21 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 73' ' ' ILE . 20.9 p -46.39 -53.41 11.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.166 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 74' ' ' THR . 83.9 p -49.88 -33.57 17.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.524 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.3 OUTLIER -71.17 -37.71 72.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.292 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.22 -67.84 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.848 . . . . 0.0 109.441 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' VAL . 5.3 tt -44.42 -40.18 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 109.948 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 71' ' ' SER . 1.5 p -57.48 -48.31 79.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.894 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -78.14 -21.57 50.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -11.54 59.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.416 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 73' ' ' ILE . 16.4 m -124.67 20.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.253 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -90.54 99.78 12.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.402 -0.812 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.57 -3.04 56.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -81.88 171.14 14.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.15 150.68 21.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.532 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.7 mt -54.79 -15.81 2.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.99 -33.4 74.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -88.36 -47.48 8.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.871 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.8 -5.58 31.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.298 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.83 31.54 6.98 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.22 -36.02 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -1.16 . . . . 0.0 109.184 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.4 pt -44.81 120.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.839 . . . . 0.0 109.545 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.437 ' H ' ' NE2' ' A' ' 92' ' ' GLN . 18.8 mttm -94.3 179.39 5.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.07 -13.9 60.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.462 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -82.75 -43.89 16.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.437 ' NE2' ' H ' ' A' ' 89' ' ' LYS . 58.3 mt-30 -58.28 -36.59 73.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.005 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.15 -33.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.02 -21.08 66.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.261 -0.899 . . . . 0.0 108.971 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -94.18 -35.32 12.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.179 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -58.74 -36.18 73.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.352 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.2 mt -106.03 -3.87 21.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 47.12 50.88 13.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.517 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.431 HD12 ' C ' ' A' ' 99' ' ' LEU . 3.5 pp -85.88 146.8 44.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.427 ' O ' HG12 ' A' ' 102' ' ' VAL . 37.0 Cg_endo -69.08 151.99 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.744 2.296 . . . . 0.0 112.053 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.621 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.5 Cg_endo -69.5 19.13 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.887 2.391 . . . . 0.0 112.369 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.532 ' C ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -35.53 -28.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.31 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.649 ' C ' HG23 ' A' ' 104' ' ' VAL . 5.9 tptt -173.35 -31.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.374 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 ' C ' ' A' ' 103' ' ' LYS . 1.6 t 69.87 2.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 37.4 p-80 -65.15 -36.76 85.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.494 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 3.9 t -58.7 -56.39 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.06 -44.31 74.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.589 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.8 mt -56.53 -41.58 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.39 -32.28 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -63.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.887 . . . . 0.0 109.62 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.1 -49.77 76.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.82 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -53.52 -28.03 29.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.973 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -79.3 -64.42 1.19 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.872 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.6 tp -44.94 -41.16 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 109.833 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.497 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -73.45 -37.15 65.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.122 -0.986 . . . . 0.0 109.442 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.09 80.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -68.59 -60.34 2.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ALA . 44.4 mt -38.57 -49.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.48 80.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.567 ' OD2' ' O ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -52.67 -66.64 0.35 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.253 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -46.92 -39.02 11.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 109.177 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -59.54 -51.17 70.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.814 . . . . 0.0 109.366 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.72 -6.48 2.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -97.21 40.21 1.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -117.85 -74.77 0.59 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 128' ' ' GLU . . . -176.38 -49.97 0.06 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 127' ' ' LEU . 6.8 tp -45.64 -11.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -1.124 . . . . 0.0 109.447 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 126' ' ' GLY . 2.5 tm-20 -56.78 -55.06 39.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.347 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.419 ' C ' ' ND1' ' A' ' 129' ' ' HIS . 0.5 OUTLIER 57.45 86.23 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.76 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 154.64 40.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.06 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -175.79 80.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.084 -1.01 . . . . 0.0 109.681 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.522 ' CG ' ' H ' ' A' ' 133' ' ' HIS . 4.8 t60 -57.97 -177.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 109.087 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.522 ' H ' ' CG ' ' A' ' 132' ' ' HIS . 4.3 m80 -129.09 159.36 36.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.105 -0.997 . . . . 0.0 109.566 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.449 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 4' ' ' SER . . . -70.28 170.6 11.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.55 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -47.45 82.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.548 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 2' ' ' ALA . 14.0 t -166.69 10.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.657 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.522 ' CD ' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -112.34 113.2 25.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.162 -0.962 . . . . 0.0 109.46 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -59.36 163.94 3.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -18.61 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.717 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.3 mt -95.31 83.83 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.188 -0.945 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -145.62 66.28 1.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.407 ' CD2' ' N ' ' A' ' 10' ' ' HIS . 1.4 m170 -77.41 115.81 17.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.448 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.62 26.55 6.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.452 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.04 70.32 0.73 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -134.28 60.33 43.14 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.476 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -65.33 -152.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.758 2.305 . . . . 0.0 112.349 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.14 -170.14 0.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.297 -0.877 . . . . 0.0 109.215 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -154.74 -105.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.669 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.91 87.62 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.131 -0.981 . . . . 0.0 109.594 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' SER . . . -50.57 176.12 0.05 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' GLY . 1.8 t -42.57 148.43 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -1.217 . . . . 0.0 109.377 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.567 ' O ' ' O ' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -92.25 51.57 1.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.442 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 23' ' ' LYS . 9.4 m-20 53.73 159.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 15.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.124 -0.985 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.583 ' H ' ' C ' ' A' ' 21' ' ' ASP . 11.5 mmtm -95.99 23.62 6.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.838 . . . . 0.0 109.335 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' HG23 ' A' ' 27' ' ' VAL . 4.2 t0 -96.11 167.42 11.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.538 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.529 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 3.7 m -101.61 7.24 42.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.529 ' OD1' ' O ' ' A' ' 25' ' ' SER . 56.9 m-20 -144.2 14.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.435 HG23 ' OD2' ' A' ' 24' ' ' ASP . 32.9 t -118.46 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.192 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.53 153.13 34.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.542 ' O ' ' OD2' ' A' ' 120' ' ' ASP . 7.8 m -127.15 120.7 29.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -1.043 . . . . 0.0 109.108 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.24 106.5 1.81 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.0 ttt -112.33 112.4 23.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -1.216 . . . . 0.0 109.462 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.48 154.44 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.39 -170.1 11.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.31 92.24 4.91 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 53.7 Cg_exo -48.55 -48.03 18.65 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.689 2.259 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.09 -34.2 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.469 ' O ' ' C ' ' A' ' 38' ' ' GLY . 21.2 m -120.01 12.05 11.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.83 56.89 3.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -124.5 117.6 24.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.382 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.29 130.06 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -128.86 137.04 51.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.855 . . . . 0.0 109.325 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -121.54 164.01 17.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.689 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tp -158.51 126.19 5.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -117.77 140.55 49.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.426 HD11 ' HB1' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -129.54 124.34 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.57 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -101.39 143.6 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 48' ' ' ASP . 92.5 t -131.3 156.36 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.291 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 49' ' ' ASP . 12.0 t70 -85.16 -106.12 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.448 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' OD2' ' OD2' ' A' ' 48' ' ' ASP . 2.1 p30 -140.02 8.65 2.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.637 HD22 ' H ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -124.75 -29.52 3.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.461 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.437 ' N ' HD22 ' A' ' 50' ' ' ASN . . . 135.66 -5.6 4.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.637 ' H ' HD22 ' A' ' 50' ' ' ASN . 50.0 mm -79.38 137.04 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -1.151 . . . . 0.0 109.487 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 53' ' ' ILE . 8.1 mt -91.17 107.01 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -70.93 -16.45 62.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.725 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 15.7 t0 -172.91 151.75 2.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.053 -1.029 . . . . 0.0 109.791 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.556 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -133.12 107.76 8.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.346 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.22 154.77 17.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 109.561 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 74' ' ' THR . 2.4 p90 -136.99 -176.5 4.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.534 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.58 106.94 0.56 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.349 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.43 ' CG2' ' OG ' ' A' ' 70' ' ' SER . 81.9 p -112.77 145.15 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -154.45 108.79 3.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 109.423 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.84 -58.19 0.3 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 48.6 t -106.68 136.02 47.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -1.153 . . . . 0.0 109.371 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.63 38.25 2.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.5 20.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -1.185 . . . . 0.0 109.525 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -93.43 -29.49 15.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.805 ' CD1' ' H ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -42.93 -27.16 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -46.72 -57.59 4.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.852 . . . . 0.0 109.705 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -49.89 29.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 109.707 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.43 ' OG ' ' CG2' ' A' ' 60' ' ' THR . 0.3 OUTLIER -48.63 -41.62 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.873 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.57 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.15 -45.17 74.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 73' ' ' ILE . 46.3 tp -57.06 -71.22 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.74 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.641 HD12 ' HB1' ' A' ' 110' ' ' ALA . 9.5 tt -40.78 -44.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 109.941 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.824 HG21 ' CD1' ' A' ' 58' ' ' PHE . 1.1 p -59.22 -36.92 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.764 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 72' ' ' LEU . 21.6 tt0 -71.69 -55.65 7.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -31.88 27.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.664 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 77' ' ' VAL . 4.2 m -105.37 63.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.7 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -144.58 95.5 2.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.56 -15.47 35.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -76.08 -160.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -1.109 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 t -117.96 159.08 23.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 82' ' ' LEU . 14.0 mt -57.11 -19.18 18.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.327 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -67.83 -30.8 70.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.376 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.7 tp10 -86.39 -45.86 10.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.608 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.26 -11.46 60.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.62 46.73 1.13 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -168.33 -33.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.093 . . . . 0.0 108.93 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 84' ' ' GLU . 16.2 pt -50.3 179.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.49 -0.756 . . . . 0.0 109.579 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -143.58 179.98 6.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.855 . . . . 0.0 109.282 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -96.15 -13.22 23.73 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.173 -0.954 . . . . 0.0 109.188 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 t -70.84 -41.93 70.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.813 . . . . 0.0 109.268 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -65.86 -52.15 52.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.212 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.7 mt -57.97 -27.01 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.221 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.67 -42.06 78.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.318 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -70.51 -22.02 62.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.19 -54.92 5.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.532 ' O ' ' C ' ' A' ' 98' ' ' GLU . 4.4 tp -80.75 -3.47 51.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.532 ' C ' ' O ' ' A' ' 97' ' ' LEU . 7.6 tm-20 36.0 70.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.326 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.04 149.76 36.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.373 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -71.03 151.66 62.03 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.714 2.276 . . . . 0.0 112.112 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -71.02 19.39 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.797 2.331 . . . . 0.0 112.211 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.31 16.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.31 -0.869 . . . . 0.0 109.493 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 105' ' ' HIS . 8.8 tttp -176.49 46.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 104' ' ' VAL . 18.7 t -65.86 20.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.64 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.611 ' H ' ' C ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -86.24 -30.51 22.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 p -65.85 -44.37 85.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.296 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.25 -45.92 89.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.7 mt -68.2 -30.04 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 mp -73.27 -40.93 64.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.641 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -60.15 -53.77 53.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.831 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.31 -56.85 8.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.709 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -51.55 -17.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 109.732 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.38 -55.06 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.801 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 tp -51.13 -33.07 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.0 109.653 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.503 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -75.39 -61.25 1.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -37.47 -35.61 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -0.981 . . . . 0.0 109.304 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 119' ' ' ALA . . . -77.75 -66.34 0.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 117' ' ' ALA . 48.0 mt -37.47 -28.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 117' ' ' ALA . . . -77.9 -52.9 8.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD2' ' O ' ' A' ' 29' ' ' THR . 37.3 m-20 -49.75 -44.19 48.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.71 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.59 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -76.12 -59.17 2.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 109.547 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' TYR . 22.6 tptt -43.11 -33.26 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.8 -20.87 16.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -111.23 24.12 13.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -154.5 44.15 0.52 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.656 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.08 -36.43 0.13 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -96.05 -14.2 23.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -1.194 . . . . 0.0 109.697 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -152.9 164.94 36.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.583 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -167.13 49.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.487 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 4.5 p80 -134.08 132.27 39.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.565 ' ND1' ' N ' ' A' ' 131' ' ' HIS . 1.0 OUTLIER -178.84 87.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.379 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' HIS . 31.2 m80 -40.18 -80.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.504 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.447 ' CD2' ' H ' ' A' ' 134' ' ' HIS . 1.7 t-160 -124.27 -143.47 0.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.552 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.447 ' H ' ' CD2' ' A' ' 133' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.454 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.09 172.17 13.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 109.432 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -125.74 131.89 52.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 t -124.48 137.84 54.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.4 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -90.61 -74.36 0.5 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.339 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -151.8 -57.54 0.15 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.427 -0.795 . . . . 0.0 109.121 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.548 ' O ' ' C ' ' A' ' 8' ' ' ILE . 15.9 m -87.47 160.96 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.358 -0.838 . . . . 0.0 109.139 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.548 ' C ' ' O ' ' A' ' 7' ' ' VAL . 26.1 mm -36.13 143.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.31 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -100.35 161.97 13.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.09 -1.006 . . . . 0.0 109.734 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -107.39 141.68 38.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.399 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -87.42 -15.84 36.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 63.07 -122.43 0.6 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.657 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.49 146.47 86.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.608 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.679 ' O ' ' N ' ' A' ' 16' ' ' ASN . 57.4 Cg_endo -74.44 8.24 2.29 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.836 2.357 . . . . 0.0 112.408 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 14' ' ' PRO . 14.4 ptm180 -42.81 -13.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 109.57 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.679 ' N ' ' O ' ' A' ' 14' ' ' PRO . 4.0 m-80 -64.14 86.85 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.203 -0.936 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.534 ' C ' ' O ' ' A' ' 16' ' ' ASN . 3.0 m -36.18 118.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -162.72 -177.1 35.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 0.9 OUTLIER 77.11 177.58 0.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.144 -1.209 . . . . 0.0 109.428 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.91 -49.13 4.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD2' ' OD2' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 47.22 32.23 2.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.836 . . . . 0.0 109.524 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 21' ' ' ASP . 21.5 tptp -45.3 -43.91 11.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.321 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.582 ' O ' ' O ' ' A' ' 24' ' ' ASP . 3.1 tttt -155.11 13.91 0.39 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.588 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 48.95 172.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.538 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 58.91 -4.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.337 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 24' ' ' ASP . 8.9 p-10 -146.65 13.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.383 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 t -129.06 101.58 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.744 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.19 128.86 9.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.74 152.9 21.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -1.212 . . . . 0.0 109.661 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 43' ' ' LEU . . . -131.51 118.18 2.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.96 95.3 4.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -1.146 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.92 145.56 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.86 177.75 20.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.57 77.15 73.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.171 -1.194 . . . . 0.0 109.555 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.03 -6.36 1.8 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.854 2.369 . . . . 0.0 112.107 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.62 -11.08 59.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.588 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.4 -39.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.98 69.63 0.1 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.1 145.89 44.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -1.157 . . . . 0.0 109.583 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.22 117.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.85 . . . . 0.0 109.212 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 ttt -120.11 120.24 35.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 109.893 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.34 142.72 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 108.97 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 30' ' ' GLY . 1.1 tt -150.62 149.39 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 109.886 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 12.9 pt20 -150.99 123.27 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.787 . . . . 0.0 109.214 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.3 151.12 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -112.68 150.0 32.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.91 . . . . 0.0 109.568 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.84 144.52 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 0.0 109.203 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.605 ' CG ' ' H ' ' A' ' 49' ' ' ASP . 36.7 p-10 -85.13 -108.76 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.963 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.605 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 34.0 t0 -131.95 -23.39 2.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.545 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -91.37 -1.68 57.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 28.83 12.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 53' ' ' ILE . 45.9 mm -108.89 161.43 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 109.373 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.463 ' N ' HG22 ' A' ' 52' ' ' ILE . 8.4 mt -100.49 105.47 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.222 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.3 -36.29 20.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.803 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -135.79 160.31 38.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.707 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.29 112.88 4.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 109.417 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -107.77 146.63 31.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -140.35 -175.44 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.159 -0.963 . . . . 0.0 109.542 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -170.75 107.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.433 HG21 ' CB ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -121.39 105.87 10.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.474 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.1 122.54 24.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.09 -39.44 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.0 139.06 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -1.099 . . . . 0.0 109.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.52 60.45 1.52 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.565 ' C ' ' H ' ' A' ' 67' ' ' ILE . 2.3 p -175.73 -59.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 106' ' ' CYS . . . -54.02 -1.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.532 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.565 ' H ' ' C ' ' A' ' 65' ' ' SER . 4.2 mt -65.76 -8.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.25 -49.75 9.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.09 -52.82 59.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.327 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -43.37 -56.51 3.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.831 . . . . 0.0 109.294 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 t -53.21 -30.43 37.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.406 -0.809 . . . . 0.0 109.352 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 69' ' ' SER . 11.4 tp -70.53 -67.45 0.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 109.554 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.651 ' O ' HG22 ' A' ' 77' ' ' VAL . 3.9 tt -48.72 -40.35 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.458 ' N ' HG23 ' A' ' 73' ' ' ILE . 21.0 p -58.66 -47.19 85.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.74 -10.17 58.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.87 -31.37 17.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 73' ' ' ILE . 4.2 m -102.42 64.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -133.93 100.5 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.67 -9.39 77.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 mmtp -81.45 -171.22 3.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.153 -1.204 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.11 -178.27 3.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.24 -10.32 49.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -71.06 -34.48 71.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.156 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.0 -37.13 13.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.402 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 -29.53 63.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.67 48.29 1.51 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.97 -42.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -1.12 . . . . 0.0 109.027 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.465 ' C ' ' O ' ' A' ' 87' ' ' ALA . 2.3 pt -40.98 151.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.398 -0.814 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -129.53 173.42 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 109.669 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.495 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 4.1 p-10 -86.75 -7.86 57.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.357 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.79 -47.38 39.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -60.08 4.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.857 . . . . 0.0 109.409 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -53.31 -38.25 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 90' ' ' ASN . . . -62.75 -33.87 76.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.55 -22.31 30.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.486 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.02 -24.85 58.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.4 mt -111.21 -19.26 12.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.242 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.47 62.79 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.684 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -97.56 153.23 38.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.335 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.0 152.13 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.547 2.164 . . . . 0.0 112.028 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.41 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 57.6 Cg_endo -74.67 -11.05 22.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.752 2.301 . . . . 0.0 112.229 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.6 m -92.01 11.11 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 105' ' ' HIS . 34.7 mttt -139.83 6.56 2.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.454 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 104' ' ' VAL . 3.8 t -47.09 -17.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 0.0 109.496 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.628 ' ND1' ' N ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -51.4 -14.69 0.31 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 109.514 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.628 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 42.2 t -76.05 -71.12 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.668 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.0 p -48.62 -44.06 36.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.7 mt -57.93 -51.83 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp -52.52 -27.91 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.82 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 16.4 tt0 -64.5 -44.92 89.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.62 -35.23 79.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.37 -52.36 65.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp -58.53 -41.37 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.975 . . . . 0.0 109.567 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.485 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 40.4 tttm -61.27 -28.56 69.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 0.0 109.155 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.37 -47.53 19.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.6 -32.41 41.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.92 -41.34 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.42 84.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.11 -52.64 22.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.307 -0.87 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -49.36 -42.13 41.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.224 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -28.55 63.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.289 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 127' ' ' LEU . . . -92.96 4.64 53.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.345 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -79.05 -58.45 3.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.37 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -99.22 54.93 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.547 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -161.82 -50.4 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.953 HD13 ' HB1' ' A' ' 123' ' ' ALA . 1.2 mp -35.28 -51.3 0.58 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -1.124 . . . . 0.0 109.423 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -155.5 -141.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.572 ' C ' ' ND1' ' A' ' 129' ' ' HIS . 0.2 OUTLIER -146.31 -83.86 0.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.482 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -155.34 -63.32 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.406 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.414 ' CD2' ' O ' ' A' ' 131' ' ' HIS . 32.0 p-80 -86.55 134.08 33.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.908 . . . . 0.0 109.347 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -140.52 -58.1 0.53 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.647 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -110.27 146.27 35.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.631 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.48 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.607 ' O ' ' NZ ' ' A' ' 6' ' ' LYS . 3.7 ttm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.555 ' O ' ' CB ' ' A' ' 3' ' ' TYR . . . -97.34 105.81 18.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER 78.44 98.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.16 -80.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -126.29 29.1 5.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.607 ' NZ ' ' O ' ' A' ' 1' ' ' MET . 6.8 mttt -76.22 -75.35 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.882 . . . . 0.0 109.426 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -61.46 -178.26 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.183 -0.948 . . . . 0.0 109.367 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 8' ' ' ILE . 5.6 mt 46.56 78.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.09 -99.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.303 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.467 ' O ' ' C ' ' A' ' 11' ' ' TYR . 2.0 t60 -90.07 -64.88 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.181 -0.949 . . . . 0.0 109.304 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 10' ' ' HIS . 3.8 m-85 -42.09 134.24 2.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 109.254 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.7 62.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.581 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.675 ' O ' ' N ' ' A' ' 15' ' ' ARG . 4.0 m-20 177.31 72.09 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -55.91 31.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.761 2.307 . . . . 0.0 112.036 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.675 ' N ' ' O ' ' A' ' 13' ' ' ASN . 9.5 mtt180 52.2 67.93 0.9 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.296 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.51 ' CG ' ' O ' ' A' ' 16' ' ' ASN . 5.8 p30 -161.96 116.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.54 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -54.22 -67.97 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.895 . . . . 0.0 109.4 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.557 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 136.43 112.24 1.16 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.557 ' O ' ' O ' ' A' ' 18' ' ' GLY . 1.0 OUTLIER 52.11 165.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -1.116 . . . . 0.0 109.574 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.52 ' HB2' HG21 ' A' ' 27' ' ' VAL . 87.8 mt -82.13 88.51 6.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 3.1 t0 73.71 -40.53 0.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 109.525 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 5.5 tttt 74.41 -9.07 1.36 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -0.833 . . . . 0.0 109.731 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -131.0 48.7 2.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -114.92 161.23 18.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.424 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -82.99 9.31 10.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.684 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -118.92 -13.68 9.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.363 -0.836 . . . . 0.0 109.364 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 20' ' ' LEU . 21.1 t -121.12 94.08 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.369 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.73 142.5 20.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -120.94 158.88 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -1.089 . . . . 0.0 109.177 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.15 145.4 12.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 ttt -145.62 119.3 9.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.1 m -126.17 170.34 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.75 178.29 28.27 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.29 75.34 70.72 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.345 -1.091 . . . . 0.0 109.187 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 36' ' ' ALA . 75.3 Cg_exo -44.48 -25.74 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 112.434 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -44.1 -51.2 8.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.8 p -114.79 -24.54 8.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.45 46.11 1.09 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 36.9 t0 -108.09 135.61 49.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -1.116 . . . . 0.0 109.488 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 4.0 m -108.43 137.72 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.9 ttt -137.86 128.56 26.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.531 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -117.26 142.91 46.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 109.409 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 tp -149.53 121.09 7.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.67 155.41 29.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.849 . . . . 0.0 109.371 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.79 125.48 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.618 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.66 ' NZ ' ' OE1' ' A' ' 54' ' ' GLU . 11.2 tttp -100.0 114.71 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -122.39 127.55 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.195 -0.941 . . . . 0.0 109.495 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 50' ' ' ASN . 6.3 m-20 -158.02 -32.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.616 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -62.57 50.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.348 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.676 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.3 m-80 78.54 54.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.384 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' C ' HG12 ' A' ' 47' ' ' VAL . . . 68.61 18.17 71.7 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.2 mm -105.73 134.9 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.389 -1.065 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.703 HG22 ' O ' ' A' ' 53' ' ' ILE . 32.4 mt -63.06 80.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.216 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.66 ' OE1' ' NZ ' ' A' ' 46' ' ' LYS . 35.5 tt0 -49.61 -22.73 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 110.18 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -169.11 159.57 9.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.034 -1.041 . . . . 0.0 109.808 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.05 134.0 53.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.548 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -116.68 144.59 44.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -143.66 170.64 15.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.947 . . . . 0.0 109.758 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -171.7 96.54 0.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.414 -0.804 . . . . 0.0 108.975 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.32 148.64 42.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.779 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -152.79 147.93 26.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 109.152 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.73 -74.03 0.45 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 1.6 p -116.24 122.18 44.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.134 . . . . 0.0 109.348 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.25 -9.68 2.28 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 63' ' ' CYS . 0.5 OUTLIER -93.27 10.3 32.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.711 ' HB2' ' SG ' ' A' ' 63' ' ' CYS . . . -100.88 -3.49 29.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.86 -24.71 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.8 65.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.622 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -76.91 -50.78 12.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.1 t -49.34 -38.41 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.359 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.1 t -72.21 -39.28 68.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 HG23 ' A' ' 93' ' ' ILE . 49.9 tp -61.0 -59.87 4.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.344 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.727 HG23 ' H ' ' A' ' 74' ' ' THR . 1.0 OUTLIER -53.13 -59.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.727 ' H ' HG23 ' A' ' 73' ' ' ILE . 2.4 p -42.86 -32.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.824 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -91.01 -11.31 39.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.782 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.556 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -93.87 -17.31 23.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.975 . . . . 0.0 109.533 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.36 40.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -95.89 116.93 29.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.43 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.69 5.37 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -73.74 -173.78 1.6 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.4 m -101.49 158.4 16.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.865 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -70.21 -16.56 63.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.86 -26.22 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.208 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -93.43 -43.4 8.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.349 -0.844 . . . . 0.0 109.376 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.21 67.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.47 33.11 4.46 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.1 26.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -1.109 . . . . 0.0 109.253 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -78.57 -25.02 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.368 -0.832 . . . . 0.0 109.621 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER 71.16 156.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.448 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.55 ' OD1' ' OE1' ' A' ' 111' ' ' GLU . 6.6 p-10 -93.48 -41.96 9.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.616 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -35.96 79.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -58.54 -67.75 0.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.661 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.408 HG23 HD23 ' A' ' 72' ' ' LEU . 4.3 mt -49.8 -33.47 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.751 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 107' ' ' SER . . . -69.3 -31.08 69.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 109.741 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -75.4 -36.14 60.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.23 -43.3 82.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.25 -17.15 62.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.404 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 54.24 39.08 30.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 100' ' ' PRO . 1.3 pp -82.27 149.0 60.99 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.304 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.404 ' O ' HD12 ' A' ' 99' ' ' LEU . 29.3 Cg_endo -66.16 149.31 85.63 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.645 2.23 . . . . 0.0 112.147 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -73.2 20.06 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.926 2.417 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.0 m -85.47 -13.52 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.052 -1.03 . . . . 0.0 109.885 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 105' ' ' HIS . 1.0 OUTLIER -150.12 55.8 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.081 -1.012 . . . . 0.0 109.889 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.849 HG12 ' O ' ' A' ' 104' ' ' VAL . 74.5 t -73.3 40.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.139 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.467 ' H ' ' C ' ' A' ' 103' ' ' LYS . 62.4 m80 -97.42 -26.46 14.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.868 . . . . 0.0 109.718 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.642 ' SG ' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -74.94 -45.11 44.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.626 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.642 ' N ' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -53.84 -46.92 71.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 56.2 mt -68.05 -43.65 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.4 mp -58.27 -37.35 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -63.33 -59.07 5.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.422 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.55 ' OE1' ' OD1' ' A' ' 90' ' ' ASN . 87.1 tt0 -56.09 -60.51 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.88 . . . . 0.0 109.362 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 111' ' ' GLU . 1.6 t0 -43.9 -32.39 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.354 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -68.89 -61.2 1.9 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.46 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.1 tp -49.61 -20.68 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -85.26 -57.9 2.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.353 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -47.99 -31.56 5.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.225 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.94 -58.03 3.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.864 . . . . 0.0 109.126 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 39.5 mt -46.72 -31.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.365 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.27 -46.89 38.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.05 -0.79 12.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.147 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -102.81 -32.05 10.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.356 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -95.74 -31.4 13.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.26 -18.18 63.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.484 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.49 5.61 30.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -100.99 -21.66 14.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 109.287 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -87.21 -18.75 56.98 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 128' ' ' GLU . 3.5 tp -69.66 -15.13 63.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.425 -1.044 . . . . 0.0 109.223 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' A' ' 130' ' ' HIS . 1.6 tt0 41.92 87.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.328 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.45 ' C ' ' O ' ' A' ' 128' ' ' GLU . 1.9 m-70 -41.24 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 109.643 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.652 ' N ' ' O ' ' A' ' 128' ' ' GLU . 0.9 OUTLIER -102.89 -139.44 0.35 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.207 -0.933 . . . . 0.0 109.141 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.525 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 48.9 t-80 -45.11 156.23 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.31 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.51 ' N ' ' HD1' ' A' ' 131' ' ' HIS . 40.1 m80 -123.15 167.99 12.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 109.501 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.13 146.62 32.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.69 ' CG ' ' O ' ' A' ' 134' ' ' HIS . 1.9 t60 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.522 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.59 139.29 30.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.425 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -89.14 79.94 7.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -123.56 38.69 4.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.319 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.85 73.68 3.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HG2' ' H ' ' A' ' 6' ' ' LYS . 7.0 pttp -83.93 19.36 1.76 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.301 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 7' ' ' VAL . 25.7 m -89.22 62.47 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.469 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 mt -83.69 21.26 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.267 -0.895 . . . . 0.0 109.474 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -119.51 -72.19 0.7 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.61 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.512 ' C ' ' O ' ' A' ' 9' ' ' ASP . 37.7 t60 36.69 63.75 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -106.58 58.47 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 109.59 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -127.85 -51.23 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.624 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 12' ' ' GLU . 2.4 m120 -42.33 157.88 0.22 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.51 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 15' ' ' ARG . 53.6 Cg_endo -73.93 -0.08 9.01 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.883 2.389 . . . . 0.0 112.314 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.545 ' O ' ' O ' ' A' ' 14' ' ' PRO . 16.2 mmm180 57.94 139.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.313 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -100.17 59.56 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.963 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 18' ' ' GLY . 9.4 p -57.55 165.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' N ' HG22 ' A' ' 17' ' ' VAL . . . 142.66 -65.38 0.48 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.419 ' N ' HE22 ' A' ' 44' ' ' GLN . 0.3 OUTLIER -82.29 160.54 22.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.371 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.3 mt -124.88 142.01 51.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.509 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER 53.2 90.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.35 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 1.47 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 21' ' ' ASP . 11.7 ttmt -60.36 -22.65 63.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.951 . . . . 0.0 109.015 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 57.23 25.26 10.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -71.27 2.4 4.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.277 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 25' ' ' SER . 2.4 p30 165.75 33.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.35 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.41 96.76 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.454 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.0 100.95 1.4 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 m -86.17 133.16 33.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -1.152 . . . . 0.0 109.657 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.33 145.78 17.57 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.21 110.8 5.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -1.213 . . . . 0.0 109.774 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.77 144.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.34 178.17 21.09 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.93 92.57 49.07 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.139 . . . . 0.0 109.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 36' ' ' ALA . 52.8 Cg_exo -50.15 -40.15 51.28 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.852 2.368 . . . . 0.0 112.332 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -38.43 -44.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.922 . . . . 0.0 109.671 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.32 -13.03 9.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.599 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.22 57.9 2.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -113.35 110.84 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.5 130.54 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.99 118.96 15.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -111.14 136.23 50.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.707 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' CB ' ' HB1' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -126.35 141.89 51.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.419 HE22 ' N ' ' A' ' 19' ' ' SER . 25.0 mt-30 -140.84 135.84 31.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 109.512 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -118.09 136.01 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' CD ' ' OD2' ' A' ' 55' ' ' ASP . 36.8 tttt -105.87 118.92 37.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.6 t -109.25 146.46 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.7 m-20 -173.92 -33.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.614 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -62.47 42.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.672 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.8 m-80 80.99 43.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 109.667 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.13 0.54 82.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.525 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.0 mm -98.23 151.62 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.494 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.8 mt -84.39 116.03 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.9 -44.57 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD2' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -130.11 131.2 45.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.561 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.96 121.51 45.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.39 -0.819 . . . . 0.0 109.425 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 115.13 29.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.402 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.744 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -101.78 167.91 9.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.54 83.74 1.55 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.92 127.47 41.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.47 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -151.57 141.56 22.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.596 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.98 -53.06 0.59 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 64' ' ' GLY . 42.6 t -91.11 172.57 8.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -1.188 . . . . 0.0 109.442 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.495 ' N ' ' SG ' ' A' ' 63' ' ' CYS . . . -129.92 -10.85 2.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.8 13.65 30.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -1.112 . . . . 0.0 109.368 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.542 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -103.93 -31.37 9.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.845 . . . . 0.0 109.486 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.6 mp -36.7 -35.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.933 . . . . 0.0 109.172 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -75.44 -55.86 5.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.263 -0.898 . . . . 0.0 109.295 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.7 m -51.11 -39.87 57.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -70.05 -66.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.67 -19.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.859 . . . . 0.0 109.328 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -79.75 -78.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.2 -0.937 . . . . 0.0 109.573 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 74' ' ' THR . 11.3 tt -45.95 -36.77 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.57 HG21 ' CG ' ' A' ' 58' ' ' PHE . 43.7 p -68.76 -39.07 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.873 . . . . 0.0 109.82 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -79.78 -12.22 59.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -98.6 -26.36 14.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.539 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.3 -34.76 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -50.73 116.31 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.41 57.49 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -89.22 -177.89 5.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -1.156 . . . . 0.0 109.391 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.525 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 50.6 m -107.17 -178.95 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.9 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.2 mt -77.68 -23.07 49.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.45 -14.22 60.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.378 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -101.23 -41.95 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.14 1.71 56.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.6 47.07 1.08 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -176.85 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -1.127 . . . . 0.0 109.394 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.498 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.2 pt -38.16 155.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.421 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -116.43 158.6 23.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.539 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.534 ' OD1' ' OE1' ' A' ' 111' ' ' GLU . 1.4 p-10 -71.5 -40.17 70.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -47.55 -37.06 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.19 -66.97 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 109.555 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -44.95 -44.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.309 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.46 -39.76 77.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.105 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -75.86 -10.01 59.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.234 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -79.47 -62.87 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 97' ' ' LEU . 6.2 mt -72.52 -2.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.09 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 46.9 77.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 110.086 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -126.69 148.52 65.21 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 108.875 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -37.78 148.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.887 2.391 . . . . 0.0 112.358 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.71 -79.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.676 2.251 . . . . 0.0 112.348 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 103' ' ' LYS . 3.3 t 47.16 -138.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.195 -0.941 . . . . 0.0 109.298 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.69 ' H ' HG12 ' A' ' 102' ' ' VAL . 14.6 tttt -78.42 -6.45 55.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 104' ' ' VAL . 12.0 p 31.97 41.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.485 -0.759 . . . . 0.0 109.783 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.666 ' HA ' HD12 ' A' ' 108' ' ' ILE . 16.0 p80 -68.65 -24.4 64.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.8 t -59.48 -71.18 0.13 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 69.6 m -46.35 -42.19 14.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.299 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 105' ' ' HIS . 87.5 mt -54.77 -70.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.273 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 108' ' ' ILE . 6.4 mp -36.64 -34.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 109.452 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -61.4 -72.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' OD1' ' A' ' 90' ' ' ASN . 16.9 tt0 -54.49 -38.33 66.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -27.99 68.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.892 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 43' ' ' LEU . . . -79.09 -58.26 3.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 109.529 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.5 tp -44.7 -39.5 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.868 . . . . 0.0 109.548 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -67.79 -55.9 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.553 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -45.54 -50.17 13.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.584 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.87 -59.98 4.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.506 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.9 mt -52.02 -22.18 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -73.25 -49.93 25.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.47 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -68.77 -50.85 47.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -48.53 -50.56 31.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 123' ' ' ALA . 3.4 mttm -65.13 -39.36 92.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.297 -0.877 . . . . 0.0 109.626 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -43.16 -42.82 4.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.81 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -53.61 -43.96 69.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.928 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -51.22 -21.78 2.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 109.666 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.94 28.96 11.04 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.6 mt 54.28 14.98 0.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -1.197 . . . . 0.0 109.54 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.575 ' C ' ' CG ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER 61.63 -173.97 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.433 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER 179.1 81.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 130' ' ' HIS . 2.1 t60 -138.06 13.34 2.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.319 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -50.7 161.89 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.559 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.661 ' ND1' ' N ' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -173.76 69.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.376 -0.827 . . . . 0.0 109.497 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.528 ' O ' ' C ' ' A' ' 134' ' ' HIS . 9.8 m-70 -101.74 -117.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.528 ' C ' ' O ' ' A' ' 133' ' ' HIS . 35.5 m170 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.455 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.258 0.552 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.91 -159.24 0.29 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.945 . . . . 0.0 109.524 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -100.31 -5.7 27.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.409 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -132.49 163.1 29.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 4' ' ' SER . 3.3 tp10 75.05 55.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 109.517 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.35 -56.15 4.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 7' ' ' VAL . 5.1 t -58.19 151.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.346 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 mt -66.9 -57.92 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.434 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -148.68 153.27 38.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.384 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.797 ' H ' ' CD2' ' A' ' 10' ' ' HIS . 1.8 p80 -94.61 60.66 2.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 0.0 109.496 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -164.06 147.67 9.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.537 ' C ' ' OD1' ' A' ' 13' ' ' ASN . 72.7 mt-10 -145.14 -120.6 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.2 -0.937 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.537 ' OD1' ' C ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -148.9 162.23 30.05 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.37 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.18 -28.45 28.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.757 2.304 . . . . 0.0 112.013 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.728 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -73.19 124.75 26.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -136.81 6.59 2.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.109 -0.994 . . . . 0.0 109.627 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.89 29.07 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.516 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.53 158.9 23.22 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 20' ' ' LEU . 26.7 p -144.06 -129.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.165 . . . . 0.0 109.438 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.541 ' N ' ' OG ' ' A' ' 19' ' ' SER . 3.0 tp 77.15 -28.26 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.553 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -46.43 -15.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.501 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 22.3 tttt 78.13 -21.64 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 21' ' ' ASP . 3.2 pttt -117.04 36.03 4.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.878 . . . . 0.0 109.391 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -102.89 158.55 16.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.439 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.22 13.13 14.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.888 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -108.83 16.95 22.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -148.07 116.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.16 140.18 15.6 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.3 m -119.89 120.51 36.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.1 132.94 6.06 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -136.02 131.43 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -1.141 . . . . 0.0 109.282 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.03 -174.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.23 -169.17 38.71 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -140.31 100.51 6.97 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.265 -1.138 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 37' ' ' CYS . 69.0 Cg_exo -47.06 -60.55 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.52 2.146 . . . . 0.0 112.152 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.71 -20.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 35' ' ' PRO . 3.7 m -118.85 -32.39 4.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 81.0 25.81 54.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.78 132.39 35.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -1.115 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -107.36 115.39 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.7 ttt -113.94 102.15 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -84.92 155.04 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.51 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.89 110.83 2.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -115.26 123.56 49.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.405 HG13 ' H ' ' A' ' 45' ' ' ILE . 0.6 OUTLIER -103.95 153.23 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -126.0 134.38 51.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.75 148.1 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 0.0 109.199 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.58 -94.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.039 -1.038 . . . . 0.0 109.612 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -156.43 20.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.46 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.81 -1.2 3.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.915 . . . . 0.0 109.46 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.11 15.06 31.74 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 mm -105.32 122.35 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -1.147 . . . . 0.0 109.452 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.0 mt -67.82 111.93 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.253 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' CD ' ' O ' ' A' ' 54' ' ' GLU . 14.9 tm-20 -88.19 -8.07 55.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.817 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 56' ' ' ALA . 7.0 t70 -171.96 165.86 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.004 . . . . 0.0 109.718 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 55' ' ' ASP . . . -149.55 139.79 22.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 165.46 24.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD1' HG21 ' A' ' 74' ' ' THR . 8.3 p90 -170.61 -174.49 1.63 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.809 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -172.03 111.08 0.28 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.038 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.1 p -84.32 149.45 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.816 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.7 116.09 2.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.37 -0.832 . . . . 0.0 109.316 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.49 -87.23 0.14 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.7 140.32 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -1.11 . . . . 0.0 109.443 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.11 55.37 3.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.55 -32.57 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -83.6 1.23 43.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 67' ' ' ILE . 5.8 mm -59.07 4.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -94.09 -38.66 11.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -70.62 -52.82 18.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 0.0 109.427 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -53.11 -33.67 53.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.514 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' ' OG1' ' A' ' 74' ' ' THR . 6.2 m -71.51 -35.77 70.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.97 -65.64 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.488 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.802 ' O ' HG22 ' A' ' 77' ' ' VAL . 1.2 tt -46.12 -39.56 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.781 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 70' ' ' SER . 16.6 p -62.89 -40.01 96.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 109.913 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.56 1.39 51.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.902 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -17.37 14.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.823 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 73' ' ' ILE . 17.8 m -114.03 53.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.038 -1.039 . . . . 0.0 109.648 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -126.26 104.34 8.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.375 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -24.02 33.99 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -65.38 -179.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -1.125 . . . . 0.0 109.405 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.6 159.17 15.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.124 -0.985 . . . . 0.0 109.65 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mt -56.43 -22.29 30.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.888 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.08 -46.47 70.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.138 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.81 -45.58 93.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.132 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.46 72.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.226 -0.921 . . . . 0.0 109.153 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 49.0 4.15 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -164.98 -32.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -1.075 . . . . 0.0 109.182 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.544 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -34.16 -44.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.45 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 88' ' ' ILE . 49.3 mttt 57.79 145.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.835 . . . . 0.0 109.559 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.35 -28.82 63.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 0.0 109.37 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.3 p -54.53 -39.86 68.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -53.9 12.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.425 ' H ' HG13 ' A' ' 93' ' ' ILE . 23.3 mt -51.49 -40.61 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.912 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.45 -58.82 5.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.392 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.63 -53.01 34.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.214 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -47.24 -50.51 21.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.342 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 3.5 mp -70.19 -40.34 74.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.357 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.594 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 1.8 tp10 81.71 32.6 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.865 . . . . 0.0 109.444 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.19 146.14 50.6 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 102' ' ' VAL . 20.5 Cg_endo -64.77 152.59 81.5 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.558 2.172 . . . . 0.0 112.082 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.11 20.11 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.875 2.383 . . . . 0.0 112.131 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 100' ' ' PRO . 33.0 m -87.93 -21.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.63 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -137.18 47.74 2.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.793 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.2 t -59.45 -9.5 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 108.998 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.764 ' O ' HD13 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -56.28 -27.15 54.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 45.2 t -69.87 -64.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.469 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -49.59 -65.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.363 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 107' ' ' SER . 80.0 mt -40.98 -44.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.764 HD13 ' O ' ' A' ' 105' ' ' HIS . 2.0 mp -57.46 -44.23 84.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -57.69 -48.1 80.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.271 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -59.61 -59.68 5.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.35 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 -25.89 3.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.885 . . . . 0.0 109.441 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -72.1 -38.9 69.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 111' ' ' GLU . 2.1 tp -70.23 -35.76 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.476 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 13.7 mttt -77.92 -30.4 50.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.531 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.86 -43.85 87.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.358 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.14 77.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.273 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.16 -45.72 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.429 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.14 -45.83 75.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 29' ' ' THR . 4.8 m-20 -66.92 -8.64 30.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -87.22 -52.36 5.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -61.89 -41.78 98.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.633 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.51 -0.59 5.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.559 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.7 18.1 22.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.429 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -90.16 -69.58 0.72 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -89.41 -10.88 65.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.56 ' N ' ' OE2' ' A' ' 128' ' ' GLU . 11.4 mt 61.44 41.27 12.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -1.16 . . . . 0.0 109.384 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.635 ' CD ' ' H ' ' A' ' 128' ' ' GLU . 2.4 pm0 -89.16 166.99 13.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.279 -0.888 . . . . 0.0 109.45 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 128' ' ' GLU . 51.3 m80 -155.68 -137.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.862 . . . . 0.0 109.383 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -135.92 -29.4 1.02 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -0.98 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -162.48 97.7 0.99 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 109.698 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.708 ' ND1' ' N ' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -134.21 109.92 9.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.932 . . . . 0.0 109.307 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -111.17 11.14 21.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.144 -0.973 . . . . 0.0 109.491 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.438 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.403 ' O ' ' CE2' ' A' ' 3' ' ' TYR . 3.5 ttm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.313 0.578 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.5 150.33 24.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.512 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 1' ' ' MET . 39.5 m-85 -134.28 -18.54 1.99 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.466 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -48.52 73.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.97 -129.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.723 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.85 87.99 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.563 ' C ' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -106.86 -56.86 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.524 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.789 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.7 mp 53.97 109.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.433 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 3.7 p30 -143.35 -13.62 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.877 . . . . 0.0 109.638 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.661 ' ND1' ' N ' ' A' ' 11' ' ' TYR . 3.3 p80 -70.99 -106.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.661 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 50.8 t80 44.6 53.38 7.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.677 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 3.5 pm0 -65.91 142.67 57.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.466 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.767 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -82.64 155.93 68.25 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.614 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.92 140.25 37.9 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.881 2.387 . . . . 0.0 112.442 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -100.14 -177.24 3.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.57 ' OD1' HG22 ' A' ' 17' ' ' VAL . 17.1 p-10 -166.85 -50.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 109.684 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.57 HG22 ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -92.0 120.87 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.623 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' SER . . . -111.91 -109.95 3.08 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER 44.36 77.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -1.153 . . . . 0.0 109.633 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 21' ' ' ASP . 12.3 mt -64.94 160.84 19.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.445 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 20' ' ' LEU . 2.8 m-20 -49.72 174.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.355 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -81.01 16.16 1.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.142 -0.974 . . . . 0.0 109.403 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 23' ' ' LYS . 19.8 ttpt -83.37 -11.93 57.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.516 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.95 156.59 16.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.527 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -92.11 12.31 22.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.333 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.418 HD22 HG23 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -114.89 19.96 15.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.418 HG23 HD22 ' A' ' 26' ' ' ASN . 38.0 t -139.29 99.42 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.52 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.04 120.87 5.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -82.96 136.69 34.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 109.52 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.12 85.59 0.32 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mtt -94.69 107.27 19.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -1.103 . . . . 0.0 109.559 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.1 170.78 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.526 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.94 -173.21 34.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.1 87.09 55.97 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.184 . . . . 0.0 109.481 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.94 -12.8 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.736 2.291 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.8 m -120.18 -38.68 2.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.5 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.12 36.88 0.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.41 115.8 28.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.127 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 t -91.72 131.23 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.091 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -134.55 131.5 38.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.801 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' OE1' ' NE2' ' A' ' 44' ' ' GLN . 5.4 tt0 -125.41 131.88 52.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 0.0 109.274 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -142.96 111.87 6.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.506 ' NE2' ' OE1' ' A' ' 42' ' ' GLN . 9.2 mt-30 -103.22 143.92 32.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.454 HG12 ' HB1' ' A' ' 117' ' ' ALA . 0.3 OUTLIER -106.77 147.5 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.574 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.53 117.94 29.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.8 134.0 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.675 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.6 m-20 -170.39 -31.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.575 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 14.0 m-20 -62.7 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.092 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-80 74.49 48.17 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.488 -0.758 . . . . 0.0 109.067 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.65 -8.54 58.97 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 53' ' ' ILE . 45.2 mm -87.71 162.6 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.118 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.524 ' N ' HG22 ' A' ' 52' ' ' ILE . 62.3 mt -79.37 120.33 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.75 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -86.38 -31.9 21.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.64 157.11 1.99 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 109.221 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.87 139.09 50.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -103.22 117.66 35.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' HG21 ' A' ' 74' ' ' THR . 15.1 p90 -103.88 166.42 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.5 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -167.05 93.49 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.357 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.78 135.66 50.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.505 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -150.59 139.61 21.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.71 -45.21 0.76 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.6 OUTLIER -119.58 123.71 44.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -1.107 . . . . 0.0 109.389 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 67.19 0.17 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.6 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -174.8 -48.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -1.15 . . . . 0.0 109.633 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.03 -2.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 109.609 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.6 ' H ' ' C ' ' A' ' 65' ' ' SER . 6.2 mm -82.4 -12.05 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.317 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.16 -48.45 12.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 109.683 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.545 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -63.72 -40.68 97.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.687 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 74' ' ' THR . 1.0 OUTLIER -55.25 -47.16 75.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.72 -42.99 99.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.862 . . . . 0.0 109.813 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.412 HD21 ' OE1' ' A' ' 96' ' ' GLU . 1.9 tp -61.93 -68.25 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.61 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.635 HG23 ' N ' ' A' ' 74' ' ' THR . 17.7 tt -47.99 -49.61 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.754 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.635 ' N ' HG23 ' A' ' 73' ' ' ILE . 6.5 p -50.49 -46.79 57.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.84 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.52 -5.42 54.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.775 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -5.98 26.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.52 -5.85 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.261 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.22 114.09 19.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.627 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.21 -6.72 63.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -91.24 165.48 13.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -1.21 . . . . 0.0 109.635 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.486 ' OG ' ' CD1' ' A' ' 52' ' ' ILE . 18.1 m -100.42 166.98 10.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.543 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -23.44 67.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.51 -44.82 93.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -77.83 -59.03 2.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.92 . . . . 0.0 109.387 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.42 -26.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.269 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.17 44.21 1.66 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.554 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -161.99 -37.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.096 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.554 ' O ' ' O ' ' A' ' 87' ' ' ALA . 3.0 pt -41.54 169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -136.84 154.49 50.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.54 ' O ' ' C ' ' A' ' 91' ' ' SER . 18.5 p-10 -73.77 -50.71 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.522 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.54 ' C ' ' O ' ' A' ' 90' ' ' ASN . 4.0 t -35.01 -46.16 0.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.536 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -62.94 -49.9 72.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.2 mt -55.68 -35.61 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.288 -0.883 . . . . 0.0 109.221 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.95 -24.3 60.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -81.6 -47.47 13.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.412 ' OE1' HD21 ' A' ' 72' ' ' LEU . 11.2 tt0 -62.28 -29.36 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 99' ' ' LEU . 1.3 mp -98.05 -28.81 13.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.534 ' O ' ' C ' ' A' ' 99' ' ' LEU . 1.6 tt0 64.8 -2.94 0.62 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.259 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.534 ' C ' ' O ' ' A' ' 98' ' ' GLU . 1.7 pp -34.58 150.23 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.391 -0.818 . . . . 0.0 109.477 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -40.33 108.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.858 2.372 . . . . 0.0 112.097 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.23 8.54 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.536 2.157 . . . . 0.0 112.445 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 102' ' ' VAL . 2.5 m -56.84 -14.95 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -153.11 -38.8 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.987 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' CYS . 5.9 t 64.85 5.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.362 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.471 ' ND1' ' N ' ' A' ' 105' ' ' HIS . 7.6 p-80 -45.6 -20.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 104' ' ' VAL . 1.8 m -75.41 -75.67 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 4.4 m -43.24 -38.78 2.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.8 mt -57.86 -52.65 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.5 mp -59.25 -23.08 62.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.298 -0.876 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 107' ' ' SER . . . -66.74 -65.6 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.534 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 6.9 tp10 -60.08 -40.06 88.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.533 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -27.69 69.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.177 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -73.44 -65.59 0.8 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.47 HG22 ' OE1' ' A' ' 111' ' ' GLU . 2.4 tp -43.08 -33.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -67.6 -73.25 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.352 -0.843 . . . . 0.0 109.414 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.544 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -35.48 -36.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 115' ' ' LYS . . . -60.96 -63.93 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.9 mt -47.49 -25.34 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.412 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -67.1 -59.22 3.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.083 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -61.58 -40.28 94.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.313 -0.867 . . . . 0.0 109.093 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -52.43 -57.77 8.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 109.188 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' LYS . 1.7 ttmm -54.44 -47.94 72.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.478 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -44.43 -21.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.51 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 122' ' ' LYS . 42.6 mmtt -98.4 -49.64 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.387 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -119.27 68.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.602 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -95.29 -93.28 1.72 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mt -114.51 -17.51 11.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -1.145 . . . . 0.0 109.175 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 58.15 175.54 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.847 . . . . 0.0 109.609 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.75 25.1 11.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 109.298 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -153.1 106.4 3.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' A' ' 132' ' ' HIS . 6.8 t-80 -129.42 118.0 21.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.68 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.59 ' O ' ' CE1' ' A' ' 131' ' ' HIS . 23.9 t60 -84.65 149.52 25.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.421 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 132' ' ' HIS . 2.2 m-70 -42.75 -48.9 5.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.411 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 2' ' ' ALA . 16.2 mtp . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -42.57 -72.89 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.78 124.99 22.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.193 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -120.33 -9.39 9.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 109.679 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.5 ' C ' ' CD ' ' A' ' 5' ' ' GLU . 3.0 tm-20 -74.85 101.44 4.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -153.24 53.0 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.539 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 8' ' ' ILE . 14.7 p -106.4 157.41 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.426 ' N ' HG22 ' A' ' 7' ' ' VAL . 11.5 mt -99.79 146.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.55 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.635 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -120.53 -87.36 0.64 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.39 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -60.49 -175.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 109.526 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.432 ' C ' ' CD ' ' A' ' 12' ' ' GLU . 60.6 m-85 -109.98 -116.87 0.29 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 109.368 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.432 ' CD ' ' C ' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -131.34 -176.15 3.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.922 . . . . 0.0 109.385 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.732 HD22 ' N ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -144.34 80.06 12.32 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.171 -0.955 . . . . 0.0 109.423 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 15' ' ' ARG . 50.1 Cg_exo -48.8 -179.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.762 2.308 . . . . 0.0 112.188 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.563 ' O ' ' O ' ' A' ' 14' ' ' PRO . 11.1 mtp180 36.1 95.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.684 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.7 127.65 56.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.344 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 t -120.34 126.96 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.403 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.83 145.7 10.93 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.655 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -70.48 -169.37 0.31 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -1.124 . . . . 0.0 109.464 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 mt 61.58 -33.94 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 109.68 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.655 ' N ' ' O ' ' A' ' 19' ' ' SER . 9.5 t0 -82.42 168.42 17.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.587 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -85.39 23.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.445 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -115.39 22.45 13.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.96 165.06 18.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.521 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 3.3 m -103.97 -0.41 28.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.659 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -102.71 11.98 36.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.336 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.37 110.06 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.86 145.68 17.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.3 m -139.96 137.28 34.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.6 150.73 22.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.9 mtt -144.11 105.0 4.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -1.112 . . . . 0.0 109.209 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.25 -176.15 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.84 157.11 17.17 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.63 138.4 20.61 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.178 -1.189 . . . . 0.0 109.466 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.99 3.72 4.28 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.609 2.206 . . . . 0.0 112.216 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.17 -79.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.5 m -109.37 20.74 17.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.868 . . . . 0.0 109.354 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.43 53.51 16.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.644 ' OD2' ' SG ' ' A' ' 63' ' ' CYS . 1.5 m-20 -86.56 116.93 25.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -1.105 . . . . 0.0 109.698 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.2 p -95.09 121.17 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 109.211 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.34 112.89 20.62 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.168 -0.957 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -99.76 140.15 34.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 109.084 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.428 HD21 HD12 ' A' ' 114' ' ' ILE . 3.3 tt -151.11 121.31 7.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.727 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -126.49 176.79 6.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.98 157.44 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -131.88 134.93 46.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.582 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 30.0 t -124.9 122.65 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.686 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.3 m-20 -157.78 -32.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.546 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 11.1 t70 -62.22 50.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.5 m-20 78.89 52.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -0.833 . . . . 0.0 109.535 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.86 9.45 66.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 53' ' ' ILE . 43.6 mm -105.03 155.52 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -1.18 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.42 ' N ' HG22 ' A' ' 52' ' ' ILE . 74.4 mt -75.27 114.46 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -85.37 -35.35 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -160.73 164.2 31.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.72 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.14 120.36 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.303 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -99.21 122.48 42.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.868 ' CD2' HG21 ' A' ' 74' ' ' THR . 11.6 p90 -139.7 160.49 39.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.565 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -140.02 120.02 13.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 109.305 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.6 HG21 ' OG ' ' A' ' 70' ' ' SER . 7.1 p -121.44 137.48 54.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.733 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -162.12 100.73 1.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.8 -50.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.975 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.644 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 11.5 m -122.01 179.1 4.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -1.232 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.752 ' O ' HG22 ' A' ' 67' ' ' ILE . . . -102.87 -21.08 10.56 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 67' ' ' ILE . 9.6 t -83.91 -66.68 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -1.164 . . . . 0.0 109.412 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -45.66 -21.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.323 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 64' ' ' GLY . 0.6 OUTLIER -64.79 -5.04 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.396 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -105.19 -55.33 2.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.5 m -52.47 -45.55 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.597 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.6 ' OG ' HG21 ' A' ' 60' ' ' THR . 0.5 OUTLIER -50.24 -51.41 44.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.64 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.98 -43.52 81.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.754 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.19 -68.5 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.9 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.633 HG23 ' N ' ' A' ' 74' ' ' THR . 9.1 tt -50.86 -53.05 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.868 HG21 ' CD2' ' A' ' 58' ' ' PHE . 33.4 p -48.01 -28.37 2.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 109.814 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -101.29 -4.62 26.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.702 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -89.84 -18.16 26.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.68 26.18 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -102.75 103.83 14.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.43 0.15 27.9 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -100.38 -176.51 3.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -1.14 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -108.23 173.85 6.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.594 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.8 mt -65.58 -18.04 65.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.594 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.42 -30.57 67.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -86.43 -53.17 5.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.57 -18.89 64.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.306 -0.871 . . . . 0.0 109.351 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.93 40.1 2.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -158.02 -35.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.348 -1.089 . . . . 0.0 109.24 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -44.65 169.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.842 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -133.01 -170.4 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.185 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -99.02 -30.33 12.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.59 -40.83 93.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 95' ' ' GLU . 4.0 mm-40 -58.5 -70.92 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.644 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 93' ' ' ILE . 40.9 mt -44.46 -34.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.99 73.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 92' ' ' GLN . 2.2 tt0 -80.65 -15.49 56.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.193 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -81.24 -51.98 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 109.582 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -78.79 -22.98 45.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 2.4 tt0 73.2 36.15 0.86 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.449 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -74.37 146.0 83.45 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.4 155.74 50.64 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.658 2.239 . . . . 0.0 112.261 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.6 Cg_endo -75.31 -2.24 12.31 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.852 2.368 . . . . 0.0 112.374 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.87 -2.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.657 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 101' ' ' PRO . 29.4 tttt -166.07 61.38 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.378 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 106' ' ' CYS . 20.4 t -60.63 -25.79 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.422 ' ND1' ' CD1' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -49.15 -17.9 0.27 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.159 -0.963 . . . . 0.0 109.287 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -74.01 -62.86 1.36 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.9 t -57.19 -36.55 70.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.319 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 109' ' ' LEU . 4.6 mt -61.43 -64.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.268 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.543 ' N ' HG22 ' A' ' 108' ' ' ILE . 2.7 mp -42.61 -41.12 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -54.92 -63.4 1.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 109.677 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.496 ' O ' ' C ' ' A' ' 112' ' ' ASP . 2.1 tm-20 -52.89 -67.84 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.588 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 111' ' ' GLU . 11.4 t70 -37.47 -37.14 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -60.88 -67.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.81 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 113' ' ' ALA . 2.9 tp -41.14 -39.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.9 tmtt? -58.82 -55.3 36.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.98 -56.66 9.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.689 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.96 5.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.587 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 119' ' ' ALA . 66.7 mt -75.55 -59.63 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 118' ' ' ILE . . . -37.02 -51.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 122' ' ' LYS . 27.2 t0 -68.69 -58.09 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.154 -0.966 . . . . 0.0 109.701 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.534 ' C ' ' O ' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -33.17 -30.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 109.7 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.676 ' HB2' ' HZ2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -96.93 -34.24 11.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.585 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -78.96 -17.78 54.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 123' ' ' ALA . 0.2 OUTLIER -41.99 -41.64 2.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.509 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -84.15 -32.45 24.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.563 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.43 3.35 55.41 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 128' ' ' GLU . 2.9 mm? -61.54 -42.05 98.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -1.104 . . . . 0.0 109.553 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 127' ' ' LEU . 5.7 mt-10 39.06 86.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 109.367 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -144.57 119.38 9.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.963 . . . . 0.0 109.604 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -154.15 -54.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.638 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 1.7 t60 -151.11 -129.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.365 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.638 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 95.4 m-70 -141.42 -56.41 0.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -46.93 -72.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.458 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.63 ' OXT' ' CG ' ' A' ' 134' ' ' HIS . 4.1 p80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.586 179.907 . . . . . . . . 1 1 . 1 stop_ save_